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Fluorination is an important strategy for perturbing the biophysical properties of 
compounds in medicinal chemistry. Specifically, fluorination modulates both the 
pharmacodynamic and pharmacokinetic properties of bioactive molecules in generally 
beneficial ways. However, fluorination similarly manipulates the reactivity of compounds 
in synthetic chemistry, leaving many traditional synthetic methods unable to perform as 
expected in organofluorine chemistry. Chapter 1 provides background on the effects of 
fluorine on medicinal and synthetic chemistry, and specifically discusses the effects of 
fluorine upon alkenes. 
Gem-difluoroalkenes are an appealing substructure for nucleophilic addition 
reactions, as they readily react with nucleophiles. However, upon nucleophilic addition 
defluorination reactions occur, providing fluoroalkene products. Reactions of 
difluoroalkenes which retain both fluorine atoms would provide access to underexplored 
difluorinated substructures. To this end, Chapter 2 describes the development of 
organocatalyzed addition of thiols to gem-difluoroalkenes to provide b,b-difluorophenethyl 
thioethers. 
Alcohol nucleophiles possess similar reactivity to thiols, including with gem-
difluoroalkenes. Moreover, in medicinal chemistry ethers are a more common 
 
iv 
substructure than thioethers. Thus, Chapter 3 describes the addition of phenolic 
nucleophiles across gem-difluoroalkenes in a hydrophenolation reaction to provide b,b-
difluorophenethyl arylethers. 
Gem-difluoroalkenes also possess unusual reactivity with transition metal catalysts. 
Typically, transition metals perform oxidative addition to C–halogen bonds to initiate cross 
coupling chemistry. However, the high C–F bond strength generally precludes oxidative 
addition, enabling alternate mechanistic pathways. Chapter 4 discusses the development 
of a Co-catalyzed deoxygenation reaction of gem-difluoroalkenes with phenol 
nucleophiles and O2 to provide b-phenoxy-b,b-difluorobenzyl alcohols. This reaction 
proceeds by an unusual radical reaction pathway in which superoxide oxidizes phenol to 
phenoxyl radical, which adds to gem-difluoroalkenes to provide a benzyl radical that 
quenches with peroxide anion.  
Finally, Chapter 5 discusses the ongoing work on metal-catalyzed dioxygenation 
reactions of gem-difluoroalkenes. This work covers the further development of b-
phenoxy-b,b-difluorobenzyl alcohols under Pt catalysis, specifically to expand the 
reaction scope to heteroaryl alcohols, aliphatic alcohols, and aliphatic gem-
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Chapter 1 – Fluorine-Induced Perturbations of Reactivity 
1.1. The Physical Chemistry of Fluorine 
Fluorination affects a molecule’s physicochemical properties, which in turn can perturb 
a bioactive molecule’s pharmacodynamic (PD), pharmacokinetic (PK), distribution, and/or 
metabolic profiles.1 For example, the addition of fluorinated functional groups to a 
therapeutic candidate can greatly enhance the lipophilicity (logP; octanol/water 
partitioning coefficient) of a molecule,1e, 1f which in turn can enhance bioavailability, tissue 
distribution, and cell permeability.1i This non-trivial relationship between the properties 
imparted by a fluorinated substituent and the subsequent biophysical perturbations also 
relates to synthetic transformations in which fluorinated substructures demonstrate 
distinct reactivity and/or selectivity relative to analogous non-fluorinated substrates. The 
chemical and biological perturbations attributed to fluorine drive the development of new 
methods in organofluorine chemistry. 
These fluorine-induced perturbations arise due to the unique biophysical properties of 
fluorine. Electronically, fluorine is the most electronegative element, significantly more so 
than the other halogens or similarly sized atoms (Figure 1-1a),1a allowing fluorine to easily 
adopt or stabilize a negative charge (Figure 1-1a). However, despite fluorine’s 
electronegativity and ionization potential, it is not highly polarizable. Fluorine is less 
polarizable than hydrogen, and significantly less polarizable than the other halogens or 
oxygen (Figure 1-1a).1a 
 
2 
Figure 1-1: Electronic Characteristics of Fluorine  
 
The electronic characteristics of fluorine affect the stability and reactivity of various 
organic intermediates. Fluorination decreases carbocation stability by s-induction, 
reducing the electron density of an already electron deficient center (Figure 1-1b). Thus, 
fluorine reduces the susceptibility of a compound to electrophilic attack. Conversely, 
fluorination stabilizes carbanions through the same s-inductive effect, while 
trifluoromethyl substituents stabilize carbanions through both a s-inductive effect and 













































a) Electronic Characteristics of Fluorine and Related Atoms


























The electronic properties of fluorine influence the strength of X–F bonds. Fluorine 
forms exceptionally strong bonds with electropositive atoms, as the bond dissociation 
energy of alkyl C–F bond is 110 kcal/mol, stronger than a C–H bond (104 kcal/mol) and 
a C–O bond (90 kcal/mol).2 Similarly, fluorine bonds tightly with silicon (129 kcal/mol) and 
boron (125–183 kcal/mol).2 Conversely, fluorine forms exceedingly weak bonds with 
electronegative heteroatoms, such as oxygen (53 kcal/mol).2 The weak bonds between 
F and electronegative atoms enable electrophilic fluorination with N–F fluorinating 
reagents, such as Selectfluor (64.0 kcal/mol),3 NFSI (63.4 kcal/mol),3 and the N–F 
pyridine fluorinating reagents (49.4–77.8 kcal/mol, Figure 1-2).3 Additionally, the low 
polarizability of fluorine (Figure 1-1) alters the strength of intermolecular interactions with 
fluorine, making dipole-dipole interactions, van der Waals interactions, and H-bonds 
generally weaker than with other heteroatoms.4 
Figure 1-2: N–F Fluorinating Reagents 
 
1.2. The Impact of Fluorine on Medicinal Chemistry  
Fluorination of bioactive compounds affects a molecule’s pharmacodynamic (PD), 
pharmacokinetic (PK), distribution, and metabolic profiles both in vitro and in vivo.1a-h 
Thus, many fluorinated bioisosteres exist to replace a wide variety of functional groups, 

















properties.5 These effects of fluorine on biological properties are explained by the 
physicochemical effects of fluorine on organic compounds. 
Effects on PD:  
Fluorine is often invoked as an isosteric replacement for hydrogen, allowing an H to F 
substitution without affecting molecular size. Thus, in theory H to F substitutions can be 
employed without affecting potency. However, comparing the van der Waals radii, fluorine 
(1.47 Å) is actually closer in size to oxygen (1.52 Å) or nitrogen (1.55 Å) than to hydrogen 
(1.20 Å).1a The Taft steric parameters Eos shows the same results, as do the axial 
rotational barriers of a 2’-Me 2-X system, in which fluorine falls between hydrogen and a 
methyl group in size (Figure 1-3). Similarly, C–F bonds are longer than C–H bonds, closer 
to a C–O or a C–C bond.1a Further, the trifluoromethyl group has been misidentified as 
an isosteric replacement for the methyl group. Comparing axial rotational barriers, the 
trifluoromethyl group is significantly larger than a methyl group, instead serving as an 
isostere for an isopropyl group (Figure 1-3). Further, comparing Taft steric parameters, 




Figure 1-3: Steric Parameters of Fluorine 
 
Beyond molecular size, fluorine affects the binding of compounds with their biological 
targets. One direct effect of fluorine on binding interactions are multipolar interactions. 
Multipolar interactions occur when a properly oriented C–F bond creates a strong dipole-
dipole interaction with the carbonyl C of a backbone amide or an arginine guanidine.6 
While these interactions are not exceptionally strong, accounting for less binding energy 
than a hydrogen bond, they still can exert a fold change on potency (Figure 1-4).6b, 7 
Multipolar interactions are commonly observed in crystal structures, although not all close 
contacts of fluorine with a carbonyl imply a multipolar interaction. Fluorine must come 
within 3.6 Å, and no closer than 2.8 Å, of the carbonyl carbon, or in rare cases the 


































































C angles expand as the contact distance increases, although at further distances the 
strength of the interaction weakens.  
Figure 1-4: Identifying Multipolar Interactions7c 
 
According to a matched molecular pair analysis conducted by Pfizer,7c multipolar 
interactions of fluorine with carbonyl carbons occur when separated by 2.8–3.6 Å. Closer 
than 2.8 Å steric repulsion dominates, while beyond 3.3 Å (the van der Waals contact 
distance), the strength of the interaction falls rapidly. Further, the C–F bond must be 
oriented within 70–110˚ of the carbonyl carbon (Figure 1-4).7c This nearly perpendicular 
interaction between the C–F bond and the carbonyl carbon arises as the fluorine lone pair 
electrons must point at the p-orbital of the carbonyl. At smaller separations, this angle 
narrows.7c Computational predictions of when a fluorine multipolar interaction might occur 





O=C----F–C Distance: 2.8–3.6 Å
O=C----F–C Angle: 70–110˚
ΔG = 0.3–0.6 kcal/mol



















Multipolar interactions help explain the increased potency of a 4-fluorinated aryl ring in a 
series of thrombin inhibitors (Figure 1-5a).6b Multipolar interactions also help explain the 
increased potency of Lipitor relative to non-fluorinated analogs,6a and more recently were 
observed in an HIV-1 gp120 inhibitor (PDB: 4DKO, Figure 1-5b)8 and a Procaspase-6 
inhibitor (PDB: 4NBL; Figure 1-5c).9 
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R = H Kd = 3.7 µM














R = H Kd = 2.9 µM













b) Multipolar Interactions in an HIV-1 gp120 inhibitor8
c) Multipolar Interactions in a 
    Procaspase-6 Inhibitor9





Fluorine also alters PD properties through conformational control of organic 
molecules. Specifically, fluorine can lock bioactive compounds into the active 
conformation without paying an entropic penalty for reorganization. This ability is 
particularly useful in saturated systems or systems with a high fraction of sp3 carbons, 
which are highly flexible in the absence of fluorine. Bioactive compounds gain many 
benefits through a high fraction of sp3 carbons, such as improved solubility and higher 
binding affinity through chirality.10 Typically, such improvements come with an entropic 
penalty to binding free energy, as sp3 carbons possess rotational freedom and require 
pre-organization before binding. Strategic incorporation of fluorine at a key site can 
preclude structural rearrangement, avoiding preorganization and the attendant entropic 
penalty. 
Fluorine exerts conformational control via several means. First, the high 
electronegativity of fluorine destabilizes improperly aligned dipoles through electrostatic 
repulsion (Figure 1-6),11 which occurs when the dipoles of fluorine and another 
electronegative substituent align in the same direction. In contrast, alignment of the 
dipoles in an anti-conformation stabilizes the structure by minimizing electrostatic 
repulsion. In the case of an a-fluoro amide, anti-alignment of dipoles increases stability 
by 8 kcal/mol over the eclipsed, electrostatically repelling conformation (Figure 1-6). This 




Figure 1-6: Dipole-Dipole Interactions of Fluorine Enforce Anti-Alignment of Dipoles11 
 
In addition to dipole alignment, fluorine can also control conformation by other means. 
In non-fluorinated alkanes, the large substituents prefer an anti-alignment to one another. 
This alignment keeps the larger substituents as far apart as possible to minimize 
unfavorable steric overlaps. Alternately, the anti-alignment of heteroatom-based 
substituents might stabilize through hyperconjugation and anomeric effects, in which the 
occupied orbital of one substituent donates electron density into the s* orbital of the other 
substituent. The anomeric effect requires an anti-orientation for proper orbital overlap.11a 
In contrast, fluorine prefers gauche orientations with non-hydrogen substituents, 
especially heteroatoms. This gauche preference arises as the low-lying s* C–F orbital is 
stabilized by hyperconjugation with C–H s-bonds. This gauche preference is typically <2 
kcal/mol, although with cationic or electropositive groups the gauche effect is reinforced 



















































substituent. As such, when positioned vicinal to an ammonium group the gauche 
preference increases to –5.8 kcal/mol (Figure 1-7a). Further, the gauche effect is 
additive, thus the more substituents fluorine can orient gauche to the stronger the effect.11 
The gauche preference of fluorine helps stabilize the active conformation of nucleoside 
HIV viral replication inhibitors (Figure 1-7b).12 In these compounds, the sugar 
conformation affects binding to HIV-1 reverse transcriptase. Thus, stabilizing the 
appropriate sugar conformer improves potency. Several effects from fluorination increase 
structural rigidity and conformational preference, observed in crystal structures12a, 12b or 
by analysis of 1- and 2-D NMR spectra. 11a, 12c, 13 In a monofluorinated system, the gauche 
preference of fluorine drives conformational rigidity. In the inactive conformer, an a-2’ 
fluorine orients gauche to the ring oxygen and anti to the nucleobase, which aligns the 
nucleobase nitrogen and the tetrahydrofuran oxygen to stabilize the conformation through 
the anomeric effect (Figure 1-7b.i).13 In the active conformer, the a-2’ fluorine orients 
gauche to the nucleobase, but anti to the ring oxygen, which does not properly align the 
nucleobase nitrogen and tetrahydrofuran oxygen to stabilize through the anomeric 
effect.13 However, a b-2’ fluorine has a stable conformer that forms gauche interactions 
with both the nucleobase and the ring oxygen in the active conformer, generating a single 
rigid structure (Figure 1-7b.ii). In the active conformer, a b-2’, a-3’ difluorinated 
nucleoside possesses two stabilizing gauche interactions through the b-2’ fluorine, a 
stabilizing anti-alignment of the fluorine dipoles of the b-2’ and a-3’ fluorine, and an 
additional stabilizing gauche orientation between the a-3’ fluorine and the ring oxygen, 
further rigidifying the active conformer (Figure 1-7b.iii). 
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b) Fluorination Controls Nucleoside Conformation12, 13

















Fluorinated aryl ethers exhibit another form of conformational control. Non-fluorinated 
aryl methyl ethers align the methyl group in the plane of the aryl ring, and the oxygen lone 
pair of electrons resonate with the p-system.14 Fluorination decreases the participation of 
the oxygen lone pair electrons in resonance, by withdrawing electron density from the 
oxygen atom and into hyperconjugation with the C–F s*.15 Therefore, for partially 
fluorinated aryl methyl ethers, a variety of torsion angles are observed, indicating mixed 
steric and resonance effects.15 Once the methyl group becomes fully fluorinated, the lone 
pair electrons of the ether oxygen no longer resonate with the p-system, instead 
interacting with the C–F s*, thus steric hindrance of the 2 and 6 groups dominates. Thus, 
trifluoromethyl ethers sit orthogonal to the aromatic ring, increasing their effective size 
(Figure 1-8).15 
Figure 1-8: Physical and Biological Effects of Fluorinated Aryl Ethers15 
 
One specific fluorinated substructure, the difluoromethyl group, acts as an H-bond 
donor. Specifically, the s-withdrawing effects of fluorine weakens the C–H bond, making 
the C–H bond act like a heteroatom–H bond. Thus, difluoromethyl groups are lipophilic 



































the difluoromethyl group formed H-bonds with nearly the same strength as H-bond to a 
hydroxyl group (–3.1 vs –3.5 kcal/mol),16 and a recently developed HCV NS3 protease 




Figure 1-9: CF2H Donates Lipophilic H-Bonds 
 
The conformational effects of fluorine enable the investigation of the active conformers 
of bioactive compounds.18 For example, peptide amide bonds interchange between cis 
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b) CF2H as an H-Bond Donor in an

























a) CF2H H-Bond Strength16
 
16 
interrogate the active conformation is to institute conformationally locked amide mimics, 
such as fluoroalkenes, in both the cis and trans isomer, and then investigate the biological 
activity.19 In a PEPT1 peptide transporter study, such a strategy revealed that only the cis 
isomer was recognized by PEPT1, implying that only one amide isomer, the trans amide 
isomer, is recognized by PEPT1.19a In another example, intramolecular H-bonding of 
fluorine has been exploited to enforce g-turns structures in investigational therapeutics.20 
In a non-peptide Calcitonin Gene-Related Peptide (CGRP) antagonist, dipole alignment 
and H-bonding of fluorinated aryl rings with an amide enforced two different rotamers, 
demonstrating the likely active conformer (Figure 1-10).18 
 
17 
Figure 1-10: Determination of Active Conformer Through Fluorination  
 
Fluorination also alters pKa and hydrogen bonding, as fluorine affects the polarization 
and ionization of functional groups, disrupting solvation networks and partitioning 
characteristics.1a In the case of carboxylic acids and alcohols, fluorination increases the 
acidity and H-bond donating ability and decreases the H-bond accepting ability (Figure 
1-11). Similarly, fluorination increases the acidity of amines, decreasing the H-bond 
accepting ability without a major effect upon H-bond donating ability. For carbonyls, 
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18 
drives these perturbations, the more fluorine added, the greater the acidity increase, 
making the pKa changes due to fluorination predictable, as seen for amines (Figure 
1-12b).21 
Figure 1-11: Effect of Fluorination on pKa1a 
 
The perturbations in acidity due to fluorine can control the tissue selectivity of bioactive 
compounds by selectively modulating the binding interactions with molecular targets 
through tissue pH. For example, the opioid fentanyl is constitutively active throughout the 
body. µ-Opioid receptor activation requires an ion-pairing interaction with the basic 
nitrogen in Fentanyl. Since the pKa of Fentanyl is approximately 8, once within the body 
fentanyl is active. However, fluorination near the basic nitrogen reduces the pKa to <7, 
preventing Fentanyl from activating µ-opioid receptors in non-acidic tissues. Damaged 
tissue is acidic, thus the fluorinated Fentanyl derivative activates the µ-opioid receptor 
only at the site of injury. Thus, in mouse models the fluorinated Fentanyl derivative shows 
similar analgesic activity to Fentanyl, without the same neurological effects, theoretically 


















































































Figure 1-12: pKa Modulation of Amines via Fluorination 
 
Effects on PK:  
Fluorine modulates the PK properties of bioactive compounds, especially in the late 
stages of lead development, when modifying PK properties with minor effects on binding 
become necessary. As detailed above, fluorine is a small element that, despite being 
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a) Fluorination Affect on pKa Decreases as Distance Increases21b,c
b) Predictable Affect of Fluorination Affect on amine pKa21a
c) Fluorination Controls Fentanyl pKa and Tissue Selective Activity22
 
20 
in a compound, intermolecular interactions with fluorine are weak. Specifically, fluorine 
does not form strong H-bonding interactions with water molecules and affects the 
intermolecular interactions of vicinal functional groups with water by s-induction. As such, 
fluorination generally results in increases in logP and permeability, with a few unique 
fluorinated substituents reducing logP. 
The effect of fluorine on logP can be predicted and controlled by fluorination 
patterning. First, the vicinity of a heteroatom to the fluorine substitution greatly affects the 
resulting modulation of logP (Figure 1-13).1a In the absence of a heteroatom, fluorination 
reduces logP, as in the case of ethane. When close to a heteroatom, fluorination 
increases logP, such as for ethanol or propanol. As the fluorination moves further from 
the heteroatom, the logP increases less, as in hexanol. Additionally, the amount of 
fluorine in a molecule affects to what extent fluorine changes logP. Generally, the more 
fluorine in a molecule, the greater the effect. 
Figure 1-13: Fluorine-Driven logP Modulation1a 
 
Polarity vector analysis enables prediction of the effects of fluorination on logP. For 
instance, in the case of a cyclohexane ring, trans fluorination makes the polarity vectors 
cancel (Figure 1-14a).23 Thus, fluorine acts as a lipophilic hydrogen and increases logP 




























polarity vectors add together, increasing the overall polarity and reducing logP.23 For an 
all-cis tetrafluorinated cyclohexane, the logP decreases by 2.41 log units relative to the 
non-fluorinated cyclohexane (Figure 1-14b).23a Recently, the Müller group recently 
systematically explored the effect of many fluorination patterns on polarity, logP, solubility, 
and metabolism.15b, 24 In their studies, by patterning the fluorine substitutions to enable 
additive polarity vectors, vicinal fluorination reliably reduced logP and increased solubility 
beyond either the non-fluorinated or germinal difluorinated analog. In cases where the 
fluorine polarity vectors cancelled, specifically germinal difluorination, logP increased and 
solubility decreased relative to the non-fluorinated compound (Figure 1-14c).23 
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b) Fluorination Patterning of Cyclohexane Rings Lowers LogP23a
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In aromatic systems, the effect of fluorination is more simple, as no additive or 
cancelling polarity vectors form. Instead, fluorination adjusts the electron density of the p-
system, resulting in a small increase in logP for each fluorine substituent.1a Such an effect 
is maintained for perfluoroalkyl groups. Partially fluorinated aryl substituents, such as 
difluoromethylene groups, reduce logP through the previously discussed polarity vector 
addition (Figure 1-15).14b, 23 The effect is especially pronounced for fluorinated alkyl 
chains with vicinal rather than germinal fluorination.15b, 24 
Figure 1-15: Effect of Aromatic Fluorination on Lipophilicity 
 
Mostly, fluorine is used to block metabolism, or shift the site of metabolism. Multiple 
effects, including the strength of C–F bonds relative to C–H bonds, and the electronic 
character of fluorine, drive these shifts in metabolism. First, at aliphatic metabolic sites, 
fluorination precludes metabolism altogether, due to the interactions of fluorine and the 
main metabolic enzymes, CYP450s. At aliphatic sites, CYP450s use electron rich iron-








































fluorinated systems, the hydrogen of the C–H bond is not electron-rich, enabling the iron-
oxo species to approach and interact with the hydrogen. Thus, the transition state of 
homolytic cleavage is relatively low in energy. Since the resulting O–H bond is stable, the 
reaction intermediate is also relatively low energy, only about 10 kcal/mole less stable 
than the initial C–H bond.  
When F replaces H, several changes prevent the oxidative cleavage of the C–F bond. 
First, the C–F bond is generally 5–8 kcal/mol stronger than the analogous C–H bond, 
making homolytic bond cleavage more difficult.2 Second, the C–F bond possesses partial 
negative charge on the fluorine atom, which repels the electron rich oxygen of the iron-
oxo species and raises the transition state energy of CYP450 mediated oxidative cleavage. 
Finally, the resulting O–F bond is exceptionally weak, about 60 kcal/mol weaker than the 
C–F bond, making the intermediate far higher energy than the starting material (Figure 
1-16b). Combined, these effects raise the activation barrier of CYP-mediated metabolism 
beyond an achievable level. Blocking CYP-mediated metabolism through fluorination has 
been exploited in many medicinal chemistry campaigns, such as the development of 
Bosentan25 and Begacestat26 (Figure 1-16c, Figure 1-17).  
 
25 
Figure 1-16: Fluorination Prevents CYP450 Mediated Oxidation 
 




































































































Another example of fluorination inhibiting the oxidative activation of C–H bonds by 
CYP450 enzymes is the development of Begacestat, as the half-life of the preclinical lead 
in microsomes precluded further use, necessitating further compound development 
(Figure 1-17).26 The compounds underwent both phase 1 aliphatic oxidation and phase 
2 glucuronidation. To prevent phase 1 oxidation, the terminal methyl groups were 
replaced with trifluoromethyl groups, which shifted but did not sufficiently slow phase 1 
metabolism. By decreasing the chain length between the sulfonamide and the 
trifluoromethyl groups, phase 1 metabolism was effectively stopped. Conversely, 
glucuronidation could not be prevented, as the free hydroxyl was necessary for activity. 
However, the vicinal trifluoromethyl groups withdraw electron density from the free 
alcohol, reducing the nucleophilicity of the alcohol and indirectly controlling phase 2 
metabolism. Generally, phase 2 metabolism requires nucleophilic heteroatoms, 
especially alcohols, in order to undergo processes such as glucuronidation. The reduced 
electron density of the heteroatom is expected to slow or stop this metabolism.  
 
27 
Figure 1-17: Fluorination Pattern of Begacestat Perturbs Metabolism26 
 
In aromatic systems, fluorination alters the “NIH” hydride shift that occurs upon 
CYP450-mediated aromatic oxidation reactions.27 CYP450 mediated aromatic metabolism 
generally requires electron-rich aromatic rings, as aromatic metabolism initiates via an 
epoxidation where the p-system of the aromatic ring acts as a nucleophile to react with 










































































































1,2-hydride shift, to generate an aromatic alcohol (Figure 1-18a). Fluorination affects 
aromatic metabolism through two charge effects. 
 First, fluorine perturbs the distribution of electron density of an aromatic ring, which 
might decrease metabolism by slowing the initial reaction of the nucleophilic arene p-
system on the CYP450 Fe–O species. Second, the dearomatized C–F bond is strong, and 
does not readily undergo 1,2-fluoride shifts, such as the “NIH” shift. Thus, when oxidation 
does occur, the site of oxidation changes, whether by the initial epoxide opening through 
a 1,2-hydride shift resulting in a different aromatic alcohol isomer, or a different initial 
oxidation site (Figure 1-18b).27 Thus, aromatic fluorination is frequently exploited in 
medicinal chemistry to either reduce, shift, or shut down aromatic oxidative metabolism, 
as in the development of Taranabant (Figure 1-18c).28 Aromatic oxidative metabolism of 
the electron-rich aryl ether of an early analog of Taranabant generated a glutathione 
adduct, which causes allergic reactions. To reduce this aromatic metabolism, the aryl 
ether was difluorinated; however, metabolism and formation of a glutathione adduct still 
occurred. To further reduce the electron density, the aryl ether was changed to an 
electron-deficient pyridine, which further reduced metabolism. Further reduction of the 
electron density of the ring by the addition of a trifluoromethyl substituent ultimately 
prevented this metabolism.  
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Figure 1-18: Fluorination of Aryl Rings Perturbs Metabolism 
 
1.3. The Impact of Fluorine on the Reactivity of Organic Compounds 
The aforementioned perturbations of biological properties make synthetic methods to 






















































































chemists.29 However, fluorination of a substrate can present distinct reactivity patterns in 
organic chemistry, making many synthetic transformations challenging to extrapolate to 
fluorinated systems. Often, standard organic reactions do not work in the presence of 
fluorinated reagents or with fluorinated substrates, which requires changes to the system 
or alternate synthetic strategies to provide the desired products. 
For example, many standard transition metal-catalyzed reactions commonly 
employed to generate C–C and C–heteroatom bonds might fail when applied to the 
generation of C–C(F)n or C–F bonds. To illustrate this type of challenge, consider the 
distinct conditions and mechanisms of Cu-catalyzed and -mediated 1,4-addition reactions 
of non-fluorinated and fluorinated groups to a,b-unsaturated carbonyl systems. Cu-
catalyzed and -mediated 1,4-addition reactions of non-fluorinated substrates remain one 
of the most robust strategies in synthetic organic chemistry,30 compatible with a broad 
spectrum of organic nucleophiles, including simple methyl groups.31 While the first 
examples of the Cu-mediated 1,4-addition of a methyl group date back at least to 1941,32 
the first examples of 1,4-addition of –CF3 were only reported in 198833 and 1989,34 with 
the first general strategy reported in 2003.35  
In the non-fluorinated case, the reaction proceeds with catalytic quantities of Cu(I) at 
0 ˚C or lower,36 with a mechanism that involves an oxidative addition of a higher-order 
cuprate to the b-position of the Michael acceptor to generate a Cu(III) intermediate, 
followed by reductive elimination of the new C(b)–Me bond (Figure 1-19).37 In contrast, 
similar reaction conditions do not promote conjugate addition reactions of –CF3. Instead, 
reactions to generate a new C(b)–CF3 bond require super-stoichiometric quantities of Cu 
 
31 
at 60 °C, and proceed by a distinct mechanism involving addition of “free •CF3” to the b-
position unsaturated system with no indication of an analogous Cu(III) intermediate 
(Figure 1-19).38 
Figure 1-19: Different Mechanisms for Cu-Catalyzed 1,4-Additions of Methyl and 
Trifluoromethyl Nucleophiles36-38 
 
As a second example, Pd-catalyzed cross-coupling reactions to generate C(aryl)–CF3 
bonds have proven challenging. The Pd–CF3 bond resists reductive elimination, because 
the high electronegativity of the trifluoromethyl group39 imparts strong ionic bond 
character to the Pd–C bond (Figure 1-20a).40 This reductive elimination step requires ~22 
kcal/mol to reach the transition state, with most of the energy required to break the Pd–
CF3 bond (Figure 1-20b).41 Since reductive elimination of the Ln(Ar)Pd–CF3 bond is slow, 
other unexpected reaction pathways can occur.42 For instance, under the elevated 
temperatures necessary for the reductive elimination of the C(aryl)–CF3 bond, the 
Ruppert-Prakash reagent (TMS–CF3), the most common –CF3 source, decomposes to 
:CF2 and TMS–F, thus complicating transmetallation to Pd.41 As a result, most common 








































CF3 bond, which instead requires specialized ligands or higher oxidation states of Pd to 
promote reductive elimination.41, 42b, 43 
Figure 1-20: Challenging Reductive Elimination of Pd–CF3 
 
The challenging reductive elimination from Pd can be avoided by employing other 
metal catalysts. For example, reductive elimination of CF3 from a Cu(III) complex is facile, 
although oxidative addition of an aryl halide to Cu(I) to form a Cu(III) complex is slow, 
requiring weak C–X bonds or high temperatures. To address this issue, radical CF3 
addition to Cu(II) enables access to the Ar–Cu(III)–CF3 complex that can undergo a more 
facile reductive elimination (Scheme 1-1a).44 This strategy exploits a variety of •CF3 


















































b) High energy at TS for reductive elimination derives from lengthening and 













a) High electronegativity of CF3 group resists red. elim. of Ar–R bond39





transfer of •CF3 to a Cu(I) catalyst from Togni or Umemoto’s reagent (Scheme 1-1b).45 
Reductive elimination of Ar–CF3 from Cu(III) is so facile that it is possible even at room 
temperature (Scheme 1-1c).46 
Scheme 1-1: Facile Reductive Elimination from Cu(III) 
 
These two examples in which fluorinated reagents pose unique challenges relative to 
reactions of non-fluorinated reagents demonstrate why so much effort from the synthetic 
community has been devoted to finding new strategies for incorporating fluorinated 
substituents into organic molecules.29, 47 
While the presence of fluorine in a substrate poses challenges to standard synthetic 
transformations, fluorine can also open other avenues of reactivity by altering the energy 
barriers for transformations. For example, consider classical [3,3]-sigmatropic 
rearrangements. The thermal Claisen reaction of allyl cinnamyl ether requires forcing 
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conditions (190 °C, 6 h) to provide 75% yield of product.48 Presumably, this high 
temperature arises from the conjugated phenyl substitution at the terminal C6 position 
that removes p-electron density from allyl vinyl ether, disfavoring the bond-making event 
at the diyl transition state.49 However, when fluorinated at the a-position of the enol ether, 
the Claisen reaction occurs under more mild conditions (80 °C, 1 h).50 In this case, the 
gem-difluorinated carbon prefers an sp3-hybridized state rather than the sp2-hybrized 
state, thus providing a thermodynamic driving force that disfavors the reverse reaction 
(Figure 1-21a).51 This same effect also controls other sigmatropic rearrangements, such 
as the Cope rearrangement. For example, 1,1-difluoro-1,5-hexadiene prefers to 
rearrange to the 3,3-difluoro-1,5-hexadiene product (5 kcal/mol more stable), and the 
fluorinated substituents lower the activation barrier (2.5 kcal/mol) relative to the 
corresponding rearrangement of 1,5-hexadiene (Figure 1-21b).51a, 51b 
Figure 1-21: The Presence of Fluorinate Facilitates [3,3]–Sigmatropic Rearrangements 
 
Fluorination also affects the reactivity of carbonyl and other sp2 hybridized 
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explained through Bent’s rule, which states that atoms with more electron withdrawing 
substituents prefer hybrid orbitals with more p-character. This relieves electronic strain, 
as the p orbitals sit further from the nucleus than s orbitals and thus donate more electron 
density to the electron withdrawing substituents. Thus, fluorinated carbon atoms generally 
prefer sp3-hybridization that can better release electron density to stabilize the partial 
cationic charge, thus driving some reactivity trends. For instance, a-fluorinated carbonyls 
hydrate easily to hybridize from sp2 to sp3, allowing the carbonyl carbon to relieve the 
strain of the electron withdrawing fluorinated a-carbon and the carbonyl oxygen (Figure 
1-22a). This property has been exploited for developing therapeutically relevant agents, 
such as Lubiprostone, in which the a,a-difluoroketone prefers to rehybridize from the 
open ketone form (sp2-hybridized) to the closed lactol form (sp3-hybridized, Figure 
1-22a).52 Additionally, medicinal chemists harness these physicochemical perturbations 
to facilitate inhibition of serine and aspartyl proteases (Figure 1-22b).1a, 1b, 53 Proteases 
cleave peptide bonds by adding oxygen-based nucleophiles to the amide carbonyl to 
generate a tetrahedral intermediate. This process involves an sp2 to sp3 rehybridization 
of the carbonyl carbon. When a peptide amide is replaced with an a,a-difluoroketone, two 
effects combine to inhibit proteases. First, the labile C–N bond is replaced with a stable 
C–C bond, preventing cleavage of the peptide bond isostere. Second, a,a-
difluoroketones prefer sp3-hybridization at the carbonyl carbon, thus stabilizing the 
tetrahedral intermediate and acting as a mechanism-based inhibitor. 
 
36 
Figure 1-22: a,a-Difluoroketones Prefer sp3-Hybridization  
 
Separately, a,a-difluoroketones possess low enolate reactivity driven by the 
inappropriate orbital alignment of fluorinated ketones. However, despite the electron-
withdrawing effect of the difluoromethylene group, a,a-difluoroketones do not possess 
increased acidity relative to non-fluorinated ketones (Figure 1-23b). In order to 
deprotonate, the proton must align with the p orbital of the carbonyl.54 Typically, electron 











b) Fluorinated ketone-based protease inhibitors 
    exploit stabilized tetrahedral intermediate1a,b, 52




















































withdrawing effects that weaken the C–H bond, while deprotonation requires overlap 
between the a-H and the p-orbitals. However, in this orientation, the F and O atoms would 
eclipse and cause unfavorable electrostatic repulsion. Thus, the F atoms likely reside in 
a conformation that minimizes C=O---F–C repulsion, and places the a-H atom orthogonal 
to the p system, which disfavors deprotonation (Figure 1-23a). As such, ketones bearing 
an a,a-difluoromethyl group and a simple alkyl group will preferentially generate the non-
fluorinated enolate under both kinetic and thermodynamic conditions (Figure 1-23b).55 
Thus, alternate strategies, such as Mg0-mediated F– elimination from a trifluoromethyl 
ketone and subsequent trapping with TMS (Figure 1-23c),56 are required to access a,a-
difluoroketone enolate derivatives. 
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Figure 1-23: a,a-Difluoroketones Perturb Traditional Enolate Reactivity 
 
Enolates typically exhibit strong nucleophilicity at the a-carbon, providing a functional 
handle for C–C bond formation via an SN2 reaction between a ketone enolate and an sp3-
hybridized electrophile (Figure 1-23d),57 and are frequently exploited in complex 
molecule synthesis.  Fluorinated enolates perturb this reactivity, as the strong inductive 
effect of two fluorine atoms lowers the electron density58 at the traditionally nucleophilic 
a-position,59 thus shifting the reactive site to the O atom. As a result, alkylation occurs on 
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fluorinated enolates changes from a nucleophilic center to an electrophilic center. For 
example, C–F functionalization reactions of a,a-difluorinated enolates with strong 
nucleophiles generate various a-substituted-a-fluoroenols (Figure 1-23g).60  
Nucleophilic C–C bond forming reactions of fluorinated enolates require metal 
catalysts and reactions strategies that activate the a,a-difluorinated carbon (Scheme 
1-2). Specifically, this strategy enables regioselective formation of a Pd-enolate 
intermediate by the formation of an activated ester. Oxidative addition of Pd occurs at the 
activated ester, thus only the C-bound a,a-difluoroketone enolate forms, not the O-bound 
Pd species. Once Pd binds at the difluorinated position, reductive elimination enables C–
C bond formation with the difluorinated carbon (Scheme 1-2).61 
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Scheme 1-2: Metal Catalyzed Reactions Enable Nucleophilic Enolate Reactivity for a,a-
Difluoroketones61 
 
1.4. Fluorine-Induced Perturbations of Alkene Reactivity 
Similar to the cases of a,a-difluorinated and non-fluorinated enolates, gem-
difluoroalkenes demonstrate complementary reactivity to non-fluorinated alkenes. Both 
fluorinated and non-fluorinated alkenes can provide versatile building blocks for synthetic 
organic chemistry. Non-fluorinated alkene groups commonly react with electrophiles 
through the p-HOMO orbitals,30, 62 while also reacting with nucleophiles through the p*-
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through incorporation of carbonyl, nitrile, and nitro groups that lower the LUMO through 
resonance effects.62 This activation restricts nucleophilic attack to the electrophilic b-
carbon (Figure 1-24a),63 while functional groups that facilitate attack at the a-carbon are 
less common. 
In contrast, fluorination of alkenes allows an alternate mode of reactivity,64 thus 
providing a distinct subset of products relative to classical 1,4-addition reactions (Figure 
1-24a).65 For fluorinated alkenes, the inductive, s-withdrawing effect of fluorine atoms 
activates the geminal carbon, while the resonance effect of fluorine disfavors attack of the 
b-position (Figure 1-24b).58b This regioselectivity is reinforced by the s-withdrawing effect 
that stabilizes the b-fluorocarbanion intermediate after nucleophilic attack (Figure 1-24c). 
Further, in gem-difluoroalkenes, the sp2 hybridization of the difluorinated carbon 
increases the electrophilicity, as, according to Bent’s rule, a carbon center containing two 
electron deficient substitutions is more stable when the hybrid orbital bears more p-
character (Figure 1-24c).66 Combined with the extreme electron deficiency of a 
difluorinated carbon, difluoroalkenes are exceptionally electrophilic at the difluorinated 
carbon,67 encouraging nucleophiles to the attack the a-carbon (Figure 1-24b). Overall, 
the fluorine-induced polarization of alkenes and enolates is sufficiently strong to 
overcome the intrinsic reactivity of non-fluorinated substrates and render electrophilic 
character at the typically nucleophilic site (Figure 1-24b).  
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Figure 1-24: Uncommon Reactivity of gem-Difluoroalkenes 
 
Notably, C–F bond cleavage in gem-difluoroalkenes is easier than in other fluorinated 
systems,67 due to the formation of the b-anionic intermediate enabling an addition / 
elimination mechanism (Figure 1-24c).64, 67-68 Upon attack by a nucleophile, the reaction 
generates an unstable anionic intermediate vicinal to the fluorinated position. As a fluoride 
anion is more thermodynamically stable than a carbanion or other heteroatom centered 
anion, the elimination process eliminates fluoride rather than the recently incorporated 
nucleophile to relieve the disfavored anionic charge (Figure 1-24).  Based on this 
reactivity, many net C–F functionalizations of difluoroalkenes are used to generate useful 
fluorinated moieties, enabling the synthesis of valuable fluorinated compounds. This 
reactivity has been exploited in intramolecular cyclizations (Scheme 1-3a) and 
intermolecular C–F functionalizations with amine, alcohol, thiol, and carbon nucleophiles 
(Scheme 1-3b).64, 69 Previous efforts have not overridden this elimination step to deliver 
products bearing two fluorine atoms. Efforts that override this elimination step via 
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Scheme 1-3: C–F Functionalization Reactions of gem-Difluoroalkenes with Nucleophiles 
Involve Nucleophilic Addition / F– Elimination Mechanisms 
 
The gem-difluoroalkene group also provides opportunities for developing new 
transition metal catalyzed reactions. For example, transition metals might be used to 
engage the anionic fluoroalkyl intermediate prior to elimination. This type of strategy 
would enable domino nucleophilic addition / metal catalyzed cross-coupling reactions, 
such as has been recently developed by the Loh70 and Hu71 groups to form new C–C 
bonds and to produce highly functionalized b,b,b-trifluoroethylarenes (Figure 1-25a). 
Additionally, gem-difluoroalkenes can interact directly with metals, often by unexpected 
pathways (Figure 1-25b, c).64 For these substrates the strong olefinic C–F bonds (120–














a) Intramolecular cyclizations by net C–F functionalization with nucleophiles68a,b
















































reported Pd-based73 and Ni-based73d, 74 systems (Figure 1-25b). However, metal catalyst 
systems derived from Cu, Rh, Co, and alternate Pd complexes avoid oxidative addition 
to the C–F bond, and instead initiate the net C–F functionalization reaction by either 
olefin–metal coordination75 or C–H oxidative addition76 (in the presence of two vinylic C–
X bonds), followed by regioselective insertion, and termination of the sequence through 
facile b-fluoride elimination to deliver mono-fluoroalkenes (Figure 1-25c). Current metal-
catalyzed reactions of gem-difluoroalkenes either undergo difunctionalization reactions 
using a fluoride nucleophile or cannot retain both fluorines when using other nucleophiles. 
This limitation of transition-metal catalyzed reactions with gem-difluoroalkenes is 
addressed in Chapter 4 and Chapter 5. 
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Figure 1-25: Metal-Catalyzed Paradigms for Functionalization of gem-Difluoroalkenes 
 
Exploiting the reactivity of gem-difluoroalkenes is a valuable goal, as gem-
difluoroalkenes are easily-accessible64, 77 synthetic building blocks. These a,a-
difluoroalkene substrates can be generated by a variety of methods,64 including cross 
coupling reactions of aryl halides77g and aryl boronic acids,77f and olefination reactions of 
diazo compounds,77e ketones, and aldehydes (Wittig77b and Julia-Kocienski77d reactions). 
The diverse strategies for generating gem-difluoroalkenes encourage the development of 
subsequent reactions for accessing a diverse subset of products, such as 
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Chapter 2 – Organocatalytic Reactions of Thiols with gem-Difluoroalkenes 
2.1. Metal-Free Reactions of gem-Difluoroalkenes 
Gem-difluoroalkenes are an easily accessed1 fluorinated functional group that can be 
elaborated into more complex fluorinated compounds. A variety of commercially available 
compounds bearing simple functional groups provide access to gem-difluoroalkenes 
(Scheme 2-1) including carbonyls through Wittig1a-f, 1n-p or Julia-Kocienski1j, 1q, 1r 
olefinations (Scheme 2-1i), alkenes through radical functionalization (Scheme 2-1ii),1s 
and alkyl halides via nucleophilic addition reactions (Scheme 2-1iii).1t-v Other methods to 
access gem-difluoroalkenes require synthesis of fluorinated intermediates, such as SN2’ 
reactions with vinyl trifluoromethanes (Scheme 2-1iv),1w-ac or cross coupling with 
difluoroethylene derived compounds, such as difluorovinyl organo-zinc compounds,1g, 1af 
difluorovinyl stannanes,1ad and difluorovinyl tosylates (Scheme 2-1v).1ae Due to the wide 
variety of methods and starting materials to access gem-difluoroalkenes, many 
functionalization reactions of this moiety have been developed.  
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Scheme 2-1: Methods to Synthesize gem-Difluoroalkenes 
 
The incorporation of fluorine in gem-difluoroalkenes perturbs physicochemical 
properties thus enabling new reactivity that contrasts the reactivity of the non-fluorinated 
alkene.1h, 2 The s-withdrawing effects of the fluorine substituents activate the difluorinated 
position for regioselective nucleophilic attack under both transition metal-catalyzed and 
non-catalyzed conditions (Figure 2-2).1h, 1x The difluorinated carbon of the alkene is 
electrophilic, which activates gem-difluoroalkenes for regioselective attack at the a-
position. This activation delivers a distinct regioselectivity from common alkene activating 
groups, such as carbonyls and nitro groups, which react at the b-position relative to the 
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difluoroalkenes to serve as mechanism-based inhibitors of enzymes with nucleophilic 
residues in the active sites (Figure 2-1).3 
















































































Many reactions that exploit the electrophilicity of the difluorinated position of gem-
difluoroalkenes undergo a net addition / elimination process that defluorinates the 
substrate. Specifically, these reactions proceed through either unstable b-fluoroanions 
(Figure 2-2a)1x, 5 or b-fluoroorganometal intermediates (Figure 2-2b)6 that both undergo 
b-fluoride elimination and deliver monofluorinated products, specifically 
monofluoroalkenes.1h  
Figure 2-2: Types of Reactions of gem-Difluoroalkenes 
 
The fluoroalkene products are lipophilic, conformationally locked mimics of peptide 
amide bonds,7 found in a variety of bioactive compounds. Typical fluoroalkene synthesis 
proceeds through the direct fluorination of non-fluorinated starting materials, including 
Shapiro fluorination,8 olefination reactions with mono-fluorinated ylides,9 or the 
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synthesis require fluorinated starting materials, such as elimination reactions of 
fluoroalkanes,11  SN2’ reactions of allylic gem-difluorides,12 or transition-metal catalyzed 
cross-coupling reactions.1ae, 13 Fluoroalkene synthesis from gem-difluoroalkenes occurs 
via an orthogonal process, enabling access to otherwise hard to make compounds. For 
instance, intramolecular nucleophilic cyclizations of gem-difluoroalkenes enable access 
to five-member heterocycles fluorinated at the 2-position, such as 2-fluoro-indoles or -
benzo[b]thiophenes (Scheme 2-2a).14 Other methods to provide the same fluorination 
pattern remain lacking. Similar reactions allow access to various fluorinated 6-member 
heterocycles (Scheme 2-2b).15 Such cyclization reactions generally do not require strong 
bases, as the proximity of the nucleophile to the electrophile enables facile nucleophilic 
addition. 
Scheme 2-2: Representative Intramolecular Cyclization Reactions of gem-
Difluoroalkenes 
 
a) Representative C–F Funtionalization of gem-Difluoroalkenes:











b) Representative C–F Funtionalization of gem-Difluoroalkenes:
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Intermolecular nucleophilic addition reactions to gem-difluoroalkenes exploit the same 
reactivity. However, the intermolecular attack of C-based nucleophiles to gem-
difluoroalkenes requires strong bases, such as organolithium species.16 Aryl and alkyl 
lithium species efficiently react with TMS-containing gem-difluoroalkenes,16 while alkynyl 
lithium nucleophiles react with b,b-difluorostyrenes to generate b-fluoroenynes (Scheme 
2-3a).17 More acidic, activated C-based nucleophiles, such as heterocycles18 (Scheme 
2-3b) or malonates,19 require activation by slightly weaker bases, such as KHMDS or 
NaH, rather than an organolithium reagent. If the nucleophile is further activated, such as 
cyanide nucleophiles, C-F functionalization can occur with weak butoxide bases.20 
Grignard reagents react without base, and preferentially react with gem-difluoroalkenes 
over carbonyls in an a,b-unsaturated system (Scheme 2-3c),21 highlighting the ability of 
the gem-difluoroalkenes to increase the “hardness” of the electrophile. Even nucleophilic 
substitution reaction of weak nucleophiles such as phenol to gem-difluoroalkenes occurs 
in the presence of the weak base K3PO4, providing fluorovinyl aryl ethers via a three 
component reaction from a boronic acid nucleophile and O2 (Scheme 2-3d).22 Even under 
forcing conditions, using organolithium reagents, carbon-based nucleophiles undergo 
almost exclusively mono-addition, because the electrophilicity of the resulting 
fluoroalkene is significantly reduced, precluding further nucleophilic attack.  
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Scheme 2-3: C-Based Nucleophilic C–F Functionalization Reactions of gem-
Difluoroalkenes 
 
For intermolecular reactions of N- or S-based nucleophiles with gem-difluoroalkenes 
sequential nucleophilic addition / fluoride elimination reactions are facile, resulting in non-
fluorinated products (Scheme 2-4a).23 For these nucleophiles, achieving a single 
nucleophilic addition / fluoride elimination reaction requires control of nucleophile 
equivalents and reaction time (Scheme 2-4b).24 However, mono-addition of a basic N-
derived nucleophile results in a non-fluorinated product. When a basic nitrogen sits a to 
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2-4c).25 This elimination makes the fluorine-retentive intermolecular functionalization of 
gem-difluoroalkenes with N-based nucleophiles to generate basic-nitrogen containing 
products an immense challenge. 
Scheme 2-4: Representative C–F Functionalization Reactions of gem-Difluoroalkenes 
with Heteroatom-Based Nucleophiles 
 
Uniquely, the addition of F– to gem-difluoroalkenes to form trifluoromethanes26 never 
results in a defluorinated product; instead, the reaction follows a nucleophilic addition / 
protonation process. This uncommon reaction proceeds through a reversible equilibrium 
between the gem-difluoroalkene and an unstable a-trifluoromethyl anion that is trapped 
with residual H2O (Figure 2-3a). Initially, these reactions required the use of crown ethers 
and the explicit preparation, isolation, and purification of the gem-difluoroalkene.1t In 2014 
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ketones to their respective trifluoromethanes proved that such reactions do not require 
additives to temporarily control the b-fluoroanion.26 Other reactions exploit this equilibrium 
process to intercept the b-fluoroanion with transition metals and further functionalizing 
gem-difluoroalkenes.26-27 Unfortunately, if the b-fluoride elimination does not regenerate 
the starting material, no stable equilibrium forms, making the protonation of the unstable 
anionic intermediate more challenging (Figure 2-3b). Thus, general examples of such 
“fluorine-retentive” nucleophilic hydro-functionalization of gem-difluoroalkenes remain 
elusive (Figure 2-2d). 
Figure 2-3: Fluorinated Alkenes React via Nucleophilic Addition / Protonation. 
 
Such an undeveloped general intermolecular “fluorine-retentive” nucleophilic 
functionalization of gem-difluoroalkenes would allow access to underexplored fluorinated 
functional groups. Specifically, fluorine-retentive reactions with thiols would provide 
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substructures alter the metabolism of the traditionally labile vicinal carbon of thioethers, 
and may reduce the oxidation of the thioether itself, and are thus important for medicinal 
and agricultural purposes, such as in anti-cancer28 and anti-inflammatory29 agents and 
agrichemicals (Figure 2-4a).30 Only a few suboptimal strategies exist to form a,a-
difluoroalkylthioethers, leaving most of the potentially bioactive a,a-difluoroalkylthioethers 
prophetic in patents. Of these strategies, nucleophilic substitution reactions of silylated31 
or halogenated (Figure 2-4bi)32 difluoroalkyl intermediates are the mildest methods, 
allowing for the broadest scope of compatible functional groups. However, the necessary 
starting materials require multi-step preparations, reducing the utility of these 
transformations. Radical processes to access a,a-difluoroalkylthioethers are more direct; 
however, the existing radical methods use a limited set of starting materials (Figure 
2-4biii).32b, 32c, 33 For compounds containing simple alkyl or polyfluorinated alkyl 
substituents, gaseous fluorinated alkene electrophiles allow direct access to the 
difluorinated (thio)ether from thiols or alcohols. However, both the gaseous reagent and 
controlling the undesired fluoride elimination require cryogenic conditions (Figure 
2-4bv).34 In a non-convergent method, oxidative methods that utilize harsh fluorinating 
reagents enable direct access to the desired a,a-difluoroalkylthioether substructure 
(Figure 2-4bii).35 The most common of these oxidative methods incorporates fluorine 
through deoxyfluorination, which precludes the presence of carbonyl and unprotected 
alcohol functionalities, and liberates toxic HF as a byproduct. Thus, a preparation of a,a-
difluoroalkylthioethers via the base-catalyzed hydrofunctionalization of gem-
difluoroalkenes with thiols, exploiting a nucleophilic addition / protonation mechanism, 
 
75 
complements existing methods to access a,a-difluoroalkylthioethers, and should facilitate 
access to valuable, underexplored bioactive compounds. 
Figure 2-4: b,b-Difluorophenethyl (Thio)ethers in Medicinal and Synthetic Chemistry 
 
2.2. Base Catalysis Enables Access to b,b-Difluorophenethyl Arylthioethers 
Our initial studies focused on the addition / protonation reaction of aryl thiol 
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are both highly nucleophilic (Swain-Scott = 9.92)36 and moderately acidic (pKa = 6.52), 
aryl thiols subjected to catalytic amounts of weak base would rapidly deprotonate and 
add to the gem-difluoroalkene. We selected a styrene-derived difluoroalkene substrate to 
stabilize the proposed intermediate anion (Scheme 2-5A) after thiol addition through 
resonance, ideally speeding nucleophilic addition, while slowing b-fluoride elimination. 
Once the unstable b-anionic intermediate would form, either the protonated catalyst 
or the remaining thiol pronucleophile would provide the proton to quench the reactive 
intermediate. Since the expected b,b-difluorophenethyl thioether product is significantly 
less acidic than either the protonated catalyst or thiol, proton transfer might occur faster 
than b-fluoride elimination, generating the desired product and closing the catalytic cycle 




Scheme 2-5: Base Catalyst Enables Nucleophilic Addition to gem-Difluoroalkenes 
 
After extensive optimization, we identified a general base-catalyzed protocol for 
adding aryl thiols to b,b-difluorostyrenes. Initial attempts to functionalize difluorostyrene 
2.1 with thiophenol involved catalytic amounts of inorganic bases, which either generated 
non-fluorinated disubstituted alkene 2.3 (likely arising from sequential C–F 
functionalizations),23b, 23c or which did not react (Scheme 2-6). When higher quantities of 
inorganic base were employed, large amounts of a-fluorovinylthioethers formed. In 
contrast, catalytic quantities of organic bases generated the desired a,a-
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difluoroalkylthioether in modest to excellent yield and selectivity. Of the bases evaluated, 
1,1,3,3-tetramethylguanidine (TMG) provided the best yield and selectivity for product 2.2 
over product 2.4 (Table 2-1, entries 1–4). Notably, the use of preformed PhSNa as a 
base only formed small amounts of desired product 2.2 or eliminated product 2.4 (Table 
2-1, entry 5), which suggests that ArSH might not serve as the H+ donor, but rather TMG–
H+. Subsequent evaluation of solvents revealed that chlorinated solvents provided the 
best yield and selectivity, with 1,2-dichloroethane (DCE) proving optimal (Table 2-1, 
entries 1, 5–11). 
Scheme 2-6: Undesired Reactivity with Inorganic Bases 
 
Table 2-1: Optimization of the Reaction Conditions[a] 
 
entry base solvent conv/yield [%][b] 2.2:2.4[b] 
1 TMG DCE >99/96 >25:1 
2 Et3N DCE >99/82 >25:1 
3 DMAP DCE >99/67 >25:1[e] 
4 TBD DCE >99/77 >25:1 
5[c] PhSNa DCE 15/<1 N/A 
6 TMG PhNO2 94/60 4:1 
7 TMG DMF >99/36 1:1.2 



































9 TMG MeCN 83/15 1:3.5 
10[d] TMG DCM >99/88 >25:1 
11[c] TMG DCE >99/91 >25:1 
 
[a] Standard conditions: 2.1 (1.0 equiv.), PhSH (2.0 equiv.), solvent (0.50 M), base (25 
mol %), 80 ˚C, 4 h. [b] Determined by 19F NMR standardized with PhCF3 (1.0 equiv.). [c] 
Solvent (0.25 M), base (5.0 mol %), 70 ˚C, 0.5 h. [d] 40 ˚C. [e] Reaction generated a 
sulfoxide side product. TBD = 1,5,7-triazabicyclo[4.4.0]dec-5-ene. 
Of note, as the scale of the reaction increased, the optimized reaction conditions (5% 
TMG, 1.5 equiv. thiophenol, 70 ̊ C, 0.5–4 h) showed reduced efficiency. Specifically, when 
the scale increase from a 0.1 mmol exploratory scale to a 0.5 mmol preparative scale, the 
reaction quickly approached completion (~80% conversion), but then stalled. This might 
be a result of worse heat transfer from the reaction block to the reaction mixture, as the 
increased volume of the reaction brings the total volume to the top of the heating element. 
Other possibilities include micro-aggregates of the TMG and thiophenolate in DCE that 
prevent the thiolate from reacting with the difluoroalkene, although as best we observed 
the reactions were homogenous. Complete conversion required either extended reaction 
times, elevated temperatures, or an additional equivalent of aryl thiol. 
The optimized reaction conditions enabled coupling between thiophenol and a broad 
spectrum of functionalized b,b-difluorostyrenes (2.5a–n and 2.1), with selectivity generally 
















the b,b-difluorostyrene, such as halides (2.6c, 2.6i, 2.6k), ethers (2.2, 2.6a–c, 2.6h), 
thioethers (2.6b), and nitrogenous functional groups (2.6d, 2.6e, 2.6l–n). Ortho-
substituted b,b-difluorostyrenes required higher reaction temperatures (2.6c, 2.6g, 2.6i). 
Carbonyl-containing compounds were also tolerated (2.6j, 2.6l), and notably a substrate 
bearing an a,b-unsaturated ester reacted exclusively at the fluorinated position, with no 
evidence of irreversible Michael addition (2.6j) highlighting the high electrophilicity of the 
difluorinated position. Electron-rich and -neutral b,b-difluorostyrenes generally provided 
high yields and selectivities, and required low temperatures and short reaction times (2, 
6a–e, 6h). In contrast, under standard reaction conditions, electron-deficient substrates 
reacted sluggishly, affording products in modest yields and selectivities. To reach full 
conversion, these reactions required higher temperatures and longer times (6k–n). 




Scheme 2-7: Scope of Distinct b,b-Difluorostyrenes[a] 
 
2.6d, 77%[b]
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70 ˚C, 0.5 h
2.2, 86% 
70 ˚C, 1 h
2.6j, 73%[b]
90 ˚C, 5 h
2.6b, 59%[b]
90 ˚C, 5 h
2.6f, 75%[b]
100 ˚C, 20 h
2.6k, 60%[b,c]
100 ˚C, 20 h
2.6c, 87% 
70 ˚C, 0.5 h
2.6g, 90%[b]
90 ˚C, 5 h
2.6l, 83%[b]
90 ˚C, 5 h
2.6h, 88% 
80 ˚C, 0.5 h
2.6m, 57%[b,d]
100 ˚C, 20 h
2.6e, 79% 
70 ˚C, 14 h
2.6i, 72%[b]
90 ˚C, 5 h
2.6n, 54%[b,e]
100 ˚C, 20 h
2.5a–n and 2.1 2.6a–n and 2.2
5% TMG 








[a] Standard conditions: 2.5a–n (1.0 equiv.), PhSH (2.0 equiv.), TMG (5.0 mol %), 
DCE (0.25 M), temperature and time as indicated. Selectivity >25:1 as determined by 19F 
NMR analysis of the reaction mixture, unless otherwise indicated. Yields represent an 
average of two runs. [b] PhSH (3.0 equiv.). [c] Selectivity = 13:1. [d] Selectivity = 6.6:1. 
[e] Selectivity = 8:1. PMB = 4-methoxybenzyl, Tf = trifluoromethylsulfonate. 
To determine whether the reduced selectivity arose from the instability of the product 
or of anionic intermediate A (Scheme 2-5c), purified products 2.2, 2.6d, and 2.6n were 
re-subjected to the reaction conditions (Scheme 2-8a). 19F NMR analysis of the reaction 
mixtures showed no evidence of degradation, which corroborates the fact that even with 
extended reaction times the selectivity is not reduced. Combined, these results suggest 
that b-fluoride elimination from A occurs more rapidly for electron-deficient species than 
for electron-rich or -neutral species, explaining the reduced selectivity (Scheme 2-8b). 
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Scheme 2-8: Decomposition of Anionic Intermediate A Reduces the Selectivity for e--
Deficient Substrates 
 
Further, under the optimized conditions heteroaromatic gem-difluoroalkenes reacted 
smoothly (Scheme 2-9). Electron-rich and -deficient N-based heterocycles (indole 2.8a, 
pyridine 2.8b, pyrrole 2.8c), and S-based heterocycles (benzothiophene 2.8d, 
phenothiazine 2.8e, thiazole 2.8f) all provided good yield and selectivity, suggesting that 
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Scheme 2-9: Scope of Heteroaromatic b,b-Difluorostyrenes[a] 
 
[a] Standard conditions: 2.7a–n (1.0 equiv.), PhSH (2.0 equiv.), TMG (5.0 mol %), 
DCE (0.25 M), temperature and time as indicated. Selectivity >25:1 as determined by 19F 
NMR analysis of the reaction mixture. Yields represent an average of two runs. [b] PhSH 
(3.0 equiv.). Ts = 4-toluenesulfonyl. 
A broad scope of functionalized aryl thiol nucleophiles were also tolerated (Scheme 
2-10). Aryl thiols bearing halides (2.10h, 2.10e), ethers (2.10a, 2.10b, 2.10f), 
trifluoromethane (2.10g), carbonyl groups (2.10b), and even a secondary amide (2.10c) 
afforded a,a-difluoroalkylthioether products, confirming that electron-rich, -neutral, and -
weakly-deficient aryl thiols generally reacted smoothly. Thiols bearing strong electron-
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90 ˚C, 5 h
2.8f, 83%[b]
90 ˚C, 5 h
2.8e, 76%[b]
90 ˚C, 5 h
2.8a, 69% 
70 ˚C, 0.5 h
2.8c, 86% 
70 ˚C, 0.5 h
2.8b, 73%[b]










reaction times. Notably, all reactions demonstrated excellent selectivity (>25:1) 
regardless of the nature of the nucleophile. However, under these conditions heteroaryl 
thiol nucleophiles did not add to b,b-difluorostyrenes electrophiles. 
Scheme 2-10: Scope of Distinct Aryl Thiols[a] 
 
[a] Standard conditions: 2.1 (1.0 equiv.), ArSH 2.9a–j (2.0 equiv.), TMG (5.0 mol %), 

































































100 ˚C, 20 h
2.10b, 81% 
70 ˚C, 0.5 h
2.10g, 82% 
70 ˚C, 0.5 h
2.10a, 76% 
70 ˚C, 0.5 h
2.2, 86% 
70 ˚C, 1 h
2.10e, 83% 
70 ˚C, 2 h
2.10h, 86% 
70 ˚C, 0.5 h
2.10j, 81% 
70 ˚C, 4 h
2.10d, 70% 
90 ˚C, 20 h
2.10f, 93%[b]
90 ˚C, 5 h
2.10i, 81%[b]
100 ˚C, 20 h
2.9a–j 2.1 2.10a–j and 2.2
5% TMG 






NMR analysis of the reaction mixtures. Yields represent an average of two runs. [b] ArSH 
(3.0 equiv.). 
Finally, the mild conditions tolerated many useful protecting groups, including a Ts-
protected indole (2.8a), an acetal (2.8b), a Boc-protected amine (2.8f), benzyl- and p-
methoxylbenzyl-protected alcohols and amines (2.6c, 2.6h, 2.8e), and an acetyl-
protected amine (2.10c), all potentially useful in multistep synthetic sequences. 
While aryl thiol nucleophiles reacted efficiently, alkyl thiols reacted poorly, giving 
mainly addition / elimination products, presumably due to a mismatched thiol-base pair. 
To assess whether a system bearing two distinct nucleophiles could selectively react with 
the efficient aryl thiol nucleophile and avoid this undesired reactivity of alkyl thiols, an aryl 
thiol was reacted with 2.1 in the presence of an alkyl thiol under the harshest conditions 
explored (Scheme 2-11). Under these conditions, the aryl thiol selectively coupled to form 
aryl thioether 2.2 with <1% formation of alkyl thioether 2.11, likely because the increased 
acidity of the aryl thiol allows preferential deprotonation, and the resulting thiolate is more 
nucleophilic than the neutral thiol. 










100 ˚C, DCE, 20 h














2.3. Mechanistic Considerations 
While we propose that the current reaction to achieve the hydrothiophenolation of 
gem-difluoroalkenes occurs via a base-catalyzed addition / protonation pathway, other 
mechanisms are possible. Thiols, especially aryl thiols, undergo facile one electron 
oxidation to thiol radicals, which are stable and competent at performing the same 
reaction. In fact, when difluoroalkene 2.1 was subjected to a strong radical initiator (AIBN) 
and thiophenol under similar conditions to the aforementioned base-catalyzed 
hydrothiophenolation reaction, the desired b,b-difluorophenethyl arylthioether was 
generated in high yield and selectivity. Thus, we set out to rule out the possibility that the 
current reaction proceeds via one-electron chemistry. 
Several experiments support the proposed addition / protonation pathway over a 
mechanism involving S-based radicals. First, the reaction ran smoothly in the absence of 
light and O2, which are known radical initiators of thiols (Table 2-2, entry 1–3). Second, 
although the reaction utilizes TMG (which can have inorganic impurities that can oxidize 
a thiolate),37 other amine bases that lack such impurities (e.g. distilled Et3N) are 
competent base catalysts (Table 2-1, entry 2). Third, when running the reaction in CD2Cl2 
(which can transfer •D)38 D was not incorporated into the product (Table 2-2, entry 4). 
Fourth, reactions run in presence of radical traps (e.g. 1,4-dicyanobenzene and BHT) 
proceed to full conversion and in comparable yields to the standard reaction conditions 
(Table 2-2, entries 5 and 6). In contrast, reactions run in the presence of TEMPO, both 
with and without TMG, gave no desired product and generated (PhS)2, presumably by 
transfer of H• from PhSH to TEMPO and subsequent homocoupling of the resulting PhS• 
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(Table 2-2, entry 7), although control reactions revealed that, in the presence of TEMPO, 
thiophenol formed the corresponding dithiane and thus cannot add to the gem-
difluoroalkene. Thus, under our conditions, S-based radicals are not likely reactive 
intermediates. 
Table 2-2: Experiments for Mechanistic Determination[a] 
 
entry additive conv/yield [%][b] 2.2:2.4[b] 
1[c] O2 >99/90 >25:1 
2[c] Dark >99/90 >25:1 
3[c] O2 and Dark >99/95 >25:1 
4[d] DCM-D2 >99/86 >25:1 
5 1,4-(CN)2-C6H4 >99/88 >25:1 
6 BHT >99/82 >25:1 
7 TEMPO >0/0 N/A 
 
[a] Standard conditions: 2.1 (1.0 equiv.), PhSH (2.0 equiv.), additive (2.0 equiv.), DCE 
(0.50 M), TMG (5 mol %), 70 ̊ C, 1 h. [b] Determined by 19F NMR standardized with PhCF3 
(1.0 equiv.). [c] Run at 80 ˚C. [d] Run in DCM-D2 instead of DCE for 4 h at 40 ˚C. BHT = 





























2.4. Organocatalysis to Access b,b-Difluorophenethyl Alkylthioethers 
As evidenced in Scheme 2-11, alkyl thiols are less competent nucleophiles than aryl 
thiols in the TMG catalyzed hydrothiolation of gem-difluoroalkenes. In fact, when 
subjected to TMG-catalysis in the absence of a competing aryl thiol nucleophile, reactions 
of alkyl thiol nucleophiles selectively formed the undesired a-monofluorovinyl thioether 
side product (Scheme 2-12a). While not ideal, this result indicates that the reduced 
nucleophilicity of alkyl thiols (Swain-Scott = 6.95)39 relative to aryl thiols (Swain-Scott = 
9.92)36 does not preclude nucleophilic attack under mild conditions with catalytic base. 
Unfortunately, the proton quench with alkyl thiols does not sufficiently outcompete the b-
fluoride elimination, necessitating re-optimization of the reaction conditions.  
Interestingly, when alkyl thiols were subjected to conditions utilizing the same 
inorganic bases that provided exclusive formation of the a-monofluorovinyl thioether 
when using aryl thiols, the desired b,b-difluorophenethyl alkylthioether was formed in high 
yield and high selectivity (Scheme 2-12b). This result might indicate that the excess alkyl 
thiol provides the protons needed to quench the b-fluoroanionic intermediate, which 
explains the reduced protonation as alkyl thiols are less acidic (pKa = 10.86) than aryl 
thiols (pKa = 6.61).40  
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Scheme 2-12: Inorganic Base Catalysis Provides Desired Product 
 
Initial optimization of this reaction revealed that either catalytic NaH or catalytic pre-
formed sodium alkylthiolate were ideal bases for electron rich and electron neutral gem-
difluoroalkenes. However, under these reaction conditions, the substrate scope for 
selective hydrofunctionalization versus b-fluoride elimination was limited to electron-rich 
and neutral gem-difluoroalkenes. Reactions of electron-deficient gem-difluoroalkenes 
provided especially poor selectivity. 
At this point a new graduate student, Jacob Sorrentino, joined the project. Under my 
mentorship, he performed extensive optimization to reveal the final optimized conditions; 
an organocatalytic catalyst mixture of pyridine, LiOTf, and 2-methoxyethanol. This 
optimized catalyst system provides high yields and high reactivity over a broad range of 
gem-difluoroalkenes and alkylthiols. My contributions to the substrate scope are 




a) 25 % TMG
    (NO2)-C6H5
    120 ˚C, 4 h
b) 5 % NaSnOct
    (NO2)-C6H5













Scheme 2-13: Scope of Aromatic and Heteroaromatic b,b-Difluorostyrenes[a] 
 
[a] Standard conditions: 2.5 or 2.7 (1.0 equiv.), nOctSH (1.5 equiv.), Pyridine (20.0 mol 
%), LiOTf (10.0 mol %), 2-OMe-EtOH (2.0 equiv.), o-Xylene (0.33 M), 110 ˚C, 15 h, 
equipped with a balloon of air through a 16.5 G needle. Selectivity >25:1 as determined 
by 19F NMR analysis of the reaction mixtures. Yields represent an average of two runs. 






































































In summary, we developed a new organo-catalytic strategy to generate b,b-
difluorophenethyl thioethers by directly adding nucleophiles to gem-difluoroalkenes. In 
contrast to classical syntheses of such products that require multistep intermediate 
synthesis,31-32 harsh conditions,41 and/or gaseous reagents,34 and that many times rely 
on functional group interconversions31-32, 35 to generate the fluorine-based substructure, 
our convergent method utilizes only catalytic quantities of a weak amine base to add thiol 
nucleophiles across gem-difluoroalkenes and deliver the desired products in moderate to 
good yields and selectivities. These reactions proceed via an unstable anionic 
intermediate that is prone to eliminate F–; however, the mild conditions avoid this 
undesired unimolecular elimination, contrasting the many reactions of gem-
difluoroalkenes that selectively generate monofluoroalkene products.1h 
The organocatalytic strategy enabled two reactions to access to a variety of 
functionalized b,b-difluorophenethyl thioethers in high yield and selectivity versus the a-
fluorovinylthioether. Using aryl thiols as a nucleophile, a simple, common, and 
commercially available guanidine base (TMG) was employed as catalyst in low loading 
and at moderate temperatures. This reaction is highly efficient and effective, providing the 
desired b,b-difluorophenethyl arylthioethers in high yield and generally >25:1 selectivity, 
although, as with SNAr reactions, different substrates require minor reoptimization of 
reaction conditions. However, this reaction does suffer reduced selectivity when applied 
to electron deficient difluoroalkenes. When employing the less-acidic alkyl thiol 
nucleophiles, we developed a new reaction employing a unique organo-catalyst of 
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pyridine and LiOTf to affect the hydrothiolation of gem-difluoroalkenes, while similarly 
avoiding the formation of the undesired a-monofluorovinyl thioether. This reaction is 
broadly tolerant of substitutions to the gem-difluoroalkene electrophile, remaining highly 
selective.  
This convergent organo-catalytic strategy to hydrofunctionalize gem-difluoroalkenes 
delivers a class of products that are underrepresented in synthetic and biomedical 
literature. Combined with direct preparations of b,b-difluorostyrenes,1h the present 
reactions should facilitate access to this underutilized functional group in medicinal and 
agrichemistry. Further efforts aim to enable the addition of other nucleophiles, such as 
alkyl alcohols or C-based nucleophiles, to gem-difluoroalkenes, and to expand the scope 
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Unless otherwise noted, reactions were performed under an atmosphere of air using 
oven-dried glassware. Coupling reactions with thiols and difluorostyrenes were performed 
in either 1-dram borosilicate glass vials sealed with a PTFE-lined silicone septa in a 
screw-top cap, or 5 mL pressure-resistant microwave vials sealed with a PTFE-lined 
silicone septa in a crimp-top cap. All other reactions were performed in round-bottom 
flasks sealed with rubber septa. Stainless steel syringes were used to transfer air- and 
moisture-sensitive liquid reagents. Reactions were monitored by either 19F NMR with an 
internal standard of  a,a,a-trifluorotoluene or by thin-layer chromatography (TLC) on 
UNIPLATE Silica Gel HLF plates, visualized by quenching of fluorescence. Column 
chromatography was conducted using a Teledyne Isco CombiFlash Rf 200 system 
utilizing gradient elution. Isolated yields reported in the manuscript represent an average 
of at least 2 independent runs of material deemed to be at least 95% pure by NMR. Yields 
reported in the supporting information refer to a single experiment. 
Unless otherwise noted, reagents were purchased from commercial sources and used 
as received. 1,2 Dichloroethane (DCE, reagent grade, 99+%) and tetramethylguanidine 
(TMG) were purchased from Alfa Aesar.  N-methylpyrrolidine (NMP, anhydrous) was 
purchased from Sigma Aldrich. Solvents, including dimethylformamide (DMF), toluene 
(PhMe), dichloromethane (DCM), methanol (MeOH), acetonitrile (MeCN), and 
tetrahydrofuran (THF) were used directly from a solvent purification system, in which 
solvent was dried by passage through two columns of activated alumina under argon. 
30% hydrogen peroxide in water (H2O2) was purchased from Fisher Scientific. Other 
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chemical abbreviations utilized in this document include: a,a,a-Trifluorotoluene (TFT), 
sodium sulfate (Na2SO4), magnesium sulfate (MgSO4), ethyl acetate (EtOAc), diethyl 
ether (Et2O), ammonium chloride (NH4Cl), n-butyl lithium (nBuLi), sodium hydroxide 
(NaOH), sodium metabisulfite (Na2S2O5), Room Temperature (R.T.), tbutyl carbonate 
anhydride (Boc2O), potassium carbonate (K2CO3), hydrochloric acid (HCl),  
Proton nuclear magnetic resonance (1H NMR) and fluorine nuclear magnetic 
resonance (19F NMR) were taken on a Bruker AVIIIHD 400 AVANCE spectrometer (400 
and 376 MHz respectively). Proton and carbon nuclear magnetic resonance (13C NMR) 
were taken on an Bruker AVIII 500 Avance spectrometer with a CPDUL cryoprobe (500 
and 126 MHz respectively). Chemical shifts (d) for protons are reported in parts per million 
(ppm) downfield from tetramethylsilane, and are referenced to the proton resonance of 
residual CHCl3 in the NMR solvent (CHCl3: d = 7.26 ppm). Chemical shifts (d) for carbon 
are reported in ppm downfield from tetramethylsilane, and are referenced to the carbon 
resonance of the solvent residual peak (CDCl3: d = 77.16 ppm). Chemical shifts for 
fluorine are reported in ppm upfield from trichlorofluoromethane (0 ppm). NMR data are 
represented as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, m = multiplet), coupling constant in Hertz (Hz), integration. 
High-resolution mass determinations were obtained either by electrospray ionization 
(ESI) on a Waters LCT PremierTM mass spectrometer or by atmospheric-pressure 
chemical ionization (APCI-hexane/PhMe, HAPCI) on a Waters Q-Tof PremierTM, for which 
sample plus near mass internal exact mass standard were dissolved in hexane, and 
hexane or PhMe/hexane were used as ionization solvent. Infrared spectra were 
measured on a Shimadzu FTIR-8400S Fourier Transform Infrared Spectrometer by 
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drying samples on a salt plate. Uncorrected melting points were measured on a Thomas 
Hoover Capillary Melting Point apparatus. 
 
Preparation of Compound SI-2.1: 
 
2,2-difluoro-2-(triphenylphosphonio)acetate (SI-2.1):1 An oven-dried 2-neck 1000 mL 
round bottom flask, equipped with an internal thermometer and magnetic stirbar, was 
charged with 24.6 g (97.0 mmol) of triphenylphosphine and brought into the glovebox. In 
the glovebox, 20.0 g (97.0 mmol) of potassium bromodifluoroacetate (hygroscopic) was 
added. The vessel was sealed with a rubber septum, transferred out of the glovebox, and 
placed into a 0–10 ˚C water bath. Anhydrous DMF (250 mL) was added via cannula 
transfer, and the reaction was maintained at <18 ˚C for 21 h. At 21 h, the reaction was 
filtered, and the solid was washed 2X with 30 mL of DMF, 3X with 30 mL of H2O, and 3X 
with 30 mL of Et2O. The filtrate was placed into a 500 mL round bottom flask and dried 
overnight on high vacuum to afford 29.5 g (88%) of the compound SI-2.1 as a colorless 
solid. After drying, 1H NMR in MeOD was used to assess the purity of the material. If 
















Note 1: Reaction times longer than 21 h decrease the yield of product. By 36 h, the yield 
will stabilize at ~60%. Product degredation is accompanied by the appearance of a 
yellow/brown color. If the color appears prior to 21 h, the reaction will not yet be complete. 
However, lowering the temperature will slow the degradation and allow the completion of 
the reaction. 
Note 2: If the filtrate is not thoroughly washed, the material will be contaminated with 
either triphenylphosphine or water, and the subsequent reactions will have lower yields. 
Note 3: Selection of reaction vessel size is important. For optimal yield, the volume of 
DMF should be approximately ¼ the volume of the reaction vessel. 
Note 4: If the potassium bromodifluoroacetate is not a powder, presumably due to water, 
the yield will drop by ~10–15%. 
 
General Procedure for the Preparation of Gem-Difluoroalkenes (A1): An oven dried 
round bottom flask was charged with 1 equivalent of aryl aldehyde and 1.75 equivalents 
of SI-2.1.  The system was evacuated and backfilled with N2 three times. Dry NMP or 
DMF was added via syringe (PTFE syringe with oven-dried stainless steel needle), and 
the system was immediately immersed in an oil bath at 60–90 ˚C for 1–3 hours. Upon 
completion, the reaction was quenched with aqueous NH4Cl. Subsequently, 3 N HCl was 
added, and the aqueous layer was extracted 4X with EtOAc. The combined organic layers 
were washed 2X with 3 N HCl, 2X with H2O, and 1X with a saturated brine solution. The 
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organic layers were dried over Na2SO4 or MgSO4 and concentrated, and the residue was 
purified by flash chromatography using EtOAc and hexanes. 
 
General Procedure for the Preparation of Gem-Difluoroalkenes (A2): An oven dried 
round bottom flask was charged with 1 equivalent of aryl aldehyde and 1.75 equivalents 
of SI-2.1.  The system was evacuated and backfilled with N2 three times. Dry NMP or 
DMF was added via syringe (PTFE syringe with oven-dried stainless steel needle), and 
the system was immediately immersed in an oil bath at 60–90 ˚C for 1–3 hours. Upon 
completion, the reaction was quenched with aqueous NH4Cl. Subsequently, 3 N HCl was 
added, and the aqueous layer extracted 4X with EtOAc. The combined organic layers 
were washed 2X with 3 N HCl, 2X with H2O, and 1X with a saturated brine solution. After 
extraction, the residual triphenylphosphine in the organic layers was subjected to 
oxidation by vigorously stirring with a 30% aqueous H2O2 solution for 15 min at R.T.. The 
aqueous layer was removed in a separatory funnel, and the organic layers were dried 
over Na2SO4 or MgSO4, concentrated, and purified by flash chromatography using EtOAc 
and hexanes. 
 





5-(2,2-difluorovinyl)-1,2,3-trimethoxybenzene (2.1): Following General Procedure A1, 
6.28 g (32.0 mmol) of 3,4,5-trimethoxybenzaldehyde was reacted with 20.0 g (56.0 mmol) 
of SI-2.1 in anhydrous NMP (48 mL) at 80 ˚C for 2 h. After workup, the compound was 
purified by flash chromatography, using 0–5–10% EtOAc in hexanes, furnishing 6.65 g 
(90% yield) of desired product 2.1 as a colorless solid, m.p. 37 ˚C.  
1H NMR (400 MHz, CDCl3): d 6.55 (s, 2 H), 5.21 (dd, J = 25.8, 3.9 Hz, 1 H), 3.86–3.85 
(m, 9 H); 
13C NMR (126 MHz, CDCl3): d 156.2 (dd, J = 297.6, 287.8 Hz), 153.5, 137.3, 126.0 (t, J 
= 5.8 Hz), 15.0 (dd, J = 6.7, 3.5 Hz), 82.5 (dd, J = 29.6, 13.3 Hz), 61.1, 56.2; 
19F NMR (376 MHz, CDCl3): d –82.91 (dd, J = 33.4, 25.8 Hz, 1 F), –84.72 (dd, J = 33.4, 
3.9 Hz, 1 F);  
IR (film): 2941, 2841, 2359, 1730, 1583, 1510, 1456, 1421, 1358, 1325, 1300, 1252, 
1205, 1178, 1130, 1011, 901, 843, 712 cm-1;  



















1-(2,2-difluorovinyl)-4-methoxybenzene (2.5a): Following General Procedure A2, 2.40 
mL (20.0 mmol) of 4-anisealdehyde was reacted with 12.5 g (35.0 mmol) of SI-2.1 in of 
anhydrous NMP (80 mL) at 60 ˚C for 2 h. After workup, the compound was purified by 
flash chromatography, using 0–5% EtOAc in hexanes, furnishing 1.48 g (44% yield) of 
desired product 2.5a as a yellow oil, which turns purple after standing in the freezer.  
1H NMR (400 MHz, CDCl3): d 7.27 (d, J = 8.8 Hz, 2 H), 6.89 (d, J = 8.4 Hz, 2 H), 5.23 
(dd, J = 26.4, 3.8 Hz, 1 H), 3.82 (s, 3 H);  
13C NMR (126 MHz, CDCl3): d 158.6 (t, J = 2.2 Hz), 155.9 (dd, J = 296.1, 286.9 Hz), 128.9 
(dd, J = 6.3, 3.5 Hz), 122.8 (t, J = 6.2 Hz), 114.3, 81.7 (dd, J = 29.2, 14.2 Hz), 55.4;  
19F NMR (376 MHz, CDCl3): d –84.67 (dd, J = 36.8, 26.4 Hz, 1 F), –86.47 (dd, J = 36.8, 
3.9 Hz, 1 F);  
IR (film): 2959, 2912, 2839, 1732, 1612, 1516, 1466, 1352, 1298, 1250, 1182, 1167, 
1036, 937, 839, 609, 552, 523 cm-1;  









(4-(2,2-difluorovinyl)phenyl)(methyl)sulfane (2.5b): Following General Procedure A2, 
1.9 mL (13 mmol) of 4-methylthiobenzaldehyde was reacted with 8.4 g (24 mmol) of SI-
2.1 in anhydrous DMF (52 mL) at 60 ˚C for 2 h. After workup, the compound was purified 
by flash chromatography, using 0–5% EtOAc in hexanes, to furnish 1.48 g (44% yield) of 
desired product 2.5b as a yellow-green semi-solid. 
1H NMR (400 MHz, CDCl3): d 7.26–7.21 (m, 4 H), 5.23 (dd, J = 26.3, 3.7 Hz, 1 H), 2.48 
(s, 3 H) 
13C NMR (126 MHz, CDCl3): d 156.2 (dd, J = 298.0, 288.1 Hz), 137.3 (t, J = 2.3 Hz), 128.0 
(dd, J = 6.4, 3.5 Hz), 127.1 (t, J = 6.4 Hz), 126.7, 81.8 (dd, J = 29.4, 13.7 Hz), 15.8  
19F NMR (376 MHz, CDCl3): d –82.26 (dd, J = 32.1, 26.2 Hz, 1 F), –84.45 (dd, J = 32.1, 
3.8 Hz, 1 F) 
IR (film): 3032, 2922, 1730, 1599, 1497, 1435, 1406, 1350, 1248, 1167, 1096, 937, 837, 
729, 509 cm-1  
HRMS (HAPCI+): calc. for C9H8F2S (M+) 186.0315, found 186.0302, 1.3 mmu. 
 








5-bromo-2-((4-methoxybenzyl)oxy)benzaldehyde (2.5c-1):2 Compound 2.5c-1 was 




4-bromo-2-(2,2-difluorovinyl)-1-((4-methoxybenzyl)oxy)benzene (2.5c): Following 
General Procedure A2, 2.50 g (7.80 mmol) of 2.5c-1 was reacted with 4.85 g (14.0 mmol) 
of SI-2.1 in anhydrous NMP (32 mL) at 80 ˚C for 2 h. After workup, the product was 
purified by flash chromatography, using 0–2.5–5% EtOAc in hexanes, to furnish 2.23 g 
(81% yield) of desired product 2.5c as a colorless solid, m.p. 65–67 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.59–7.58 (m, 1 H), 7.32 (d, J = 8.4 Hz, 2 H), 7.30–7.27 
(m, 1 H), 6.93 (d, J = 8.2 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 1 H), 5.63 (dd, J = 25.9, 4.8 Hz, 1 













13C NMR (126 MHz, CDCl3): d 159.7, 156.6 (dd, J = 298.2, 288.6 Hz), 155.0 (dd, J = 4.7, 
1.6 Hz), 131.0 (dd, J = 10.7, 2.0 Hz), 130.8, 129.3, 128.4, 121.9 (t, J = 6.4 Hz), 114.2, 
113.9, 113.4, 75.9 (dd, J = 31.9, 12.5 Hz), 70.6, 55.5 
19F NMR (376 MHz, CDCl3): d –81.71 (dd, J = 28.2, 5.0 Hz, 1 F), –81.90 (dd, J = 27.9, 
25.9 Hz, 1 F) 
IR (film): 3043, 2955, 2835, 1726, 1614, 1587, 1514, 1487, 1464, 1406, 1381, 1344, 
1300, 1285, 1248, 1223, 1173, 1117, 1034, 1005, 947, 878, 824, 802, 652, 581 cm-1 
HRMS (HAPCI+): calc. for C16H12BrF2O2 (M-H) 352.9989, found 352.9983, 1.7 ppm.  
 
Preparation of Compound 2.5d 
 
2-(3-bromophenyl)-1,3-dioxolane (2.5d-2):3 Compound 2.5d-2 was prepared according 























60 ˚C, NMP, 3 h
1) Pd2(dba)3, rac-BINAP
    KOt Bu, PhMe, 100 ˚C, 18 h
2) HCl, ambient temp, 2 h
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A 250 mL round-bottomed flask was charged with 5.8 mL (50 mmol) of 3-
bromobenzaldehyde, 3.4 mL (60 mmol) of ethylene glycol, and 0.050 g (0.25 mmol) of p-
toluenesulfonic acid. The reactants were dissolved in toluene (100 mL), and a Dean-Stark 
apparatus and reflux condenser was added to the top of the round-bottom flask. The 
reaction was placed in a preheated oil bath at 120 ˚C, and refluxed for 18 h. The reaction 
was washed with NaHCO3, dried with MgSO4, and concentrated. The product was used 
as is. The 1H NMR spectrum matched previous reports.3 
 
3-morpholinobenzaldehyde (2.5d-1):3 Compound 2.5d-1 was prepared according to a 
previous report. The 1H NMR spectrum matched previous reports.3 
 
4-(3-(2,2-difluorovinyl)phenyl)morpholine (2.5d):  Following General Procedure A1, 
0.62 g (3.0 mmol) of 2.5d-1 was reacted with 1.87 g (5.25 mmol) of SI-2.1 in anhydrous 
NMP (12 mL) at 60 ˚C for 3 h. After workup, the product was purified by flash 
chromatography, using 0–20% EtOAc in hexanes, to furnish 0.45 g (62% yield) of desired 
product 2.5d as a yellow oil.  
1H NMR (400 MHz, CDCl3): d 7.25 (t, J = 8.2 Hz, 1 H), 6.88–6.86 (m, 2 H), 6.81 (ddd, J 
= 8.3, 2.5, 1.0 Hz, 1 H), 5.24 (dd, J = 26.2, 4.0 Hz, 1 H), 3.88–3.85 (m, 4 H), 3.17–3.15 
(m, 4 H) 
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13C NMR (126 MHz, CDCl3): d 156.4 (dd, J = 298.1, 288.0 Hz), 151.7, 131.3 (dd, J = 7.0, 
6.1 Hz), 129.6, 119.6 (dd, J = 6.4, 3.4 Hz), 115.0 (dd, J = 6.4, 3.6 Hz), 114.7 (t, J = 1.9 
Hz), 82.6 (dd, J = 28.9, 13.1 Hz), 67.0, 49.4 
19F NMR (376 MHz, CDCl3): d –82.05 (dd, J = 31.7, 26.2 Hz, 1 F), –84.21 (dd, J = 31.6, 
3.7 Hz, 1 F) 
IR (film): 2964, 2856, 2826, 2361, 2343, 1730, 1601, 1578, 1497, 1439, 1379, 1352, 
1304, 1254, 1213, 1163, 1122, 1070, 999, 926, 885, 860, 820, 777, 744, 690, 644, 571, 
527 cm-1 
HRMS (ESI+): calc. for C12H14F2NO (M+H) 226.1043, found 226.1062, 1.9 mmu. 
 
 
4-(2,2-difluorovinyl)-N,N-dimethylaniline (2.5e): Following General Procedure A2, 1.49 
g (10.0 mmol) of 4-dimethylaminobenzaldehyde was reacted with 6.24 g (17.5 mmol) of 
SI-2.1 in anhydrous DMF (20 mL) at 60 ˚C for 2 h. After workup, the product was purified 
by flash chromatography, using 0–10% EtOAc in hexanes, to furnish 1.09 g (60% yield) 
of desired product 2.5e as a yellow oil.  
1H NMR (400 MHz, CDCl3): d 7.22–7.20 (m, 2 H), 6.71–6.69 (m, 2 H), 5.17 (dd, J = 26.9, 







13C NMR (126 MHz, CDCl3): d 155.7 (dd, J = 295.7, 285.3 Hz), 149.5 (t, J = 1.8 Hz), 128.6 
(dd, J = 6.1, 3.5 Hz), 118.3 (t, J = 5.9 Hz), 112.7, 81.8 (dd, J = 28.7, 14.3 Hz), 40.6 
19F NMR (376 MHz, CDCl3): d –85.89 (dd, J = 40.5, 26.8 Hz, 1 F), –88.03 (dd, J = 40.5, 
4.0 Hz, 1 F) 
IR (film): 2891, 2806, 2361, 2341, 1730, 1614, 1526, 1481, 1445, 1348, 1250, 1200, 
1169, 1063, 933, 833, 810, 542, 521 cm-1 
HRMS (ESI+): calc. for C10H12F2N (M+H) 184.0938, found 184.0930, 0.8 mmu. 
 
Preparation of Compound 2.5f 
 
4-formylphenyl trifluoromethanesulfonate (2.5f-1):4 Compound 2.5f-1 was prepared 
according to a previous report. The 1H NMR spectrum matched previous reports.4 
 
4-(2,2-difluorovinyl)phenyl trifluoromethanesulfonate (2.5f): Following General 
Procedure A2, 3.67 g (14.4 mmol) of 2.5f-1 was reacted with 9.00 g (25.3 mmol) of SI-
















flash chromatography, using 0–10% EtOAc in hexanes, to furnish 1.51 g (36% yield) of 
desired product 2.5f as a clear oil.  
1H NMR (400 MHz, CDCl3): d 7.42–7.39 (m, 2 H), 7.27–7.23 (m, 2 H), 5.31 (dd, J = 25.6, 
3.4 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 156.7 (dd, J = 299.2, 290.2 Hz), 148.2 (t, J = 2.7 Hz), 131.1 
(dd, J = 7.3, 6.1 Hz), 129.4 (dd, J = 6.8, 3.6 Hz), 121.8, 118.9 (q, J = 320.9 Hz), 81.3 (dd, 
J = 30.4, 13.5 Hz) 
19F NMR (376 MHz, CDCl3): d –72.80 (s, 3 F), –80.72 (dd, J = 26.7, 26.1 Hz, 1 F), –81.99 
(dd, J = 26.7, 3.5 Hz, 1 F) 
IR (film): 2361, 2344, 1732, 1505, 1427, 1356, 1252, 1213, 1173, 1140, 1018, 943, 889, 
851, 741, 610, 525 cm-1 
HRMS (HAPCI+): calc. for C9H5F5O3S (M+) 287.9880, found 287.9872, 2.8 ppm. 
 
Preparation of Compound 2.5g 
 
Ph3P+CF2CO2-

















4’-(tert-butyl)-[1,1’-biphenyl]-2-carbaldehyde (2.5g-1):5 An oven dried 500 mL round 
bottom flask was charged with 2.9 mL (25 mmol) of 2-bromobenzaldehyde and 8.90 g 
(50.0 mmol) of 4-tert-butylphenylboronic acid and the system was moved to glovebox for 
the addition of 24.4 g (75.0 mmol) of Cs2CO3, 0.29 g (0.25 mmol) of Pd(PPh3)4 and 
anhydrous 1,4-dioxane (250 mL). After removal from the glovebox the system was 
immediately immersed in an oil bath at 80 ˚C and stirred overnight. The reaction was 
diluted with water and the aqueous layer was extracted with DCM (3 x 100 mL). The 
combined organic layers were dried over MgSO4 and concentrated. Chromatography on 
silica gel (hexanes/EtOAc) afforded 5.11 g (86%) of desired product 2.5g-1 as a colorless 
solid, m.p. 55 ˚C. 
1H NMR (400 MHz, CDCl3): d 10.01 (d, J = 0.9 Hz, 1 H), 8.02 (dd, J = 7.4, 1.2 Hz, 1 H), 
7.63 (td, J = 7.5, 1.5 Hz, 1 H), 7.52–7.44 (m, 4 H), 7.32 (d, J = 8.3 Hz, 2 H), 1.38 (s, 9 H).  
 
4'-(tert-butyl)-2-(2,2-difluorovinyl)-1,1'-biphenyl (2.5g): Following General Procedure 
A1, 5.11 g (21.4 mmol) of 5g-1 was reacted with 13.0 g (36.4 mmol) of SI-2.1 in anhydrous 
DMF (85 mL) at 60 ˚C for 2 h. After workup, the product was purified by flash 
chromatography, using 0–10% EtOAc in hexanes, to furnish 4.67 g (80% yield) of desired 
product 2.5g as a colorless solid, m.p. 46–48 ˚C. 
1H NMR (500 MHz, CDCl3): d 7.59 (d, J = 8.1 Hz, 1 H), 7.43 (d, J = 8.5 Hz, 2 H), 7.34 
(dd, J = 6.8, 3.5 Hz, 1 H), 7.32 (dd, J = 8.1, 5.4 Hz, 1 H), 7.29 (dd, J = 6.1, 1.3 Hz, 2 H), 
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7.26 (d, J = 2.0 Hz, 1 H), 7.24 (d, J = 1.3 Hz, 1 H), 5.27 (dd, J = 26.2, 4.3 Hz, 1 H), 1.37 
(s, 9 H) 
13C NMR (126 MHz, CDCl3): d 156.4 (dd, J = 297.6, 286.8 Hz), 150.3, 141.3 (dd, J = 4.9, 
1.6 Hz), 137.8, 130.4, 129.4, 128.2 (dd, J = 9.6, 1.5 Hz), 128.1 (d, J = 6.3 Hz), 127.5, 
127.2, 125.3, 80.9 (dd, J = 30.4, 12.3 Hz), 34.7, 31.5 
19F NMR (376 MHz, CDCl3): d –83.28 (dd, J = 32.5, 4.3 Hz, 1 F), –85.14 (ddd, J = 32.6, 
26.1, 1.8 Hz, 1 F) 
IR (film): 2964, 1726, 1483, 1398, 1348, 1269, 1232, 1173, 1117, 939, 835, 762 cm-1 
HRMS (HAPCI+): calc. for C18H19F2 (M+H) 273.1455, found 273.1452, 1.1 ppm. 
 
 
1-(benzyloxy)-4-(2,2-difluorovinyl)-2-methoxybenzene (2.5h): Following General 
Procedure A2, 2.42 g (10.0 mmol) of 5h-1 was reacted with 6.24 g (17.5 mmol) of SI-2.1 
in anhydrous DMF (40 mL) at 60 ˚C for 2 h. After workup, the product was purified by 
flash chromatography, using 0–10% EtOAc in hexanes, to furnish 2.18 g (79% yield) of 








1H NMR (400 MHz, CDCl3): d 7.43 (d, J = 7.6 Hz, 2 H), 7.39–7.35 Hz (m, 2 H), 7.32–7.28 
(m, 1 H), 6.90 (d, J = 1.9 Hz, 1 H), 6.84 (d, J = 8.3 Hz, 1 H), 6.80 (dd, J = 8.4, 2.0 Hz, 1 
H), 5.21 (dd, J = 26.2, 3.9 Hz, 1 H), 5.17 (s, 2 H), 3.89 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 156.0 (dd, J = 296.8, 286.9 Hz), 149.8, 147.4 (t, J = 2.2 
Hz), 137.1, 128.7, 128.0, 127.4, 123.7 (t, J = 6.3 Hz), 120.5 (dd, J = 6.1, 4.0 Hz), 114.2, 
111.2 (dd, J = 6.9, 3.1 Hz), 82.0 (dd, J = 29.4, 13.7 Hz), 71.1, 56.1 
19F NMR (376 MHz, CDCl3): d –84.07 (dd, J = 35.9, 26.2 Hz, 1 F), –85.90 (dd, J = 36.0, 
3.8 Hz, 1 F) 
IR (film): 3410, 2359, 2341, 1734, 1520, 1472, 1456, 1421, 1340, 1265, 1211, 1182, 
1142, 1030, 1003, 858, 798, 744, 696, 681, 650, 440, 417 cm-1 
HRMS (HAPCI+): calc. for C16H14F2O2 (M+) 276.0962, found 276.0953, 3.3 ppm. 
 
Preparation of Compound 2.5i 
 
 (2-iodophenyl)methanol (2.5i-2):6 Compound 2.5i-2 was prepared according to a 
previous report.6 An oven-dried 250 mL round bottom flask was charged with a magnetic 























and the solution cooled to 0 ˚C. At 0 ˚C, 22 mL of BH3•THF (22 mmol, 1 M in THF) was 
added dropwise. The reaction was allowed to warm to ambient temperature and stir 
overnight. The reaction was quenched with 50 mL of a solution of 1:1 THF:H2O. The THF 
was removed in vacuo, and 50 mL of a saturated aq. solution of K2CO3 added. The 
resulting solution was extracted 3X with 25 mL of Et2O, and the combined organic layers 
dried over MgSO4 and concentrated in vacuo. The resulting compound was of sufficient 
purity to use for the next step, and the reaction afforded 4.50 g (96%) of desired product 
2.5i-2 as a colorless solid. The 1H NMR spectrum matched previous reports.6 
 
2-iodobenzaldehyde (2.5i-1):7 Compound 2.5i-1 was prepared according to a previous 
report.7 An oven-dried 500 mL flask was charged with a magnetic stirbar, 4.50 g (19.0 
mmol) of 5i-2, and 12.32 g (29.0 mmol) of Dess-Martin periodinane. The system was 
evacuated and backfilled with N2 3X, and then anhydrous DCM (200 mL) was added at 
R.T.. The reaction was stirred overnight at ambient temperature, and quenched with 
approximately 50 mL of H2O. Upon the addition of H2O, a white precipitate formed, and 
the reaction was filtered. The precipitate was loaded on silica gel and purified by flash 
chromatography with 20% EtOAc in hexanes. The reaction furnished 3.34 g (75%) of 
desired product 2.5i-1 as a colorless solid. The 1H NMR spectrum matched previous 
reports.7 
 
1-(2,2-difluorovinyl)-2-iodobenzene (2.5i): Following General Procedure A1, 3.00 g 
(13.0 mmol) of 2.5i-1 was reacted with 8.11 g (23.0 mmol) of SI-2.1 in anhydrous NMP 
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(52 mL) at 80 ˚C for 2 h. After workup, the product was purified by flash chromatography, 
using a very slow gradient of 0–5% EtOAc in hexanes, to furnish 2.16 g (63% yield) of 
desired product 2.5i as a clear oil. 
1H NMR (400 MHz, CDCl3): d 7.86 (dd, J = 7.9, 1.2 Hz, 1 H), 7.47 (dt, J = 7.9, 1.7 Hz, 1 
H), 7.34 (J = 7.9, 7.3, 1.3 Hz, 1 H), 6.95 (td, 7.7, 1.7 Hz, 1 H), 5.57 (dd, J = 25.0, 3.7 Hz, 
1 H) 
13C NMR (126 MHz, CDCl3): d 156.7 (dd, J = 298.6, 289.0 Hz), 139.6, 134.0 (dd, J = 8.0, 
5.6 Hz), 128.9 (d, J = 1.6 Hz), 128.85 (dd, J = 8.7, 1.4 Hz), 128.5, 99.7 (dd, J = 5.7, 2.0 
Hz), 86.5 (32.1, 12.6 Hz) 
19F NMR (376 MHz, CDCl3): d –82.34 (dd, J = 26.7, 3.6 Hz, 1 F), –83.88 (dd, J = 26.7, 
24.9 Hz, 1 F) 
IR (film): 1729, 1468, 1433, 1348, 1275, 1244, 1175, 1113, 1013, 941, 810, 748, 712, 
665, 635, 571 cm-1 
HRMS (HAPCI+): calc. for C8H5F2I (M+) 265.9404, found 265.9400, 1.5 ppm. 
 



















DMF, 125 ˚C, 18 h
Ph3P+CF2CO2-
NMP, 80 ˚C, 2 h
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ethyl (E)-3-(3-formylphenyl)acrylate (2.5j-1):8 Compound 2.5j-1 was prepared 
according to a previous report.8 A flame dried 500 mL round bottom flask was equipped 
with a magnetic stirbar and charged with Pd(OAc)2 (0.112 g, 0.500 mmol) of and (o-
MeC6H4)3P (0.305 g, 1.00 mmol). The system was evacuated and backfilled 3X with N2, 
and anhydrous DMF (125 mL) was added via cannula. By syringe, 3.33 mL (31.3 mmol) 
of ethyl acrylate and 3.0 mL (25 mmol) of 3-bromobenzaldehyde were added, followed by 
7.0 mL (50 mmol) of anhydrous Et3N. The system was immediately submerged in a 
preheated 125 ˚C oil bath and stirred for 18 h. After returning to ambient temperature, the 
reaction was quenched with H2O and extracted 3X with DCM. The combined organic 
layers were washed 2X with 1 N aq. HCl and 2X with saturated brine solution. The organic 
layers were then dried over MgSO4, concentrated, and purified by flash chromatography 
on silica gel (0–20% EtOAc in hexanes), to furnish 3.19 (63%) of desired product 2.5j-1 
as a clear oil. The 1H NMR spectrum matched reference.8 
 
ethyl (E)-3-(3-(2,2-difluorovinyl)phenyl)acrylate (2.5j): Following General Procedure 
A2, 3.07 g (15.0 mmol) of 2.5j-1 was reacted with 9.08 g (25.5 mmol) of SI-2.1 in 
anhydrous NMP (30 mL) at 80 ˚C for 2 h. After workup, the product was purified by flash 
chromatography using 0–10–20% EtOAc in hexanes, to furnish 2.32 g (65% yield) of 
desired product 2.5j as a colorless solid, m.p. 24 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.69 (d, J = 16.0 Hz, 1 H), 7.49 (s, 1 H), 7.43 (td, J = 6.2, 
3.3 Hz, 1 H), 7.38 (d, J = 6.1 Hz, 1 H), 6.47 (d, J = 16.0 Hz, 1 H), 5.31 (dd, J = 26.0, 3.6 
Hz, 1 H), 4.30 (q, J = 7.1 Hz, 2 H), 1.37 (t, J = 7.1 Hz, 3 H) 
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13C NMR (126 MHz, CDCl3): d 167.0, 156.56 (dd, J = 298.8, 289.3 Hz), 144.2, 135.0, 
131.2 (t, J = 7.1, 6.1 Hz), 129.4, 127.3 (dd, J = 6.4, 3.6 Hz), 126.6, 119.0, 81.9 (dd, J = 
29.5, 13.3 Hz), 60.7, 14.5 
19F NMR (376 MHz, CDCl3): d –81.17 (dd, J = 29.2, 25.9 Hz, 1 F), –82.99 (dd, J = 29.0, 
3.7 Hz, 1 F) 
IR (film): 2982, 2361, 2343, 1730, 1713, 1639, 1431, 1367, 1352, 1312, 1267, 1248, 
1178, 1038, 980, 922, 897, 862, 824, 791, 685 cm-1 
HRMS (HAPCI+): calc. for C13H13F2O2 (M+H) 239.0884, found 239.0879, 2.1 ppm. 
 
 
1,3-dichloro-5-(2,2-difluorovinyl)benzene (2.5k): Following General Procedure A2, 
1.61 g (10.0 mmol) of 3,5-dichlorobenzaldehyde was reacted with 5.70 g (17.5 mmol) of 
SI-2.1 in anhydrous NMP (40 mL) at 80 ˚C for 2 h. After workup, the product was purified 
by flash chromatography using 0–10% EtOAc in hexanes, to furnish 0.99 g (52% yield) 
of desired product 2.5k as a pale oil. 
1H NMR (400 MHz, CDCl3): d 7.24 (t, J = 1.9 Hz, 1 H), 7.21 (d, J = 1.9 Hz, 2 H), 5.21 (dd, 








13C NMR (126 MHz, CDCl3): d 156.9 (dd, J = 300.2, 291.1 Hz), 135.4, 133.5 (dd, J = 7.7, 
6.1 Hz), 127.2 (t, J = 2.0 Hz), 126.0 (dd, J = 6.9, 3.6 Hz), 81.1 (dd, J = 31.0, 13.1 Hz) 
19F NMR (376 MHz, CDCl3): d –78.72 (dd, J = 25.2, 23.8 Hz, 1 F), –80.80 (dd, J = 23.8, 
3.3 Hz, 1 F) 
IR (film): 2361, 2341, 1728, 1589, 1560, 1419, 1350, 1254, 1177, 1124, 1105, 980, 899, 
876, 856, 802, 690, 669 cm-1 
HRMS (HAPCI+): calc. for C8H4Cl2F2 (M+) 207.9658, found 207.9648, 4.8 ppm. 
 
Preparation of Compound 2.5l 
 
4-formyl-N,N-dipropylbenzamide (2.5l-1):9 Compound 2.5l-1 was prepared according 
to a previous report. The 1H NMR spectrum matched previous reports.9 
 
4-(2,2-difluorovinyl)-N,N-dipropylbenzamide (2.5l): Following General Procedure A1, 
2.06 g (8.60 mmol) of 5l-1 was reacted with 5.35 g (15.0 mmol) of SI-2.1 in anhydrous 
NMP (34.4 mL) at 80 ˚C for 2 h. After workup, the product was purified by flash 
2.5l-1
H
O 1) SOCl2, PhMe,
    reflux, 1 h
2) dipropylamine,
    Hunig's base,
    DCM, 0 ˚C–R.T.
Ph3P+CF2CO2-














chromatography, using 0–20–50% EtOAc in hexanes, to furnish 1.84 g (80% yield) of 
desired product 2.5l as a yellow oil.  
1H NMR (400 MHz, CDCl3): d 7.36–7.31 (m, 4 H), 5.29 (dd, J = 26.1, 3.6 Hz, 1 H), 3.45 
(bs, 2 H), 3.18 (bs, 2 H), 1.68 (bs, 2 H), 1.53 (bs, 2 H), 0.97 (bs, 3 H), 0.75 (bs, 3 H) 
13C NMR (126 MHz, CDCl3): d 171.4, 156.6 (dd, J = 299.2, 289.3 Hz), 136.0 (t, J = 2.1 
Hz), 131.3 (t, J = 6.7 Hz), 127.6 (dd, J = 6.4, 3.5 Hz), 127.1, 82.0 (dd, J = 29.5, 13.5 Hz), 
50.8, 46.5, 22.1, 20.8, 11.6, 11.2 
19F NMR (376 MHz, CDCl3): d –81.03 (dd, J = 28.6, 26.2, 1 F), –82.96 (dd, J = 28.6, 3.7, 
1 F) 
IR (film): 2966, 2935, 2876, 2361, 2343, 1730, 1634, 1514, 1464, 1425, 1381, 1352, 
1246, 1169, 1099, 939, 856, 762, 586 cm-1 
HRMS (ESI+): calc. for C15H20F2NO (M+H) 268.1513, found 268.1517, 0.4 mmu. 
 
 
4-(2,2-difluorovinyl)benzonitrile (2.5m): Following General Procedure A2, 2.17 g (16.6 
mmol) of 4-cyanobenzaldehyde was reacted with 10.3 g (29.0 mmol) of SI-2.1 in 






flash chromatography, using 0–10% EtOAc in hexanes, to furnish 1.20 g (44% yield) of 
desired product 2.5m as a colorless solid, m.p. 66–67 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.55 (d, J = 8.4 Hz, 2 F), 7.36 (d, J = 8.4, 2 H), 5.27 (dd, J 
= 25.6, 3.4 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 157.1 (dd, J = 301.3, 292.3 Hz), 135.5 (dd, J = 7.4, 6.4 
Hz), 132.6, 128.2 (dd, J = 6.9, 3.6 Hz), 118.8, 110.7 (t, J = 2.4 Hz), 82.0 (dd, J = 30.5, 
12.9 Hz) 
19F NMR (376 MHz, CDCl3): d –77.77 (dd, J = 25.5, 20.4 Hz, 1 F), –79.44 (dd, J = 20.5, 
3.3 Hz, 1 F) 
IR (film): 3423, 3406, 2361, 2341, 2228, 1732, 1610, 1514, 1244, 1173, 945, 856, 746, 
548 cm-1 
HRMS (HAPCI+): calc. for C9H6F2N (M+H) 166.0468, found 166.0462, 3.6 ppm. 
 
 
1-(2,2-difluorovinyl)-3-nitrobenzene (2.5n): Following General Procedure A2, 3.03 g 
(20.0 mmol) of 3-nitrobenzaldehyde was reacted with 12.5 g (35.0 mmol) of SI-2.1 in 







flash chromatography, using 0–5% EtOAc in hexanes, to furnish 2.38 g (64% yield) of 
desired product 2.5n as a pale yellow solid, m.p. 30–32 ˚C. 
1H NMR (400 MHz, CDCl3): d 8.20 (s, 1 H), 8.10 (d, J = 8.7 Hz, 1 H), 7.65 (d, J = 7.8 Hz, 
1 H), 7.52 (t, J = 8.0 Hz, 1 H), 5.39 (dd, J = 25.3, 3.1 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 157.1 (dd, J = 299.8, 291.5 Hz), 148.7, 133.4 (dd, J = 6.7, 
3.6 Hz), 132.4 (dd, J = 7.8, 6.1 Hz), 129.8, 122.5 (dd, J = 6.8, 3.7 Hz), 122.0 (t, J = 2.0 
Hz), 81.3 (dd, J = 30.9, 13.3 Hz) 
19F NMR (376 MHz, CDCl3): d –78.94 (dd, J = 25.2, 23.7 Hz, 1 F), –80.67 (dd, J = 23.8, 
3.2 Hz, 1 F) 
IR (film): 3101, 2361, 2341, 1730, 1531, 1350, 1296, 1248, 1177, 972, 914, 901, 824, 
735, 706, 677 cm-1 
HRMS (HAPCI+): calc. for C8H6F2NO2 (M+H) 186.0367, found 186.0359, 4.3 ppm. 
 
Preparation of Compound 2.7a 
 
1-tosyl-1H-indole-3-carbaldehyde (2.7a-1):10 Compound 2.7a-1 was prepared 





















3-(2,2-difluorovinyl)-1-tosyl-1H-indole (2.7a): Following General Procedure A1, 1.80 g 
(6.00 mmol) of 2.7a-1 was reacted with 3.77 g (10.5 mmol) of SI-2.1 in anhydrous DMF 
(24 mL) at 80 ˚C for 2 h. After workup, the product was purified by flash chromatography, 
using hexanes, increasing to 5% DCM in hexanes, then 5% EtOAc in hexanes, and then 
increasing to 10% EtOAc in hexanes, to furnish 1.59 g (79% yield) of desired product 2.7a 
as a colorless solid, m.p. 106–108 ˚C. 
1H NMR (400 MHz, CDCl3): d 8.04 (d, J = 8.3 Hz, 1 H), 7.79 (d, J = 8.0 Hz, 2 H), 7.65 (s, 
1 H), 7.48 (d, J = 7.9 Hz, 1 H), 7.36 (t, J = 7.8 Hz, 1 H), 7.27 (t, J = 7.5 Hz, 1 H), 7.20 (d, 
J = 8.0 Hz, 2 H), 5.39 (d, 26.7 Hz, 1 H), 2.31 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 156.8 (dd, J = 296.1, 289.9 Hz), 145.2, 135.0, 134.7, 130.0, 
129.4 (d, J = 3.3 Hz), 126.9, 125.3, 123.5, 123.3 (dd, J = 9.8, 3.9 Hz), 119.1 (d, J = 1.3 
Hz), 113.8, 111.9 (J = 6.6, 5.2 Hz), 72.5 (dd, J = 32.1, 18.4 Hz), 21.6 
19F NMR (376 MHz, CDCl3): d –78.18 (t, 26.4 Hz, 1 F), –84.63 (d, J = 26.3 Hz, 1 F) 
IR (film): 2361, 2341, 1732, 1597, 1558, 1448, 1375, 1323, 1286, 1175, 1134, 1094, 980, 
918, 837, 814, 760, 744, 702, 677, 656, 590, 573, 538 cm-1 
HRMS (ESI+): calc. for C17H14F2NO2S (M+H) 334.0713, found 334.0733, 2.0 mmu. 
 




2-bromo-5-(1,3-dioxolan-2-yl)pyridine (2.7b-2):11 Compound 2.7b-2 was prepared 
according to a previous report.11 A 1 L round-bottom flask was charged with 10.1 g (54.0 
mmol) of 6-bromonicotinaldehyde, PhMe (540 mL), 13.2 mL (220 mmol) of ethylene 
glycol, and 1.17 g (5.40 mmol) of PTSA-H2O were sequentially added. The system was 
equipped with a Dean-Stark apparatus and a reflux condenser, placed in a 120 ˚C oil 
bath, and stirred for 18 h. The resulting solution was washed with saturated NaHCO3 (3X 
100 mL) followed by brine (2X 100 mL). The organic layer was dried with Na2SO4 and 
concentrated under reduced pressure to afford 8.87 g (71% yield) of desired product 2.7b-
2 as a clear oil. The 1H NMR spectrum matched previous reports.11 
 
3-(5-(1,3-dioxolan-2-yl)pyridin-2-yl)benzaldehyde (2.7b-1): An oven-dried 1 L round 
bottom flask was charged with 8.87 g (39.0 mmol) of 7b-2, 8.71 g (58.0 mmol) of 3-
boronobenzaldehyde, 1.31 g (5.80 mmol) of Pd(OAc)2, and 26.1 g (77.0 mmol) of K3PO4-
7H2O. The flask was sealed with a rubber septum and evacuated and backfilled with N2 


























80 ˚C, 13 h
Ph3P+CF2CO2-
NMP, 60 ˚C, 1 h
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and 200 mL of H2O (freshly distilled under N2 gas). The reaction vessel was submerged 
in an 80 ˚C oil bath for 13 h. At R.T., brine (100 mL) was added to the reaction, followed 
by an extraction with EtOAc (3X 150 mL). The organic layer was concentrated with 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by 
silica gel flash chromatography using a gradient from 0–20–50% EtOAc in hexanes, to 
furnish 4.81 g (49% yield) of desired product 2.7b-1 as a yellow/white solid, m.p. 57–59 
˚C. 
1H NMR (400 MHz, CDCl3): d 10.12 (s, 1 H), 8.81 (d, J = 2.1 Hz, 1 H), 8.52 (t, J = 1.7 Hz, 
1 H), 8.31 (ddd, J = 7.9, 1.9, 1.1 Hz, 1 H), 7.95 (dt, J = 7.7, 1.4 Hz, 1 H), 7.92 (dd, J = 8.2, 
2.2 Hz, 1 H), 7.83 (dd, 8.2, 0.9 Hz, 1 H), 7.66 (t, J = 7.7 Hz, 1 H), 5.93 (s, 1 H), 4.19–4.07 
(m, 4 H) 
13C NMR (126 MHz, CDCl3): d 192.4, 156.8, 148.6, 140.1, 137.0, 135.5, 133.0, 132.8, 
130.1, 129.7, 128.7, 120.4, 102.0, 65.6 
IR (film): 2959, 2888, 2729, 1697, 1601, 1587, 1474, 1356, 1182, 1163, 1086, 1024, 982, 
941, 837, 800, 764, 689, 652, 403 cm-1 
HRMS (ESI+): calc. for C15H14NO3 (M+H) 256.0974, found 256.0996, 2.2 mmu. 
 
2-(3-(2,2-difluorovinyl)phenyl)-5-(1,3-dioxolan-2-yl)pyridine (2.7b): Following 
General Procedure A1, 4.56 g (18.0 mmol) of 2.7b-1 was reacted with 11.0 g (31.0 mmol) 
of SI-2.1 in anhydrous NMP (38 mL) at 60 ˚C for 1 h. After workup, the product was 
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purified by flash chromatography on silica gel, using a gradient from 0–20–50% EtOAc in 
hexanes, to furnish 3.95 g (76% yield) of desired product 2.7b as a tan solid, m.p. 35 ˚C. 
1H NMR (400 MHz, CDCl3): d 8.78 (dt, J = 2.2, 0.7 Hz, 1 H), 7.95 (t, J = 1.8 Hz, 1 H), 7.87 
(dd, J = 8.3, 2.3 Hz, 1 H), 7.84 (dt, J = 7.2, 1.7 Hz, 1 H), 7.74 (dd, J = 8.2, 0.8 Hz, 1 H), 
7.47–7.41 (m, 2 H), 5.91 (s, 1 H), 5.38 (dd, J = 26.1, 3.8 Hz, 1 H), 4.18–4.06 (m, 4 H) 
13C NMR (126 MHz, CDCl3): d 158.0, 156.5 (dd, J = 298.5, 288.6 Hz), 148.4, 139.6, 135.2, 
132.2, 131.1 (t, J = 6.5 Hz), 129.3, 128.3 (dd, J = 6.9, 3.2 Hz), 126.6 (dd, J = 5.8, 3.8 Hz), 
125.8 (t, J = 2.0 Hz), 120.4, 102.1, 82.3 (dd, J = 29.4, 13.3 Hz), 65.6 
19F NMR (376 MHz, CDCl3): d –81.56 (dd, J = 30.3, 26.1 Hz, 1 F), –83.63 (dd, J = 30.3, 
3.8 Hz, 1 F) 
IR (film): 2982, 2888, 1728, 1601, 1566, 1474, 1427, 1410, 1352, 1296, 1227, 1165, 
1138, 1088, 1024, 982, 951, 891, 856, 833, 797, 766, 692, 571 cm-1 
HRMS (ESI+): calc. for C16H14F2NO2 (M+H) 290.0993, found 290.0996, 1.0 ppm. 
 
  
4-(2,2-difluorovinyl)-1-phenyl-1H-pyrazole (2.7c): Following General Procedure A1, 









(15.0 mmol) of SI-2.1 in anhydrous NMP (17.4 mL) at 60 ˚C for 1 h. After workup, the 
product was purified by flash chromatography, using hexanes, increasing to 10% DCM in 
hexanes, then 5% EtOAc in hexanes, and then increasing to 10% EtOAc in hexanes, to 
furnish 1.18 g (66% yield) of desired product 2.7c as a colorless solid, m.p. 70–71 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.88 (s, 1 H), 7.70 (s, 1 H), 7.67 (d, J = 7.9 Hz, 2 H), 7.44 
(t, J = 7.7 Hz, 2 H), 7.29 (t, J = 7.2 Hz, 1 H), 5.22 (dd, J = 26.9, 1.7 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 156.3 (dd, J = 293.6, 287.3 Hz), 140.0 (dd, J = 4.3, 3.0 
Hz), 139.9, 129.5, 126.7, 124.5 (t, J = 4.9 Hz), 119.1, 113.2 (dd, J = 7.2, 4.9 Hz), 72.9 
(dd, J = 32.0, 18.7 Hz) 
19F NMR (376 MHz, CDCl3): d –82.09 (dd, J = 34.7, 27.0 Hz, 1 F), –88.03 (dd, J = 34.8, 
1.7 Hz, 1 F) 
IR (film): 2361, 2341, 1741, 1466, 1398, 1317, 1238, 1165, 1074, 1018, 825, 751, 689, 
656 cm-1 
HRMS (ESI+): calc. for C11H9F2N2 (M+H) 207.0734, found 207.0720, 1.4 mmu. 
 










THF, 0 ˚C, 1.5 h
Ph3P+CF2CO2-
NMP, 80 ˚C, 2 h
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dibenzo[b,d]thiophene-4-carbaldehyde (2.7d-1):12 An oven dried 100 mL round bottom 
flask was equipped with a magnetic stirbar and charged with 1.87 g (10.0 mmol) of 
dibenzothiophene. The system was evacuated and backfilled with N2, and then 
anhydrous THF (30 mL) was added. The system was cooled to 0 ˚C, and 7.45 mL (10.0 
mmol) of freshly titrated n-BuLi (titrated at 1.38 M in hexanes) was added dropwise to the 
reaction. The reaction was stirred 1.5 h at 0 ˚C, and then 1.60 mL (20.0 mmol) of 
anhydrous DMF was added dropwise at 0 ˚C, and the reaction was stirred for 2.5 h at 0 
˚C. The reaction was poured into 50 mL of ice water to quench the reaction, and the 
resulting solution was extracted 3X with 20 mL of EtOAc, dried over MgSO4, and 
concentrated. After workup, the product was purified by flash chromatography on silica 
gel using a gradient from 0–20% EtOAc in hexanes, to furnish 1.41 g (66%) of desired 
product 2.7d-1 was isolated as a colorless solid. 
1H NMR (400 MHz, CDCl3): d 10.31 (s, 1 H), 8.45 (d, J = 7.8 Hz, 1 H), 8.25–8.23 (m, 1 
H), 8.01 (dd, J = 7.5, 1.1 Hz, 1 H), 7.99–7.96 (m, 1 H), 7.69 (t, J = 7.6 Hz, 1 H), 7.54 (td, 
J = 6.5, 5.7, 3.6 Hz, 2 H). 
 
4-(2,2-difluorovinyl)dibenzo[b,d]thiophene (2.7d): Following General Procedure A2, 
1.37 g (5.70 mmol) of 2.7d-1 was reacted with 3.59 g (9.99 mmol) of SI-2.1 in anhydrous 
NMP (23 mL) at 80 ˚C for 2 h. After workup, the product was purified by flash 
chromatography on silica gel, using a gradient from 0–10–20% EtOAc in hexanes, to 
furnish 0.97 g (61%) of desired product 2.7d as a colorless solid, m.p. 79–80 ˚C. 
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1H NMR (400 MHz, CDCl3): d 8.18–8.13 (m, 1 H), 8.07 (dd, J = 7.8, 1.1 Hz, 1 H), 7.90–
7.86 (m, 1 H), 7.59 (dt, J = 7.7, 1.5 Hz, 1 H), 7.51–7.46 (m, 3 H), 5.54 (dd, J = 25.1, 3.2 
Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 157.1 (dd, J = 299.2, 290.2 Hz), 138.8, 136.02, 135.99, 
127.1, 125.5 (dd, J = 8.9, 1.9 Hz), 125.1, 125.0, 124.8, 123, 122, 120.5 (t, J = 1.6 Hz), 
80.1 (dd, J = 30.4, 14.6 Hz) 
19F NMR (376 MHz, CDCl3): d –80.64 (dd, J = 25.0, 1.7 Hz, 1 F), –81.64 (dd, J = 24.7, 
3.2 Hz, 1 F) 
IR (film): 2361, 2341, 1728, 1394, 1354, 1265, 1205, 1167, 955, 820, 750, 667, 424 cm-
1 
HRMS (HAPCI+): calc. for C14H8F2S (M+) 246.0315, found 246.0304, 4.5 ppm. 
 


















1) NaH, THF, 60 ˚C, 4 h
2) a) BnBr, R.T., 18 h
    b) 60 ˚C, 1 h, HCl
POCl3, DMF
DCE, 80 ˚C, 14 h
Ph3P+CF2CO2-





10-benzyl-10H-phenothiazine (2.7e-2):13 Compound 2.7e-2 was prepared according to 
a previous report.13 An oven dried 500 mL round bottom flask was charged with 3.03 g 
(126 mmol) of NaH in a glovebox. Upon removal from the glovebox, the NaH was 
suspended in anhydrous THF (60 mL). In a separate 100 mL round bottom flask, 5.97 g 
(30.0 mmol) of phenothiazine was dissolved in anhydrous THF (30 mL) and transferred 
by cannula to the 500 mL round bottom flask. The system was immediately immersed in 
an oil bath at 60 ˚C for 4 h or until the appearance of a yellow/orange color. The reaction 
was cooled to ambient temperature, and 6.07 mL (51.0 mmol) of benzyl bromide was 
added dropwise. The solution was stirred for 18 h, and then heated at 60 ˚C for 1 h or 
until the color faded. The reaction was quenched with cold 1 N HCl, and the aqueous 
layer was extracted with EtOAc (3 x 100 mL). The combined organic layers were washed 
with 1 M HCl, dried over Na2SO4 and concentrated. Chromatography on silica gel 
(hexanes/EtOAc) afforded 5.37 g (62%) of desired product 2.7e-2 as a colorless solid, 
m.p. 87–88 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.32–7.23 (m, 5 H), 7.03 (dd, J = 7.6, 1.6 Hz, 2 H), 6.92 
(td, J = 7.4, 1.6 Hz, 2 H), 6.80 (td, J = 7.5, 1.2 Hz, 2 H), 6.58 (dd, J = 8.1, 1.2 Hz, 2 H), 
5.04 (s, 2 H). 
 
10-benzyl-10H-phenothiazine-3-carbaldehyde (2.7e-1):14 Compound 2.7e-1 was 
prepared according to a previous report.14 An oven dried 100 mL 3-necked round bottom 
flask with reflux condenser was charged with 2.90 g (10.0 mmol) of 2.7e-2, and the system 
was evacuated and backfilled with N2 three times. Anhydrous DCE (50 mL) was added 
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via cannula followed by the addition of 3.10 mL (40.0 mmol) of DMF. The system was 
cooled to 0 ˚C, and 3.70 mL (40.0 mmol) of POCl3 was added dropwise. The system was 
immediately immersed in an oil bath at 80 ˚C and refluxed overnight. The reaction was 
cooled to 0 ˚C, quenched slowly with 5 mL of water while stirring, and the aqueous layer 
was extracted DCM (3 x 25 mL). The combined organic layers were washed with brine 
(50 mL), dried over anhydrous Na2SO4 and concentrated. Chromatography on silica gel 
(hexanes/EtOAc) afforded 1.00 g (31%) of 2.7e-1 as a yellow solid, m.p. 99–102 ˚C. 
1H NMR (400 MHz, CDCl3): d 9.75 (s, 1 H), 7.56 (d, J = 1.9 Hz, 1 H), 7.45 (dd, J = 8.4, 
2.0 Hz, 1 H), 7.40–7.26 (m, 5 H), 7.08 (dd, J = 7.5, 1.7 Hz, 1 H), 7.00 (td, J = 7.8, 1.7 Hz, 
1 H), 6.92 (td, J = 7.4, 1.3 Hz, 1 H), 6.67 (dd, J = 8.1, 1.3 Hz, 1 H), 6.65 (d, J = 8.4 Hz, 1 
H), 5.13 (s, 2 H). 
 
10-benzyl-3-(2,2-difluorovinyl)-10H-phenothiazine (2.7e): Following General 
Procedure A2, 1.10 g (3.40 mmol) of 2.7e-1 was reacted with 2.07 g (5.80 mmol) of SI-
2.1 in anhydrous DMF (14 mL) at 60 ˚C for 2 h. After workup, the product was purified by 
flash chromatography, using 0–20% EtOAc in hexanes, to furnish 1.00 g (84% yield) of 
desired product 2.7e as a yellow/orange semisolid.  
1H NMR (500 MHz, CDCl3): d 7.38–7.33 (m, 2 H), 7.32–7.27 (m, 3 H), 7.10 (dd, J = 7.6, 
1.6 Hz, 1 H), 7.08 (d, J = 2.2 Hz, 1 H), 7.03–6.95 (m, 1 H), 6.92 (dd, J = 8.5, 2.2 Hz, 1 H), 
6.88 (td, J = 7.5, 1.2 Hz, 1 H), 6.64 (dd, J = 8.2, 1.2 Hz, 1 H), 6.58 (d, J = 8.5 Hz, 1 H), 
5.12 (dd, J = 26.3, 3.7 Hz, 1 H), 5.08 (s, 2 H) 
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13C NMR (126 MHz, CDCl3): d 156.0 (dd, J = 297.6, 287.7 Hz), 144.2, 143.3 (t, J = 2.2 
Hz), 136.5, 128.9, 127.5, 127.2, 127.0, 126.6, 125.7 (dd, J = 6.6, 3.4 Hz), 124.7 (t, J = 
6.3 Hz), 123.5, 122.8, 122.6, 115.5, 81.2 (dd, J = 29.6, 13.8 Hz), 52.7 
19F NMR (376 MHz, CDCl3): d –83.09 (dd, J = 33.9, 26.4 Hz, 1 F), –85.21 (dd, J = 34.0, 
3.5 Hz, 1 F) 
IR (film): 3061, 3030, 2922, 2853, 1728, 1603, 1578, 1497, 1470, 1454, 1445, 1366, 
1344, 1259, 1238, 1173, 955, 879, 825, 746, 735, 696 
HRMS (ESI+): calc. for C21H16F2NS (M+H) 352.0972, found 352.0989, 1.7 mmu.  
 
Preparation of Compound 2.7f 
 
2-(piperazin-1-yl)thiazole (2.7f-3):15 Compound 2.7f-3 was prepared according to a 
previous report.15 A 250 mL 2-neck round bottom flask, equipped with a magnetic stirbar 



































THF, –78 ˚C, 1 h
Ph3P+CF2CO2-
DMF, 80 ˚C, 2 h
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6.03 g (70.0 mmol) of piperazine. The system was dissolved in 1-butanol (60 mL) and 
immersed in an oil bath at 125 ̊ C and refluxed for 5 h. The reaction was cooled to ambient 
temperature and stirred for an additional 15 h. The system was filtered, the filtrate 
concentrated in vacuo, combined with sat. aq. Na2CO3, and extracted with DCM (3 x 50 
mL). The combined organic layers were dried over anhydrous MgSO4 and concentrated. 
Flash chromatography on silica gel (1:1 MeOH/EtOAc) afforded 2.20 g (65% yield) of 
desired product 2.7f-3 as a clear oil. 
1H NMR (400 MHz, CDCl3): d 7.19 (d, J = 3.7 Hz, 1 H), 6.56 (d, J = 3.7 Hz, 1 H), 3.45 
(dd, J = 6.6, 3.5 Hz, 4 H), 2.98 (dd, J = 6.7, 3.5 Hz, 4 H), 1.69 (s, 1 H). 
 
tert-butyl 4-(thiazol-2-yl)piperazine-1-carboxylate (2.7f-2):16 Compound 2.7f-2 was 
prepared according to a previous report.16 A flame dried 250 mL round bottom flask was 
charged with 2.15 g (12.7 mmol) of 7f-3 and 0.16 g (1.3 mmol) of 4-
dimethylaminopyridine, and the system was evacuated and backfilled with N2 three times. 
Anhydrous CH3CN (65 mL) was added via cannula transfer followed by the addition of 
4.40 mL (31.8 mmol) of Et3N. The system was cooled to 0 ˚C for the addition of 5.80 mL 
(25.4 mmol) of Boc2O and stirred at ambient temperature overnight. The reaction was 
quenched with water, and the aqueous layer was extracted EtOAc (3 x 25 mL). The 
combined organic layers were washed with brine (25 mL), dried over anhydrous Na2SO4 
and concentrated. Flash chromatography on silica gel (1:1 MeOH/EtOAc) afforded 3.29 
g (96%) of desired product 2.7f-2 as a yellow solid, m.p. 110–111 ˚C. 
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1H NMR (400 MHz, CDCl3): d 7.21 (d, J = 3.6 Hz, 1 H), 6.60 (d, J = 3.6 Hz, 1 H), 3.56 
(dd, J = 6.5, 3.9 Hz, 4 H), 3.47 (dd, J = 6.5, 3.8 Hz, 4 H), 1.48 (s, 9 H). 
 
tert-butyl 4-(5-formylthiazol-2-yl)piperazine-1-carboxylate (2.7f-1):17 A flame dried 
100 mL round bottom flask was charged with 3.18 g (11.8 mmol) of 2.7f-2, and the system 
was evacuated and backfilled with N2 three times. Anhydrous THF (35 mL) was added 
via cannula transfer and the system was cooled to –78 ˚C for the addition of 9.02 mL 
(14.2 mmol) of freshly titrated n-BuLi. The reaction was stirred at –78 ̊ C for 0.5 h followed 
by the dropwise addition of 1.80 mL (23.6 mmol) of anhydrous DMF. The system was 
stirred for an additional hour at –78 ˚C before being quenched with cold isopropanol and 
moved to 0 ˚C ice bath for a H2O quench. The aqueous layer was extracted EtOAc (3 x 
25 mL). The combined organic layers were washed with brine (25 mL), dried over 
anhydrous Na2SO4 and concentrated. Flash chromatography on silica gel by a gradient 
from 0–20–50–100% EtOAc in hexanes afforded 2.68 g (76%) of desired product 2.7f-1 
as a tan solid, m.p. 135 ˚C. 
1H NMR (400 MHz, CDCl3): d 9.72 (s, 1 H), 7.87 (s, 1 H), 3.72–3.44 (m, 8 H), 1.49 (s, 9 
H). 
 
tert-butyl 4-(5-(2,2-difluorovinyl)thiazol-2-yl)piperazine-1-carboxylate (2.7f): 
Following General Procedure A1, 1.5 g (5.0 mmol) of 2.7f-1 was reacted with 3.0 g (8.5 
mmol) of SI-2.1 in anhydrous DMF (20 mL) at 80 ˚C for 2 h. After workup, the product 
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was purified by flash chromatography on silica gel, using a gradient from 0–20–100% 
EtOAc in hexanes, to furnish 1.2 g (74% yield) of desired product 2.7f as a tan solid, m.p. 
112 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.20 (s, 1 H), 5.55 (dd, J = 25.9, 1.9 Hz, 1 H), 3.71 (dd, J = 
6.5, 3.9 Hz, 4 H), 3.62 (dd, J = 6.5, 3.8 Hz, 4 H), 2.33 (s, 1 H), 1.64 (s, 9 H) 
13C NMR (126 MHz, CDCl3): d 171.6 (dd, J = 5.1, 2.8 Hz), 155.3 (dd, J = 294.2, 288.0 
Hz), 154.8, 138.3 (dd, J = 8.0, 3.4 Hz), 116.1 (dd, J = 8.1, 5.4 Hz), 80.6, 75.5 (dd, J = 
34.3, 18.7 Hz), 48.4, 43.1 (d, J = 11.8 Hz), 28.6 
19F NMR (376 MHz, CDCl3): d –83.42 (dd, J = 34.9, 25.8 Hz, 1 F), –89.90 (d, J = 34.4 Hz, 
1 F) 
IR (film): 3468, 2978, 2930, 2868, 2359, 2342, 1732, 1688, 1530, 1476, 1456, 1422, 
1366, 1341, 1323, 1285, 1269, 1231, 1177, 1142, 1126, 1045, 1001, 974, 918, 851, 804, 
775, 739, 667, 652 cm-1 
HRMS (ESI+): calc. for C14H20F2N3O2S (M+H) 332.1244, found 332.1257, 1.3 mmu. 
 
General Procedure for the Coupling Reaction of Arylthiols and Difluoroalkenes (B): 
An oven-dried 1-dram vial was charged with difluoroalkene (0.50 mmol) and a magnetic 
stirbar. The substrate was dissolved in DCE (2.0 mL), and aryl-thiol (1.0–1.5 mmol) was 
added via a 250 µL micro syringe. Tetramethylguanidine (TMG) (3.1 µL, 0.025 mmol) was 
added via a 10 µL micro syringe. The vial was sealed with a screw top cap with a PTFE 
 
151 
septum and stirred for 3 min at ambient temperature. Subsequently, the vial was placed 
on a pre-heated reaction block, and stirred at 70–90 ˚C for 0.5–20 h. The vial was cooled 
to R.T., and 60 µL of  a,a,a-trifluorotoluene was added by microsyringe. The solution was 
stirred at ambient temperature for 10 min to ensure mixing, after which an aliquot was 
taken from the vial and analyzed by 19F NMR. The NMR sample was then returned to the 
vial, 2 mL of water was added, and the reaction mixture was extracted 3X with 5 mL DCM 
and 5 mL H2O. After extraction, the organic layer was dried with MgSO4 or Na2SO4 and 
concentrated, and the crude mixture was purified by flash chromatography.  
 
General Procedure for the Coupling Reaction of Arylthiols and Difluoroalkenes (C): 
An oven-dried 10 mL microwave vial was charged with difluoroalkene (0.50 mmol) and a 
magnetic stirbar. The substrate was dissolved in DCE (2.0 mL), and aryl-thiol (1.0–1.5 
mmol) was added via a 250 µL micro syringe. Tetramethylguanidine (TMG) (3.1 µL, 0.025 
mmol) was added via a 10 µL micro syringe. The vial was sealed with a crimp-top cap 
with a PTFE septum and stirred for 3 min at ambient temperature. Subsequently, the vial 
was placed in a pre-heated oil bath, and stirred at 100 ˚C for 5–20 h. The vial was cooled 
to R.T., and 60 µL of  a,a,a-trifluorotoluene was added by microsyringe. The solution was 
stirred at ambient temperature for 10 min to ensure mixing, after which an aliquot was 
taken from the vial and analyzed by 19F NMR. The NMR sample was then returned to the 
vial, 2 mL of water was added, and the reaction mixture was extracted 3X with 5 mL DCM 
and 5 mL H2O. After extraction, the organic layer was dried with MgSO4 or Na2SO4 and 




General Procedure for the Coupling Reaction of Alkylthiols and Difluoroalkenes 
(D): An oven-dried 1 dram vial was charged with difluoroalkene (0.50 mmol) and a 
magnetic stirbar. The compound was brought into the glovebox, and lithium triflate (0.05 
mmol) was added, then pyridine (0.1 mmol) was added via 10 µL glass microsyringe, and 
the mixture was dissolved in o-xylene (1.5 mL). The 1 dram vial was sealed with a screw-
top cap equipped with a PTFE-lined silicon septum, and removed from the glovebox. The 
reaction mixture was exposed to air, and alkyl-thiol (0.75 mmol) was added via a 1.0 mL 
PTFE syringe. The vial was sealed with the same screw-top cap lined with a PTFE-lined 
silicon septum, and a balloon of air was equipped through a 16.5 G needle. Subsequently, 
the vial was placed in a pre-heated reaction plate and stirred at 110 ˚C for 15 h. The vial 
was cooled to R.T., and 50 µL of  a,a,a-trifluorotoluene was added by microsyringe. The 
solution was diluted with EtOAc, and stirred at ambient temperature for 10 min to ensure 
mixing, after which an aliquot was taken from the vial and analyzed by 19F NMR. The 
NMR sample was then returned to the vial, 2 mL of water was added, and the reaction 
mixture was extracted 3X with 5 mL EtOAc and 5 mL saturated NaHCO3 (aq). After 
extraction, the organic layer was dried with Na2SO4 and concentrated, and the crude 
mixture was purified by flash chromatography. 
 
Preparation and Characterization of Compounds in Scheme 2-6:  




Reactions were performed following General Procedure C, with the following 
modifications: 
• Reactions were run with 0.1 mmol of compound 2.1. 
• The bases used were inorganic in nature. Representative bases include: NaH, 
K2CO3, KO-tBu. 
• All reactions were run at 80 ˚C for 4 h, standardized with 12 µL (0.10 mmol) of 
TFT, and analyzed by 19F NMR through relative integration to the TFT 
resonance. 
 
Preparation and Characterization of Compounds Described in Table 2-1 
 
Following a modified General Procedure C, 0.023 g (0.10 mmol) of compound 2.1 was 
added to an oven-dried 1 dram screw-top vial. In the case of solid bases (DMAP, TBD, 
preformed thiolate), the base (0.025 mmol) was added, and the mixture dissolved in 



































by the addition of 0.025 mmol of liquid bases (Et3N, TMG). The solution was stirred for 3 
min at R.T., and then stirred at 80 ˚C for 4 h (except where marked as different). After 
returning to R.T., the reaction was standardized with 12 µL (0.10 mmol) of TFT, diluted 
with DCM, and stirred for 10 min. The reaction was then added to an NMR tube and 
analyzed by 19F NMR. The conversion of 2.1, the yield of 2.2, and the yield of 2.4 were 
determined by relative integration vs. the TFT resonance. 
 
Synthesis of Sodium Phenylthiolate: An oven dried, 25 mL round bottomed flask 
equipped with a magnetic stirbar was transferred into the glovebox, and 95% sodium 
hydride (0.049 g, 2.0 mmol) was added. The flask was sealed with a rubber septum, 
transferred to a fume hood, and immersed in an ice bath under a nitrogen atmosphere. 
Anhydrous THF (10 mL) was added, and the suspension was stirred vigorously. 
Anhydrous thiophenol (0.20 mL, 2.0 mmol) was added dropwise at 0 ˚C, and the resulting 
suspension was stirred at R.T. After 5 h, the solvent was removed in vacuo, and the 
















 (1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethyl)(phenyl)sulfane (22): Following 
General Procedure B, 0.12 g (0.50 mmol) of compound 2.1 was reacted with 0.105 mL 
(1.00 mmol) of thiophenol at 70 ˚C for 1 h. After workup, the product was purified by flash 
chromatography using 0–10% Et2O in PhMe, furnishing 0.14 g (83% yield) of desired 
product 2.2 as a colorless solid, m.p. 57–58 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.59 (d, J = 7.4 Hz, 2 H), 7.44–7.35 (m, 3 H), 6.49 (s, 2 H), 
3.86 (s, 9 H), 3.37 (t, J = 14.7 Hz, 2 H);  
13C NMR (126 MHz, CDCl3): d 153.2, 137.7, 136.3, 129.9, 129.2, 128.8 (t, J = 279.8 Hz), 
127.6 (t, J = 3.3 Hz), 127.0 (t, J = 2.5 Hz), 107.7, 61.0, 56.3, 45.6 (t, 24.4 Hz);  
19F NMR (376 MHz, CDCl3): d –71.50 (t, J = 14.8, 2 F);  
IR (film): 3065, 2939, 2839, 2361, 2341, 1591, 1508, 1462, 1423, 1346, 1315, 1246, 
1225, 1151, 1128, 1036, 1014, 947, 924, 874, 831, 777, 750, 706, 692, 667, 436 cm-1;  
HRMS (HAPCI+): calc. for C17H19F2O3S (M+H) 341.1023, found 341.1007, 4.7 ppm. 
 
 
(E)-(1-fluoro-2-(3,4,5-trimethoxyphenyl)vinyl)(phenyl)sulfane (2.4): To an oven-dried 









2.1, 0.50 mL of nitrobenzene, 0.26 mL (2.5 mmol) of thiophenol, and 16 µL (0.125 mmol) 
of TMG. The resulting yellow solution was stirred for 3 min at R.T., and then stirred for 4 
h at 100 ˚C. A 60 µL (0.50 mmol) aliquot of TFT was added as an internal standard to 
determine the amount of a-monofluorovinylthioether formed. Analysis of the crude 
reaction mixture by 19F NMR (376 MHz, no deuterated solvent) showed a ratio of 1.5:1 
compounds 2.2:2.4. After workup, water was added, and the reaction mixture extracted 
3X with 5 mL of DCM and 5 mL of H2O. Chromatographic purification by a gradient elution 
from 0% EtOAc in hexanes to 50% EtOAc in hexanes (removal of PhNO2) followed by a 
gradient elution from 0% Et2O in PhMe to 5% Et2O in PhMe afforded a 6.3:1 mixture of 
compound 2.4 (2.9:1 diastereoselectivity):compound 2.2. 
1H NMR (400 MHz, CDCl3): d Major isomer 7.46–7.43 (m, 2 H), 7.37–7.28 (m, 3 H), 6.83 
(s, 2 H), 6.71 (d, J = 16.5 Hz, 1 H), 3.86 (s, 6 H), 3.83 (s, 3 H); Minor isomer 7.48–7.46 
(m, 2 H), 7.37–7.28 (m, 3 H), 6.78 (s, 2 H), 6.23 (d, J = 31.9 Hz, 1 H), 3.86 (s, 6 H), 3.83 
(s, 3 H);  
19F NMR (376 MHz, CDCl3): d –80.15 (d, J = 16.5 Hz, integration 2.85 - major 
diasteromer), –86.59 (d, J = 31.9 Hz, integration 1 – minor diastereomer). 
 
Experimental Procedures for Mechanistic Determination 
Experiments in the Absence of Oxygen: Following a modified General Procedure C, 
0.023 g (0.01 mmol) of compound 2.1 was added to a 1 dram vial and sealed with a 
screw-top cap containing a PTFE lined septum. The system was evacuated and backfilled 
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3X with N2, and subsequently dissolved in anhydrous DCE (0.4 mL, sparged with N2 for 
1 h prior to use). Anhydrous thiophenol (0.030 mL, 0.30 mmol) was added, and then TMG 
(0.6 µL, 0.005 mmol, sparged with N2 for 1 h prior to use). The reaction was stirred for 3 
min at R.T., and then for 1 h at 80 ˚C. Once returned to R.T., the reaction was 
standardized with 12 µL of TFT (0.10 mmol), diluted with DCM, and analyzed by 19F NMR. 
The conversion of 2.1, the yield of 2.2, and the yield of 2.4 were determined by relative 
integration vs. the TFT resonance. Compound 2.1 conversion: >99%, compound 2.2 
yield: 90%, compound 2.4 yield: 0%. 
A second reaction was run following the above procedure, modified to exclude light 
by wrapping the 1 dram vial in aluminum foil before evacuation and backfill with N2. 
Compound 2.2 yield: 95%, conversion: >99%, compound 2.4 yield: 0%. 
 
Experiments in the Absence of Light: Following a modified General Procedure C, 
0.023 g (0.01 mmol) of compound 2.1 was added to a 1 dram vial. The compound was 
dissolved in DCE (0.4 mL), and the 1 dram vial was wrapped in aluminum foil to exclude 
light. Thiophenol (0.030 mL, 0.30 mmol) was added, and then TMG (0.6 µL, 0.005 mmol). 
The reaction was stirred for 3 min at R.T., and then for 1 h at 80 ˚C. Once returned to 
R.T., the reaction was standardized with 12 µL of TFT (0.10 mmol), diluted with DCM, 
and analyzed by 19F NMR. The conversion of 2.1, the yield of 2.2, and the yield of 2.4 
were determined by relative integration vs. the TFT resonance. Compound 2.1 




Experiments with Radical Scavengers 
Using 1,4-dicyanobenzene: Following a modified General Procedure C, 0.023 g 
(0.01 mmol) of compound 2.1 and 0.026 g (0.20 mmol) of 1,4-dicyanobenzene were 
added to a 1 dram vial. The compound was dissolved in DCE (0.4 mL). Thiophenol (0.020 
mL, 0.20 mmol) was added, and then TMG (0.6 µL, 0.005 mmol). The reaction was stirred 
for 3 min at R.T., and then for 1 h at 70 ˚C. Once returned to R.T., the reaction was 
standardized with 12 µL of TFT (0.10 mmol), diluted with DCM, and analyzed by 19F NMR. 
The conversion of 2.1, the yield of 2.2, and the yield of 2.4 were determined by relative 
integration vs. the TFT resonance. Compound 2.1 conversion: >99%, compound 2.2 
yield: 88%, compound 2.4 yield: 0%. The presence of non-fluorinated adducts was 
evaluated by GC-MS (EI+). GC-MS analysis showed 1,4-dinitrobenzene and compound 
2.2 with no evidence of dithiane formation. 
 
Using Butylated Hydroxytoluene (BHT): Following a modified General Procedure 
C, 0.023 g (0.01 mmol) of compound 2.1 and 0.044 g (0.20 mmol) of BHT were added to 
a 1 dram vial. The compound was dissolved in DCE (0.4 mL). Thiophenol (0.020 mL, 0.20 
mmol) was added, and then TMG (0.6 µL, 0.005 mmol). The reaction was stirred for 3 
min at R.T., and then for 1 h at 70 ˚C. Once returned to R.T., the reaction was 
standardized with 12 µL of TFT (0.10 mmol), diluted with DCM, and analyzed by 19F NMR. 
The conversion of 2.1, the yield of 2.2, and the yield of 2.4 were determined by relative 
integration vs. the TFT resonance. Compound 2.1 conversion: 99%, compound 2.2 yield: 
82%, compound 2.4 yield: 0%. The presence of non-fluorinated adducts was evaluated 
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by GC-MS (EI+). GC-MS analysis showed BHT and compound 2.2 with no evidence of 
dithiane formation. 
 
Using TEMPO: Following a modified General Procedure C, 0.023 g (0.01 mmol) of 
compound 2.1 and 0.031 g (0.20 mmol) of TEMPO were added to a 1 dram vial. The 
compound was dissolved in DCE (0.4 mL). Thiophenol (0.020 mL, 0.20 mmol) was added, 
and then TMG (0.6 µL, 0.005 mmol). The reaction was stirred for 3 min at R.T., and then 
for 1 h at 70 ˚C. Once returned to R.T., the reaction was standardized with 12 µL of TFT 
(0.10 mmol), diluted with DCM, and analyzed by 19F NMR. The conversion of 2.1, the 
yield of 2.2, and the yield of 2.4 were determined by relative integration vs. the TFT 
resonance. Compound 2.1 conversion: 0%, compound 2.2 yield: 0%, compound 2.4 yield: 
0%. The presence of non-fluorinated adducts was evaluated by GC-MS (EI+). GC-MS 
analysis showed TEMPO, TEMPO-H, compound 2.1 and dithiane. 
 
Control Reactions with TEMPO: Following a modified General Procedure C, 0.023 
g (0.01 mmol) of compound 2.1 and 0.031 g (0.20 mmol) of TEMPO were added to a 1 
dram vial. The compound was dissolved in DCE (0.4 mL). TMG (0.6 µL, 0.005 mmol) was 
added to the solution. The reaction was stirred for 3 min at R.T., and then for 1 h at 70 
˚C. Once returned to R.T., the reaction was standardized with 12 µL of TFT (0.10 mmol), 
diluted with DCM, and analyzed by 19F NMR. The conversion of 2.1, the yield of 2.2, and 
the yield of 2.4 were determined by relative integration vs. the TFT resonance. Compound 
2.1 conversion: 0%, compound 2.2 yield: 0%, compound 2.4 yield: 0%. The presence of 
 
160 
non-fluorinated adducts was evaluated by GC-MS (EI+). GC-MS analysis showed 
TEMPO and compound 2.1. 
 
Following a modified General Procedure C, 0.023 g (0.01 mmol) of compound 2.1 and 
0.031 g (0.20 mmol) of TEMPO were added to a 1 dram vial. The compound was 
dissolved in DCE (0.4 mL). The reaction was stirred for 3 min at R.T., and then for 1 h at 
70 ˚C. Once returned to R.T., the reaction was standardized with 12 µL of TFT (0.10 
mmol), diluted with DCM, and analyzed by 19F NMR. The conversion of 2.1, the yield of 
2.2, and the yield of 2.4 was determined by relative integration vs. the TFT resonance. 
Compound 2.1 conversion: 0%, compound 2.2 yield: 0%, compound 2.4 yield: 0%. The 
presence of non-fluorinated adducts was evaluated by GC-MS (EI+). GC-MS analysis 
showed TEMPO and compound 2.1. 
 
Following a modified General Procedure C 0.031 g (0.20 mmol) of TEMPO was added 
to a 1 dram vial and dissolved in DCE (0.4 mL). Thiophenol (0.020 mL, 0.20 mmol) and 
then TMG (0.6 µL, 0.005 mmol) was added to the solution. The reaction was stirred for 3 
min at R.T., and then for 1 h at 70 ˚C. Once returned to R.T., the reaction was diluted with 





Following a modified General Procedure C 0.031 g (0.20 mmol) of TEMPO was added 
to a 1 dram vial and dissolved in DCE (0.4 mL). Thiophenol (0.020 mL, 0.20 mmol) was 
added to the solution. The reaction was stirred for 3 min at R.T., and then for 1 h at 70 
˚C. Once returned to R.T., the reaction was diluted with DCM, and analyzed by GC-MS 
(EI+). GC-MS analysis showed TEMPO, TEMPO-H, and dithiane. 
 
Experiment with DCM-D2: Following a modified General Procedure C, 0.023 g (0.01 
mmol) of compound 2.1 was added to a 1 dram vial and dissolved in DCM-D2 (0.4 mL). 
Thiophenol (0.020 mL, 0.20 mmol) was added, and then TMG (0.6 µL, 0.005 mmol). The 
reaction was stirred for 3 min at R.T., and then for 4 h at 40 ˚C. Once returned to R.T., 
the reaction was standardized with 12 µL of TFT (0.10 mmol), diluted with DCM, and 
analyzed by 19F NMR. Conversion, yield of 2.2, and yield of 2.4 was determined by relative 
integration vs. the TFT resonance. The presence or absence of deuterium was evaluated 
by GC-MS and by analysis the 2D NMR spectrum. Compound 2.2 yield: 86%, conversion: 
>99%. No evidence of compound 2.4. Analysis of the 2D NMR revealed no deuterated 
resonances (other than DCM-D2). GC-MS analysis showed no deuterated product. The 




Preparation and Characterization of Compounds in Scheme 2-7 
 
(1,1-difluoro-2-(4-methoxyphenyl)ethyl)(phenyl)sulfane (2.6a): Following General 
Procedure B, 0.085 g (0.50 mmol) of compound 2.5a was reacted with 0.105 mL (1.00 
mmol) of thiophenol at 70 ˚C for 0.5 h. After workup, the product was purified by flash 
chromatography using 0–10% EtOAc in hexanes, furnishing 0.104 g (74% yield) of 
desired product 2.6a as a pale oil.  
1H NMR (400 MHz, CDCl3): d 7.58 (d, J = 7.3 Hz, 2 H), 7.43–7.34 (m, 3 H), 7.22 (d, J = 
8.4 Hz, 2 H), 6.88 (d, J = 8.3 Hz, 2 H), 3.81 (s, 3 H), 3.37 (t, J = 14.3 Hz, 2 H);  
13C NMR (126 MHz, CDCl3): d 159.3, 136.3, 131.7, 129.8, 129.1, 129.0 (t, J = 279.8 Hz), 
127.1 (t, J = 2.1 Hz), 124.1 (t, J = 3.5 Hz), 114.0, 55.4, 44.5 (t, J = 24.3 Hz);  
19F NMR (376 MHz, CDCl3): d –71.85 (t, J = 14.8 Hz, 2 F);  
IR (film): 3433, 3063, 2934, 2837, 1612, 1514, 1474, 1441, 1304, 1254, 1221, 1180, 
1153, 1113, 1032, 1007, 976, 872, 822, 781, 748, 690, 646, 606, 422 cm-1;  








(1,1-difluoro-2-(4-(methylthio)phenyl)ethyl)(phenyl)sulfane (2.6b): Following General 
Procedure B, 0.093 g (0.50 mmol) of compound 2.5b was reacted with 0.16 mL (1.5 
mmol) of thiophenol at 90˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–5–10% EtOAc in hexanes, to furnish 0.099 g (66% yield) of 
desired product 2.6b in 97% purity (as determined by 1H and 19F NMR) as a pale oil.  
1H NMR (400 MHz, CDCl3): d 7.57 (d, J = 7.6 Hz, 2 H), 7.43–7.34 (m, 3 H), 7.24–7.19 
(m, 4 H), 3.38 (t, J = 14.7 Hz, 2 H), 2.49 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 138.2, 136.3, 131.1, 129.9, 129.1, 128.75 (t, J = 279.7 
Hz), 128.74 (t, J = 3.5 Hz), 127.0 (t, J = 2.1 Hz), 126.5, 44.7 (t, J = 24.4 Hz), 15.8 
19F NMR (376 MHz, CDCl3): d –71.76 (t, J = 14.7 Hz, 2 F) 
IR (film): 3059, 3024, 2920, 1601, 1584, 1495, 1476, 1441, 1408, 1325, 1279, 1219, 
1155, 1094, 1036, 1009, 976, 874, 843, 808, 768, 750, 704, 691, 638, 596, 575, 505 cm-
1 










(2.6c): Following General Procedure B, 0.18 g (0.50 mmol) of compound 2.5c was 
reacted with 0.105 mL (1.00 mmol) of thiophenol at 70˚C for 0.5 h. After workup, the 
product was purified by flash chromatography using 0–10% EtOAc in hexanes, to furnish 
0.204 g (88% yield) of desired product 2.6c as a yellow oil.  
1H NMR (400 MHz, CDCl3): d 7.58 (d, J = 7.5 Hz, 2 H), 7.42–7.32 (m, 7 H), 6.93 (d, J = 
8.3 Hz, 2 H), 6.83 (d, J = 8.7 Hz, 1 H), 5.00 (s, 2 H), 3.83 (s, 3 H), 3.51 (t, J = 14.9 Hz, 2 
H) 
13C NMR (126 MHz, CDCl3): d 159.4, 156.3, 136.2, 134.8, 131.7, 129.7, 129.0, 128.7 (t, 
J = 280.4 Hz), 128.5, 127.0 (t, J = 2.0 Hz), 123.3 (t, J = 2.8 Hz), 114.0, 113.8, 112.7, 70.3, 
55.3, 38.0 (t, J = 24.8 Hz) 
19F NMR (376 MHz, CDCl3): d –71.10 (t, J = 14.9 Hz, 2 F) 
IR (film): 2934, 2835, 1612, 1585, 1514, 1489, 1464, 1302, 1281, 1246, 1175, 1153, 
1130, 1032, 1009, 982, 862, 810, 750, 690, 642 cm-1 










4-(3-(2,2-difluoro-2-(phenylthio)ethyl)phenyl)morpholine (2.6d): Following General 
Procedure B, 0.11 g (0.50 mmol) of compound 2.5d was reacted with 0.16 mL (1.5 mmol) 
of thiophenol at 90 ˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–5–10–20% EtOAc in hexanes, to furnish 0.13 g (77% yield) of 
desired product 2.6d as a tan solid, m.p. 42–44 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.58 (d, J = 6.9 Hz, 2 H), 7.43–7.34 (m, 3 H), 7.25 (t, J = 
7.7 Hz, 1 H), 6.88 (d, J = 8.3 Hz, 1 H), 6.83 (d, J = 8.2 Hz, 2 H), 3.87 (t, J = 4.8 Hz, 4 H), 
3.39 (t, J = 14.8 Hz, 2 H), 3.17 (t, J = 4.9 Hz, 4 H) 
13C NMR (126 MHz, CDCl3): d 151.4, 136.3, 133.1 (t, J = 3.2 Hz), 129.8, 129.3, 129.1, 
128.8 (t, J = 280.1 Hz), 127.1 (t, J = 2.0 Hz), 122.3, 118.0, 115.1, 67.0, 49.4, 45.6 (t, J = 
24.1 Hz) 
19F NMR (376 MHz, CDCl3): d –71.35 (t, J = 14.8 Hz, 2 F) 
IR (film): 3059, 2963, 2855, 2824, 2359, 2342, 1603, 1584, 1495, 1476, 1449, 1379, 
1337, 1304, 1265, 1244, 1227, 1155, 1123, 1036, 1017, 986, 887, 764, 750, 693, 667, 
571, 550, 498 cm-1 










4-(2,2-difluoro-2-(phenylthio)ethyl)-N,N-dimethylaniline (2.6e): Following General 
Procedure B, 0.092 g (0.50 mmol) of compound 2.5e was reacted with 0.105 mL (1.00 
mmol) of thiophenol at 70˚C for 14 h. After workup, the product was purified by flash 
chromatography using 0–10–20% EtOAc in hexanes, to furnish 0.12 g (81% yield) of 
desired product 2.6e as an off-white solid, m.p. 57 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.59–7.57 (m, 2 H), 7.42–7.33 (m, 3 H), 7.16 (d, J = 8.2 Hz, 
2 H), 6.70 (d, J = 8.1 Hz, 2 H), 3.33 (t, J = 14.7 Hz, 2 H), 2.96 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 150.2, 136.2, 131.3, 129.7, 129.4 (t, J = 279.9 Hz), 129.1, 
127.4 (t, J = 2.0 Hz), 119.6, 112.5, 44.4 (t, J = 24.2 Hz), 40.7 
19F NMR (376 MHz, CDCl3): d –71.68 (t, J = 14.8 Hz, 2 F) 
IR (film): 2903, 2806, 2361, 2341, 1616, 1524, 1354, 1234, 1151, 1034, 1007, 974, 810, 
748, 690, 667 cm-1 









4-(2,2-difluoro-2-(phenylthio)ethyl)phenyl trifluoromethanesulfonate (2.6f): 
Following General Procedure C, 0.145 g (0.500 mmol) of compound 2.5f was reacted 
with 0.16 mL (1.5 mmol) of thiophenol. After workup, the product was purified by flash 
chromatography using 0–10% EtOAc in hexanes, to furnish 0.152 g (76% yield) of desired 
compound 2.6f as a clear oil in 97% purity (as determined by 1H and 19F NMR). 
1H NMR (400 MHz, CDCl3): d 7.59–7.56 (m, 2 H), 7.45–7.35 (m, 5 H), 7.27–7.23 (m, 2H), 
3.45 (t, J = 14.6 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 149.3, 136.3, 132.8 (t, J = 3.1 Hz), 132.5, 130.1, 129.3, 
128.2 (t, J = 279.9 Hz), 126.6 (t, J = 2.2 Hz), 121.5, 118.9 (q, J = 320.8 Hz), 44.5 (t, J = 
24.8 Hz) 
19F NMR (376 MHz, CDCl3): d –72.12 (t, J = 14.6 Hz, 2 F), –72.84 (s, 3 F) 
IR (film): 3065, 2359, 2342, 1599, 1505, 1476, 1425, 1331, 1250, 1215, 1182, 1140, 
1109, 1036, 1018, 982, 943, 889, 854, 835, 750, 727, 691, 638, 608, 519, 498 cm-1 








(2-(4’-(tert-butyl)-[1,1’-biphenyl]-2-yl)-1, 1-difluoroethyl)(phenyl)sulfane (2.6g): 
Following General Procedure B, 0.14 g (0.50 mmol) of compound 2.5g was reacted with 
0.16 mL (1.5 mmol) of thiophenol at 90 ˚C for 5 h. After workup, the product was purified 
by flash chromatography using 0–2.5–5–10–20% EtOAc in hexanes, to furnish 0.18 g 
(93% yield) of desired product 2.6g as a clear oil. 
1H NMR (500 MHz, CDCl3): d 7.51 (d, J = 7.8 Hz, 2 H), 7.40 (d, J = 8.3 Hz, 2 H), 7.37 (d, 
J = 7.4 Hz, 1 H), 7.36–7.33 (m, 1 H), 7.32 (d, J = 8.3 Hz, 2 H), 7.29 (d, J = 13.3 Hz, 1 H), 
7.21 (d, J = 7.9 Hz, 2 H), 3.51 (t, J = 15.4 Hz, 2 H), 1.38 (d, J = 0.7 Hz, 9 H) 
13C NMR (126 MHz, CDCl3): d 149.9, 143.6, 138.2, 136.2, 131.1 (t, J = 1.9 Hz), 130.8, 
129.7, 129.10 (t, J = 280.4 Hz), 129.06, 127.6, 127.3, 127.2 (t, J = 2.3 Hz), 125.2, 41.5 (t, 
J = 23.8 Hz), 34.7, 31.6 
19F NMR (376 MHz, CDCl3): d –70.08 (t, J = 15.36 Hz, 2 F) 
IR (film): 3061, 3026, 2962, 2905, 2868, 2361, 2330, 1485, 1441, 1398, 1364, 1329, 
1269, 1223, 1155, 1107, 1024, 1007, 978, 839, 766, 750, 690, 545 cm-1 










Following General Procedure B, 0.14 g (0.50 mmol) of compound 2.5h was reacted with 
0.105 mL (1.00 mmol) of thiophenol at 80 ˚C for 0.5 h. After workup, the product was 
purified by flash chromatography using 0–2.5–5–10–20% EtOAc in hexanes, to furnish 
0.17 g (87% yield) of desired product 2.6h as a colorless solid, m.p. 52–53 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.59–7.57 (m, 2 H), 7.45–7.44 (m, 2 H), 7.42–7.40 (m, 1 
H), 7.39–7.35 (m, 4 H), 7.32–7.29 (m, 1 H), 6.85 (d, J = 8.2 Hz, 1 H), 6.83 (d, J = 2.0 Hz, 
1 H), 6.77 (dd, J = 8.3, 2.0 Hz, 1 H), 5.16 (s, 2 H), 3.89 (s, 3 H), 3.36 (t, J = 14.6 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 149.5, 148.0, 137.2, 136.3, 129.8, 129.1, 129.0 (t, J = 
279.9 Hz), 128.7, 128.0, 127.4, 127.1 (t, J = 2.0 Hz), 125.0 (t, J = 3.4 Hz), 123.0, 114.2, 
113.7, 71.1, 56.1, 44.9 (t, J = 24.3 Hz) 
19F NMR (376 MHz, CDCl3): d –71.63 (t, J = 14.7 Hz, 2 F) 
IR (film): 3060, 2933, 1591, 1514, 1454, 1265, 1223, 1144, 1036, 1014, 984, 746, 694, 
660 cm-1 









(1,1-difluoro-2-(2-iodophenyl)ethyl)(phenyl)sulfane (2.6i): Following General 
Procedure B, 0.13 g (0.50 mmol) of compound 2.5i was reacted with 0.16 mL (1.5 mmol) 
of thiophenol at 90˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–5% EtOAc in hexanes, to furnish 0.14 g (74% yield) of 
compound 2.6i in 99% purity (as determined by 1H and 19F NMR) as a colorless solid, 
m.p. 34 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.87 (dd, J = 7.9, 1.3 Hz, 1 H), 7.63–7.61 (m, 2 H), 7.45–
7.35 (m, 4 H), 7.33 (td, J = 7.5, 1.3 Hz, 1 H), 6.99 (td, J = 7.7, 1.8 Hz, 1 H), 3.69 (t, J = 
15.0 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 140.0, 136.5, 135.7 (t, J = 2.3 Hz), 131.6 (d, J = 1.6 Hz), 
130.0, 129.5, 129.2, 128.7 (t, J = 280.9 Hz), 128.4, 126.9 (t, J = 2.2 Hz), 102.3, 49.1 (t, J 
= 24.1 Hz) 
19F NMR (376 MHz, CDCl3): d –71.31 (t, J = 15.0 Hz, 2 F) 
IR (film): 3059, 2359, 2340, 1474, 1439, 1329, 1296, 1219, 1153, 1119, 1032, 1018, 978, 
885, 868, 745, 719, 691 cm-1 









ethyl (E)-3-(3-(2,2-difluoro-2-(phenylthio)ethyl)phenyl)acrylate (2.6j): Following 
General Procedure B, 0.12 g (0.50 mmol) of compound 2.5j was reacted with 0.16 mL 
(1.5 mmol) of thiophenol at 90 ˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–2.5–5–10–20% EtOAc in hexanes, to furnish 0.14 g (79% yield) 
of desired product 2.6j as a colorless solid, m.p. 58 ˚C. 
1H NMR (500 MHz, CDCl3): d 7.68 (d, J = 16.0 Hz, 1 H), 7.60–7.55 (m, 2 H), 7.49 (dd, J 
= 7.8, 1.5 Hz, 1 H), 7.46–7.39 (m, 2 H), 7.40–7.35 (m, 3 H), 7.33–7.29 (m, 1 H), 6.45 (d, 
J = 16.0 Hz, 1 H), 4.27 (q, J = 7.2 Hz, 2 H), 3.44 (t, J = 14.7 Hz, 2 H), 1.34 (t, J = 7.1 Hz, 
3 H) 
13C NMR (126 MHz, CDCl3): d 167.0, 144.3, 136.3, 134.8, 132.9 (t, J = 3.2 Hz), 132.5, 
130.3, 130.0, 129.2, 129.1, 128.6 (t, J = 279.9 Hz), 127.5, 126.8 (t, J = 2.2 Hz), 60.7, 45.1 
(t, J = 24.5 Hz), 14.5 
19F NMR (376 MHz, CDCl3): d –71.71 (t, J = 14.7 Hz, 2 F) 
IR (film): 3063, 2982, 2935, 1713, 1639, 1475, 1441, 1367, 1312, 1265, 1231, 1180, 
1161, 1094, 1036, 984, 943, 866, 750, 690 cm-1 










(2-(3,5-dichlorophenyl)-1,1-difluoroethyl)(phenyl)sulfane (2.6k): Following General 
Procedure C, 0.11 g (0.50 mmol) of compound 2.5k was reacted with 0.16 mL (1.5 mmol) 
of thiophenol at 100 ̊ C for 20 h. After extraction from a mixture of 1 N NaOH and saturated 
aq. Na2S2O5 (a mixture designed to remove residual thiophenol and small amounts of 
diphenyl sulfide that are difficult to remove by flash chromatography) with DCM, the 
product was purified by flash chromatography using 0–5% EtOAc in hexanes, to furnish 
0.11 g (68% yield) of desired product 2.6k as a clear oil.  
1H NMR (400 MHz, CDCl3): d 7.60–7.57 (m, 2 H), 7.46–7.37 (m, 3 H), 7.33 (t, J = 1.9 Hz, 
1 H), 7.18 (d, J = 1.9 Hz, 2 H), 3.36 (t, J = 14.5 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 136.3, 135.2 (t, J = 3.0 Hz), 135.0, 130.2, 129.3, 129.1, 
128.2, 128.0 (t, J = 280.0 Hz), 126.5 (t, J = 2.2 Hz), 44.5 (t, J = 25.0 Hz) 
19F NMR (356 MHz, CDCl3): d –71.91 (t, J = 14.5 Hz, 2 F) 
IR (film): 3075, 3063, 2359, 2332, 1589, 1570, 1476, 1435, 1387, 1327, 1260, 1213, 
1153, 1121, 1103, 1038, 1017, 984, 901, 880, 858, 799, 779, 741, 691, 667, 575 cm-1 











4-(2,2-difluoro-2-(phenylthio)ethyl)-N,N-dipropylbenzamide (2.6l): Following General 
Procedure B, 0.13 g (0.50 mmol) of compound 2.5l was reacted with 0.16 mL (1.5 mmol) 
of thiophenol at 90 ˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–10–20–30% EtOAc in hexanes, to furnish 0.17g (88% yield) of 
desired product 2.6l in 95% purity (as determined by 1H and 19F NMR) as a pale yellow 
solid, m.p. 25 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.57 (d, J = 7.7 Hz, 2 H), 7.42–7.29 (m, 7 H), 3.44 (bs, 2 
H), 3.43 (t, J = 14.8 Hz, 2 H), 3.16 (bs, 2 H), 1.68 (bs, 2 H), 1.53 (bs, 2 H), 0.97 (bs, 3 H), 
0.75 (bs, 3 H) 
13C NMR (126 MHz, CDCl3): d 171.6, 136.9 (d, J = 2.9 Hz), 136.3, 133.1 (t, J = 3.1 Hz), 
130.7, 129.9, 129.2, 128.6 (t, J = 280.0 Hz), 126.9, 126.8, 50.8, 46.5, 45.0 (t, J = 24.5 
Hz), 22.1, 20.8, 11.6, 11.2 
19F NMR (376 MHz, CDCl3): d –71.79 (t, J = 14.8 Hz, 2 F) 
IR (film): 3061, 2965, 2934, 2874, 1634, 1514, 1464, 1427, 1381, 1306, 1258, 1221, 
1155, 1099, 1036, 1011, 980, 893, 876, 853, 750, 704, 692, 640, 557 cm-1 









4-(2,2-difluoro-2-(phenylthio)ethyl)benzonitrile (2.6m): Following General Procedure 
C, 0.082 g (0.50 mmol) of compound 2.5m was reacted with 0.155 mL (1.5 mmol) of 
thiophenol at 100 ˚C for 20 h. After workup, the product was purified by flash 
chromatography using 0–5–20% EtOAc in hexanes, to furnish 0.080 g (58% yield) of 
desired compound 2.6m as a colorless solid, m.p. 63–64 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.64 (d, J = 8.0 Hz, 2 H), 7.56 (d, J = 7.5 Hz, 2 H), 7.46–
7.36 (m, 5 H), 3.47 (t, J = 14.5 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 137.5 (t, J = 3.1 Hz), 136.3, 132.3, 131.5, 130.2, 129.3, 
128.1 (t, J = 280.2 Hz), 126.4 (t, J = 2.2 Hz), 118.7, 112.0, 45.2 (t, J = 24.8 Hz) 
19F NMR (376 MHz, CDCl3): d –71.85 (t, J = 14.5 Hz, 2 F) 
IR (film): 2359, 2342, 2228, 1611, 1505, 1474, 1441, 1429, 1416, 1321, 1211, 1144, 
1013, 988, 959, 891, 853, 824, 775, 752, 708, 691, 577, 548, 498 cm-1 









(1,1-difluoro-2-(3-nitrophenyl)ethyl)(phenyl)sulfane (2.6n): Following General 
Procedure C, 0.093 g (0.50 mmol) of compound 2.5n was reacted with 0.16 mL (1.5 
mmol) of thiophenol at 100 ˚C for 20 h. After workup, the product was purified by flash 
chromatography using 0–5–10–20% EtOAc in hexanes, to furnish 0.081 g (55% yield) of 
desired product 2.6m as a colorless solid, m.p. 49–50 ˚C. 
1H NMR (400 MHz, CDCl3): d 8.20 (ddd, J = 8.2, 2.3, 1.1 Hz, 1 H), 8.16 (t, J = 1.9 Hz, 1 
H), 7.63 (d, J = 7.7 Hz, 1 H), 7.59–7.57 (m, 2 H), 7.53 (t, J = 7.9 Hz, 1 H), 7.46–7.37 (m, 
3 H), 3.52 (t, J = 14.5 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 148.4, 136.8, 136.3, 134.1 (t, J = 3.1 Hz), 130.2, 129.6, 
129.4, 128.1 (t, J = 280.0 Hz), 126.4 (t, J = 2.3 Hz), 125.6, 123.1, 44.7 (t, J = 25.1 Hz) 
19F NMR (376 MHz, CDCl3): d –72.17 (t, J = 14.5 Hz, 2 F) 
IR (film): 3077, 2359, 2342, 1531, 1476, 1441, 1435, 1350, 1319, 1298, 1223, 1153, 
1084, 1034, 1015, 984, 916, 870, 820, 804, 750, 727, 692, 679, 652, 569, 422 cm-1 








Experimental Procedures and Characterization of Compounds in Scheme 2-9 
 
3-(2,2-difluoro-2-(phenylthio)ethyl)-1-tosyl-1H-indole (2.8a): Following General 
Procedure B, 0.17 g (0.50 mmol) of compound 2.7a was reacted with 0.11 mL (1.0 mmol) 
of thiophenol at 70 ˚C for 0.5 h. After workup, the product was purified by flash 
chromatography using 0–10% EtOAc in hexanes, to furnish 0.16 g (72% yield) of desired 
product 2.8a in 98% purity (as determined by 1H and 19F NMR) as a translucent crystalline 
solid, m.p. 121–124 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.98 (d, J = 8.3 Hz, 1 H), 7.76 (d, J = 8.0 Hz, 2 H), 7.58 (s, 
1 H), 7.54 (d, J = 7.5 Hz, 2 H), 7.48 (d, J = 7.8 Hz, 1 H), 7.41 (q, J = 7.1 Hz, 1 H), 7.34 
(dt, J = 14.7, 7.6 Hz, 3 H), 7.25 (s, 1 H), 7.21 (d, J = 8.0 Hz, 2 H), 3.50 (t, J = 14.3 Hz, 2 
H), 2.32 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 207.2, 145.1, 136.3, 135.2, 135.1, 130.8, 130.02, 129.99, 
129.2, 128.8 (t, J = 280.0 Hz), 127.0, 126.8 (t, J = 1.8 Hz), 125.0, 123.5, 119.8 (d, J = 1.8 
Hz), 113.8, 113.5 (J = 3.7 Hz), 35.1 (t, J = 26.4 Hz), 30.1 
19F NMR (376 MHz, CDCl3): d –70.94 (t, J = 14.4 Hz, 2 F) 








1175, 1134, 1121, 1099, 1084, 1038, 1018, 991, 962, 878, 812, 785, 744, 704, 690, 669, 
602, 571, 536, 494 cm-1 




Following General Procedure C, 0.14 g (0.50 mmol) of compound 2.7b was reacted with 
0.16 mL (1.5 mmol) of thiophenol at 100 ̊ C for 20 h. After workup, the product was purified 
by flash chromatography on silica gel using a gradient from 0–10–30% EtOAc in hexanes, 
to furnish 0.15 g (73% yield) of desired product 2.8b in 97% purity (as determined by 1H 
and 19F NMR) as a pale solid, m.p. 77–80 ˚C. 
1H NMR (400 MHz, CDCl3): d 8.78 (d, J = 1.7 Hz, 1 H), 7.95–7.93 (m, 2 H), 7.86 (dd, J = 
8.2, 2.2 Hz, 1 H), 7.75 (dd, J = 8.2, 0.9 Hz, 1 H), 7.60–7.58 (m, 2 H), 7.46 (dd, J = 8.4, 
7.6 Hz, 1 H), 7.43–7.34 (4 H), 5.91 (s, 1 H), 4.18–4.06 (m, 4 H), 3.52 (t, J = 14.8 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 158.0, 148.4, 139.4, 136.3, 135.2, 132.7 (t, J = 3.2 Hz), 
132.1, 131.4, 129.9, 129.4, 129.2, 129.0, 128.8 (t, J = 280.0 Hz), 127.0 (t, J = 2.2 Hz), 
126.6, 120.4, 102.1, 65.6, 45.3 (t, J = 24.4 Hz) 









IR (film): 3059, 2989, 2888, 1722, 1601, 1568, 1474, 1441, 1414, 1356, 1223, 1155, 
1088, 1057, 1024, 980, 941, 862, 839, 800, 750, 692, 658, 658, 573 cm-1 
HRMS (ESI+): calc. for C22H20F2NO2S (M+H) 400.1183, found 400.1175, 2.0 ppm. 
 
 
4-(2,2-difluoro-2-(phenylthio)ethyl)-1-phenyl-1H-pyrazole (2.8c): Following General 
Procedure B, 0.10 g (0.50 mmol) of compound 2.7c was reacted with 0.11 mL (1.0 mmol) 
of thiophenol at 70 ˚C for 0.5 h. After workup, the product was purified by flash 
chromatography using 0–10% EtOAc in hexanes, to furnish 0.14 g (85% yield) of desired 
product 2.8c in 98% purity (as determined by 1H and 19F NMR) as a colorless solid, m.p. 
65 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.88 (s, 1 H), 7.69 (d, J = 8.0 Hz, 2 H), 7.65 (s, 1 H), 7.60 
(d, J = 7.4 Hz, 2 H), 7.45 (dd, J = 8.3, 7.8 Hz, 3 H), 7.39 (dd, J = 7.2, 6.7 Hz, 2 H), 7.29 
(t, J = 7.5 Hz, 1 H), 3.38 (t, J = 14.5 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 142.1, 140.1, 136.3, 130.0, 129.6, 129.2, 128.7 (t, J = 











19F NMR (376 MHz, CDCl3): d –72.51 (t, J = 14.6 Hz, 2 F) 
IR (film): 3055, 2924, 2359, 2341, 1599, 1574, 1504, 1474, 1441, 1400, 1329, 1238, 
1211, 1157, 1040, 1018, 1007, 972, 955, 906, 860, 752, 690, 667, 577, 501, 474 cm-1 
HRMS (ESI+): calc. for C17H15F2N2S (M+H) 317.0924, found 317.0911, 4.1 ppm. 
 
 
4-(2,2-difluoro-2-(phenylthio)ethyl)dibenzo[b,d]thiophene (2.8d): Following General 
Procedure B, 0.12 g (0.50 mmol) of compound 2.7d was reacted with 0.16 mL (1.5 mmol) 
of thiophenol at 90 ˚C for 5 h. After workup, the product was purified by flash 
chromatography on silica gel using a gradient from 0–5–10% EtOAc in hexanes, to furnish 
0.16 g (88% yield) of desired product 2.8d in 97% purity (as determined by 1H and 19F 
NMR) as a yellow-green solid, m.p. 84–87 ˚C.  
1H NMR (400 MHz, CDCl3): d 8.15 (ddd, J = 8.6, 6.5, 2.8 Hz, 2 H), 7.88–7.86 (m, 1 H), 
7.60 (d, J = 7.0 Hz, 2 H), 7.49–7.46 (m, 4 H), 7.39 (ddd, J = 14.7, 8.2, 6.7 Hz, 3 H), 3.74 
(t, J = 14.7 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 141.2, 139.1, 136.4, 136.2, 136.0, 130.0, 129.21, 129.18, 
129.0 (t, J = 280.9 Hz), 127.0, 126.84 (m), 126.82 (t, J = 3.0 Hz), 124.9, 124.7, 122.9, 








19F NMR (376 MHz, CDCl3): d –70.29 (t, J = 14.7 Hz, 2 F) 
IR (film): 3061, 2359, 1586, 1474, 1443, 1402, 1333, 1317, 1260, 1219, 1155, 1096, 
1055, 1022, 980, 905, 870, 748, 723, 704, 691, 652, 586, 498 cm-1 
HRMS (HAPCI+): calc. for C20H14F2S2 (M+) 356.0505, found 356.0516, 3.1 ppm. 
 
 
10-benzyl-3-(2,2-difluoro-2-(phenylthio)ethyl)-10H-phenothiazine (2.8e): Following 
General Procedure B, 0.18 g (0.50 mmol) of compound 2.7e was reacted with 0.16 mL 
(1.5 mmol) of thiophenol at 90 ˚C for 5 h. After workup, the product was purified by flash 
chromatography using 0–5–10–20% EtOAc in hexanes, to furnish 0.19 g (83% yield) of 
desired product 2.8e as a yellow semisolid.  
1H NMR (400 MHz, CDCl3): d 7.61–7.55 (m, 2 H), 7.34 (dtd, J = 24.1, 12.3, 11.9, 6.0 Hz, 
9 H), 7.08 (dd, J = 7.6, 1.5 Hz, 1 H), 7.01–6.93 (m, 2 H), 6.89–6.83 (m, 2 H), 6.60 (dd, J 
= 17.9, 8.2 Hz, 2 H), 5.08 (s, 2 H), 3.26 (t, J = 14.7 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 144.3 (d, J = 26.6 Hz), 136.6, 136.3, 129.8, 129.5, 129.1, 
128.9, 128.8, 128.7 (t, J = 279.7 Hz), 128.4, 127.4, 127.1 (d, J = 25.6 Hz), 126.7, 126.2 










19F NMR (376 MHz, CDCl3): d –71.72 (t, J = 14.7 Hz, 2 F) 
IR (film): 3430, 2388, 2288, 1647, 1578, 1495, 1470, 1443, 1366, 1288, 1258, 1223, 
1153, 1034, 1028, 1013, 912, 746, 692 




carboxylate (2.8f): Following General Procedure B, 0.17 g (0.50 mmol) of compound 
2.7f was reacted with 0.16 mL (1.5 mmol) of thiophenol at 90 ˚C for 5 h. After workup, the 
product was purified by flash chromatography on silica gel using a gradient from 0–20–
50% EtOAc in hexanes, to furnish 0.19 g (86% yield) of desired product 2.8f as a yellow 
solid, m.p. 82 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.61–7.58 (m, 2 H), 7.45–7.35 (m, 3 H), 7.00 (d, J = 1.0 Hz, 
1 H), 3.55 (dd, J = 6.7, 3.8 Hz, 4 H), 3.48–3.41 (m, 6 H), 1.48 (s, 9 H) 
13C NMR (126 MHz, CDCl3): d 172.4, 154.7, 140.3, 136.4, 130.1, 129.3, 128.3 (t, J = 
280.0 Hz), 126.7, 116.1 (t, J = 3.5 Hz), 80.5, 48.2, 43.0 (bs), 37.3 (t, J = 27.1 Hz), 28.5 









IR (film): 2976, 2926, 2859, 2361, 1697, 1522, 1452, 1420, 1366, 1285, 1254, 1238, 
1167, 1140, 1034, 1009, 999, 968, 897, 750, 691, 669 cm-1 
HRMS (ESI+): calc. for C20H25F2N3O2S2Na (M+Na) 464.1254, found 464.1263, 1.9 ppm. 
 
Experimental Procedures and Characterization of Compounds in Scheme 2-10 
 
(1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethyl)(4-methoxyphenyl)sulfane (2.10a): 
Following General Procedure B, 0.115 g (0.500 mmol) of compound 2.1 was reacted with 
0.125 mL (1.00 mmol) of 4-methoxythiophenol at 70 ˚C for 30 min. After workup, the 
product was purified by flash chromatography using 0–5% Et2O in PhMe, to furnish 0.148 
g (80% yield) of desired product 2.10a as a colorless solid, m.p. 66–67 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.50 (d, J = 8.4 Hz, 2 H), 6.89 (d, J = 8.4 Hz, 2 H), 6.49 (s, 
2 H), 3.85 (s, 9 H), 3.82 (s, 3 H), 3.34 (t, J = 14.7 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 161.2, 153.2, 138.2, 137.6, 128.6 (t, J = 279.4 Hz), 127.7 
(t, J = 3.2 Hz), 117.4 (t, J = 2.3 Hz), 114.7, 107.7, 61.0, 56.3, 55.5, 45.4 (t, 24.4 Hz) 









IR (film): 2999, 2939, 2839, 2361, 2339, 1591, 1508, 1495, 1462, 1423, 1346, 1315, 
1290, 1250, 1225, 1175, 1151, 1128, 1028, 1007, 995, 947, 924, 874, 829, 777, 692, 667, 
646, 528 cm-1 
HRMS (HAPCI+): calc. for C18H21F2O4S (M+H) 371.1129, found 371.1114, 4.9 ppm. 
 
Preparation of Compound 2.9b 
 
ethyl 2-(o-tolyloxy)acetate (2.9b-2):18 Compound 2.9b-2 was prepared according to a 
previous report.18 An oven-dried 250 mL two-neck round-bottom flask equipped with a 
magnetic stirbar and reflux condenser was charged with 10.4 g (75.0 mmol) of anhydrous 
grade K2CO3, and evacuated and backfilled with N2 3X. o-Cresol (5.80 mL, 56.0 mmol) 
was added, and the mixture dissolved in anhydrous MeCN (100 mL). The mixture was 
stirred for 15 min at R.T., and then 7.0 mL (63 mmol) of ethyl bromoacetate was added. 
The reaction vessel was submerged in a 90 ˚C oil bath, and the reaction refluxed 
























MeOH, reflux, 14 h
K2CO3
MeCN, reflux, 14 h
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give 10.6 g (97%) of desired product 2.9b-2 as a yellow oil. 2.9b-2 was of sufficient purity 
to use in the next step.  
1H NMR (400 MHz, CDCl3): d 7.17–7.11 (m, 2 H), 6.90 (td, J = 7.4, 1.1 Hz, 1 H), 6.71 (d, 
J = 8.3 Hz, 1H), 4.64 (s, 2 H), 4.27 (q, J = 7.1 Hz, 2 H), 2.30 (s, 3 H), 1.30 (t, J = 7.2 Hz, 
3 H). 
 
Note: The reaction can be run without utilizing anhydrous solvents or dry glassware. 
However, the yield will be lower and purification will be necessary. The most important 
component is the quality of K2CO3. For full conversion, we recommend anhydrous grade 
K2CO3. 
 
ethyl 2-(4-(chlorosulfonyl)-2-methylphenoxy)acetate (2.9b-1):18 Compound 2.9b-1 
was prepared according to a previous report.18 An oven-dried 25 mL round bottom flask 
equipped with a magnetic stirbar was sealed with a rubber septum. To the round bottom 
flask was added 7.00 mL (105 mmol) of chlorosulfonic acid. The round bottom flask was 
submerged in a 0 ˚C ice bath, and the chlorosulfonic acid stirred rapidly, to which 3.90 g 
(20.0 mmol) of 2.9b-2 was added dropwise. Once all 2.9b-2 was added, the reaction was 
warmed to ambient temperature over 1 h and stirred for another 2 h. The reaction was 
then carefully poured over ice (caution: the reaction with the ice can cause splatter). After 
drying on high vacuum, 4.60 g (78%) of desired product 2.9b-1 was recovered as a grey 




methyl 2-(4-mercapto-2-methylphenoxy)acetate (2.9b):18 Compound 2.9b was 
prepared according to a previous report.18 A 3-neck flask was equipped with a magnetic 
stirbar and a reflux condenser and charged with 4.60 g (15.7 mmol) of 2.9b-1 and 9.36 g 
(78.6 mmol) of powdered tin metal. The mixture was suspended in MeOH (150 mL), and 
the side-arms sealed with rubber septa. Concentrated HCl (20 mL) was added dropwise 
while the mixture was rapidly stirring. During the addition of the HCl, the exotherm caused 
the reaction to begin refluxing. Once all HCl was added, the reaction vessel was 
submerged in a 90 ˚C oil bath, and the mixture refluxed overnight. The reaction was 
returned to ambient temperature, and then quenched by pouring the reaction over ice. 
The reaction was extracted with ether (3X 50 mL), and the organic layer washed 2X with 
20 mL of H2O. The organic layer was dried with Na2SO4, and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel by 30% EtOAc in 
hexanes. The reaction afforded 1.89 g (57%) of desired product 2.9b as a clear oil. The 
















compound 2.1 was reacted with 0.21 g (1.0 mmol) of compound 10b at 70 ˚C for 0.5 h. 
After workup, the product was purified by flash chromatography using 0–30% EtOAc in 
hexanes, to furnish 0.19 g (81% yield) of desired product 2.10b in 97% purity (assessed 
by 1H and 19F NMR) as an off-white solid, m.p. 60–63 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.38–7.35 (m, 2 H), 6.66 (d, J = 8.4 Hz, 1 H), 6.49 (s, 2 H), 
4.67 (s, 2 H), 3.86 (s, 6 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.34 (t, J = 14.7 Hz, 2 H), 2.28 (s, 
3 H) 
13C NMR (126 MHz, CDCl3): d 169.3, 157.7, 153.2, 139.2, 137.6, 135.5, 128.7 (t, J = 
279.4 Hz), 128.4, 127.7 (t, J = 3.1 Hz), 118.2, 111.4, 107.7, 65.5, 61.0 (d, J = 2.5 Hz), 
56.3 (d, J = 2.4 Hz), 52.5 (d, J = 2.3 Hz), 45.4 (t, J = 24.4 Hz), 16.3 
19F NMR (376 MHz, CDCl3): d –72.36 (t, J = 14.8 Hz, 2 F) 
IR (film): 2922, 1761, 1591, 1508, 1491, 1460, 1423, 1311, 1240, 1213, 1126, 1040, 
1005, 881, 806, 771, 702, 663 cm-1 














Folllowing General Procedure C, 0.12 g (0.50 mmol) of compound 2.1 was reacted with 
0.25 g (1.5 mmol) of 4-acetamidothiophenol at 100 ˚C for 20 h. After workup, the product 
was purified by flash chromatography on silica gel using a gradient of 0–40–70–100% 
EtOAc in hexanes with 1% Et3N, to furnish 0.18 g (88% yield) of desired product 2.10c in 
98% purity (as determined by 1H and 19F NMR) as a colorless solid, m.p. 120–121 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.53 (s, 4 H), 7.22 (bs, 1 H), 6.49 (s, 2 H), 3.86 (s, 6H), 
3.85 (s, 3 H), 3.34 (t, J = 14.7 Hz, 2 H), 2.19 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 168.5, 153.2, 139.6, 137.7, 137.4, 128.65 (t, J = 279.9 
Hz), 127.6 (t, J = 3.2 Hz), 121.6, 120.0, 107.7, 61.0, 56.3, 45.5 (t, J = 24.3 Hz), 24.9 
19F NMR (376 MHz, CDCl3): d –72.05 (t, J = 14.8 Hz, 2 F) 
IR (film): 3318, 2999, 2940, 2839, 1694, 1682, 1591, 1530, 1510, 1462, 1424, 1397, 
1371, 1346, 1314, 1292, 1248, 1225, 1180, 1150, 1126, 1036, 1011, 995, 945, 874, 833, 
777, 737, 692, 665, 590, 525 cm-1 











3-((1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethyl)thio)aniline (2.10d): Following 
General Procedure B, 0.12 g (0.50 mmol) of compound 2.1 was reacted with 0.11 mL (1.0 
mmol) of 3-aminothiophenol at 90 ˚C for 20 h. After extraction from 1 N NaOH (to remove 
the residual 3-aminothiophenol that is difficult to remove by normal-phase 
chromatography) with DCM, the product was purified by flash chromatography using 0–
30–40–70% EtOAc in hexanes, to furnish 0.13 g (71% yield) of desired product 2.10d in 
95% purity (by 1H and 19F NMR) as an orange/pink solid, m.p. 87–90 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.14 (t, J = 7.8 Hz, 1 H), 6.96 (dt, J = 7.7, 1.2 Hz, 1 H), 6.91 
(t, J = 2.0 Hz, 1 H), 6.71 (ddd, J = 8.0, 2.4, 1.0 Hz, 1 H), 6.49 (s, 2 H), 3.86 (s, 6 H), 3.85 
(s, 3 H), 3.72 (bs, 2 H), 3.35 (t, J = 14.8 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 147.0, 137.6, 129.9, 128.9 (t, J = 279.5 Hz), 127.75 
(t, J = 2.1 Hz), 127.69 (t, J = 3.2 Hz), 126.0, 122.1, 116.5, 107.7, 61.0, 56.2, 45.5 (t, J = 
24.6 Hz) 
19F NMR (376 MHz, CDCl3): d –71.50 (t, J = 14.8 Hz, 2 F) 
IR (film): 3462, 3372, 3231, 2999, 2940, 2837, 2359, 1622, 1593, 1508, 1481, 1460, 
1424, 1344, 1316, 1225, 1150, 1126, 1001, 990, 872, 777, 689, 667, 405 cm-1 






Following General Procedure B, 0.12 g (0.50 mmol) of compound 2.1 was reacted with 
0.12 mL (1.0 mmol) of 2-bromothiophenol at 70 ˚C for 2 h. After workup, the product was 
purified by flash chromatography using 0–10% Et2O in PhMe, to furnish 0.18 g (84% yield) 
of desired product 2.10e as a colorless solid, m.p. 57–58 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.74 (d, J = 7.7 Hz, 1 H), 7.67 (dd, J = 8.0 Hz, 1.6 Hz, 1 H), 
7.26-7.24 (m, 1 H), 6.52 (s, 2 H), 3.86 (s, 6 H), 3.85 (s, 3 H), 3.42 (t, J = 14.8 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 137.84, 137.76, 133.7, 131.1, 130.3, 129.0, 128.9 
(t, J = 281.5 Hz), 128.0, 127.3 (t, J = 3.1 Hz), 107.7, 61.0, 56.3, 45.7 (t, J = 23.9 Hz) 
19F NMR (376 MHz, CDCl3): d –71.03 (t, J = 14.9 Hz, 2 F) 
IR (film): 2997, 2937, 2837, 2359, 2341, 1591, 1506, 1462, 1423, 1346, 1315, 1246, 
1225, 1151, 1126, 1038, 1009, 993, 945, 926, 874, 829, 777, 756, 690, 667, 646, 633, 
581, 563, 525 cm-1 
HRMS (HAPCI+): calc. for C17H17BrF2O3S (M+) 418.0050, found 418.0050, 0.0 ppm. 
 










ethyl 2-(4-mercapto-2-methylphenoxy)acetate (2.9f-1):19 A three-neck, 250 mL round 
bottom flask was equipped with a magnetic stirbar, an internal thermometer, and a reflux 
condenser and then charged with 3.51 g (53.0 mmol) of zinc dust. The zinc dust was 
suspended in 54 mL of EtOAc, and rapidly stirred. The reaction vessel was submerged 
in a 40 ˚C oil bath, and the temperature modulated to achieve an internal reaction 
temperature of 40 ˚C. At this temperature, 1.80 mL (31.0 mmol) of glacial acetic acid and 
0.56 mL (31 mmol) of deionized H2O were added to the suspension. Subsequently 4.47 
g (15.3 mmol) of 9b-1 were added in portions, maintaining an internal reaction 
temperature less than 60 ˚C. After all 2.9b-1 was added, the reaction was stirred at 40 ˚C 
for 1 h. Subsequently, 12.0 mL (91.0 mmol) of TMS-Cl was added dropwise, maintaining 
an internal temperature less than 55 ˚C. Once all of the TMS-Cl was added, the reaction 
was brought to reflux, which requires an internal temperature of approximately 77 ˚C, and 
refluxed overnight. At ambient temperature, the reaction was quenched with saturated 
aq. NH4Cl and extracted with EtOAc (3X 50 mL). The organic layer was dried with Na2SO4 
and concentrated in vacuo, and the crude product was purified by flash chromatography 
on silica gel using a gradient of 0–10–30% EtOAc in hexanes. The reaction afforded 1.74 













1) Zn, AcOH, H2O
    EtOAc, 40 ˚C, 1 h










1H NMR (400 MHz, CDCl3): d 7.14 (d, J = 2.4 Hz, 1 H), 7.09 (dd, J = 8.5, 2.3 Hz, 1 H), 
6.59 (d, J = 8.4 Hz, 1 H), 4.60 (s, 2 H), 4.25 (q, J = 7.1 Hz, 2 H), 3.33 (s, 1 H), 2.24 (s, 3 
H), 1.29 (t, J = 7.1 Hz, 3 H). 
 
2-(4-mercapto-2-methylphenoxy)ethan-1-ol (2.9f): An oven-dried 100 mL round 
bottom flask, equipped with a magnetic stirbar, was charged with 0.29 g (7.5 mmol) of 
lithium aluminum hydride in the glovebox and sealed with a rubber septum. The reaction 
vessel was removed from the glovebox and submerged in a 0 ˚C ice bath, and the lithium 
aluminum hydride was suspended in anhydrous THF (32 mL). 0.65 g (3.0 mmol) of 9f-1 
was added to the reaction at 0 ˚C. The reaction solidified, so additional anhydrous THF 
(approx. 10 mL) was added, and the temperature was allowed to rise to R.T., and 
subsequently stirred for 3 h. The reaction was cooled to 0 ˚C in an ice bath and quenched 
by the addition of 10 mL of EtOAc. Then, a saturated solution of Rochelle’s salt (20 mL) 
was added, and the reaction was stirred overnight at R.T.. The reaction was extracted 
with EtOAc (3X 20 mL), and the organic layer dried over Na2SO4 and concentrated in 
vacuo to provide 0.320 g (60%) of desired product 2.9f as a colorless solid, m.p. 74–76 
˚C. Note, if contaminated with a disulfide impurity, purification on silica gel by a gradient 
from 0% EtOAc in hexanes to 40% EtOAc in hexanes furnishes pure product, albeit in 
lower yield.  
1H NMR (400 MHz, CDCl3): d 7.13–7.10 (m, 2 H), 6.70 (d, J = 8.8 Hz, 1 H), 4.03 (dd, J = 
5.2, 3.8 Hz, 2 H), 3.97–3.95 (m, 2 H), 3.34 (s, 1 H), 2.21 (s, 1 H), 2.18 (s, 3 H) 
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13C NMR (126 MHz, CDCl3): d 155.7, 133.6, 129.5, 128.0, 120.2, 112.1, 69.6, 61.7, 16.2 
IR (film): 3196, 2938, 2872, 2552, 2359, 2342, 1595, 1493, 1454, 1400, 1294, 1246, 
1196, 1138, 1101, 1086, 1049, 928, 914, 897, 876, 866, 804, 658 cm-1 




ol (2.10f): Following General Procedure B, 0.12 g (0.50 mmol) of compound 2.1 was 
reacted with 0.26 g (1.5 mmol) of 10f at 90 ˚C for 5 h. After workup, the product was 
purified by flash chromatography on silica gel using a gradient from 0–10–30–60% EtOAc 
in hexanes, to furnish 0.21 g (99% yield) of desired product 2.10f in 96% purity 
(determined by 1H and 19F NMR) as a colorless solid, m.p. 55–57 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.40–7.35 (m, 2 H), 6.81 (d, J = 8.2 Hz, 1 H), 6.50 (s, 2 H), 
4.11 (dd, J = 5.2, 3.8 Hz, 2 H), 4.02–3.98 (m, 2 H), 3,86 (s, 6 H), 3.85 (s, 3 H), 3.34 (t, J 











13C NMR (126 MHz, CDCl3): d 158.4, 153.2, 139.0, 137.6, 135.7, 128.7 (t, J = 279.3 Hz), 
127.8, 127.7 (t, J = 3.0 Hz), 117.3, 111.5, 107.7, 69.5, 61.6, 61.0, 56.3, 45.4 (t, J = 24.4 
Hz), 16.3 
19F NMR (376 MHz, CDCl3): d –72.49 (t, J = 14.7 Hz, 2 F) 
IR (film): 3457, 2938, 2839, 2359, 2332, 1593, 1506, 1493, 1456, 1424, 1346, 1316, 
1298, 1250, 1225, 1194, 1126, 1103, 1034, 997, 922, 889, 872, 810, 692, 667, 581, 530 
cm-1 




(2.10g): Following General Procedure B, 0.12 g (0.50 mmol) of compound 2.1 was 
reacted with 0.14 mL (1.0 mmol) of 3-trifluoromethyl thiophenol at 70 ˚C for 0.5 h. After 
workup, the product was purified by flash chromatography using 0–5% Et2O in PhMe, to 
furnish 0.16 g (78% yield) of desired product 2.10g as a colorless solid, m.p. 59–60 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.84 (s, 1 H), 7.77 (d, J = 7.8 Hz, 1 H), 7.67 (d, J = 7.9 Hz, 









13C NMR (126 MHz, CDCl3): d 153.3, 139.3, 137.9, 132.7 (q, J = 3.8 Hz), 131.6 (q, J = 
32.6 Hz), 129.6, 128.6 (t, J = 281.1 Hz), 128.3 (d, J = 2.1 Hz), 127.1 (t, J = 3.4 Hz), 126.7 
(q, J = 3.7 Hz), 122.6 (q, J = 273.2 Hz), 107.7, 61.0, 56.3, 45.6 (t, J = 23.9 Hz) 
19F NMR (376 MHz, CDCl3): d –62.77 (s, 3 F), –70.77 (t, J = 14.5 Hz, 2 F) 
IR (film): 2999, 2941, 2841, 1591, 1508, 1462, 1423, 1346, 1325, 1304, 1275, 1246, 
1225, 1169, 1151, 1128, 1070, 1041, 1013, 947, 926, 876, 800, 777, 714, 696 cm-1 




Following General Procedure B, 0.16 g (0.50 mmol) of compound 2.1 was reacted with 
0.13 mL (1.0 mmol) of 3,4-dichlorothiophenol at 70 ˚C for 0.5 h. After workup, the product 
was purified by flash chromatography using 0–10% Et2O in PhMe, to furnish 0.17 g (83% 
yield) of desired product 2.10h as a colorless solid, m.p. 59 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.67 (d, J = 1.9 Hz, 1 H), 7.43 (q, J = 8.4 Hz, 2 H), 6.49 (s, 










13C NMR (126 MHz, CDCl3): d 153.3, 137.9, 137.5, 135.2, 134.8, 133.1, 130.9, 128.6 (t, 
J = 281.3 Hz), 127.1 (t, J = 3.5 Hz), 126.8 (d, J = 2.2 Hz), 107.6, 61.1, 56.3, 45.6 (t, J = 
23.9 Hz) 
19F NMR (376 MHz, CDCl3): d –78.78 (t, J = 14.5 Hz, 2 F) 
IR (film): 2999, 2937, 2839, 2359, 2341, 1591, 1508, 1456, 1423, 1366, 1346, 1315, 
1246, 1225, 1184, 1151, 1126, 1034, 1013, 995, 947, 924, 876, 814, 777, 690, 667 cm-1 
HRMS (HAPCI+): calc. for C17H17Cl2F2O3S (M+H) 409.0244, found 409.0241, 0.7 ppm. 
 
Preparation of Compound 9i 
 
4-mercaptobenzonitrile (2.9i):20 Compound 2.9i was prepared according to a previous 
report, with modifications to the first step.20 An oven dried 250 mL 3-neck round bottom 
flask was equipped with a magnetic stirbar and reflux condenser was charged with 3.65 
g (20 mmol) of p-bromobenzonitrile, 0.58 g (1.0 mmol) of Xantphos, and 0.46 g (0.5 mmol) 
of Pd2(dba)3 and evacuated and backfilled 3X with N2. The reactants were dissolved in 
anhydrous PhMe (114 mL), and subsequently 2.3 mL (20 mmol) of methyl-3-
mercaptopropionate and 8 mL (46 mmol) of Hunig’s base were added. The reaction 

















PhMe, reflux, 14 h
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the reaction was filtered, the filtrate was concentrated, and the crude product purified by 
flash chromatography on silica gel by a gradient using 0–10–30–100% EtOAc in hexanes 
to furnish 2.9i-1 as an orange/pink solid, m.p. 51 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.55 (d, J = 8.5 Hz, 2 H), 7.33 (d, J = 8.5 Hz, 2 H), 3.71 (s, 
3 H), 3.25 (t, J = 7.4 Hz, 2 H), 2.69 (t, J = 7.4 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 171.8, 143.6, 132.5, 127.4, 118.9, 108.9, 52.2, 33.6, 27.2 
IR (film): 3090, 3007, 2951, 2845, 2226, 1738, 1595, 1489, 1437, 1418, 1404, 1364, 
1252, 1194, 1177, 1090, 1061, 1015, 978, 901, 845, 820, 787, 706, 679, 588, 546 cm-1 
HRMS (HAPCI+): calc. for C11H12NO2S (M+H) 222.0589, found 222.0585, 1.8 ppm. 
 
An oven-dried 500 mL round bottom flask equipped with a magnetic stirbar and rubber 
septum was charged with anhydrous MeOH (200 mL). The reaction flask was submerged 
in a 0 ˚C bath. On a clean paper towel 1.38 g (60 mmol) of sodium metal in mineral oil 
was washed with hexanes and added to the MeOH in portions. Once all of the sodium 
metal was dissolved the NaOMe solution was poured into a 500 mL round bottom flask 
containing 2.9i-1 at R.T.. The reaction was stirred overnight and then quenched with 
aqueous 1 N HCl. The MeOH was removed in vacuo and the resulting aqueous solution 








4-((1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethyl)thio)benzonitrile (2.10i): Following 
General Procedure C, 0.12 g (0.50 mmol) of compound 2.1 was reacted with 0.14 g (1.0 
mmol) of 2.10i at 100 ˚C for 20 h. After workup, the product was purified by flash 
chromatography using 0–10–40% EtOAc in hexanes, to furnish 0.151 g (82% yield) of 
desired product 10i as a yellow solid, m.p. 130–132 ˚C.  
1H NMR (400 MHz, CDCl3): d 7.67 (d, J = 8.3 Hz, 2 H), 7.64 (d, J = 8.4 Hz, 2 H), 6.50 (s, 
2 H), 3.41 (t, J = 14.5 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 138.0, 135.6, 133.8, 132.5, 128.8 (t, J = 281.9 Hz), 
126.8 (t, J = 3.4 Hz), 118.2, 113.3, 107.7, 61.1, 56.3, 45.8 (t, J = 23.7 Hz) 
19F NMR (376 MHz, CDCl3): d –70.08 (t, J = 14.6 Hz, 2 F) 
IR (film): 3001, 2963, 2940, 2839, 2230, 1593, 1508, 1487, 1462, 1424, 1346, 1317, 
1246, 1227, 1152, 1128, 1040, 1013, 995, 874, 831, 781, 692, 664, 548 cm-1 











3-((1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethyl)thio)phenol (2.10j): Following 
General Procedure B, 0.16 g (0.50 mmol) of compound 2.1 was reacted with 0.10 mL (1.0 
mmol) of 3-hydroxythiophenol at 70 ˚C for 4 h. After workup, the product was purified by 
flash chromatography using 0–15–30% EtOAc in hexanes, to furnish 0.15 g (84% yield) 
of desired product 2.10j in 99% purity (as determined by 1H and 19F NMR) as a colorless 
solid, m.p. 98–102 ˚C. 
1H NMR (400 MHz, CDCl3): d 7.24 (t, J = 7.9 Hz, 1 H), 7.15 (d, J = 7.7 Hz, 1 H), 7.08 (s, 
1 H), 6.89 (dd, J = 8.2, 2.5 Hz, 1 H), 6.49 (s, 2 H), 4.95–4.92 (m, 1 H), 3.86 (s, 9 H), 3.36 
(t, J = 14.7 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 155.8, 153.2, 137.7, 130.1, 128.8 (t, J = 280.1 Hz), 128.4, 
128.2 (t, J = 2.0 Hz), 127.6 (t, J = 3.2 Hz), 122.7, 117.1, 107.7, 61.0, 56.3, 45.5 (t, J = 
24.4 Hz) 
19F NMR (376 MHz, CDCl3): d –71.27 (t, J = 14.7 Hz, 2 F) 
IR (film): 3404, 2939, 2361, 2341, 1593, 1508, 1458, 1423, 1346, 1315, 1248, 1225, 









HRMS (ESI+): calc for C17H18F2O4SNa (M+Na) 379.0792, found 379.0793, 0.3 ppm. 
 
Scheme 2-12: Coupling of Aryl Thiols over Alkyl Thiols: 
 
Prepared according to General Procedure C, with the following modifications. To an oven-
dried 5 mL microwave vial equipped with a magnetic stirbar was added 0.12 g (0.50 mmol) 
of 2.1, 2 mL of DCE, 0.16 mL (1.5 mmol) of thiophenol, 0.26 mL (1.5 mmol) of 1-
octanethiol, and 3.2 µL (0.025 mmol) of TMG. The vial was sealed with a PTFE-lined 
silicon septa in a crimp-top cap, and then General Procedure C was followed as normal. 
To assess the selectivity of the coupling reaction for thiophenol, the reaction mixture was 
assessed by 19F NMR, GC-MS, and FID-GC. By 19F NMR no formation of compound 2.11 
was observed, while both GC methods showed less than 1% of compound 2.11 formed. 
Upon isolation 0.155 g (91% yield) of compound 2.2 was recovered, which compares 










100 ˚C, DCE, 20 h














Preparation and Characterization of Compounds in Scheme 2-13 
 
4-(3-(2,2-difluoro-2-(octylthio)ethyl)phenyl)morpholine (2.12d): Prepared according 
to General Procedure D, 0.113 g (0.50 mmol) of compound 2.5d was reacted with 0.13 
mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL (0.10 
mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-xylene at 
110 ˚C for 15 h. After workup, the product was purified by flash chromatography using 0–
100% DCM in hexanes to furnish 0.111 g (60 % yield) of desired compound 2.12d as a 
pale orange oil. 
1H NMR (500 MHz, CDCl3): d 7.30 (t, J = 7.88 Hz, 1 H), 7.03 (dd, J = 7.89, 1.97 Hz, 1 H), 
6.99 (d, J = 2.19 Hz, 1 H), 6.96 (d, J = 7.57 Hz, 1 H), 3.94–3.92 (m, 4 H), 3.37 (t, J = 14.50 
Hz, 2 H), 3.27–3.25 (m, 4 H), 2.80 (t, J = 7.47 Hz, 2 H), 1.62 (tt, J = 7.65, 6.34 Hz, 2 H), 
1.36–1.33 (m, 2 H), 1.29–1.25 (m, 9 H), 0.88 (t, J = 6.95 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 149.3, 133.8 (t, J = 3.82 Hz), 130.1 (t, J = 277.98 Hz), 
129.6, 124.7, 119.3, 116.4, 66.4, 50.7, 46.0 (t, J = 24.66 Hz), 31.9, 29.9, 29.3, 29.2, 29.0, 
28.1 (t, J = 3.59 Hz), 22.8, 14.2 











Prepared according to General Procedure D, 0.136 g (0.50 mmol) of compound 2.5g was 
reacted with 0.13 mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 
0.008 mL (0.10 mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL 
of o-xylene at 110 ˚C for 15 h. After workup, the product was purified by flash 
chromatography using 0–100% DCM in hexanes to furnish 0.159 g (76 % yield) of desired 
compound 2.12d as a pale orange oil. 
1H NMR (500 MHz, CDCl3): d 7.57–7.54 (m, 4 H), 7.49 (d, J = 8.43 Hz, 2 H), 7.41 (t, J = 
7.61 Hz, 1 H), 7.28 (d, J = 7.62 Hz, 1 H), 3.47 (t, J = 14.50 Hz, 2 H), 2.83 (t, J = 7.47 Hz, 
2 H), 1.64 (p, J = 7.34 Hz, 2 H), 1.39 (s, 9 H), 1.35–1.26 (m, 11 H), 0.88 (t, J = 6.95 Hz, 
3 H) 
13C NMR (126 MHz, CDCl3): d 150.6, 141.4, 138.2, 132.8 (t, J = 3.45 Hz), 130.3 (t, J = 
277.55 Hz), 129.5, 129.3, 128.9, 127.0, 126.5, 125.9, 46.0 (t, J = 24.63 Hz), 34.9, 32.0, 
31.8, 31.5, 30.0, 29.2, 29.0, 28.2 (t, J = 3.28 Hz), 22.8, 14.2 









ethyl (E)-3-(3-(2,2-difluoro-2-(octylthio)ethyl)phenyl)acrylate (2.12j): Prepared 
according to General Procedure D, 0.119 g (0.50 mmol) of compound 2.5j was reacted 
with 0.13 mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL 
(0.10 mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-
xylene at 110 ˚C for 15 h. After workup, the product was purified by flash chromatography 
using 0–100% DCM in hexanes to furnish 0.148 g (77 % yield) of desired compound 2.13c 
as a white semisolid. 
1H NMR (500 MHz, CDCl3): d 7.68 (d, J = 16.03 Hz, 1 H), 7.48 (d, J = 7.58 Hz, 1 H), 7.45 
(d, J = 2.03 Hz, 1 H), 7.36 (t, J = 7.57 Hz, 1 H), 7.31 (d, J = 7.51 Hz, 1 H), 6.45 (d, J = 
16.01 Hz, 1 H), 4.27 (q, J = 7.13 Hz, 2 H), 3.40 (t, J = 14.40 Hz, 2 H), 2.80 (t, J = 7.54 Hz, 
2 H), 1.61 (p, J = 7.28 Hz, 2 H), 1.34 (t, J = 7.12 Hz, 6 H), 1.27–1.25 (m, 9 H), 0.88 (t, J 
= 6.93 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 167.0, 144.3, 134.8, 133.2 (t, J = 3.76 Hz), 132.4, 130.3, 
130.0 (t, J = 277.09 Hz), 129.1, 127.4, 118.8, 60.7, 45.6 (t, J = 24.98 Hz), 31.9, 29.9, 28.9, 
29.1, 28.9, 28.1 (t, J = 3.51 Hz), 22.8, 14.5, 14.2 










(2-(3,5-dimethylphenyl)-1,1-difluoroethyl)(octyl)sulfane (2.12p): Prepared according 
to General Procedure D, 0.084 g (0.50 mmol) of compound 2.5p was reacted with 0.13 
mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL (0.10 
mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-xylene at 
110 ˚C for 15 h. After workup, the product was purified by flash chromatography using 0–
100% DCM in hexanes to furnish 0.094 g (60 % yield) of desired compound 2.13p as a 
clear oil. 
1H NMR (500 MHz, CDCl3): d 6.95 (s, 1 H), 6.91 (s, 2 H), 3.32 (t, J = 14.71 Hz, 2 H), 2.80 
(t, J = 7.50 Hz, 2 H), 2.32 (s, 6 H), 1.62 (tt, J = 7.67, 5.45 Hz, 2 H), 1.41–1.33 (m, 2 H), 
1.30–1.26 (m, 9 H), 0.89 (t, J = 6.96 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 138.0, 132.1 (t, J = 3.92 Hz), 130.4 (t, J = 277.16 Hz), 
129.5, 128.5, 45.7 (t, J = 24.58 Hz), 39.4, 32.0, 29.9, 29.4, 29.3, 29.2, 29.0, 28.1 (t, J = 
3.69 Hz), 21.4, 14.3 















(2-(2,6-dimethylphenyl)-1,1-difluoroethyl)(octyl)sulfane (2.12r): Prepared according 
to General Procedure D, 0.084 g (0.50 mmol) of compound 2.5r was reacted with 0.13 
mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL (0.10 
mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-xylene at 
110 ˚C for 15 h. After workup, the product was purified by flash chromatography using 0–
100% DCM in hexanes to furnish 0.082 g (52 % yield) of desired compound 2.13r as a 
clear oil. 
1H NMR (500 MHz, CDCl3): d 7.10 (dd, J = 8.56, 6.30 Hz, 1 H), 7.05 (d, J = 7.05 Hz, 2 
H), 3.54 (t, J = 15.42 Hz, 2 H), 2.83 (t, J = 7.52 Hz, 2 H), 2.38 (s, 6 H), 1.64 (p, J = 7.49 
Hz, 2 H), 1.37 (t, J = 7.53 Hz, 2 H), 1.28 (dt, J = 9.78, 4.93 Hz, 9 H), 0.88 (t, J = 6.72 Hz, 
3 H) 
13C NMR (126 MHz, CDCl3): d 138.7, 131.1 (t, J = 278.94 Hz), 129.8 (t, J = 2.24 Hz), 
128.4, 127.6, 127.4, 39.3 (t, J = 24.69 Hz), 29.9, 29.3, 29.2, 29.0, 28.3 (t, J = 3.60 Hz), 
22.8, 20.9, 14.2 
19F NMR (376 MHz, CDCl3): d –71.37 (t, J = 15.47 Hz, 2 F) 
 
 
3-(2,2-difluoro-2-(octylthio)ethyl)-1-tosyl-1H-indole (2.13a): Prepared according to 








(1.50 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL (0.10 mmol) 
of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-xylene at 110 ˚C 
for 15 h. After workup, the product was purified by flash chromatography using 0–100% 
DCM in hexanes to furnish 0.160 g (66 % yield) of desired compound 2.13a as an orange 
semisolid. 
1H NMR (500 MHz, CDCl3): d 7.96 (d, J = 8.26 Hz, 1 H), 7.75 (d, J = 8.45 Hz, 2 H), 7.57 
(s, 1 H), 7.53 (d, J = 7.80 Hz, 1 H), 7.31 (ddd, J = 8.34, 7.22, 1.31 Hz, 1 H), 7.27–7.24 
(m, 1 H), 7.20 (d, J = 8.18 Hz, 2 H), 3.48 (t, J = 14.09 Hz, 2 H), 2.80 (t, J = 7.46 Hz, 2 H), 
2.33 (s, 3 H), 1.61 (p, J = 7.45 Hz, 2 H), 1.34–1.31 (m, 2 H), 1.30–1.23 (m, 9 H), 0.88 (t, 
J = 6.92 Hz) 
13C NMR (126 MHz, CDCl3): d 145.1, 135.3, 135.1, 130.9, 130.2 (t, J = 277.62 Hz), 130.1, 
130.0, 127.0, 126.4, 125.0, 123.5, 119.9 (t, J = 2.05 Hz), 113.8, 35.7 (t, J = 26.76 Hz), 
31.9, 29.9, 29.3, 29.2, 28.9, 29.2 (t, J = 3.48 Hz), 22.8, 21.7, 14.2 
19F NMR (376 MHz, CDCl3): d –72.66 (t, J = 14.26 Hz, 2 F) 
 
 
4-(2,2-difluoro-2-(octylthio)ethyl)-1-phenyl-1H-pyrazole (2.13c): Prepared according 
to General Procedure D, 0.103 g (0.50 mmol) of compound 2.7c was reacted with 0.13 








mmol) of pyridine, and 0.08 mL (1.0 mmol) of 2-methoxyethanol in 1.5 mL of o-xylene at 
110 ˚C for 15 h. After workup, the product was purified by flash chromatography using 0–
100% DCM in hexanes to furnish 0.104 g (59 % yield) of desired compound 2.13c as a 
white solid (MP = ~25 ˚C). 
1H NMR (500 MHz, CDCl3): d 7.88 (s, 1 H), 7.68 (dd, J = 8.59, 1.21 Hz, 2 H), 7.66 (s, 1 
H), 7.45 (dd, J = 8.57, 7.41 Hz, 2 H), 7.29 (t, J = 7.43 Hz, 1 H), 3.35 (t, J = 14.33 Hz, 2 
H), 2.84 (t, J = 7.43 Hz, 2 H), 1.64 (tt, J = 7.60, 6.36 Hz, 2 H), 1.37 (dd, J = 9.88, 5.19 Hz, 
2 H), 1.27 (q, J = 5.42, 4.65 Hz, 9 H), 0.88 (t, J = 6.93 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 142.1, 140.2, 130.1 (t, J = 276.32 Hz), 127.1 (d, J = 2.61 
Hz), 126.7, 119.2, 113.9, 35.3 (t, J = 26.75 Hz), 31.9, 29.7, 29.3, 29.2, 29.0, 28.2 (t, J = 
3.59 Hz), 22.8, 14.2 
19F NMR (376 MHz, CDCl3): d –74.33 (t, J = 14.42 Hz, 2 F) 
 
 
4-(2,2-difluoro-2-(octylthio)ethyl)dibenzo[b,d]thiophene (2.13d): Prepared according 
to General Procedure D, 0.123 g (0.50 mmol) of compound 2.7d was reacted with 0.13 
mL (0.75 mmol) of octanethiol, 0.008 g (0.05 mmol) of lithium triflate, 0.008 mL (0.10 







110 ˚C for 15 h. After workup, the product was purified by flash chromatography using 0–
100% DCM in hexanes to furnish 0.150 g (77 % yield) of desired compound 2.13d as a 
clear solid (MP = ~25 ˚C). 
1H NMR (500 MHz, CDCl3): d 8.14 (ddd, J = 11.47, 6.19, 2.29 Hz, 2 H), 7.87 (dd, J = 6.18, 
2.94 Hz, 1 H), 7.48–7.46 (m, 4 H), 3.71 (t, J = 14.33 Hz, 2 H), 2.84 (t, J = 7.50 Hz, 2 H), 
1.63 (p, J = 7.49 Hz, 2 H), 1.35 (t, J = 7.49 Hz, 2 H), 1.27 (dd, J = 14.01, 5.23 Hz, 9 H), 
0.88 (t, J = 6.71 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 141.2, 139.1, 136.2, 136.0, 130.5 (t, J = 278.31 Hz), 129.2, 
127.1 (t, J = 3.57 Hz), 127.0, 124.9, 124.6, 122.9, 121.9, 121.2, 44.9 (t, J = 25.59 Hz), 
31.9, 29.9, 29.2, 29.2, 29.0, 28.3 (t, J = 3.62 Hz), 22.8, 14.2 




References for Chapter 2 Appendix: 
 
1. Zheng, J.; Cai, J.; Lin, J. H.; Guo, Y.; Xiao, J. C., Synthesis and decarboxylative 
Wittig reaction of difluoromethylene phosphobetaine. Chem. Commun. 2013, 49 (68), 
7513-5. 
2. Ambler, B. R.; Peddi, S.; Altman, R. A., Ligand-Controlled Regioselective Copper-
Catalyzed Trifluoromethylation To Generate (Trifluoromethyl)allenes. Org. Lett. 2015, 17 
(10), 2506–9. 
3. Nielsen, S. F.; Larsen, M.; Boesen, T.; Schonning, K.; Kromann, H., Cationic 
Chalcone Antibiotics. Design, Synthesis, and Mechanism of Action. J. Med. Chem. 2005, 
48, 2667–77. 
4. Hu, J.; Lu, Y.; Li, Y.; Zhou, J. S., Highly active catalysts of bisphosphine oxides for 
asymmetric Heck reaction. Chem. Commun. 2013, 49 (82), 9425–7. 
5. Ye, F.; Shi, Y.; Zhou, L.; Qing, X.; Zhang, Y.; Wang, J., Expeditious Synthesis of 
Phenanthrenes via CuBr2-Catalyzed Coupling of Terminal Alkynes and N-
Tosylhydrazones Derived from O-Formyl Biphenyls. Org. Lett. 2011, 13 (19), 5020–3. 
6. Chouhan, G.; Alper, H., Synthesis of ring-fused oxazolo- and 
pyrazoloisoquinolinones by a one-pot Pd-catalyzed carboxamidation and aldol-type 
condensation cascade process. J. Org. Chem. 2009, 74 (16), 6181–9. 
 
209 
7. Ghosh, D.; Jana, S.; Panja, A.; Anoop, A.; Basak, A., Reactivity of conformationally 
constrained bispropargyl sulfones: complete preference for 6π-electrocyclization 
process. Tetrahedron 2013, 69 (41), 8724–30. 
8. Biediger, R. J.; Chen, Q.; Decker, E. R.; Holland, G. W.; Kassir, J. M.; Li, W.; 
Market, R. V.; Scott, I. L.; Wu, C.; Li, J. Preparation of carboxylic acid derivatives that 
inhibit the binding of integrins to their receptors. US 20040063955, 2004. 
9. Qiao, Y.; Si, T.; Yang, M. H.; Altman, R. A., Metal-free trifluoromethylation of 
aromatic and heteroaromatic aldehydes and ketones. J. Org. Chem. 2014, 79 (15), 7122-
31. 
10. West, T. H.; Daniels, D. S.; Slawin, A. M.; Smith, A. D., An isothiourea-catalyzed 
asymmetric [2,3]-rearrangement of allylic ammonium ylides. J. Am. Chem. Soc. 2014, 
136 (12), 4476–9. 
11. Palani, A.; Xiao, D.; Aslanian, R. G.; Berlin, M. Y.; Rao, A. U.; Chen, X.; Lee, Y. J.; 
Degrado, S.; Shao, N.; Huang, Y. R.; Liu, Z. Preparation of azine derivatives useful in 
treatment and prevention of diseases. WO 2010045306, 2010. 
12. Tang, L.; Wasserman, E. P.; Neithamer, D. R.; Krystosek, R. D.; Cheng, Y.; Price, 
P. C.; He, Y.; Emge, T. J., Highly Active Catalysts for the Ring-Opening Polymerization 
of Ethylene Oxide and Propylene Oxide Based on Products of Alkylaluminum Compounds 
with Bulky Tetraphenol Ligands. Macromolecules 2008, 41, 7306–15. 
13. Cloeter, M. D.; Kar, K. K.; Matyjaszewski, K.; Mosnacek, J.; Nicolay, R. Synergistic 
polymerization inhibitor composition and method. 2012. 
 
210 
14. Cao, D.; Peng, J.; Hong, Y.; Fang, X.; Wang, L.; Meier, H., Enhanced Performance 
of the Dye-Sensitized Solar Cells with Phenothiazine-Based Dyes Containing Double D–
A Branches. Org. Lett. 2011, 13 (7), 1610–3. 
15. Reich, M.; Schunk, S.; Jostock, R.; Hees, S.; Germann, T.; Engels, M. F.-M. 
Preparation of disulfonamides as bradykinin receptor modulators. WO 2010051977, 
2010. 
16. Sun, R.; Cooper, A. B.; Deng, Y.; Wang, T.; Nan, Y.; Zhu, H. Y.; Boga, S. B.; Gao, 
X.; Kelly, J. M.; Paliwal, S.; Tsui, H.-C.; Doll, R. J.; Shih, N.-Y. Preparation of 
heterocyclicpyrazoloquinazolinylpyrrolidinylethanone derivatives for use as ERK 
inhibitors. WO 2008156739, 2008. 
17. Anandan, S. K.; Ward, J. S.; Brokx, R. D.; Denny, T.; Bray, M. R.; Patel, D. V.; 
Xiao, X. Y., Design and synthesis of thiazole-5-hydroxamic acids as novel histone 
deacetylase inhibitors. Bioorg. Med. Chem. Lett. 2007, 17 (21), 5995–9. 
18. (a) Sauerberg, P.; Jeppesen, L.; Polivka, Z.; Sindelar, K. Dicarboxylic Acid 
Derivatives as PPAR-Agonists. WO 2003DK00895, 2004; (b) Sauerberg, P.; Bury, P. S.; 
Jeppesen, L.; Mogensen, J. P. Long-chain, unsaturated, aromatic dicarboxylic acid 
derivatives, their preparation, and therapeutic use for treatment of conditions mediated 
by peroxisome proliferator-activated receptors (PPAR). WO 2002-DK692, 2003. 
19. Conner, S. E.; Mantlo, N. B.; Zhu, G.; Herr, R. J. Preparation of bicyclic derivatives 
as PPAR modulators. July 21, 2005, 2005. 
 
211 
20. Itoh, T.; Mase, T., Practical Thiol Surrogates and Protective Groups for Arylthiols 
for Suzuki–Miyaura Conditions. J. Org. Chem. 2006, 71, 2203–6. 
 
212 
Chapter 3 – Organocatalytic Reactions of Alcohols with gem-
Difluoroalkenes 
3.1. Metal-Free Reactions of Alcohols with gem-Difluoroalkenes 
Gem-difluoroalkenes are synthetically accessible1 and useful starting materials for 
generating biologically active fluorinated compounds; thus, much effort has been 
expended to further functionalize them.1h, 1x  Due to the s-withdrawing effect of the fluorine 
atoms, gem-difluoroalkenes are activated towards nucleophilic attack at the difluorinated 
carbon.1x, 2 This allows heteroatom nucleophiles to react directly with gem-
difluoroalkenes, resulting in a-fluorination of the heteroatom, perturbing normal biological 
properties. Fluorination a- to ethereal oxygens can provide many benefits,3 including 
reduced metabolic lability, modulation of logP to improve permeability, and imparting 
conformational bias (Figure 3-1).4 These perturbations arise from the e--withdrawing 
property of fluorine that reduces the electron density of the ethereal oxygen, making the 
lone pair electrons of the oxygen weaker hydrogen-bond acceptors or participants in 
resonance.4b 



























Based on the potential benefits from a-fluorination of ethers in bioactive compounds, 
the patent literature contains many fluorinated ethers. Both difluoro and trifluoromethyl 
ethers are well represented, with several trifluoromethyl arylethers present in marketed 
therapeutics (Figure 3-1a).3c, 5 However, fluorinated dialkyl ethers are less common, due 
to the synthetic difficulty in accessing this moiety. Gem-difluorinated dialkyl ethers are6 
only synthesized via deoxyfluorination7 or through reactions with gaseous 
difluoroethylene.8 The most common method to synthesize gem-difluorinated dialkyl 
ethers involves deoxyfluorination.7 However, major limitations of deoxyfluorination 
include the use of expensive deoxyfluorinating reagents and poor functional group 
compatibility with oxygen or sulfur containing substrates. Additionally, the use of 
deoxyfluorinating reagents on large scale represents a safety hazard, due to the release 
of HF as a byproduct,9 which is hazardous to human and environmental health and 
destroys many materials commonly used in synthetic chemistry labware. 
Despite these synthetic issues, the patent literature contains thousands of fluorinated 
dialkyl ethers. Considering difficulty in synthesizing these substructures, many of these 
patented compounds are prophetic, and the full utility of the gem-difluorinated dialkyl 
ether substructure in medicinal chemistry remains under explored. Based on the 
interactions of biological nucleophiles with gem-difluoroalkenes as mechanistic 
inhibitors,10 and on the specific case of a gem-difluoroalkene containing Herpes simplex 
virus replication inhibitor reacting with alcohol solvents to provide gem-difluoro dialkyl 
ethers (Figure 3-2),10f, 11 we envisioned that alcohols might react with gem-
difluoroalkenes to provide the desired gem-difluoro dialkyl ethers under mild conditions. 
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Figure 3-2: Gem-Difluoroalkenes in Medicinal Chemistry 
 
Of the existing reactions of gem-difluoroalkenes with alcohols, the vast majority result 
in a net C–F functionalization reaction to provide mono-fluoroalkenes. For instance, 
intramolecular nucleophilic cyclizations of gem-difluoroalkenes with alcohols generate 2-
fluoro benzo[b]furans (Scheme 3-1a),12 or other heterocycles, such as furans.12a, 13 
However, b-fluorination stabilizes difluoroalkenes, and in these systems controlled base 
addition can enable fluorine retentive protonation upon intramolecular cyclization with 
alcohols (Scheme 3-1b).14 Furthermore, many base-catalyzed intermolecular additions 
of alcohol nucleophiles to gem-difluoroalkenes defluorinated the substrate.15 
Under acidic conditions, solvolysis reactions with alcohols generate non-fluorinated 
products, due to rapid fluoride elimination generating a free alcohol that tautomerizes to 
an acyl fluoride and delivers acid or amide derived products.16 This same defluorination 































a) Gem-Difluoroalkene-Based Inhibitor of Herpes Simplex Virus Replication10f

























cycloadditions of gem-difluoroalkenes with N–O oxides generate non-fluorinated products 
(Scheme 3-1c).17 Similarly, when bi-dentate nucleophiles, such as catechols or glycols,18 
react with gem-difluoroalkenes, the substrate undergoes two sequential C–F 
functionalizations, providing non-fluorinated products (Scheme 3-1d).18-19 Further, with 
excess pre-activated alcohol nucleophiles,20 or with alcohol nucleophiles under high 
temperature and excess base,15d, 21 two sequential C–F functionalizations occur.  
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Scheme 3-1: Representative Reactions of gem-Difluoroalkenes with O-Based 
Nucleophiles 
 
The loss of fluoride in nucleophilic functionalization reactions of gem-difluoroalkenes 
is expected, as gem-difluoroalkenes typically undergo an addition / elimination process 











c) O-Based Nucleophiles Generate Acyl Fluorides17
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a) 1.1 equiv. NaH





















to provide the C–F functionalization product.1h, 1x This arises from the unique reactivity of 
fluorinated alkenes relative to non-fluorinated alkenes. The s-withdrawing effects of 
fluorine activate the difluorinated position for regioselective nucleophilic attack, as the 
resulting carbanion is stabilized by the gem-difluoro group, lowering the activation energy 
of nucleophilic attack (Figure 3-3).1h, 1x Unfortunately, the carbanion is less 
thermodynamically stable than a fluoride anion. Thus, the anionic intermediate undergoes 
b-fluoride elimination to deliver monofluorinated products (Figure 3-3).1h, 1x, 22  
Figure 3-3: Physicochemistry of gem-Difluoroalkenes  
 
As highlighted by the addition of alcohols to gem-difluoroalkene containing uracil 
derivatives, O-based nucleophiles can react with gem-difluoroalkenes without undergoing 
fluoride elimination, demonstrating the possibility of a general fluorine-retentive 
hydrofunctionalization reaction of alcohols with gem-difluoroalkenes. Under base-
catalyzed solvolysis conditions, intermolecular reactions of alcohols with gem-
difluoroalkenes proceed without b-fluoride elimination (Scheme 3-2a).10f, 11, 23 This 
strategy exhibits an addition / protonation mechanism, but lacks selectivity for the 
difluorinated product, unless controlled by a combination of Pd and a perfluoroalkyl 
electrophile.23b Unfortunately, the use of the nucleophile as a solvent dramatically limits 
the range of usable nucleophiles, as many nucleophiles are themselves synthetic 














hydroxypyridine nucleophile added into gem-difluoroalkenes and selectively retained both 
fluorine atoms, without using the hydroxypyridine as the solvent (Scheme 3-2b).24  
Scheme 3-2: Rare Fluorine-Retentive Reactions of gem-Difluoroalkenes with 
Nucleophiles 
 









a) Representative Fluorine Retentive Reactions of gem-Difluoroalkenes with Alcohols11
d) β-Anion Propogation Prevents Fluoride Elimination26




























































Other rare examples of fluorine-retentive nucleophilic addition of alcohols to 
difluoroalkenes exploit difunctionalization with strong oxidants or unique reagents. 
Cyclizations of gem-difluoroalkenes with O-based nucleophiles in the presence of either 
iodine14, 25 or mercury and a tin-hydride25b proceed without the loss of fluoride (Scheme 
3-2c). Two examples utilize elegant reagent design to enable fluorine-retentive 
intermolecular O-based nucleophilic addition to gem-difluoroalkenes. In the first, 
electrophiles were designed with the strategic incorporation of a g-epoxide. The b-anion 
preferentially opens the epoxide instead of eliminating fluoride, enabling fluorine retentive 
nucleophilic addition (Scheme 3-2d).26 In the second example, specially designed 
nucleophiles position an aldehyde proximal to the b-anion, rapidly trapping the b-anionic 
intermediate via intramolecular cyclization after nucleophilic addition, retaining both 
fluorine atoms (Scheme 3-2e).27 However, general examples of such “fluorine-retentive” 
nucleophilic hydro-functionalization reactions of gem-difluoroalkenes remain elusive. 
3.2. Organocatalytic Strategy for Hydrophenolation of gem-Difluoroalkenes 
After the successful hydrofunctionalization of gem-difluoroalkenes with thiol-based 
nucleophiles,28 we envisioned that, due to the similar properties of sulfur and oxygen, 
gem-difluoroalkenes might undergo fluorine-retentive hydrofunctionalization  with 
alcohols under similar conditions. However, alcohol nucleophiles present a greater 
challenge than thiol nucleophiles, as alcohols possess both lower nucleophilicity29 and 
lower acidity30 than the corresponding thiols (Figure 3-4).  
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Figure 3-4: The Physicochemistry of Alcohols Presents a Greater Challenge than Thiols 
 
Even with these challenges, we envisioned that employing alcohols in a nucleophilic 
hydrofunctionalization of gem-difluoroalkenes would enable access to an under-
represented bioactive fluorinated functional group. Thus, to complement the fluorine-
retentive, organocatalytic nucleophilic hydrofunctionalization reactions of gem-
difluoroalkenes with thiols, we developed a new organocatalytic system to 
regioselectively add phenols across gem-difluoroalkenes that minimizes the loss of 



















Scheme 3-3: Extension of Hydrofunctionalization Reactions of gem-Difluoroalkenes to 
Phenol Nucleophiles 
 
Standard optimization delivered conditions for adding phenolic nucleophiles across 
gem-difluoroalkenes (Table 3-1). Initially, we explored similar conditions to those used 
for functionalization with aryl thiols [entry 1: 25% TMG, 1,2-dichloroethane (1,2-DCE), 80 
˚C]; however, using these conditions, phenolic nucleophiles reacted poorly, giving no yield 
of the desired b,b-difluorophenethylarylether product 3.3 or the a-monofluorovinylether 
side product 3.4. Utilizing the same catalyst with a higher boiling solvent and higher 
temperatures provided low yield and moderate selectivity of 3.3 (entry 2). Considering 
the intrinsic differences in acidity and nucleophilicity between phenolic and thiophenolic 
nucleophiles, we explored the use of stronger bases, such as tBuOK (entry 3), 1,8-
diazabicylco[5.4,0]undec-7ene (DBU, entry 4), and 1,5,7-triazabicyclo[4.4.0]dec-5-ene 
(TBD, entry 5). Use of the stronger nitrogenous bases improved the yields of product 3.3, 
































3.4. The use of stronger phosphorazine superbases reduced the selectivity versus a-
monofluorovinylether side product 3.4 (entry 6), presumably due to deprotonation and b-
fluoride elimination of desired product 3.4. The use of aromatic solvents provided 
improved selectivity versus other solvents (entries 3, 7–12), while increased temperature 
improved the yield (entries 14–16). We envisioned that, similar to cation-p catalysis 
reactions, the judicious selection of solvent might enable anion-p stabilization of the 
unstable b-anionic intermediate, slowing elimination. As such, we investigated a variety 
of aromatic solvents with different electronic character. However, these solvents did not 
alter the selectivity or yield, indicating no anion-p stabilization (entries 2, 9-11). Finally, 
we settled on the use of 50% TBD in 1,2-dichlorobenzene (DCB) at 140 ˚C for 24 h as 
the standard conditions (entry 17). In control reactions, subjecting pure 3.3 to the 
optimized conditions generated mixtures of 3.3:3.4, indicating that the product is unstable 
to the reaction conditions. Thus, for any specific substrate, optimization of the time, 
temperature, and strength of base might improve the reaction outcome. 
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Table 3-1: Optimization of the Reaction Conditions[a] 
 
 [a] 3.1 (1.0 equiv., 0.10 mmol), 3.2 (5.0 equiv., 0.50 mmol), base (0.25 equiv., 0.025 
mmol), solvent (1 M, 0.10 mL), 120 ˚C, for 4 h under an N2 atmosphere. Conversion of 
3.1 and yields of 3.3 and 3.4 were determined by 19F NMR analysis using a,a,a-






































































































































































100 ˚C. [e] 0.50 equiv. base. [f] 140 ˚C. [g] 3.1 (1.0 equiv., 0.50 mmol), 3.2 (5.0 equiv., 
2.50 mmol), TBD (0.50 equiv., 0.25 mmol), DCB (1 M, 1.0 mL), 140 ˚C, for 24 h under an 
N2 atmosphere.  
Using these conditions, a range of phenols were successfully added across gem-
difluoroalkenes (Scheme 3-4). Reactions of various electron-deficient phenols (3.6a–f) 
gave the desired b,b-difluorophenethyl arylethers (3.6) in good yields (>65%) and high 
selectivities (>7:1) versus the a-monofluorovinylether side products (3.7). Using the 
standard reaction conditions, electron-neutral and ortho-substituted phenols (3.3, 3.6g–j) 
delivered the b,b-difluorophenethyl arylethers in moderate to low yields (30–50%) and 
selectivities (2:1–4:1). Reactions of electron-rich phenols delivered the anticipated 
products in low yields and selectivities (3.6k–l), although reoptimization of the base might 
improve the reactivity of these less acidic substrates. I suggest investigating three 
pathways. First, the more electron-rich phenols are less acidic, thus slightly stronger 
amine bases such as Verdake’s superbase or some of the weaker phosphorazine 
superbases might improve these substrates. Second, exploiting biphasic conditions 
similar to those for electron-deficient difluoroalkenes might improve the reactions with 
electron-rich phenols, although many electron-rich or -neutral difluoroalkenes do not 
demonstrate improved selectivity in biphasic conditions. Third, a full reoptimization to 
exploit more complex, Lewis acid / base pairs such as the pyridine / LiOTf catalyst used 
for alkyl thiol nucleophiles in Chapter 2 might improve the reaction. A range of useful 
functional groups for further functionalization were tolerated, like halides (3.6c–f) and 
nitrogen based functional groups (3.6a–b), although an aniline-derived phenol (3.6l) was 
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a poor substrate. Furthermore, heteroaryl and aliphatic alcohols did not exhibit any 
addition to the gem-difluoroalkene electrophile, providing an avenue for further research. 








































































































Standard conditions: 3.1 (1.0 equiv., 0.50 mmol), 3.5a–o (5.0 equiv., 2.5 mmol), TBD (0.50 
equiv., 0.25 mmol), DCB (0.5 M, 1.0 mL), 140 ˚C, for 24 h under an N2 atmosphere. The 
selectivity of 3.6:3.7 was determined by 19F NMR analysis of the crude reaction mixture 
using TFT (50 µL, 0.40 mmol) as a standard and is reported in parentheses. Yields are 
reported as the isolated yield of >95% pure material and represent the average of 2 runs. 
[a] 1.0 equiv. TBD. [b] Contains trifluoroethylbenzene side product. 
Many synthetically and biomedically useful functional groups were tolerated on the 
gem-difluoroalkene substrate (Scheme 3-5). Specifically, the reaction tolerated 
thioethers and ethers (3.9a–b), morpholine (3.9c), nitrogen-containing functional groups 
(3.9k–l), halides (3.9m–p) amides (3.9q), and pseudohalides (3.9r). Reactions of 
electron-rich gem-difluoroalkenes generally afforded products in good yields and high 
selectivities (3.9a–i), although aniline-based and tBu-based gem-difluoroalkenes reacted 
in lower yields (3.9e–f). Using electron-deficient substrates, the standard reaction 
conditions generally delivered products in low yield and <1:1 selectivity (3.9j–r), although 
substrates bearing 3-a,b-unsaturated carbonyl and 3-NO2 groups afforded products in 
sufficient yield and selectivity (3.9j, k). To address this limitation, further optimization 
revealed that a biphasic reaction mixture (9:1 DCB:H2O) improved both the selectivities 
and yields for electron-deficient gem-difluoroalkenes (3.9l–r). However, this modification 
provided only minor benefits for electron-rich and -neutral difluoroalkenes. Presumably 
for these electron-deficient substrates, the water in the biphasic system (1) provided 
additional protons to quench the reactive b-fluoroanion, and/or (2) minimized degradation 
of the product by sequestering some of the base in the aqueous phase. Ortho-substituted 
gem-difluoroalkenes reacted inconsistently, with a 2-(4-tBu)-Ph-substituted substrate 
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giving high yield (3.9d), a 2-Me-substituted substrate reacting in low yield and low 
conversion (3.9h), and a 2,6–Me2-substituted substrate not reacting at all (3.9i).   
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[a] 50% TBD 
     140 ˚C, DCB
     N2, 24 h
[b] 50% TBD 
     140 ˚C, DCB:H2O



































































































































[a] Standard conditions: 3.8a–r (1.0 equiv., 0.50 mmol), 3.5c (5.0 equiv., 2.5 mmol), TBD 
(0.50 equiv., 0.25 mmol), DCB (0.5 M, 1.0 mL), 140 ˚C, for 24 h under an N2 atmosphere. 
The selectivity of 3.9:3.10 was determined by 19F NMR analysis of the crude reaction 
mixture using TFT (50 µL, 0.40 mmol) as a standard and is reported in parentheses. 
Yields are reported as the isolated yield of >95% pure material and represent the average 
of 2 runs. [b] Standard conditions: 3.8a–r (1.0 equiv., 0.50 mmol), 3.5c (3.0 equiv., 1.5 
mmol), TBD (0.50 equiv., 0.25 mmol), DCB (0.45 M, 0.90 mL), H2O (0.05 M, 0.10 mL), 
140 ˚C, for 24 h under an N2 atmosphere. The selectivity of 3.9:3.10 was determined by 
19F NMR analysis of the crude reaction mixture using TFT (50 µL, 0.40 mmol) as a 
standard and is reported in parentheses. Yields are reported as the isolated yield of >95% 
pure material and represent the average of 2 runs. [c] 4-Bromophenol used as the 
nucleophile. [d] Yield is reported from 19F analysis of the crude reaction mixture. [e] 
Second run used 0.40 mmol of 3.9q. [f] Second run used 0.30 mmol of 3.9r. 
Heteroaryl-substituted gem-difluoroalkenes reacted similarly to their aryl-derived 
counterparts (Scheme 3-6). Electron-rich heteroaryl groups, such as indole and pyrazole, 
gave high selectivity (3.12a, b), although the yield of pyrazole 3.12b was moderate. A 2-
substituted dibenzothiophene reacted in moderate yield and selectivity (3.12c). When 
subjected to the biphasic conditions, a pyridyl substrate gave good yield and selectivity 
(3.12d). This series of reactions also highlighted the compatibility of sulfonamide (3.12a) 




Scheme 3-6: Scope of Heteroaryl gem-Difluoroalkene Electrophiles 
 
[a] Standard conditions: 3.11a–d (1.0 equiv., 0.50 mmol), 3.5c (5.0 equiv., 2.5 mmol), 
TBD (0.50 equiv., 0.25 mmol), DCB (0.5 M, 1.0 mL), 140 ˚C, for 24 h under an N2 
atmosphere. The selectivity of 3.12:3.13 was determined by 19F NMR analysis of the 
crude reaction mixture using TFT (50 µL, 0.40 mmol) as a standard and is reported in 
parentheses. Yields are reported as the isolated yield of >95% pure material and 
represent the average of 2 runs. [b] Standard conditions: 3.11a–d (1.0 equiv., 0.50 mmol), 
3.5c (3.0 equiv., 1.5 mmol), TBD (0.50 equiv., 0.25 mmol), DCB (0.45 M, 0.90 mL), H2O 
(0.05 M, 0.10 mL), 140 ˚C, for 24 h under an N2 atmosphere. The selectivity of 3.12:3.13 
was determined by 19F NMR analysis of the crude reaction mixture using TFT (50 µL, 
0.40 mmol) as a standard and is reported in parentheses. Yields are reported as the 




























a) 50% TBD 
    140 ˚C, DCB
    N2, 24 h
b) 50% TBD 
    140 ˚C, DCB:H2O


















3.3. Mechanistic Considerations 
The present reaction presumably operates through an addition / protonation 
sequence, in which the base plays key roles as both a promoter and a quencher of the 
reaction (Figure 3-5). Initially, organic base (B) activates the phenol pronucleophile, and 
subsequently, the phenoxide nucleophile adds to the electrophilic difluorinated carbon of 
the gem-difluoroalkene. This addition generates an unstable b-fluoro anionic intermediate 
(A) that can react via two pathways. First, intermediate (A) can either accept a proton 
from the phenol pronucleophile or from the protonated organic base (B) to provide the 
desired product 3.3. Second, fluoride elimination from anionic intermediate (A) can 
provide the undesired monofluoroalkene 3.4. Alternatively, 3.4 can form via base-
mediated elimination of HF from 3.3. 
Based on this presumed mechanism, the pKa of the base catalyst must fall within a 
narrow range to selectively provide 3.3 over 3.4. The base catalyst must be sufficiently 
basic to deprotonate the phenol. In THF, a non-coordinating aprotic solvent, phenol’s pKa 
of 18 disfavors deprotonation by weaker bases, such as TMG (pKa = 16), although 
stronger bases, such as TBD (pKa = 21), efficiently deprotonate and activate the phenol. 
However, bases that are too strong will decompose product 3.3 to generate 3.4. 
Specfically, the strong s-electron withdrawing effect of the gem-difluoro group and 
ethereal oxygen activates 3.3 for elimination. Such deprotonation was observed in control 
experiments involving the base-mediated decomposition of 3.3, particularly with strong 
“superbases,” such as the phosphorazine base P2Et (pKa = 25). Therefore, in the present 
studies, TBD provided appropriate reactivity, specifically balancing activation of the 
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phenol with decomposition of product. However, we note that other currently unexplored 
bases might also work for this reaction. Further, for any specific substrate combination 
with distinct pKas of the phenol and product, an alternate base might prove optimal. 
Figure 3-5: Proposed Mechanism 
 
3.4. Conclusions 
In conclusion, we developed an organocatalytic method to convert gem-
difluoroalkenes to b,b-difluorophenethyl ethers through the direct nucleophilic addition of 
phenols. Our convergent method uses easily accessible starting materials, adding phenol 
nucleophiles across gem-difluoroalkenes in the presence of only catalytic quantities of a 
weak amine base and delivering the desired products in moderate to good yields and 





































convergent, relying on functional group interconversions7, 32 to generate the fluorine-
based substructure, or require harsh conditions33 and/or gaseous reagents.8  
Notably, this method contrasts the many reactions of gem-difluoroalkenes that 
selectively generate monofluoroalkene products.1h Moreover, the reaction tolerates many 
useful functional groups, both for further functionalization and for medicinal chemistry. 
Ongoing efforts aim to enable the fluorine-retentive addition other nucleophiles to gem-
difluoroalkenes, and to expand the hydrophenolation of gem-difluoroalkenes to include 
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General Considerations: Unless otherwise noted, reactions were performed under an 
atmosphere of air using oven-dried glassware. Organocatalytic reactions of phenols and 
gem-difluoroalkenes were performed in one-dram borosilicate glass scintillation vials 
sealed with a screw-top cap containing a PTFE-lined septum. Unless otherwise noted all 
other reactions were performed in round-bottom flasks sealed with rubber septa. PTFE 
syringes equipped with stainless-steel needles were used to transfer air- and moisture-
sensitive liquid reagents. Reactions were monitored by either 19F NMR with an internal 
standard of a,a,a-trifluorotoluene or by thin-layer chromatography (TLC) on UNIPLATE 
Silica Gel HLF plates, visualized by quenching of fluorescence. Normal phase column 
chromatography was conducted using an automated separations system utilizing 
gradient elution with VWR Common Silica Gel 60 Å, 40–60 µm. Reverse phase column 
chromatography was conducted using an automated flash chromatography system 
utilizing gradient elution with a Teledyne ISCO C18 Redisep Rf Gold 50 g column. Isolated 
yields reported in the manuscript represent an average of at least 2 independent runs of 
final compound deemed to be at least 95% pure by NMR. Yields reported in the 
supporting information refer to a single experiment. Unless otherwise noted, compounds 
were isolated in >98% purity as determined by 1H and 19F NMR. 
Unless otherwise noted, reagents were purchased from commercial sources and used 
as received. 1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) was purchased form Sigma 
Aldrich. Solvents, including dimethylformamide (DMF), toluene (PhMe), dichloromethane 
(DCM), methanol (MeOH), acetonitrile (MeCN), and tetrahydrofuran (THF) were used 
directly from a solvent purification system, in which solvent was dried by passage through 
two columns of activated alumina under argon. Chemical abbreviations utilized in this 
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document include: 1,2–Dichlorobenzene (DCB), N-methylpyrrolidine (NMP), a,a,a-
trifluorotoluene (TFT), sodium sulfate (Na2SO4), magnesium sulfate (MgSO4), ethyl 
acetate (EtOAc), diethyl ether (Et2O), ammonium chloride (NH4Cl), nbutyl lithium (nBuLi), 
sodium hydroxide (NaOH), room temperature (R.T.), tbutyl carbonate anhydride (Boc2O), 
potassium carbonate (K2CO3), and hydrochloric acid (HCl). 
Proton nuclear magnetic resonance (1H NMR) and fluorine nuclear magnetic 
resonance (19F NMR) were taken on a Bruker DRX 500 spectrometer (500 and 376 MHz 
respectively). Fluorine nuclear magnetic resonance (19F NMR) was taken on a Bruker 
AVIII 400 Avance spectrometer (376 MHz). Proton and carbon nuclear magnetic 
resonance (13C NMR) were taken on a Bruker AVIII 500 Avance spectrometer with a 
CPDUL cryoprobe (500 and 126 MHz respectively). Chemical shifts (d) for protons are 
reported in parts per million (ppm) downfield from tetramethylsilane, and are referenced 
to the proton resonance of residual solvent in the NMR solvent (CHCl3: d = 7.26 ppm; 
DMSO: d = 2.50 ppm). Chemical shifts (d) for carbon are reported in ppm downfield from 
tetramethylsilane, and are referenced to the carbon resonance of the solvent residual 
peak (CDCl3: d = 77.2 ppm; DMSO: d = 39.52 ppm). Chemical shifts for fluorine are 
reported in ppm upfield from trichlorofluoromethane (0 ppm), and are referenced to added 
TFT as a standard (d = –63.77 ppm) unless otherwise specified. NMR data are 
represented as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, m = multiplet), coupling constant in Hertz (Hz), integration. 
High-resolution mass determinations were obtained either by electrospray ionization 
(ESI) on a Waters LCT PremierTM mass spectrometer or by atmospheric-pressure 
chemical ionization (APCI-hexanes/PhMe) on a Waters Q-Tof PremierTM, for which 
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sample plus near mass internal exact mass standard were dissolved in hexanes, and 
hexanes or PhMe/hexanes were used as ionization solvent. Infrared spectra were 
measured on a Perkin Elmer Spectrum Two Fourier Transform Infrared Spectrometer by 
drying samples on a diamond ATR Sample base plate. Uncorrected melting points were 
measured on a Thomas Hoover Capillary Melting Point apparatus. 
 
General Procedure for the Preparation of Gem-Difluoroalkenes (A): An oven-
dried 3-neck round-bottomed flask equipped with a magnetic stir bar was charged with 
aryl aldehyde (1.0 equiv.) and triphenylphosphine (1.2 or 1.5 equiv.). The system was 
sealed with three PFTE septa, and subsequently evacuated and backfilled with N2 three 
times. Dry NMP was added via syringe transfer (PTFE syringe with oven-dried stainless-
steel needle), and the system was immersed in a preheated 100 °C oil bath. Once no 
solid reagents remained (approximately 2 min of heating), potassium 
bromodifluoroacetate (1.5 or 1.8 equiv.) was added portion-wise over 0.5 h, with the rate 
of addition controlling the evolution of CO2 gas. Once all of the potassium 
bromodifluoroacetate was added, the solution was allowed to stir for 0.5–1 h. Upon 
completion, the reaction was cooled to R.T. and then quenched with H2O. Subsequently, 
Et2O was added to the reaction, and the mixture was washed with H2O (five times), and 
the aqueous layer was back-extracted with Et2O (two times). The combined organic layers 
were dried over Na2SO4 and concentrated. The crude material was dry-packed onto silica 
gel and then eluted through a plug of silica gel with EtOAc:hexanes (1:1) to remove 
triphenylphosphine oxide. Subsequently, H2O2 (30% in H2O) was added to the mother 
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liquor and allowed to react for 30 min to oxidize the residual triphenylphosphine. The 
organic layer was washed with H2O (three times), dried over Na2SO4, concentrated, and 
subjected to normal phase flash chromatography using EtOAc and hexanes. 
 
Preparation of Gem-Difluoroalkenes: 
 
5-(2,2-difluorovinyl)-1,2,3-trimethoxybenzene (3.1): Compound 3.1 corresponds to 
compound 2.1 in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(2,2-difluorovinyl)-4-methoxybenzene (3.8a): Compound 3.8a corresponds to 
compound 2.5a in Chapter 2, and was synthesized according to the procedure in the 















(4-(2,2-difluorovinyl)phenyl)(methyl)sulfane (3.8b): Compound 3.8b corresponds to 
compound 2.5b in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(3-(2,2-difluorovinyl)phenyl)morpholine (3.8c): Compound 3.8c corresponds to 
compound 2.5d in Chapter 2, and was synthesized according to the procedure in the 


















4'-(tert-butyl)-2-(2,2-difluorovinyl)-1,1'-biphenyl (3.8d): Compound 3.8d corresponds 
to compound 2.5g in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(2,2-difluorovinyl)-N,N-dimethylaniline (3.8e): Compound 3.8e corresponds to 
compound 2.5e in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(tert-butyl)-4-(2,2-difluorovinyl)benzene (3.8f): Following General Procedure A, 4-
tert-butylbenzaldehyde (3.34 mL, 20mmol) was reacted with PPh3 (6.3 g, 24 mmol) and 
BrCF2CO2K (6.2 g, 30 mmol) in NMP (10 mL, 2 M). Following workup, the product was 
purified by flash chromatography using a gradient of 0–50% Et2O in pentane, furnishing 
1.16 g of desired product 3.8f (30% yield) as a colorless oil; 1H NMR matched the 














1-(2,2-difluorovinyl)-3,5-dimethylbenzene (3.8g): Following General Procedure A, 3,5-
dimethylbenzaldehyde (2.10 mL, 15.0 mmol) was reacted with PPh3 (6.23 g, 22.5 mmol) 
and BrCF2CO2K (6.05 g, 27.0 mmol). Following workup, the product was purified by flash 
chromatography using a gradient of 0–10% EtOAc in hexanes, furnishing 1.163 g (44% 
yield) of desired product 3.8g as a clear oil 
1H NMR (400 MHz, CDCl3): d 6.97 (bs, 2 H), 6.90 (bs, 1 H), 5.21 (dd, J = 26.41, 4.03 Hz, 
1H), 2.32 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 156.3 (dd, J = 298.23, 287.44 Hz), 138.3, 130.3 (t, J = 6.70 
Hz), 128.9 (t, J = 2.15 Hz), 125.6 (dd, J = 6.56, 3.67 Hz), 82.3 (dd, J = 28.88, 13.63 Hz), 
21.4 
19F NMR (376 MHz, CDCl3): d –82.39 (dd, J = 32.54, 26.54 Hz, 1 F), –84.62 (dd, J = 
32.49, 3.99 Hz, 1F) 
IR (film): 3019, 2921, 2868, 1726, 1605, 1448, 1379, 1350, 1297, 1198, 1160, 1038, 965, 
892, 851, 814, 765, 750, 715, 690, 583, 539, 515 cm-1 










1-(2,2-difluorovinyl)-2,4-dimethylbenzene (3.8h): Following General Procedure A, 2,4-
dimethylbenzaldehyde (3.20 mL, 22.0 mmol) was reacted with PPh3 (8.84 g, 33.0 mmol) 
and BrCF2CO2K (8.76 g, 40.0 mmol). Following workup, the product was purified by flash 
chromatography using a gradient of 0–10% EtOAc in hexanes, furnishing 1.57 g (41% 
yield) of desired product 3.8h as a clear oil 
1H NMR (400 MHz, CDCl3): d 7.31 (dd, J = 8.44, 2.00 Hz, 1 H), 7.02 (dd, J = 4.24, 2.31 
Hz, 2 H), 5.34 (dd, J = 25.61, 3.94 Hz, 1 H), 2.32 (s, 3 H), 2.27 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 156.2 (dd, J = 295.18, 288.05 Hz), 137.2, 135.8 (dd, J = 
4.84, 1.67 Hz), 131.1, 128.1 (dd, J = 7.88, 1.99 Hz), 127.0, 126.0 (dd, J = 6.89, 4.94 Hz), 
79.3 (dd, J = 28.66, 14.94 Hz), 21.2, 20.0 
19F NMR (376 MHz, CDCl3): d –84.76 (dd, J = 33.14, 4.06 Hz, 1 F), –85.53 (ddd, J = 
33.09, 25.53, 1.83 Hz, 1F) 
IR (film): 2923, 1726, 1616, 1569, 1505, 1453, 1379, 1345, 1281, 1250, 1235, 1180, 
1111, 1074, 1037, 948, 917, 876, 836, 818, 765, 750, 721, 615, 581, 549, 534 cm-1 









2-(2,2-difluorovinyl)-1,3-dimethylbenzene (3.8i): Following General Procedure A, 2,6-
dimethylbenzaldehyde (2.2 mL, 15.0 mmol) was reacted with PPh3 (5.91 g, 22.5 mmol) 
and BrCF2CO2K (6.17 g, 27.0 mmol). Following workup, the product was purified by flash 
chromatography using a gradient of 0–10% EtOAc in hexanes, furnishing 0.763 g (28% 
yield) of desired product 3.8i as a clear oil. 
1H NMR (400 MHz, CDCl3): d 7.14 (dd, J = 8.57, 6.35 Hz, 1 H), 7.07 (d, J = 7.53 Hz, 2 
H), 5.23 (dd, J = 27.50, 2.26 Hz, 1 H), 2.29 (s, 6 H) 
13C NMR (126 MHz, CDCl3): 155.0 (q, J = 291.73, 288.36 Hz), 137.5 (dd, J = 2.57, 1.37 
Hz), 127.8, 127.6, 78.1 (dd, J = 27.32, 20.62 Hz), 20.5 (d, J = 2.42 Hz) 
19F NMR (376 MHz, CDCl3): d –83.38 (dd, J = 32.45, 26.96 Hz, 1 F), –87.16 (dd, J = 
33.11, 2.37 Hz, 1 F) 
IR (film): 3024, 2956, 2923, 2330, 1736, 1586, 1468, 1445, 1380, 1329, 1276, 1254, 
1222, 1166, 1096, 1032, 932, 850, 802, 768, 746, 698, 599, 537 cm-1 










ethyl (E)-3-(3-(2,2-difluorovinyl)phenyl)acrylate (3.8j): Compound 3.8j corresponds to 
compound 2.5j in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(2,2-difluorovinyl)-3-nitrobenzene (3.8k): Compound 3.8k corresponds to compound 




3-(2,2-difluorovinyl)benzonitrile (3.8l): Following General Procedure A, 3-
cyanobenzaldehyde (6.55 g, 50mmol) was reacted with PPh3 (15.75 g, 60 mmol) and 
















purified by flash chromatography using a gradient of 0–50% Et2O in pentane, furnishing 
4.41 g of desired product 3.8l (53% yield) as a colorless oil; 1H NMR matched the 
previously reported spectrum.1 
 
 
1-bromo-4-(2,2-difluorovinyl)benzene (3.8m): Following General Procedure A, 4-
bromobenzaldehyde (3.7 g, 20mmol) was reacted with PPh3 (6.3 g, 24 mmol) and 
BrCF2CO2K (6.2 g, 30 mmol) in NMP (10 mL, 2 M). Following workup, the product was 
purified by flash chromatography using a gradient of 0–50% Et2O in pentane, furnishing 
2.61 g of desired product 3.8m (60% yield) as a colorless oil; 1H NMR matched the 
previously reported spectrum.1 
 
 
1-(2,2-difluorovinyl)-2-iodobenzene (3.8n): Compound 3.8n corresponds to compound 














1-(2,2-difluorovinyl)-3-(trifluoromethyl)benzene (3.8o): Following General Procedure 
A, 3-trifluoromethylbenzaldehyde (2.7 mL, 20mmol) was reacted with PPh3 (6.3 g, 24 
mmol) and BrCF2CO2K (6.2 g, 30 mmol) in NMP (10 mL, 2 M). Following workup, the 
product was purified by flash chromatography using a gradient of 0–50% Et2O in pentane, 
furnishing 2.070 g of desired product 3.8o (50% yield) as a colorless oil; 1H NMR matched 
the previously reported spectrum.1 
 
 
1,3-dichloro-5-(2,2-difluorovinyl)benzene (3.8p): Compound 3.8p corresponds to 
compound 2.5l in Chapter 2, and was synthesized according to the procedure in the 












4-(2,2-difluorovinyl)-N,N-diisopropylbenzamide (3.8q): Following General Procedure 
A, compound 3.8q–1 (0.823, 3.60 mmol) was reacted with PPh3 (1.50 g, 5.30 mmol) and 
BrCF2CO2K (1.42 g, 6.50 mmol) in NMP (2.0 mL, 2 M). Following workup, the product 
was purified by flash chromatography using a gradient of 0–30% EtOAc in hexanes, 
furnishing 0.655 g (69% yield) of desired product 3.8q as a colorless solid (MP = 43–44 
˚C). 
1H NMR (500 MHz, DMSO-D6, 25 °C): d 7.41 (d, J = 8.09 Hz, 2 H), 7.29 (d, J = 8.21 Hz, 
2 H), 5.85 (dd, J = 28.05, 4.06 Hz, 1 H), 3.61 (bs, 2.04, 2 H), 1.38–1.15 (m, 12 H) 
1H NMR (500 MHz, DMSO-D6, 60 °C): d 7.41 (d, J = 7.92 Hz, 2 H), 7.28 (d, J = 7.89 Hz, 
2 H), 5.79 (dd, J = 27.83, 4.01 Hz, 1 H), 3.64 (hept, J = 6.41 Hz, 2 H), 1.28 (bs, 12 H) 
13C NMR (126 MHz, DMSO-D6, 60 °C): d 169.8, 156.1 (dd, J = 297.83, 286.17 Hz), 138.2 
(t, J = 2.29 Hz), 130.5 (dd, J = 7.75, 5.77 Hz), 128.1 (dd, J = 6.61, 3.79 Hz), 126.3, 82.3 
(dd, J = 29.45, 11.75 Hz), 20.9 
19F NMR (376 MHz, DMSO-D6, 25 °C): d –82.16 (dd, J = 32.14, 28.07 Hz, 1 F), –84.02 
(dd, J = 32.19, 4.05 Hz, 1 F) 








HRMS (ESI+): calc. for C15H20F2NO (M+H) 268.1513, found 268.1500, 1.3 mmu. 
 
 
4-(2,2-difluorovinyl)phenyl trifluoromethanesulfonate (3.8r): Compound 3.8r 
corresponds to compound 2.5f in Chapter 2, and was synthesized according to the 
procedure in the Chapter 2 Appendix. 
 
 
3-(2,2-difluorovinyl)-1-tosyl-1H-indole (3.11a): Compound 3.11a corresponds to 
compound 2.8a in Chapter 2, and was synthesized according to the procedure in the 




















4-(2,2-difluorovinyl)-1-phenyl-1H-pyrazole (3.11b): Compound 3.11b corresponds to 
compound 2.8c in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(2,2-difluorovinyl)dibenzo[b,d]thiophene (3.11c): Compound 3.11c corresponds to 
compound 2.8d in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
2-(3-(2,2-difluorovinyl)phenyl)-5-(1,3-dioxolan-2-yl)pyridine (3.11d): Compound 
3.11d corresponds to compound 2.8b in Chapter 2, and was synthesized according to 














General Procedure for the Organocatalyzed Addition of Phenols to Gem-
Difluoroalkenes (B-1): An oven-dried one-dram vial equipped with a magnetic stir bar 
was charged with 1.0 equivalent of difluoroalkene and 5.0 equivalents of phenol. The 
system was brought into a glovebox, and 0.50 equivalents of TBD were added. Dry DCB 
(1.0 mL) was added via syringe transfer (PTFE syringe with oven-dried stainless-steel 
needle), and the vial was sealed with a screw-top cap containing a PTFE-lined septum. 
The system was removed from the glovebox, and placed within a heating mantle 
preheated to 140 ˚C and stirred for 24 h. The reaction was cooled to R.T., and then 
standardized by adding 50 µL (0.40 mmol) of TFT. The mixture was diluted with DCM, 
and then stirred for 5 min. The reaction was analyzed by 19F NMR, and then washed 3X 
with 1 N NaOH (aq.). The combined aqueous layer was extracted 2X with DCM, and the 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The residue 
was loaded onto celite and then purified by flash reverse phase chromatography with 
gradient elution from 98% H2O in MeCN to 100% MeCN to provide the desired product in 
>95% purity. 
 
General Procedure for the Organocatalyzed Addition of Phenols to Gem-
Difluoroalkenes (B-2): An oven-dried one-dram vial equipped with a magnetic stir bar 
was charged with 1.0 equivalent of difluoroalkene and 3.0 equivalents of phenol. The 
system was brought into a glovebox, and 0.50 equivalents of TBD were added. Dry DCB 
(0.90 mL) was added via syringe transfer (PTFE syringe with oven-dried stainless-steel 
needle), and the vial was sealed with a screw-top cap containing a PTFE-lined septum. 
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The system was removed from the glovebox, and distilled H2O (0.10 mL, distilled under 
N2 to remove dissolved O2) was added via syringe transfer (PTFE syringe with oven-dried 
stainless-steel needle) under N2. The reaction was placed within a heating mantle 
preheated to 140 ˚C and stirred for 24 h. The reaction was cooled to R.T., and then 
standardized by adding 50 µL (0.40 mmol) of TFT. The mixture was diluted with DCM, 
and then stirred for 5 min. The reaction was analyzed by 19F NMR, and then washed 3X 
with 1 N NaOH (aq.). The combined aqueous layer was extracted 2X with DCM, and the 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The residue 
was loaded onto celite and then purified by flash reverse phase chromatography with 
gradient elution from 98% H2O in MeCN to 100% MeCN to provide the desired product in 
>95% purity. 
 
Compounds in Table 3-1: 
 
5-(2,2-difluoro-2-phenoxyethyl)-1,2,3-trimethoxybenzene (3.3): Following General 
Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.236 g (2.50 
mmol) of phenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C for 24 h. After 
workup with 1 N NaOH (aq.), the product was purified by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.080 g (49% yield) 









1H NMR (500 MHz, CDCl3): d 7.32 (t, J = 7.93 Hz, 2 H), 7.19 (t, J = 7.48 Hz, 1 H), 7.14 
(d, J = 7.95 Hz, 2 H), 6.60 (s, 2 H), 3.87 (s, 9 H), 3.39 (t, J = 11.01 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 150.5, 137.6 (d, J = 1.43 Hz), 129.4, 127.7 (t, J = 
3.29 Hz), 125.6, 123.8, 121.7 (t, J = 266.95 Hz), 107.6, 60.9, 56.2, 42.5 (t, J = 30.28 Hz) 
19F NMR (376 MHz, CDCl3): d –70.44 (t, J = 11.05 Hz, 2 F) 
IR (film): 2940, 2841, 2252, 1699, 1592, 1509, 1492, 1463, 1423, 1361, 1324, 1262, 
1238, 1194, 1156, 1128, 1068, 1051, 1026, 1005, 942, 909, 828, 807, 764, 749, 692, 658, 
649 cm-1 
HRMS (HAPCI+): calc. for C17H18F2O4 (M+) 324.1173, found 324.1171, 0.6 ppm. 
 
 
(Z)-5-(2-fluoro-2-phenoxyvinyl)-1,2,3-trimethoxybenzene (3.4): Following General 
Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.236 g (2.50 
mmol) of phenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C for 24 h. After 
workup with 1 N NaOH (aq.), the product was purified by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing desired product 









1H NMR (500 MHz, CDCl3): d 7.37 (dd, J = 8.66, 7.48 Hz, 2 H), 7.17–7.14 (m, 3 H), 6.66 
(s, 2 H), 5.65 (d, J = 5.63 Hz, 1 H), 3.82 (s, 3 H), 3.76 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 154.7, 154.0 (d, J = 3.50 Hz), 153.3, 130.1, 127.6 (d, J = 
8.43 Hz), 124.5, 117.5, 116.3, 105.0 (d, J = 4.09 Hz), 92.7 (d, J = 38.61 Hz), 61.0, 56.1 
19F NMR (376 MHz, CDCl3): d –83.38 (d, J = 5.55 MHz, 1 F). 
 
Compounds in Scheme 3-4: 
 
5-(2,2-difluoro-2-(4-nitrophenoxy)ethyl)-1,2,3-trimethoxybenzene (3.6a): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.348 g 
(2.50 mmol) of 4-nitrophenol in the presence of 0.066 g (0.5 mmol) of TBD at 140 ˚C for 
24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.125 g (69% yield, 
97% purity) of desired product 3.6a as a dark yellow solid (MP = 117–120 ˚C) 
1H NMR (500 MHz, CDCl3): d 8.22 (d, J = 9.16 Hz, 2 H), 7.28 (d, J = 8.93 Hz, 2 H), 6.57 










13C NMR (126 MHz, CDCl3): d 155.4, 153.3, 145.0, 138.0, 126.8 (t, J = 3.36 Hz), 125.4, 
124.0 (t, J = 269.29 Hz), 121.4 (t, J = 1.88 Hz), 116.6, 107.7, 61.0, 56.3, 42.5 (t, J = 29.26 
Hz) 
19F NMR (376 MHz, CDCl3): d –71.41 (t, J = 11.41 Hz, 2 F) 
IR (film): 2940, 2841, 1614, 1592, 1522, 1509, 1492, 1461, 1424, 1346, 1325, 1301, 
1238, 1209, 1157, 1124, 1060, 1009, 943, 930, 911, 853, 801, 764, 750, 723, 692, 649 
cm-1 
HRMS (HAPCI+): calc. for C17H18F2NO6 (M+H) 370.1102, found 370.1099, 0.8 ppm. 
 
 
4-(1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethoxy)benzonitrile (3.6b): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.298 g 
(2.50 mmol) of 4-hydroxybenzonitrile in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.143 
g (82% yield, 94% purity) of desired product 3.6b as a yellow oil 
1H NMR (500 MHz, CDCl3): d 7.62 (d, J = 8.81 Hz, 2 H), 7.23 (d, J = 8.37 Hz, 2 H), 6.56 










13C NMR (126 MHz, CDCl3): d 153.9, 153.3, 133.8, 126.9 (t, J = 3.35 Hz), 124.0 (t, J = 
269.56 Hz), 121.8 (d, J = 1.82 Hz), 118.3, 117.0, 109.2, 107.7, 61.0, 56.3, 42.5 (t, J = 
29.30 Hz) 
19F NMR (376 MHz, CDCl3): d –71.23 (t, J = 11.45 Hz, 2 F) 
IR (film): 2940, 2842, 2253, 2231, 1596, 1505, 1464, 1424, 1360, 1325, 1296, 1253, 
1241, 1210, 1173, 1156, 1129, 1068, 1004, 908, 841, 802, 732, 649 cm-1 




Following General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.145 g (72% yield) of desired product 3.6c as a clear oil 
1H NMR (500 MHz, CDCl3): d 7.40 (d, J = 2.46 Hz, 1 H), 7.27–7.25 (m, 1 H), 7.19 (dd, J 












13C NMR (126 MHz, CDCl3): d 153.2, 145.3 (t, J = 1.69 Hz), 137.8, 131.3, 130.3, 128.2, 
127.8, 127.0 (t, J = 3.45 Hz), 124.07 (t, J = 269.41 Hz), 123.93 (t, J = 2.03 Hz), 107.9, 
61.0, 56.3, 42.4 (t, J = 29.38 Hz) 
19F NMR (376 MHz, CDCl3): d –70.83 (t, J = 11.04 Hz, 2 F) 
IR (film): 2940, 2839, 1592, 1508, 1476, 1463, 1423, 1360, 1324, 1258, 1238, 1128, 
1061, 1008, 942, 867, 808, 764, 700, 666, 528 cm-1 
HRMS (HAPCI+): calc. for C17H16Cl2F2O4 (M+) 392.0394, found 394.0424, 3.8 ppm. 
 
 
5-(2,2-difluoro-2-(3-iodophenoxy)ethyl)-1,2,3-trimethoxybenzene (3.6d): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.551 g 
(2.50 mmol) of 3-iodophenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C for 
24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.158 g (71% yield, 
98% purity) of desired product 3.6d as a brown oil 
1H NMR (500 MHz, CDCl3): d 7.53–7.50 (m, 2 H), 7.12 (dd, J = 8.25, 2.15 Hz, 1 H), 7.03 









13C NMR (126 MHz, CDCl3): d 153.1, 150.7 (d, J = 2.30 Hz), 137.7 (d, J = 1.69 Hz), 134.7, 
130.9, 130.7, 127.3 (t, J = 3.39 Hz), 123.8 (t, J = 267.33 Hz), 121.2, 107.6, 93.5, 60.9, 
56.2, 42.4 (t, J = 29.73 Hz) 
19F NMR (376 MHz, CDCl3): d –70.60 (t, J = 11.13 Hz, 2 F) 
IR (film): 2938, 2839, 1591, 1583, 1509, 1465, 1422, 1360, 1324, 1260, 1237, 1192, 
1156, 1126, 1054, 1008, 945, 910, 865, 832, 765, 750, 735, 686, 665, 649 cm-1 




Following General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted 
with 0.26 mL (2.50 mmol) of 2-fluoro-3-chlorophenol in the presence of 0.033 g (0.25 
mmol) of TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was 
purified by reverse-phase flash chromatography using a gradient of 2–100% MeCN in 
H2O, furnishing 0.139 g (74% yield, 95% purity) of desired product 3.6e as a clear solid 










1H NMR (500 MHz, CDCl3): d 7.23 (ddd, J = 8.07, 6.34, 1.56 Hz, 1 H), 7.19 (ddd, J = 8.32, 
6.81, 1.40 Hz, 1 H), 7.01 (td, J = 8.26, 1.86 Hz, 1 H), 6.60 (s, 2 H), 3.87 (s, 6 H), 3.86 (s, 
3 H), 3.43 (t, J = 11.06 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d ;153.2, 150.4, 137.7 (t, J = 1.45 Hz), 127.5, 127.0 (t, J = 
3.51 Hz), 123.97, 123.96 (t J = 269.84 Hz), 123.93, 122.6, 122.3 (d, J = 15.84 Hz), 107.6, 
61.0, 56.2, 42.2 (t, J = 29.40 Hz) 
19F NMR (376 MHz, CDCl3): d –71.19 (td, J = 11.30, 5.34 Hz, 2 F), –131.17 (p, J = 6.19 
Hz, 1 F) 
IR (film): 2941, 2842, 2253, 1705, 1595, 1509, 1483, 1462, 1424, 1360, 1325, 1275, 
1260, 1243, 1181, 1156, 1129, 1069, 1027, 1004, 956, 907, 838, 821, 764, 746, 650 cm-
1 
HRMS (HAPCI+): calc. for C17H16ClF3O4 (M+) 376.0689, found 376.0682, 1.9 ppm. 
 
 
5-(2-(4-bromophenoxy)-2,2-difluoroethyl)-1,2,3-trimethoxybenzene (3.6f): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.432 g 
(2.50 mmol) of 4-bromophenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C 










flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.137 g (68% 
yield, 97% purity) of desired product 3.6f (or 2) as a clear oil 
1H NMR (500 MHz, CDCl3): d 7.42 (d, J = 8.83 Hz, 2 H), 7.01 (d, J = 8.62 Hz, 2 H), 6.57 
(s, 2 H), 3.86 (s, 9 H), 3.37 (t, J = 11.08 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 149.4, 137.7 (t, J = 1.62 Hz), 132.4, 127.4, 123.7 
(t, J = 267.88 Hz), 123.6, 118.6, 107.6, 60.9, 56.2, 42.4 (t, J = 29.85 Hz) 
19F NMR (376 MHz, CDCl3): d –70.87 (t, J = 11.24 Hz, 2 F) 
IR (film): 2939, 2842, 2252, 1594, 1509, 1486, 1464, 1424, 1361, 1324, 1275, 1260, 
1239, 1199, 1156, 1129, 1068, 1012, 908, 827, 797, 764, 744, 698, 649 cm-1 
HRMS (HAPCI+): calc. for C17H17BrF2O4 (M+) 402.0278, found 402.0267, 2.7 ppm. 
 
 
4-(1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethoxy)-1,1'-biphenyl (3.6g): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.426 g 
(2.50 mmol) of 4-phenylphenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash normal 










hexanes, furnishing 0.107 g of pure compound 3.6g as colorless solid (MP = 67–70 ˚C), 
and 0.053 g of 80% pure compound 3.6g 
1H NMR (500 MHz, CDCl3): d 7.56–7.54 (m, 4 H), 7.44 (t, J = 7.55 Hz, 2 H), 7.35 (t, J = 
7.37 Hz, 1 H), 7.22 (d, J = 8.23 Hz, 2 H), 6.62 (s, 2 H), 3.88 (s, 9 H), 3.42 (t, J = 10.95 
Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 149.9 (t, J = 2.09 Hz), 140.4, 138.7, 137.7 (t, J = 
1.33 Hz), 128.9, 128.2, 127.7 (t, J = 3.23 Hz), 127.5, 127.2, 123.9 (t, J = 266.44 Hz), 
122.0, 107.7, 61.0, 56.3, 42.6 (t, J = 30.29 Hz) 
19F NMR (376 MHz, CDCl3): d –70.42 (t, J = 10.93 Hz, 2 F) 
IR (film): 2253, 1595, 1510, 1486, 1464, 1424, 1325, 1241, 1131, 1009, 905, 729, 650 
cm-1 
HRMS (HAPCI+): calc. for C23H22F2O4 (M+) 400.1486, found 400.1478, 2.0 ppm. 
 
 
5-(2,2-difluoro-2-(o-tolyloxy)ethyl)-1,2,3-trimethoxybenzene (3.6h): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.26 mL 










h. After workup with 1 N NaOH (aq.), the product was purified by normal-phase flash 
chromatography using a gradient of 0–10% EtOAc in hexanes with 1% PhMe, followed 
by reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.068 g (40% yield) of desired product 3.6h as a pale yellow oil 
1H NMR (500 MHz, CDCl3): d 7.21 (dd, J = 8.37, 1.74 Hz, 1 H), 7.15 (t, J = 7.00 Hz, 2 H), 
7.08 (dt, J = 7.45, 6.99, 1.39 Hz, 1 H), 6.60 (s, 2 H), 3.87 (s, 6 H), 3.86 (s, 3 H), 3.41 (t, J 
= 10.56 Hz, 2 H), 2.05 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 148.9, 137.7 (d, J = 1.32 Hz), 131.22, 131.19, 127.8 
(t, J = 3.67 Hz), 126.7, 125.5, 124.1 (t, J = 266.78 Hz), 121.9 (d, J = 1.71 Hz), 107.8, 61.0, 
56.3, 42.7 (t, J = 30.67 Hz), 16.4 
19F NMR (376 MHz, CDCl3): d –69.81 (t, J = 10.57 Hz, 2 F) 
IR (film): 2939, 2840, 1591, 1508, 1494, 1460, 1423, 1360, 1324, 1262, 1238, 1177, 
1156, 1126, 1091, 1042, 1009, 944, 892, 862, 832, 749, 704, 658, 618 cm-1 













Following General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted 
with 0.336 mL (2.50 mmol) of 2-isoporpylphenol in the presence of 0.033 g (0.25 mmol) 
of TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.061 g (34% yield) of desired product 3.6i as a clear oil 
1H NMR (500 MHz, CDCl3): d 7.30–7.26 (m, 2 H), 7.18 (dt, J = 6.21, 2.47 Hz, 2 H), 6.64 
(s, 2 H), 3.90 (s, 9 H), 3.45 (t, J = 10.31 Hz, 2 H), 2.90 (p, J = 6.89 Hz, 1 H), 1.08 (d, J = 
6.92 Hz, 6 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 147.6 (t, J = 1.78 Hz), 141.3, 127.9 (t, J = 3.83 Hz), 
126.6, 126.5, 125.8, 124.0 (t, J = 266.37 Hz), 121.7 (t, J = 1.95 Hz), 107.8, 61.0, 56.2, 
42.8 (t, J = 30.60 Hz), 26.5, 23.1 
19F NMR (376 MHz, CDCl3): d –69.54 (t, J = 10.36 Hz, 2 F) 
IR (film): 2963, 2840, 1592, 1508, 1489, 1459, 1423, 1362, 1323, 1260, 1238, 1179, 
1156, 1127, 1086, 1045, 1009, 944, 892, 860, 829, 809, 752, 722, 705, 659, 603, 545, 
529 ,472, 455 cm-1 





2-(1,1-difluoro-2-(3,4,5-trimethoxyphenyl)ethoxy)-1,1'-biphenyl (3.6j): Following 
General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted with 0.426 g 
(2.50 mmol) of 2-phenylphenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-phase 
flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.127 g (40 
% yield, 63% purity) of compound 3.6j as a pale oil 
1H NMR (500 MHz, CDCl3): d 7.42–7.38 (m, 1 H), 7.34–7.29 (m, 7 H), 7.25 (td, J = 7.44, 
1.28 Hz, 1 H), 6.35 (s, 2 H), 3.84 (s, 3 H), 3.75 (s, 6 H), 3.19 (t, J = 10.75 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.0, 147.5, 138.1, 135.3, 131.3, 129.6, 129.4, 128.9,  
128.4, 128.0, 127.7, 127.4 (d, J = 3.80 Hz), 127.2, 125.7, 123.9 (t, J = 269.20 Hz), 122.1 
(d, J = 2.15 Hz), 107.6, 60.9, 56.1, 42.6 (t, J = 30.32 Hz) 
19F NMR (376 MHz, CDCl3): d –69.38 (t, J = 10.89 Hz, 2 F) 
IR (film): 2938, 2839, 1754, 1699, 1591, 1507, 1479, 1460, 1422, 1359, 1324, 1275, 
1259, 1235, 1188, 1155, 1125, 1045, 1010, 946, 916, 830, 748, 701, 660, 613, 569, 528 
cm-1 













Following General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted 
with 0.310 g (2.50 mmol) of 4-methoxyphenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.089 g (51% yield, 95% purity) of desired product 3.6k as a colorless solid 
(MP = 64–66 ˚C) 
1H NMR (500 MHz, CDCl3): d 7.05 (d, J = 8.58 Hz, 2 H), 6.83 (d, J = 8.99 Hz, 2 H), 6.59 
(s, 2 H), 3.86 (s, 9 H), 3.77 (s, 3 H), 3.36 (t, J = 10.92 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 157.3, 153.1, 143.7, 137.6 (d, J = 1.39 Hz), 127.8 (d, J = 
3.21 Hz), 123.8 (t, J = 266.76 Hz), 123.2, 114.4, 107.6, 60.9, 56.2, 55.6, 42.4 (t, J = 30.37 
Hz) 
19F NMR (376 MHz, CDCl3): d –70.65 (t, J = 11.00 Hz, 2 F) 
IR (film): 3003, 2939, 2839, 2252, 1702, 1592, 1506, 1463, 1423, 1362, 1324, 1298, 
1267, 1241, 1192, 1156, 1128, 1040, 1009, 943, 910, 842, 807, 784, 763, 735, 698, 649 
cm-1 













Following General Procedure B-1, 0.115 g (0.50 mmol) of compound 3.1 was reacted 
with 0.343 g (2.50 mmol) of 3-dimethylaminophenol in the presence of 0.033 g (0.25 
mmol) of TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was 
purified by normal-phase flash chromatography using a gradient of 0–30% EtOAc in 
hexanes to remove 3-dimethylaminophenol, followed by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.051 g (28% yield, 
97% purity) of compound 3.6l as a yellow semisolid 
1H NMR (500 MHz, CDCl3): d 7.16 (t, J = 8.20 Hz, 1 H), 6.59 (s, 2 H), 6.55 (dd, J = 8.39, 
2.50 Hz, 1 H), 6.52 (d, J = 7.52 Hz, 1 H), 6.46 (t, J = 2.39 Hz, 1 H), 3.87 (s, 6 H), 3.86 (s, 
3 H), 3.37 (t, J = 11.05 Hz, 2 H), 2.93 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 151.7, 151.6 (t, J = 2.25 Hz), 137.6, 129.6, 127.9 
(t, J = 3.21 Hz), 123.9 (t, J = 266.13 Hz), 109.7, 109.5, 107.6, 105.9, 61.0, 56.2, 42.6 (t, 
J = 30.60 Hz), 40.6 
19F NMR (376 MHz, CDCl3): d –69.93 (t, J = 11.10 Hz, 2 F) 
IR (film): 2938, 2840, 1699, 1608, 1592, 1505, 1460, 1423, 1358, 1324, 1263, 1236, 









HRMS (ESI+): calc. for C19H24F2NO4 (M+H) 368.1673, found 368.1662, 3.0 ppm. 
 
Compounds in Scheme 3-5: 
 
(4-(2-(2,4-dichlorophenoxy)-2,2-difluoroethyl)phenyl)(methyl)sulfane (3.9a): 
Following General Procedure B-1, 0.093 g (0.50 mmol) of compound 3.8a was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.112 g (68% yield, 98% purity) of desired product 3.9a as a tan solid (MP = 
69–70 ˚C) 
1H NMR (500 MHz, CDCl3): d 7.40 (d, J = 2.18 Hz, 1 H), 7.32 (d, J = 8.05 Hz, 2 H), 7.25 
(d, J = 8.37 Hz, 2 H), 7.23 (d, J = 8.65 Hz, 1 H), 7.18 (ddd, J = 8.78, 2.49, 0.98 Hz, 1 H), 
3.45 (t, J = 11.11 Hz, 2 H), 2.49 (d, J = 1.07 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 145.3, 138.3, 131.3, 131.2, 130.3, 128.4, 128.3 (t, J = 3.40 
Hz), 127.7, 126.6, 124.1 (t, J = 1.97 Hz), 124.0 (t, J = 269.68 Hz), 41.7 (t, J = 29.35 Hz), 
15.9 









IR (film): 2924, 1476, 1433, 1408, 1352, 1324, 1283, 1260, 1217, 1174, 1119, 1095, 
1061, 1019, 958, 907, 868, 843, 800, 762, 733, 696, 675, 650 cm-1 
HRMS (HAPCI+): calc. for C15H12Cl2F2OS (M+) 347.9954, found 347.9944, 2.9 ppm.  
 
 
1-bromo-4-(1,1-difluoro-2-(4-methoxyphenyl)ethoxy)benzene (3.9b): Following 
General Procedure B-1, 0.086 g (0.50 mmol) of compound 3.8b was reacted with 0.433 
g (2.50 mmol) of 4-bromophenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 
˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-phase 
flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.097 g (56% 
yield) of desired product 3.9b as a peach solid (MP = 51–52 ˚C) 
1H NMR (500 MHz, CDCl3): d 7.43 (d, J = 8.87 Hz, 2 H), 7.29 (d, J = 8.25 Hz, 2 H), 7.01 
(d, J = 8.50 Hz, 2 H), 6.91 (d, J = 8.80 Hz, 2 H), 3.82 (s, 3 H), 3.39 (t, J = 11.12 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 159.3, 149.6, 132.4, 131.6, 123.97 (t, J = 3.27 Hz), 123.91 
(t, J = 267.23 Hz), 123.6 (d, J = 1.39 Hz), 118.6, 114.0, 55.3, 41.4 (t, J = 29.79 Hz) 








IR (film): 3005, 2937, 2838, 1614, 1585, 1515, 1486, 1464, 1442, 1352, 1324, 1303, 
1248, 1200, 1179, 1127, 1116, 1087, 1067, 1036, 1013, 908, 847, 821, 796, 785, 764, 
736, 697, 677, 650 cm-1 
HRMS (HAPCI+): calc. for C15H13BrF2O2 (M+) 342.0067, found 342.0067, 0.0 ppm. 
 
 
4-(3-(2-(2,4-dichlorophenoxy)-2,2-difluoroethyl)phenyl)morpholine (3.9c): Following 
General Procedure B-1, 0.112 g (0.50 mmol) of compound 3.8c was reacted with 0.408 
g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.148 
g (78% yield, 94% purity) of desired product 3.9c as a yellow solid (MP = 61–64 ˚C) 
1H NMR (500 MHz, CDCl3): d 7.45 (d, J = 2.47 Hz, 1 H), 7.32 (d, J = 7.91 Hz, 1 H), 7.30–
7.28 (m, 1 H), 7.23 (dd, J = 8.82, 2.49 Hz, 1 H), 7.00 (t, J = 1.92 Hz, 1 H), 6.97 (d, J = 
7.50 Hz, 1 H), 6.93 (dd, J = 8.25, 2.42 Hz, 1 H), 3.92–3.90 (m, 4 H), 3.51 (t, J = 11.24 Hz, 










13C NMR (126 MHz, CDCl3): d 151.4, 145.3, 132.4 (t, J = 3.41 Hz), 131.2, 130.3, 129.2, 
128.3, 127.7, 124.1 (t, J = 269.23 Hz), 124.0 (t, J = 1.89 Hz), 122.4, 118.1, 115.1, 67.0, 
49.4, 42.4 (t, J = 29.15 Hz) 
19F NMR (376 MHz, CDCl3): d –70.77 (t, J = 11.30 Hz, 2 F) 
IR (film): 2967, 2860, 2250, 1604, 1585, 1495, 1476, 1449, 1380, 1353, 1325, 1304, 
1274, 1259, 1245, 1218, 1175, 1120, 1097, 1068, 998, 976, 908, 869, 837, 812, 763, 745, 
697, 650, 618 cm-1 




Following General Procedure B-1, 0.136 g (0.50 mmol) of compound 3.8d was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.153 g (70% yield, 97% purity) of desired product 3.9d as a colorless solid 









1H NMR (500 MHz, CDCl3): d 7.70 (s, 1 H), 7.64–7.62 (m, 3 H), 7.55 (d, J = 7.86 Hz, 2 
H), 7.49 (t, J = 7.68 Hz, 1 H), 7.46 (d, J = 2.10 Hz, 1 H), 7.43 (d, J = 7.62 Hz, 1 H), 7.31 
(dd, J = 8.90, 1.31 Hz, 1 H), 7.24 (dt, J = 8.85, 1.77 Hz, 1 H), 3.63 (t, J = 11.07 Hz, 2 H), 
1.45 (s, 9H) 
13C NMR (126 MHz, CDCl3): d 150.6, 145.3, 141.4, 138.1, 132.0 (t, J = 3.36 Hz), 131.3, 
130.3, 129.6, 129.4, 128.9, 128.5, 127.7, 127.0, 126.6, 125.9, 124.20 (t, J = 2.05 Hz), 
124.15 (t, J = 269.29 Hz), 42.3 (t, J = 29.25 Hz), 34.7, 31.5 
19F NMR (376 MHz, CDCl3): d –70.80 (t, J = 10.98 Hz, 2 F) 
IR (film): 2964, 2250, 1476, 1352, 1324, 1256, 1218, 1174, 1116, 1097, 1062, 1043, 
1016, 907, 868, 837, 813, 794, 763, 734, 704, 650, 617 cm-1 
HRMS (HAPCI+): calc. for C24H22Cl2F2O (M+) 434.1016, found 434.0999, 3.9 ppm. 
 
 
1-(2-(4-(tert-butyl)phenyl)-1,1-difluoroethoxy)-2,4-dichlorobenzene (3.9f): Following 
General Procedure B-1, 0.098 g (0.50 mmol) of compound 3.8f was reacted with 0.408 g 
(2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 









flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.074 g (41% 
yield) of desired product 3.9f as a clear oil 
1H NMR (500 MHz, CDCl3): d 7.43–7.40 (m, 3 H), 7.35 (d, J = 8.11 Hz, 2 H), 7.28–7.26 
(m, 1 H), 7.20 (ddd, J = 8.83, 2.51, 0.80 Hz, 1 H), 3.50 (t, J = 11.31 Hz, 2 H), 1.36 (9 H) 
13C NMR (126 MHz, CDCl3): d 150.8, 145.4, 131.3, 130.4, 130.3, 128.6, 128.4, 127.7, 
125.5, 124.2 (t, J = 269.81 Hz), 124.1 (t, J = 2.06 Hz), 41.7 (t, J = 29.18 Hz), 34.7, 31.5 
19F NMR (376 MHz, CDCl3): d –71.02 (t, J = 11.35 Hz, 2 F) 
IR (film): 2965, 2869, 1477, 1352, 1325, 1274, 1260, 1218, 1175, 1159, 1124, 1097, 
1062, 1026, 907, 869, 838, 805, 764, 745, 697, 651 cm-1 
HRMS (HAPCI+): calc. for C18H18Cl2F2O (M+) 358.0703, found 358.0701, 0.6 ppm. 
 
 
2,4-dichloro-1-(2-(3,5-dimethylphenyl)-1,1-difluoroethoxy)benzene (3.9g): Following 
General Procedure B-1, 0.085 g (0.50 mmol) of compound 3.8g was reacted with 0.408 
g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 









phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.092 
g (55% yield) of desired product 3.9g as a pale-yellow oil 
1H NMR (500 MHz, CDCl3): d 7.41 (d, J = 2.46 Hz, 1 H), 7.25 (d, J = 8.62 Hz, 1 H), 7.18 
(dd, J = 8.81, 2.49 Hz, 1 H), 7.02 (s, 2 H), 6.97 (s, 1 H), 3.42 (t, J = 11.40 Hz, 2 H), 2.33 
(s, 6 H) 
13C NMR (126 MHz, CDCl3): d 145.5, 138.0, 131.3 (t, J = 3.21 Hz), 131.2, 130.3, 129.5, 
128.6, 128.4, 127.7, 124.2 (t, J = 269.47 Hz), 124.1 (d, J = 2.20 Hz), 42.1 (t, J = 29.30 
Hz), 21.4 
19F NMR (376 MHz, CDCl3): d –70.95 (t, J = 11.40 Hz, 2 F) 
IR (film): 3010, 2920, 1608, 1584, 1476, 1433, 1382, 1353, 1298, 1276, 1251, 1218, 
1168, 1096, 1061, 962, 866, 847, 809, 764, 751, 715, 695, 661 cm-1 
HRMS (HAPCI+): calc. for C16H14Cl2F2O (M+) 330.0390, found 330.0391, 0.3 ppm. 
 
 
2,4-dichloro-1-(2-(2,4-dimethylphenyl)-1,1-difluoroethoxy)benzene (3.9h): Following 
General Procedure B-1, 0.084 g (0.50 mmol) of compound 3.8h was reacted with 0.408 
g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 










phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.050 
g (27% yield, 92% purity) of compound 3.9h as a pale-yellow semisolid. 
1H NMR (500 MHz, CDCl3): d 7.40 (d, J = 2.45 Hz, 1 H), 7.25–7.22 (m, 2 H), 7.17 (dd, J 
= 8.81, 2.42 Hz, 1 H), 7.04 (s, 1 H), 7.01 (d, J = 7.91 Hz, 1 H), 3.50 (t, J = 11.33 Hz, 2 H), 
2.40 (s, 3 H), 2.31 (s, 3 H) 
13C (126 MHz, CDCl3): d 145.4 (t, J = 1.58 Hz), 137.74, 137.68, 131.7, 131.4, 131.3, 
130.3, 128.5, 127.7, 127.0 (t, J = 3.05 Hz), 126.8, 124.6 (t, J = 270.97 Hz), 124.2 (t, J = 
2.00 Hz), 38.6 (t, J = 29.19 Hz), 21.2, 20.0 
19F NMR (376 MHz, CDCl3): d –70.43 (t, J = 11.44 Hz, 2 F) 
IR (film): 2923, 1702, 1618, 1583, 1508, 1476, 1382, 1347, 1311, 1258, 1217, 1126, 
1095, 1060, 963, 942, 866, 810, 792, 762, 694, 673, 626, 566, 465, 455 cm-1 
MS (EI+): calc. for C16H14Cl2F2O (M+) 330.0, found 330.0. 
 
 
ethyl (E)-3-(3-(2-(2,4-dichlorophenoxy)-2,2-difluoroethyl)phenyl)acrylate (3.9j): 
Following General Procedure B-1, 0.119 g (0.50 mmol) of compound 3.8j was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 










reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.127 g (64% yield) of desired product 3.9j as a colorless solid (MP = 70–72 
˚C). 
1H NMR (500 MHz, CDCl3): d 7.70 (d, J = 16.02 Hz, 1 H), 7.56 (s, 1 H), 7.49 (d, J = 7.46 
Hz, 1 H), 7.42–7.36 (m, 3 H), 7.23 (d, J = 8.78 Hz, 1 H), 7.17 (dd, J = 8.83, 2.49 Hz, 1 H), 
6.47 (d, J = 16.04 Hz, 1 H), 4.27 (q, J = 7.12 Hz, 2 H), 3.51 (t, J = 10.93 Hz, 2 H), 1.34 (t, 
J = 7.13 Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 167.0, 145.1, 144.2, 134.8, 132.5, 132.3 (t, J = 3.36 Hz), 
131.4, 130.4, 130.3, 129.1, 128.4, 127.7, 127.5, 124.1 (d, J = 1.84 Hz), 123.9 (t, J = 
269.66 Hz), 118.9, 60.6, 42.0 (t, J = 29.35 Hz), 14.4 
19F NMR (376 MHz, CDCl3): d –70.81 (t, J = 10.92 Hz, 2 F) 
IR (film): 2983, 2253, 1709, 1640, 1608, 1585, 1476, 1438, 1385, 1367, 1354, 1322, 
1274, 1260, 1228, 1179, 1163, 1119, 1097, 1061, 983, 909, 865, 840, 812, 763, 750, 694 
cm-1 











2,4-dichloro-1-(1,1-difluoro-2-(3-nitrophenyl)ethoxy)benzene (3.9k): Following 
General Procedure B-1, 0.093 g (0.50 mmol) of compound 3.8k was reacted with 0.408 
g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.083 
g (47% yield, 94% purity) of desired product 3.9k as a clear solid (MP = 96–97 ˚C). 
1H NMR (500 MHz, CDCl3): d 8.30 (d, J = 2.07 Hz, 1 H), 8.22 (dd, J = 8.29, 2.46 Hz, 1 
H), 7.75 (d, J = 7.72 Hz, 1 H), 7.55 (t, J = 7.94 Hz, 1 H), 7.39 (d, J = 2.45 Hz, 1 H), 7.24 
(d, J = 9.03 Hz, 1 H), 7.20 (dd, J = 8.77, 2.33 Hz, 1 H), 3.61 (t, J = 10.49 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 144.9 (d, J = 1.93 Hz), 136.9, 133.5, 131.7, 130.4, 129.5, 
128.4, 127.9, 125.8, 124.1 (t, J = 1.96 Hz), 123.5 (t, J = 269.63 Hz), 123.1, 41.9 (t, J = 
30.18 Hz) 
19F NMR (376 MHz, CDCl3): d –70.75 (t, J = 10.61 Hz, 2 F) 
IR (film): 2956, 2923, 2870, 1702, 1532, 1475, 1352, 1324, 1300, 1258, 1216, 1173, 
1158, 1125, 1097, 1068, 1061, 1027, 970, 908, 866, 802, 765, 34, 697, 677, 657 cm-1 











3-(2-(2,4-dichlorophenoxy)-2,2-difluoroethyl)benzonitrile (3.9l): Following General 
Procedure B-2, 0.083 g (0.50 mmol) of compound 3.8l was reacted with 0.245 g (1.50 
mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C for 
24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-phase flash 
chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.080 g (49% yield) 
of desired compound 3.9l as a colorless solid (MP = 81–83 ˚C). 
1H NMR (500 MHz, CDCl3): d 7.71 (d, J = 2.26 Hz, 1 H), 7.65–7.63 (m, 2 H), 7.48 (dt, J = 
8.52, 4.29 Hz, 1 H), 7.39 (t, J = 2.03 Hz, 1 H), 7.24–7.18 (m, 2 H), 3.53 (t, J = 10.57 Hz, 
2 H) 
13C NMR (126 MHz, CDCl3): d 145.0, 135.2, 134.3, 133.1, 131.72, 131.66, 130.4, 129.4, 
128.4, 127.8, 124.1. 123.5 (t, J = 269.93 Hz), 118.6, 112.9, 41.8 (t, J = 29.94 Hz) 
19F NMR (376 MHz, CDCl3): d –70.80 (t, J = 10.55 Hz, 2 F) 
IR (film): 3082, 2955, 2230, 1704, 1587, 1476, 1434, 1382, 1352, 1303, 1278, 1261, 
1242, 1232, 1219, 1179, 1102, 1071, 1056, 1003, 976, 942, 918, 904, 873, 866, 823, 811, 
800, 758, 738, 694, 644, 618, 577, 463 cm-1 











1-(2-(4-bromophenyl)-1,1-difluoroethoxy)-2,4-dichlorobenzene (3.9m): Following 
General Procedure B-2, 0.110 g (0.50 mmol) of compound 3.8m was reacted with 0.245 
g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.113 
g (59% yield) of desired compound 3.9m as a colorless solid (MP = 52–53 ˚C). 
1H NMR (500 MHz, CDCl3): d 7.49 (dd, J = 8.28, 1.66 Hz, 2 H), 7.40 (d, J = 2.33 Hz, 1 
H), 7.28 (d, J = 8.66 Hz, 2 H), 7.22 (dd, J = 8.82, 1.45 Hz, 1 H), 7.19 (dd, J = 8.82, 2.30 
Hz, 1 H), 3.45 (t, J = 10.89 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 145.2, 132.4, 131.7, 131.5, 130.6 (t, J = 3.23 Hz), 130.4, 
128.5, 127.8, 124.2, 123.8 (t, J = 269.87 Hz), 122.2, 41.7 (t, J = 29.56 Hz) 
19F NMR (376 MHz, CDCl3): d –71.02 (t, J = 10.82 Hz, 2 F) 
IR (film): 2925, 1701, 1583, 1476, 1433, 1408, 1384, 1350, 1260, 1217, 1099, 1073, 
1061, 1014, 897, 868, 843, 799, 762, 672, 623, 565, 489 cm-1 











2,4-dichloro-1-(1,1-difluoro-2-(2-iodophenyl)ethoxy)benzene (3.9n): Following 
General Procedure B-2, 0.133 g (0.50 mmol) of compound 3.8n was reacted with 0.245 
g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.105 
g (49% yield) of desired compound 3.9n as a colorless solid (MP = 54–55 ˚C). 
1H NMR (500 MHz, CDCl3): d 7.91 (dd, J = 7.91, 1.30 Hz, 1 H), 7.52 (dd, J = 7.77, 1.56 
Hz, 1 H), 7.40 (d, J = 2.48 Hz, 1 H), 7.35 (td, J = 7.56, 1.30 Hz, 1 H), 7.27–7.25 (m, 1 H), 
7.19 (dd, J = 8.79, 2.51 Hz, 1 H), 7.01 (td, J = 7.66, 1.71 Hz, 1 H), 3.77 (t, J = 10.94 Hz, 
2 H) 
13C NMR (126 MHz, CDCl3): d 145.3, 140.0, 135.2 (t, J = 2.76 Hz), 131.8, 131.5, 130.4, 
129.6, 128.7, 128.4, 127.8, 124.4, 124.1 (t, J = 270.10 Hz), 102.2, 46.1 (t, J = 29.23 Hz) 
19F NMR (376 MHz, CDCl3): d –69.75 (t, J = 10.84 Hz, 2 F) 
IR (film): 2924, 1698, 1584, 1565, 1475, 1436, 1384, 1349, 1276, 1258, 1216, 1124, 
1096, 1061, 1046, 1014, 868, 811, 765, 748, 694, 671, 652, 626, 613, 566, 488, 473, 459 
cm-1 






Following General Procedure B-2, 0.104 g (0.50 mmol) of compound 3.8o was reacted 
with 0.245 g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.094 g (51% yield) of desired compound 3.9o as a clear oil. 
1H NMR (500 MHz, CDCl3): d 7.69 (s, 1 H), 7.60 (t, J = 7.69 Hz, 2 H), 7.49 (t, J = 7.84 Hz, 
1 H), 7.40 (t, J = 2.00 Hz, 1 H), 7.24 (dd, J = 8.82, 1.38 Hz, 1 H), 7.19 (dd, J = 8.83, 2.36 
Hz, 1 H), 3.56 (t, J = 10.71 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 145.2, 134.2, 132.6 (t, J = 3.33 Hz), 131.6, 130.4, 129.0, 
128.5, 127.8, 127.6 (q, J = 3.98 Hz), 125.3, 124.9 (q, J = 3.90 Hz), 124.1, 123.8 (t, J = 
269.71 Hz), 123.1, 42.1 (t, J = 29.68 Hz) 
19F NMR (376 MHz, CDCl3, b,b,b-trifluoroethanol as standard with ppm = –79.40): d –
64.86 (s, 3 F), –72.02 (t, J = 10.96 Hz, 2 F) 
IR (film): 2949, 1584, 1477, 1454, 1435, 1354, 1329, 1257, 1202, 1166, 1126, 1100, 
1076, 1062, 870, 800, 764, 751, 703, 664, 617, 564 cm-1 











2,4-dichloro-1-(2-(3,5-dichlorophenyl)-1,1-difluoroethoxy)benzene (3.9p): Following 
General Procedure B-2, 0.105 g (0.50 mmol) of compound 3.8p was reacted with 0.245 
g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.078 
g (42% yield, 98% purity) of desired compound 3.9p as a pinkish colorless solid (MP = 
46–47 ˚C). 
1H NMR (500 MHz, CDCl3): d 7.41 (d, J = 2.38 Hz, 1 H), 7.35 (t, J = 1.92 Hz, 1 H), 7.31 
(d, J = 1.95 Hz, 2 H), 7.24 (d, J = 8.69 Hz, 1 H), 7.20 (dd, J = 8.81, 2.41 Hz, 1 H), 3.45 (t, 
J = 10.60 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 145.1, 135.1, 134.7, 131.7, 130.5, 129.3, 128.5, 128.3, 
127.8, 124.1, 123.5 (t, J = 269.84 Hz), 41.7 (t, J = 30.06 Hz) 
19F NMR (376 MHz, CDCl3): d –70.61 (t, J = 10.57 Hz, 2 F) 
IR (film): 1592, 1570, 1476, 1436, 1385, 1351, 1258, 1062, 867, 800, 763, 702, 643, 565 
cm-1 













Following General Procedure B-2, 0.134 g (0.50 mmol) of compound 3.8q was reacted 
with 0.245 g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 
furnishing 0.126 g (59% yield, 94% purity) of desired compound 3.9q as an orange solid 
(MP = 81–83 ˚C). 
1H NMR (500 MHz, CDCl3, 25 ˚C): d 7.40 (d, J = 7.91 Hz, 2 H), 7.37 (d, J = 2.48 Hz, 1 
H), 7.29 (d, J = 7.88 Hz, 2 H), 7.23 (d, J = 8.90 Hz, 1 H), 7.18 (dd, J = 8.82, 2.47 Hz, 1 
H), 3.74 (bs, 1 H), 3.49 (t, J = 10.96 Hz, 2 H), 1.46 (bs, 6 H), 1.21 (bs, 6 H) 
13C NMR (126 MHz, CDCl3): d 170.8, 145.2, 138.6, 132.1 (t, J = 3.17 Hz), 131.5, 130.9, 
130.3, 128.5, 127.8, 126.2, 125.8, 124.2, 124.0 (t, J = 270.95 Hz), 41.99 (t, J = 29.30 Hz), 
20.9 








IR (film): 2993, 2969, 2933, 1628, 1474, 1440, 1375, 1360, 1339, 1261, 1241, 1226, 
1214, 1204, 1112, 1094, 1058, 1028, 902, 876, 856, 842, 811, 800, 771, 753, 676, 578 
cm-1 




(3.9r): Following General Procedure B-2, 0.144 g (0.50 mmol) of compound 3.8r was 
reacted with 0.245 g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 
mmol) of TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was 
purified by reverse-phase flash chromatography using a gradient of 2–100% MeCN in 
H2O, furnishing 0.110 g (49% yield) of desired compound 3.9r as a light brown oil. 
1H NMR (500 MHz, CDCl3): d 7.49 (d, J = 8.59 Hz, 2 H), 7.39 (d, J = 2.38 Hz, 1 H), 7.30–
7.27 (m, 2 H) 7.23 (d, J = 8.83 Hz, 1 H), 7.20 (dd, J = 8.81, 2.36 Hz, 1 H), 3.53 (t, J = 
10.63 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 149.4, 145.0 (t, J = 1.72 Hz), 132.7, 132.2 (t, J = 3.48 Hz), 
131.7, 130.4, 129.7, 127.8, 124.2 (t, J = 2.10 Hz), 123.6 (t, J = 269.31 Hz), 121.5, 118.9 









19F NMR (376 MHz, CDCl3, delay time = 5 s): d –70.80 (t, J = 10.64 Hz, 2 F), –73.85 (s, 
3 F) 
IR (film): 1704, 1601, 1584, 1504, 1476, 1421, 1353, 1251, 1212, 1183, 1140, 1113, 
1100, 1061, 1020, 946, 890, 807, 764, 729, 694, 674, 640, 609, 579, 523, 492 cm-1 
HRMS (HAPCI+): calc. for C15H9Cl2F5O4S (M+) 449.9519, found 449.9516, 0.7 ppm. 
 
Compounds in Scheme 3-6: 
 
3-(2-(2,4-dichlorophenoxy)-2,2-difluoroethyl)-1-tosyl-1H-indole (3.12a): Following 
General Procedure B-1, 0.167 g (0.50 mmol) of compound 3.11a was reacted with 0.408 
g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of TBD at 
140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by reverse-
phase flash chromatography using a gradient of 2–100% MeCN in H2O, furnishing 0.209 
g (84% yield, 96% purity) of desired product 3.12a as an orange solid (MP = 90–93 ˚C). 
1H NMR (500 MHz, CDCl3): d 8.01 (d, J = 8.28 Hz, 1 H), 7.78 (d, J = 8.16 Hz, 2 H), 7.68 
(s, 1 H), 7.60 (d, J = 7.85 Hz, 1 H), 7.38 (d, J = 2.34 Hz, 1 H), 7.35 (t, J = 7.75 Hz, 1 H), 








13C NMR (126 MHz, CDCl3): d 145.1, 135.3, 135.0, 131.5, 130.8, 130.3, 130.0, 129.2, 
128.5, 128.3, 127.7, 126.9, 126.3, 125.4, 125.0, 124.3 (t, J = 1.90 Hz), 123.9 (t, J = 269.38 
Hz), 123.4, 119.8, 113.7, 112.8 (t, J = 3.71 Hz), 32.1 (t, J = 31.48 Hz), 21.6  
19F NMR (376 MHz, CDCl3): d –70.61 (t, J = 10.86, 2 F) 
IR (film): 2258, 1598, 1476, 1448, 1369, 1324, 1275, 1259, 1217, 1188, 1175, 1122, 
1090, 1061, 1020, 977, 908, 869, 811, 784, 765, 747, 703, 672, 750 cm-1 




Following General Procedure B-1, 0.104 g (0.50 mmol) of compound 3.11b was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
reverse-phase flash chromatography using a gradient of 2–100% MeCN in H2O, 











1H NMR (500 MHz, CDCl3): d 7.97 (s, 1 H), 7.74 (s, 1 H), 7.70–7.68 (m, 2 H), 7.45 (dd, J 
= 8.56, 7.31 Hz, 2 H), 7.42 (d, J = 2.45 Hz, 1 H), 7.30–7.26 (m, 2 H), 7.20 (dd, J = 8.85, 
2.52 Hz, 1 H), 3.47 (t, J = 10.99 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 145.2, 142.1, 140.1, 131.5, 130.4, 129.6, 128.4, 127.8, 
127.3, 126.7, 124.2 (t, J = 1.91 Hz), 123.9 (t, J = 268.72 Hz), 119.2, 113.0 (t, J = 3.88 
Hz), 31.9 (t, J = 31.29 Hz) 
19F NMR (376 MHz, CDCl3): d –71.98 (t, J = 11.04 Hz, 2 F) 
IR (film): 3053, 2927, 1601, 1576, 1505, 1476, 1431, 1403, 1385, 1343, 1258, 1215, 
1187, 1120, 1097, 1062, 1042, 1017, 955, 905, 867, 838, 808, 756, 711, 691, 674, 656 
cm-1 




Following General Procedure B-1, 0.123 g (0.50 mmol) of compound 3.11c was reacted 
with 0.408 g (2.50 mmol) of 2,4-dichlorophenol in the presence of 0.033 g (0.25 mmol) of 
TBD at 140 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 









furnishing 0.119 g (58% yield, 93% purity) of desired product 3.12c as a colorless solid 
(MP = 119–121 ˚C). 
1H NMR (500 MHz, CDCl3): d 8.15 (d, J = 7.98 Hz, 2 H), 7.90–7.88 (m, 1 H), 7.57 (d, J = 
7.39 Hz, 1 H), 7.52–7.47 (m, 3 H), 7.40 (s, 1 ), 7.25 (d, J = 8.79 Hz, 1 H), 7.18 (d, J = 7.87 
Hz, 1 H), 3.82 (t, J = 10.93 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 145.2 (d, J = 1.74 Hz), 141.3, 139.1, 136.2, 136.0, 131.5, 
130.3, 129.3, 128.7, 127.7, 127.0, 126.3 (t, J = 24.55 Hz), 124.8, 124.6, 124.4 (t, J = 1.87 
Hz), 124.3 (t, J = 270.61 Hz), 122.9, 121.9, 121.3, 41.3 (t, J = 29.97 Hz) 
19F NMR (376 MHz, CDCl3): d –69.59 (t, J = 10.99 Hz, 2 F) 
IR (film): 1476, 1444, 1405, 1385, 1352, 1325, 1265, 1170, 1122, 1099, 1062, 1022, 907, 
842, 817, 797, 733, 706, 650, 618 cm-1 




yl)pyridine (3.12d): Following General Procedure B-2, 0.1446 g (0.50 mmol) of 











presence of 0.033 g (0.25 mmol) of TBD at 140 ˚C for 24 h. After workup with 1 N NaOH 
(aq.), the product was purified by reverse-phase flash chromatography using a gradient 
of 2–100% MeCN in H2O, furnishing 0.137 g (61% yield, 95% purity) of desired compound 
3.12d as a yellow solid (MP = 84–86 ˚C). 
1H NMR (500 MHz, CDCl3): d 8.78 (d, J = 2.20 Hz, 1 H), 8.05 (s, 1 H), 7.96 (q, J = 2.71, 
1.94 Hz, 1 H), 7.86 (dd, J = 8.14, 2.33 Hz, 1 H), 7.76 (d, J = 8.15 Hz, 1 H), 7.47 (d, J = 
4.72 Hz, 2 H), 7.38 (d, J = 2.58 Hz, 1 H), 7.24 (d, J = 8.84 Hz, 1 H), 7.17 (dd, J = 8.89, 
2.58 Hz, 1 H), 5.91 (s, 1 H), 4.16–4.11 (m, 2 H), 4.10–4.05 (m, 2 H), 3.59 (t, J = 11.10 Hz, 
2 H) 
13C NMR (126 MHz, CDCl3): d 158.0, 148.4, 145.4, 139.4, 135.1, 132.24, 132.17 (t, J = 
2.94 Hz), 131.5, 131.4, 130.3, 129.5, 129.0, 128.5, 127.7, 126.6, 124.18, 124.12 (t, J = 
269.56 Hz), 120.3, 102.1, 65.6, 42.3 (t, J = 29.16 Hz) 
19F NMR (376 MHz, CDCl3): d –70.75 (t, J = 11.02 Hz, 2 F) 
IR (film): 2887, 1703, 1601, 1569, 1475, 1354, 1256, 1095, 1062, 1025, 982, 942, 864, 
839, 799, 757, 698, 564 cm-1 
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Fluorine Chem. 2014, 163, 38–41. 
 
 
Chapter 4 – Metal Catalyzed Dioxygenation Reactions of Difluoroalkenes 
4.1. Metal Catalyzed Reactions of gem-Difluoroalkenes 
b,b-Difluoroalkenes display unique reactivity relative to typical alkenes, with the 
termini possessing distinct electronic character, thus enabling differential functionalization 
of each carbon.1 Transition metal-free reactions exploit this reactivity through selective 
nucleophilic addition to the difluorinated position over the non-fluorinated position (Figure 
4-1).1a, 2 However, transition-metal-catalyzed reactions of gem-difluoroalkenes undergo 
defluorination to generate mono-fluorinated products (Figure 4-1a).1a, 3 Recently 
developed reactions have provided methods for functionalizing both the fluorinated and 
non-fluorinated carbon without eliminating fluoride via: 1) protonation of the unstable 




Figure 4-1: Representative Reactions of gem-Difluoroalkenes. 
  
Transition metals catalyze C–F functionalization reactions of gem-difluoroalkenes 
following distinct reactivity patterns relative to functionalization of other C–halogen bonds. 
Typically, transition metals perform oxidative addition to the C–X bond to begin catalytic 
reactions. However, the strong olefinic C–F bonds (120–129 kcal/mol)5 preclude direct 
oxidative addition under most conditions. As such, only a few recently reported reactions 
proceed via direct oxidative additions (Scheme 4-1a). These reactions require Pd-
catalyst systems coupled with tetrafluoroethene (Scheme 4-1b),6 or Ni-based catalyst 






















































Scheme 4-1: Transition-Metal Catalyzed Reactions of gem-Difluoroalkenes Exploiting C–
F Oxidative Addition 
 
Frequently, the metal-catalyzed reactions of gem-difluoroalkenes avoid oxidative 




























































metal coordination3d, 3p, 9 or C–H oxidative addition (Scheme 4-2a).3n, 3o, 3r, 10 These 
reaction pathways are accessible by a wide variety of metal catalyst systems, including 
Cu (Scheme 4-2b),3d, 3e, 3g, 3p, 9e, 9f, 11 Rh (Scheme 4-2c),3j, 3r Co,3o Fe,3c Mn,3f, 3l Zn,3b Ni,3h, 
3k and Pd3a, 3n systems. Following either initiation method, the same series of steps affect 
the net C–F functionalization. First, the metal undergoes regioselective insertion, adding 
the metal-bound nucleophile to the difluorinated carbon and the metal to the non-
fluorinated carbon. Then the sequence terminates through facile b-fluoride elimination 





Scheme 4-2: Transition-Metal Catalyzed Reactions of gem-Difluoroalkenes Avoiding C–
F Oxidative Addition 
 
A second mode of reactivity with transition metals involves fluoride addition to gem-
difluoroalkenes to establish an equilibrium between the unstable anionic intermediate and 




M = Pd, Cu 













a) Metal Catalyzed Reactions of Difluoroalkene without C–F Oxidative Addition
































b-anionic intermediate and performs further bond-forming reactions (Scheme 4-3a). This 
strategy enables Ag-catalyzed homo-dimerization of the b-anionic intermediate (Scheme 
4-3b)4b or Ag-catalyzed cross coupling with olefins4a after fluorination. More recent 
examples of this strategy exploit Pd-catalysis4c-f or photocatalysis12 to effect similar 
difunctionalization reactions. These metal-catalyzed difunctionalization reactions a) 
couple the non-fluorinated carbon of the gem-difluoroalkene to alcohols (Scheme 4-3c)4c 
or allyl functionalities,4e, 12 b) enable oxidative cross-coupling with olefins4a or arenes 
(Scheme 4-3b),4d or c) initiate 3+2 annulations with alkynes.4f However, current 
difunctionalization reactions currently exclusively involve fluorination followed by 
metalation, and only provide access to trifluoromethyl-derived products. One unique 
difunctionalization reaction avoids metal catalysis, but is still restricted to trifluoromethyl-
derived products.13 Thus, difunctionalization reactions of gem-difluoroalkenes with non-




























b) Ag-Catalyzed Homodimerization of gem-Difluoroalkenes4b
R–Y
Y = Halogen, H, Acid




AgF, 4 Å MS
Pyridine-THF (1:1)




















1)  NFSI, CF3CO2H  
     Pd(dba)2 (5 mol%)
     L1 (7.5 mol%) 
















4.2. Dioxygenation Reactions of Alkenes 
Alkenes undergo C–C or C–heteroatom bond formation via both nucleophilic and 
electrophilic strategies, making them a valuable functional handle in synthetic chemistry. 
Oxidation reactions of alkenes represent a particularly valuable strategy for rapid, late 
stage functionalization of simple compounds. Several strategies enable the addition of 
varying amounts of oxygen to alkenes. Mono-oxidation reactions of alkenes exploit 
classical reactions, such as epoxidation,14 hydroboration-oxidation,15 or Wacker-type 
reactions.16 Alkenes also serve as a directing group for oxidation via allylic oxidation 
strategies,17 or as a site for oxidative removal of a carbon through ozonolysis.18 
Dioxidation reactions of alkenes provide an opportunity to introduce multiple functional 
groups en route to complex structures.19 However, current dioxidations of alkenes 
typically generate either the same oxygen-based functional group on both positions of the 
alkene (e.g. dihydroxylation and epoxidation-hydroxide addition),20 or a regiochemical 
mixture of two distinct oxygen-containing groups.21 Classical dioxidation strategies 
generate two racemic alcohols, such as Co catalyzed acetylation / hydroxylation followed 
by hydrolysis,21 the use of osmium tetroxide,22 or epoxidation followed by nucleophilic 
addition of hydroxide.19b, 23 Several methods, such as Sharpless dioxidation reactions,19d 
enable the stereoselective incorporation of two alcohols to an alkene.  
Regioselective functionalization of an alkene with two different oxygen-based 
functional groups typically requires a dihydroxylation step followed by selective 




then ring opening via addition of an alcohol (Figure 4-2b),25 or non-selective oxidation 
with two different oxygen containing functional groups (Figure 4-2c).21 although an ideal 
method would selectively install both O-based functional groups in a single step, such 
selective unsymmetric dioxygenations of alkenes typically require the use of either strong 
oxidizing agents (Figure 4-2d),26 or N-hydroxy reagents as coupling partners (Figure 
4-2e).27 These latter reactions proceed through a net anti-Markovnikov addition of 





Figure 4-2: Representative Net Regioselective Unsymmetric Dioxidation Reactions of 
Styrenes. 
 
In contrast, oxidation reactions of fluoroalkenes are under-developed, as several 
obstacles prevent such reactions. First, oxidation reactions generally react through the 
HOMO of alkenes. The high electrophilicity of fluoroalkenes lowers the HOMO and makes 
any oxidation reaction of fluoroalkenes more difficult. Second, oxidation of fluoroalkenes 
is restricted to the non-fluorinated carbon, as installing an oxygen functionality at the 






























a) Net Regioselective Dioxidation Reaction via Dihydroxylation24
b) Net Regioselective Dioxidation Reaction via Epoxide Intermediate25
c) Unselective Dioxidation Reactions Mediated by Co21
d) Regioselective Unsymmetric Dioxidation Mediated by Strong Oxidants26










4.3. Co-Catalyzed Selective Unsymmetric Dioxidation of b,b-Difluorostyrenes 
To complement these recently reported difunctionalization reactions of gem-
difluoroalkenes and regioselective deoxygenation reactions of alkenes, we present a Co-
catalyzed unsymmetrical dioxygenation reaction of difluoroalkenes to generate b-
phenoxy-b,b-difluorobenzyl alcohols. This work exploits a regioselective addition of 
phenols and molecular oxygen to b,b-difluorostyrenes via one-electron redox chemistry 
with Co. The reaction avoids b-fluoride elimination through oxidation of the b-anionic 
intermediate to provide the stable b-phenoxy-b,b-difluorobenzyl alcohol products. 
Notably, the products bear fluorine within sufficient vicinity to modulate the acidity and 
basicity of both O-based functional groups,30 which influences the solubility,31 
lipophilicity,30a, 32 molecular conformation,33 and ligand-protein interactions relative to the 
non-fluorinated analogs.34 Further, the positioning of the F-atoms at the metabolic soft 
spot can block cytochrome P-450 mediated O-dealkylation processes,35 thus likely 
increasing stability of the substructure relative to the parent non-fluorinated analogs. 
Thus, we speculate that this substructure, although underrepresented in the literature, 
should be beneficial for chemical biologists and medicinal chemists.  
Following our previous work on the base-catalyzed hydrofunctionalization of 
difluoroalkenes with thiols2a and phenols,2c we initially aimed to explore the nucleophilic 
addition of phenols to gem-difluoroalkenes. In the presence of dissolved oxygen, we 
observed two intriguing products bearing alcohol and ketone groups at the benzylic 




b,b-difluorobenzyl alcohols and ketones with exclusive regioselectivity. In contrast to O2, 
external oxidants, including MnO2, K2S2O8, NMO, and oxone, mainly reduced the overall 
yield and minimally altered selectivity (Table 4-1, entry 2–5). Most oxidizing metals, such 
as Fe(III) or Ag(I), failed to increase the selectivity between the alcohol and ketone 
products (Table 4-1, entry 6–11). However, the use of a cobalt catalyst selectively 
provided the alcohol product in moderate to high yield (Table 4-1, entry 12). Further 
exploration revealed that an oxygen atmosphere increased the rate of reaction even 
without TBD as an activating base, and that Co(II) and (III) were competent catalysts, 
while Co(0), (I), and (IV) precatalysts decreased the reactivity and selectivity (Table 4-1, 
entry 13–16). After thorough optimization, a simple, unligated system of Co(acac)2, 1,2-




Table 4-1: Optimization of Selective Dioxygenation of Difluoroalkenes[a] 
 
[a] Standard conditions: 4.1 (1.0 equiv., 0.10 mmol), 4.2 (3.0 equiv., 0.30 mmol), DCB 
(0.25 M, 0.40 mL), 1,5,7-Triazabicylco[4.4.0]dec-5-ene (TBD, 10%, 0.010 mmol), 100 ˚C, 
18 h. [b] As determined by 19F NMR analysis of the reaction mixture using a,a,a-
trifluorotoluene (TFT) as a standard (10 µL). [c] In the absence of 1,5,7-
Triazabicyclo[4.4.0]dec-5-ene (TBD). [d] 110 ˚C, 24 hours. [e] isolated yield. 
Under these conditions, a broad range of gem-difluoroalkenes were competent in the 










































































































































ketone product (Scheme 4-4). Highly-reactive electron-rich substrates required lower 
reaction temperature and/or shorter reaction times, to give the products in moderate to 
good yields (4.5a–f). More forcing conditions decomposed the starting materials, but did 
not provide the desired products by 19F NMR analysis. In contrast, electron-deficient 
substrates required more forcing conditions, and yields were slightly reduced (4.5g–l). At 
extreme temperatures (>140 ˚C) the substrate decomposed. Mono-ortho-substituted 
substrates reacted sluggishly, and despite elevated time and temperature did not reach 
full conversion. However, the products were isolated in moderate yield, with the unreacted 
starting material recovered (4.5e, m). Bis-ortho-substituted substrates did not react 
(4.5n). Unfortunately, amine-containing substrates were not competent in this reaction 

































































































































[a] Standard conditions: 4.4a–n (1.0 equiv., 0.50 mmol), 4.2 (3.0 equiv., 1.5 mmol), 
DCB (0.25 M, 2.0 mL), Co(acac)2 (10 mol%, 0.050 mmol), temperature as indicated, for 
24 h under an O2 atmosphere. The selectivity of alcohol:ketone was determined by 19F 
NMR analysis of the reaction mixture and is reported in parentheses. Yields represent the 
average of 2 runs. [b] Co(acac)2 (20 mol%, 0.10 mmol). [c] 48 h. 
Many heterocycles were compatible with the reaction. These substrates followed a 
similar reactivity pattern (Scheme 4-5), in which electron-rich heterocycles performed 
better than electron deficient heterocycles under more mild conditions (4.7a–c vs. 4.7d). 
Heterocycles with and aliphatic amine (4.7c) or steric bulk at the ortho position (4.7e) 
reacted poorly. Unexpectedly, an ethylene-glycol acetal-protected aldehyde partially 




Scheme 4-5: Scope of Heteroaryl b,b-Difluorostyrenes[a] 
 
[a] Standard conditions: 4.6a–e (1.0 equiv., 0.50 mmol), 4.2 (3.0 equiv., 1.5 mmol), 
DCB (0.25 M, 2.0 mL), Co(acac)2 (10 mol%, 0.050 mmol), temperature as indicated, for 
24 h under an O2 atmosphere. The selectivity of alcohol:ketone was determined by 19F 
NMR analysis of the reaction mixture and is reported in parentheses. Yields represent the 
average of 2 runs. [b] Co(acac)2 (20 mol%, 0.10 mmol). [c] 36 h. [d] 48 h, worked up with 
4 N HCl/1,4-dioxane and ethylene glycol. 
Phenolic nucleophiles displayed distinct reactivity (Scheme 4-6). Electron-deficient 
phenols reacted favorably (4.9a–f, 4.3), although the electronic character of the phenol 



























































substrates, phenolic nucleophiles bearing an ortho-substituent reacted sluggishly (4.9j–
l), but still gave product in synthetically useful yields, with the remaining difluoroalkene 
recovered unreacted. At present, heterocyclic phenols are not competent substrates, 
leaving the difluoroalkene fully unreacted (4.9m). However, we remain optimistic that 
these substrates might become compatible with further adjustments to the catalyst 








































































































































[a] Standard conditions: 4.1 (1.0 equiv., 0.50 mmol), 4.8a–j (3.0 equiv., 1.5 mmol), 
DCB (0.25 M, 2.0 mL), Co(acac)2 (10%, 0.050 mmol), temperature as indicated, for 24 h 
under an O2 atmosphere. The selectivity of alcohol:ketone was determined by 19F NMR 
analysis of the reaction mixture and is reported in parentheses. Yields represent the 
average of 2 runs. [b] Co(acac)2 (20 mol%, 0.10 mmol). [c] 36 h. [d] 48 h. 
4.4. Mechanistic Considerations 
Based on mechanistic studies and an analysis of previous work we propose two 
mechanisms involving Co/O2-mediated generation of phenoxyl radical prior to 
engagement of the difluoroalkene.  
In the first proposed mechanism, Co plays two key roles, as both an initiator and 
quencher of the catalytic sequence (Figure 4-3). In the first step, Co reacts with O2 to 
generate superoxide radical (O2•-),36 which subsequently abstracts H• from phenol to 
generate PhO• (B) and a peroxide anion (HO2-).37 Reaction of PhO• (B) with the 
difluoroalkene generates stabilized benzyl radical C. This C–O bond-forming event occurs 
at the electron-deficient difluorinated position, consistent with other known radical addition 
reactions to gem-difluoroalkenes.4a, 4b, 38 The anticipated oxidation of C by O239 or Cobalt-
bound peroxide anion27b, 40 might generate benzylperoxide D, and subsequent single 
electron reduction of D by the Co(III) intermediate eventually generates benzyl alcohol 
product 4.5 by bond homolysis and regenerates Co(II).27b, 36b These final steps (Cà4.5) 
are consistent with reaction of styrenes and N–oxides using a Co(II) catalyst system in 




Figure 4-3: Proposed Cobalt-Catalyzed Mechanism 
   
In the second proposed mechanism, Co initiates a radical chain reaction with oxygen 
and phenol (Figure 4-4). Co initiates the reaction by reducing O2 to generate superoxide 
radical (O2•-),36 which subsequently abstracts H• from phenol to generate PhO• (B) to 
initiate the radical chain reaction, and a peroxide anion (HO2-).37 Reaction of PhO• (B) 





















































diverge, as C oxidizes with O2 to generate benzylperoxide anion D. In what is likely an 
electron transfer reaction, Co(III) abstracts an electron from benzylperoxide intermediate 
D, which likely undergoes bond homolysis to generate a benzyl alcohol radical, which 
abstracts a hydrogen radical from a molecule of phenol to regenerate PhO• (B) and 
propagate the reaction, while oxygen oxidizes Co(II) to Co(III). This mechanism explains 
both the source of the phenone side product and the influence of Co on selectivity, as the 
benzylperoxide intermediate D can undergo rapid elimination of hydroxide to generate 
phenone side product E, whereas bond homolysis to generate the benzyl alcohol radical 
































































Evidence for early-stage generation of PhO• (AàB) derives from a series of electron 
paramagnetic resonance (EPR) experiments using spin trapping reagents. Specifically, 
the reaction of Co(II), phenol, O2 and 5-tert-butoxycarbonyl-5-methyl-1-pyrroline-N-oxide 
(BMPO) or 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) generated spin-trapped adducts 
with EPR spectra (Figure 4-5A)41 consistent with previous reports of Co(II) generating O-
based radicals.42, 43 The EPR spectrum of the phenoxyl radical–BMPO adduct possessed 
a 14N hyperfine coupling constant (1.4 mT) and 1H hyperfine coupling constant (2.3 mT) 
consistent with the 2,4-dichlorophenoxyacetic acid C-based radical trapped by DMPO 
(14N hyperfine coupling constant = 1.53 mT, 1H hyperfine coupling constant = 2.27 mT).44 
Further experimental support for radical intermediates includes the decreased yields of 
product using known radical traps (butylated hydroxytoluene [BHT] and 1,4-
benzoquinone) (Table 4-2). Specifically, BHT and 1,4-benzoquinone inhibited the 
formation of desired product 4.5 without forming fluorinated adducts, which suggests that 
(1) radicals exist, and (2) the initial radical does not form on the difluoroalkene (Table 
4-2). Additional support for the early-stage involvement of phenol comes from kinetic 





Figure 4-5: Room Temperature EPR Analysis of Radicals by Spin Trapping with BMPO 
 
 
Reaction Conditions: Co(acac)2 (1.0 equiv., 0.10 mmol), 4.2 (3.0 equiv., 0.30 mmol) 
in 0.80 mL DCB 90 ˚C, for 15 min under an Ar atmosphere, followed by the gas exchange 
























Table 4-2: Radical Trap Analysis[a] 
 
[a] Standard conditions: 4.4a (1.0 equiv., 0.50 mmol), 4.2 (3.0 equiv., 1.5 mmol), DCB 
(0.25 M, 2.0 mL), Co(acac)2 (0.10 equiv., 0.050 mmol), radical trap (3.0 equiv. 1.5 mmol), 
90 ˚C, for 24 h under an O2 atmosphere. The conversion of 4.3a and the yield of 4.5a and 
4.6a was determined by 19F NMR analysis of the reaction mixture in the presence of 50 


































Table 4-3: Kinetic Analysis of the Reaction Order in Phenol by GC-FID[a] 
 
[a] Standard conditions: 4.4a (1.0 equiv., 0.25 mmol), 4.2 (1.0–5.0 equiv., 0.25–1.25 
mmol), DCB (0.25 M, 1.0 mL), Co(acac)2 (0.10 equiv., 0.025 mmol), 90 ˚C, for 30 min 
under an O2 atmosphere. The formation of 4.5a was determined by GC-FID analysis 
standardized with 57 µL (0.25 mmol) of dodecane. 
Proposed mechanisms initiating by reacting the difluoroalkene with either Co or O2 
were discounted by a series of EPR experiments. Specifically, in stoichiometric 
experiments monitored by EPR at 10 K, the difluoroalkene did not react with Co(II) or 
Co(III) by ligation or oxidation (Figure 4-6). Further, zero-order kinetics with respect to 
the difluoroalkene indicate non-involvement of difluoroalkene early in the catalytic cycle 
(Table 4-4), ruling out mechanisms involving epoxidation of the difluoroalkene or an 



































Table 4-4: Kinetic Analysis of the Reaction Order in Difluoroalkene by GC-FID[a] 
 
[a] Standard conditions: 4.4a (1.0–5.0 equiv., 0.25–1.25 mmol), 4.2 (3.0 equiv. 0.75 
mmol), DCB (0.25 M, 1.0 mL), Co(acac)2 (0.10 equiv., 0.025 mmol), 90 ˚C, for 30 min 
under an O2 atmosphere. The formation of 4.5a was determined by GC-FID analysis 



























Figure 4-6: 10 K EPR Analysis of Co Catalytic Center  
 
Reaction Conditions: [A] 0.017 g (1.0 equiv., 0.10 mmol) of 4.4a was reacted with 
0.026 g (1.0 equiv., 0.10 mmol) of Co(acac)2 in 0.40 mL of DCB at 90 ˚C in Ar for 15 min. 
A 100 µL sample was quenched in N2 (liq.), and analyzed by EPR spectroscopy. Then Ar 
was exchanged for O2, and reacted at 90 ˚C for 2 h. A 100 µL sample was quenched in 
N2 (liq.), and analyzed by EPR spectroscopy. [B] 0.026 g (1.0 equiv., 0.10 mmol) of 
Co(acac)2 was stirred in 0.40 mL of DCB at 90 ˚C in Ar for 15 min. A 100 µL sample was 
quenched in N2 (liq.), and analyzed by EPR spectroscopy. Then Ar was exchanged for 
O2, and reacted at 90 ̊ C for 2 h. A 100 µL sample was quenched in N2 (liq.), and analyzed 
by EPR spectroscopy. [C] 0.017 g (1.0 equiv., 0.10 mmol) of 4.4a was reacted with 0.0519 
g (3.0 equiv., 0.30 mmol) of 4-bromophenol in the presence of 0.0026 g (0.10 equiv., 

















































was quenched in N2 (liq.), and analyzed by EPR spectroscopy. Then Ar was exchanged 
for O2, and reacted at 90 ˚C for 2 h. A 100 µL sample was quenched in N2 (liq.), and 
analyzed by EPR spectroscopy. [D] 0.052 g (3.0 equiv., 0.30 mmol) of 4-bromophenol 
was stirred in the presence of 0.026 g (1.0 equiv., 0.10 mmol) of Co(acac)2 in 0.40 mL of 
DCB at 90 ˚C in Ar for 15 min. A 100 µL sample was quenched in N2 (liq.), and analyzed 
by EPR spectroscopy. Then Ar was exchanged for O2, and reacted at 90 ˚C for 2 h. A 
100 µL sample was quenched in N2 (liq.), and analyzed by EPR spectroscopy. [E] 
Calculated spectra using the EasySpin toolbox from Matlab45 for Co(acac)2(EtOH)2.42 
Several pieces of evidence support Co(II) and O2 playing key roles in initiating the 
catalytic cycle. First, EPR studies under stoichiometric conditions (Co(II)/O2/PhOH) 
suggest the formation of initial Co(II) complex (A) bearing two phenolic ligands and two 
acetylacetonate ligands in an octahedral complex42 prior to oxygen activation. This 
structural assignment was made based on the similarity of the measurements of the g 
tensor values (Figure 4-6C/D g tensor = 5.8, 3.8, 2.5) of the EPR spectrum in comparison 
to a known Co(acac)2(EtOH)2 complex assigned through correlation between Density 
Functional Theory and EPR spectra (Figure 4-6E, g tensor = 5.8, 2.0).42 Notably, this 
same complex is observed as an early intermediate in catalytic reactions quenched by N2 
(liq.) and studied by EPR at 10 K, suggesting that (A) forms prior to O2 activation (Figure 
4-6C).  
Second, following formation of complex A, O2 oxidizes Co(II) to Co(III).36 This pre-
catalytic oxidation of Co(II) was observed by 10 K EPR with or without either phenol or 




[Co(III)]. This step concurrently generates a superoxide radical that we propose serves 
as the oxidant for the phenol.36-37 Supporting this theory, in the absence of O2, no reaction 
of difluoroalkene 4.4a occurs (other than thermal degradation, Scheme 4-7), while zero-
order kinetics in Co indicate the non-involvement of Co in the rate-determining step 
(Table 4-5).  
Third, data suggesting that Co(II)/O2/PhOH play key roles early in the catalytic cycle 
involves the stoichiometric reactions of Co(II) or Co(III) and phenol, which were monitored 
by EPR at 10 K under Ar. In these reactions, no changes to the Co center were observed 
(Figure 4-6D) suggesting that O2 also participates in activating the phenol36a to generate 
phenoxyl radical (B) prior to reaction with the gem-difluoroalkene to generate benzyl 
radical (C). 
Scheme 4-7: Reaction in the Absence of O2[a] 
 
[a] Standard conditions: 0.017g of 4.4a (1.0 equiv., 0.1 mmol), 0.052 g of 4.2 (3.0 





































for 24 h under an Ar atmosphere. The conversion of 4.4 and formation of 4.5a or 4.6a 
was determined by 19F NMR analysis standardized with 10 µL (0.080 mmol) of TFT. 
Table 4-5: Kinetic Analysis of the Reaction Order in Co(acac)2 by GC-FID[a] 
 
[a] Standard conditions: 4.4a (1.0 equiv., 0.25 mmol), 4.2 (3.0 equiv., 0.75 mmol), 
DCB (0.25 M, 1.0 mL), Co(acac)2 (0.050–0.50 equiv., 0.013–0.13 mmol), 90 ˚C, for 30 
min under an O2 atmosphere. The formation of 4.5a was determined by GC-FID analysis 
standardized with 57 µL (0.25 mmol) of dodecane. 
4.5. Conclusions 
In conclusion, the use of a Co-based catalyst system in an oxygen-rich environment 
enables the selective dioxygenation of difluoroalkenes in a process that avoids b-fluoride 
elimination. The reaction selectively generates a difunctionalized product containing a 

































Many useful functional groups are tolerated, while the reaction’s simple and mild 
conditions provide the opportunity for wider application. Mechanistic investigation 
implicates a radical mechanism, where Co(II) generates a superoxide radical from O2, 
which abstracts a hydrogen radical from phenol to form a phenoxyl radical. This phenoxyl 
radical attacks the difluorinated position of the difluoroalkene to generate a benzyl radical, 
which quenches with peroxide anion. Then, electron transfer from the Co catalyst controls 
the selectivity for reduction of the benzyl peroxide. When viewed in combination with the 
many direct and facile preparations of difluoroalkenes,1a the current reaction provides a 
method for rapid diversification of compounds containing functional groups frequently 
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Unless otherwise noted, reactions were performed under an atmosphere of air using 
oven-dried glassware. Selective dioxygenation reactions of phenols and difluorostyrenes 
were performed in 20 mL borosilicate glass scintillation vials sealed with a PTFE-lined 
screw-top cap. All other reactions were performed in round-bottom flasks sealed with 
rubber septa. Stainless-steel syringes were used to transfer air- and moisture-sensitive 
liquid reagents. Reactions were monitored by either 19F NMR with an internal standard of 
a,a,a-trifluorotoluene or by thin-layer chromatography (TLC) on UNIPLATE Silica Gel 
HLF plates, visualized by quenching of fluorescence. Column chromatography was 
conducted using a Teledyne Isco CombiFlash Rf 200 system utilizing gradient elution. 
Isolated yields reported in the manuscript represent an average of at least 2 independent 
runs of final compound deemed to be at least 95% pure by NMR. Yields reported in the 
supporting information refer to a single experiment. 
 
Unless otherwise noted, reagents were purchased from commercial sources and used 
as received. Cobalt(II) 2,4-pentanedionate [Co(acac)2] was purchased from Alfa Aesar. 
1,2–Dichlorobenzene (DCB, anhydrous, 99+%) and N-methylpyrrolidine (NMP, 
anhydrous) were purchased from Sigma Aldrich. Solvents, including dimethylformamide 
(DMF), toluene (PhMe), dichloromethane (DCM), methanol (MeOH), acetonitrile (MeCN), 
and tetrahydrofuran (THF) were used directly from a solvent purification system, in which 




Other chemical abbreviations utilized in this document include: a,a,a-trifluorotoluene 
(TFT), sodium sulfate (Na2SO4), magnesium sulfate (MgSO4), ethyl acetate (EtOAc), 
diethyl ether (Et2O), ammonium chloride (NH4Cl), nbutyl lithium (nBuLi), sodium hydroxide 
(NaOH), room temperature (R.T.), tbutyl carbonate anhydride (Boc2O), potassium 
carbonate (K2CO3), 1,5,7–triazabicyclo[4.4.0]dec-5-ene (TBD), and hydrochloric acid 
(HCl). 
 
Proton nuclear magnetic resonance (1H NMR) and fluorine nuclear magnetic 
resonance (19F NMR) were taken on a Bruker AVIIIHD 400 AVANCE spectrometer (400 
and 376 MHz respectively). Proton and carbon nuclear magnetic resonance (13C NMR) 
were taken on a Bruker AVIII 500 Avance spectrometer with a CPDUL cryoprobe (500 
and 126 MHz respectively). Chemical shifts (d) for protons are reported in parts per million 
(ppm) downfield from tetramethylsilane, and are referenced to the proton resonance of 
residual solvent in the NMR solvent (CHCl3: d = 7.26 ppm; DMSO: d = 2.50 ppm). 
Chemical shifts (d) for carbon are reported in ppm downfield from tetramethylsilane, and 
are referenced to the carbon resonance of the solvent residual peak (CDCl3: d = 77.2 
ppm; DMSO: d = 39.52 ppm). Chemical shifts for fluorine are reported uncorrected in ppm 
upfield from trichlorofluoromethane (0 ppm). NMR data are represented as follows: 
chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, 
m = multiplet), coupling constant in Hertz (Hz), integration. Electron paramagnetic 
resonance (EPR) were taken on a Bruker EMXplus EPR spectrometer with an Oxford 




ionization (ESI) on a Waters LCT PremierTM mass spectrometer or by atmospheric-
pressure chemical ionization (APCI-hexane/PhMe) on a Waters Q-Tof PremierTM, for 
which sample plus near mass internal exact mass standard were dissolved in hexane, 
and hexane or PhMe/hexane were used as ionization solvent. Infrared spectra were 
measured on a Perkin Elmer Spectrum Two Fourier Transform Infrared Spectrometer by 
drying samples on a diamond ATR Sample base plate. Uncorrected melting points were 
measured on a Thomas Hoover Capillary Melting Point apparatus. 
 
Preparation and Characterization of Gem-Difluoroalkenes 
 
5-(2,2-difluorovinyl)-1,2,3-trimethoxybenzene (4.1): Compound 4.1 corresponds to 
compound 2.1 in Chapter 2, and was synthesized according to the procedure in the 














1-(2,2-difluorovinyl)-4-methoxybenzene (4.4a): Compound 4.4a corresponds to 
compound 2.5a in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
(4-(2,2-difluorovinyl)phenyl)(methyl)sulfane (4.4b): Compound 4.4b corresponds to 
compound 2.5b in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(benzyloxy)-4-(2,2-difluorovinyl)-2-methoxybenzene (4.4c): Compound 4.4c 
corresponds to compound 2.5h in Chapter 2, and was synthesized according to the 













4-(3-(2,2-difluorovinyl)phenyl)morpholine (4.4d): Compound 4.4d corresponds to 
compound 2.5d in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(2,2-difluorovinyl)-2,4-dimethylbenzene (4.4e): Compound 4.4e corresponds to 
compound 3.8h in Chapter 3, and was synthesized according to the procedure in the 

















1-(2,2-difluorovinyl)-3,5-dimethylbenzene (4.4f): Compound 4.4f corresponds to 
compound 3.8g in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
ethyl (E)-3-(3-(2,2-difluorovinyl)phenyl)acrylate (4.4g): Compound 4.4g corresponds 
to compound 2.5j in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(2,2-difluorovinyl)-N,N-diisopropylbenzamide (4.4h): Compound 4.4h corresponds 
to compound 3.8q in Chapter 3, and was synthesized according to the procedure in the 














1-(2,2-difluorovinyl)-3-(trifluoromethyl)benzene (4.4i): Compound 4.4i corresponds to 
compound 3.8o in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
1-(2,2-difluorovinyl)-3-nitrobenzene (4.4j): Compound 4.4j corresponds to compound 
















4-(2,2-difluorovinyl)benzonitrile (4.4k): Compound 4.4k corresponds to compound 




1,3-dichloro-5-(2,2-difluorovinyl)benzene (4.4l): Compound 4.4l corresponds to 
compound 2.5l in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4'-(tert-butyl)-2-(2,2-difluorovinyl)-1,1'-biphenyl (4.4m): Compound 4.4m corresponds 
to compound 2.5g in Chapter 2, and was synthesized according to the procedure in the 













2-(2,2-difluorovinyl)-1,3-dimethylbenzene (4.4n): Compound 4.4n corresponds to 
compound 3.8i in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
3-(2,2-difluorovinyl)-1-tosyl-1H-indole (4.6a): Compound 4.6a corresponds to 
compound 2.7a in Chapter 2, and was synthesized according to the procedure in the 



















4-(2,2-difluorovinyl)-1-phenyl-1H-pyrazole (4.6b): Compound 4.6b corresponds to 
compound 2.7c in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
tert-butyl 4-(4-(2,2-difluorovinyl)thiazol-2-yl)piperazine-1-carboxylate (4.6c): 
Compound 4.6c corresponds to compound 2.7f in Chapter 2, and was synthesized 
according to the procedure in the Chapter 2 Appendix. 
 
 
2-(3-(2,2-difluorovinyl)phenyl)-5-(1,3-dioxolan-2-yl)pyridine (4.6d): Compound 4.6d 
corresponds to compound 2.7b in Chapter 2, and was synthesized according to the 
















4-(2,2-difluorovinyl)dibenzo[b,d]thiophene (4.6e): Compound 4.6e corresponds to 
compound 2.7d in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
General Procedure for the Selective Unsymmetric Dioxygenation of 
Difluoroalkenes with Phenols (A): 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stirbar, was charged 
with difluoroalkene (0.50 mmol), phenol (1.50 mmol), and Co(acac)2 (0.050–0.20 mmol). 
The system was purged with O2 gas for 1 min before anhydrous DCB (2.0 mL) was added 
to the system under a stream of O2 gas. The system was sealed with a PTFE-lined screw-
top cap and stirred for 1 min at R.T. Subsequently, the vial was placed into a pre-heated 
reaction block and stirred vigorously at 90–140 °C for 24–48 h. The vial was cooled to 
R.T., and 50 µL (0.40 mmol) of TFT was added via microsyringe. The solution was diluted 
with approximately 1 mL of DCM and then stirred at R.T. for 10 min to allow adequate 
mixing. After mixing, an aliquot was removed from the vial and passed through a pad of 
silica gel into an NMR tube using acetone as eluent to remove Co(acac)2, after which the 







the aliquot was sampled for TLC analysis (visualized with 10% phosphomolybdic acid in 
EtOH) then returned to the vial. Aqueous base (sat. NaOH or Na2CO3) was added to the 
solution and stirred for 30 min, and then extracted with DCM (four times). The combined 
organic layers were washed with brine, dried over Na2SO4, concentrated in vacuo, and 
then purified by flash chromatography using EtOAc and hexanes. 
 
Preparation and Characterization of Compounds in Table 4-1 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (4.3): 
Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 110 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.148 












1H NMR (400 MHz, CDCl3): d 7.45–7.41 (m, 2 H), 7.03–6.99 (m, 2 H), 6.74 (s, 2 H), 5.00 
(td, J = 7.24, 3.49 Hz, 1 H), 3.86 (s, 6H), 3.85 (s, 3 H), 3.14 (d, J = 3.74 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 149.1 (t, J = 2.05 Hz), 138.4 (d, J = 2.06 Hz), 132.6, 
131.0, 123.6, 122.4 (t, J = 273.70 Hz), 119.0, 105.0, 74.2 (t, J = 31.70 Hz), 61.0, 56.3 
19F NMR (376 MHz, CDCl3): d  –81.65 (dd, J = 141.05, 6.98 Hz, 1 F), –82.16 (dd, J = 
140.99, 7.23 Hz, 1 F) 
IR (film): 3450, 2939, 1595, 1508, 1485, 1464, 1422, 1326, 1253, 1129, 1068, 1011, 829, 
750, 710 cm-1 
HRMS (ESI+): calc. for C17H17BrF2O5 (M+) 418.0227, found 418.0212, 3.6 ppm. 
 
Optimization of Reaction Conditions: 





Following General Procedure A, 0.023 g (0.10 mmol) of compound 4.1 was reacted 
with 0.052 g (0.30 mmol) of 4-bromophenol in the presence of 0.0014 g (0.010 mmol) of 
TBD, and 0.10 mmol of oxidant in 0.40 mL of DCB at 100 °C for 18 h. Reactions were 
analyzed by 19F NMR with a 0.010 mL (0.080 mmol) TFT standard. 







































































































































Following General Procedure A, 0.023 g (0.10 mmol) of compound 4.1 was reacted 
with 0.052 g (0.30 mmol) of 4-bromophenol in the presence of 0.0014 g (0.010 mmol) of 
TBD, and 0.010 mmol of metal in 0.40 mL of DCB at 100 °C for 18 h. Reactions were 

















































































Table SI-4-3: Solvent Screening: 
 
Following General Procedure A, 0.023 g (0.10 mmol) of compound 4.1 was reacted 
with 0.052 g (0.30 mmol) of 4-bromophenol in the presence of 0.003 g (0.010 mmol) of 
Co(acac)2 in 0.40 mL of solvent at 100 °C for 18 h. Reactions were analyzed by 19F NMR 
with a 0.010 mL (0.080 mmol) TFT standard. 
 
Experimental Procedures for Mechanistic Determination: 
Table SI-4-4: Control Experiments: Following General Procedure A, 0.085 g (0.50 
mmol) of compound 4.4a was reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the 































































Table SI-4-5: Radical Trap Experiments: 
  
 
Reaction with Butylated Hydroxy-Toluene (BHT): Following General Procedure A, 
0.085 g (0.50 mmol) of compound 4.4a was reacted with 0.260 g (1.50 mmol) of 4-
bromophenol in the presence of 0.331 g (1.50 mmol) of BHT and 0.013 g (0.050 mmol) 
of Co(acac)2 at 110 °C for 15 h. Reactions were analyzed by 19F NMR with a 0.050 mL 



































Reaction with 1,4-Benzoquinone: Following General Procedure A, 0.085 g (0.50 
mmol) of compound 4.4a was reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the 
presence of 0.162 g (1.50 mmol) of 1,4-benzoquinone and 0.013 g (0.050 mmol) of 
Co(acac)2 at 110 °C for 15 h. Reactions were analyzed by 19F NMR with a 0.050 mL (0.40 
mmol) TFT standard. 
 
Reaction with 1,4-Dinitrobenzene: Following General Procedure A, 0.085 g (0.50 
mmol) of compound 4.4a was reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the 
presence of 0.252 g (1.50 mmol) of 1,4-dinitrobenzene and 0.013 g (0.050 mmol) of 
Co(acac)2 at 110 °C for 15 h. Reactions were analyzed by 19F NMR with a 0.050 mL (0.40 






Kinetic Experiments by GC-FID: Following General Procedure A, varying quantities 
of compound 4.4a were reacted with varying amounts of 4-bromophenol in the presence 
of 0.057 mL (0.25 mmol) of dodecane and varying amounts of Co(acac)2 at 90 °C. At set 
timepoints, 0.050 mL samples were removed from the reaction mixture and filtered 
through a pad of silica with acetone to provide a volume of 1.5 mL. From this solution, a 
0.30 mL sample was removed and diluted with EtOAc to provide a final volume of 1.8 mL. 
The sample was mixed thoroughly and analyzed by GC-FID. 
 
Varying Difluoroalkene Concentration: Following General Procedure A, compound 
4.4a (0.0425 g, 0.250 mmol; 0.128 g, 0.075 mmol; or 0.213 g, 1.25 mmol) was reacted 
with 4-bromophenol (0.130 g, 0.75 mmol) in 1.0 mL of DCB in the presence of dodecane 
(0.057 mL, 0.25 mmol) and Co(acac)2 (0.0060 g, 0.025 mmol) at 90 °C. At T = 0, 3, 6, 9, 
12, and 15 min a 0.050 mL sample was removed from the reaction mixture and filtered 
through a pad of silica with acetone to provide a volume of 1.5 mL. From this solution, a 
0.30 mL sample was removed and diluted with EtOAc to provide a final volume of 1.8 mL. 
The sample was mixed thoroughly and analyzed by GC-FID. 
 
Varying Phenol Concentration: Following General Procedure A, compound 4.4a 
(0.0425 g, 0.250 mmol) was reacted with 4-bromophenol (0.043 g, 0.25 mmol; 0.058 g, 
0.033 mmol; 0.072 g, 0.42 mmol; 0.087 g, 0.50 mmol; 0.108 g, 0.63 mmol; 0.130 g, 0.75 




dodecane (0.057 mL, 0.25 mmol) and Co(acac)2 (0.0060 g, 0.025 mmol) at 90 °C. At T = 
0, 3, 6, 9, 12, and 15 min a 0.050 mL sample was removed from the reaction mixture and 
filtered through a pad of silica with acetone to provide a volume of 1.5 mL. From this 
solution, a 0.30 mL sample was removed and diluted with EtOAc to provide a final volume 
of 1.8 mL. The sample was mixed thoroughly and analyzed by GC-FID. 
 
Varying Cobalt Concentration: Following General Procedure A, compound 4.4a 
(0.0425 g, 0.250 mmol) was reacted with 4-bromophenol (0.13 g, 0.75 mmol) in 1.0 mL 
of DCB in the presence of dodecane (0.057 mL, 0.25 mmol) and Co(acac)2 (0.0030 g, 
0.013 mmol; 0.0060 g, 0.0250 mmol; 0.013 g, 0.050 mmol; 0.019 g, 0.075 mmol; 0.026 
g, 0.10 mmol; 0.032 g, 0.125 mmol) at 90 °C. At T = 0, 2, 5, 10, 15, 30, 60, 120 and 240 
min a 0.050 mL sample was removed from the reaction mixture and filtered through a pad 
of silica with acetone to provide a volume of 1.5 mL. From this solution, a 0.30 mL sample 
was removed and diluted with EtOAc to provide a final volume of 1.8 mL. The sample 
was mixed thoroughly and analyzed by GC-FID. 
 






Figure SI-4-2: Phenol Kinetics: 
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Figure SI-4-3: Cobalt Kinetics 
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Electron Paramagnetic Resonance (EPR) spectroscopy was used to test the 
proposed reaction mechanism. EPR is highly sensitive to the oxidation state and ligand 
sphere of molecules with unpaired electrons, such as transition metals and stable 
radicals.1 
Reacting Co(acac)2 and O2: Co(acac)2 (0.021 g, 0.082 mmol) was added to an oven 
dried one dram vial. The vial was sealed with a screw-top cap containing a PTFE-lined 
silicon septum, and the reaction was evacuated and backfilled three times with N2. DCB 
y = 0.0095x + 0.0184
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(1.0 mL) was added, and a 100 µL aliquot of the reaction mixture was transferred to an 
EPR tube, frozen in liquid N2, and then subjected to EPR analysis at 10 K. The reaction 
was then put under an O2 balloon, and stirred at 90 °C for 30 min A 100 µL aliquot of the 
reaction mixture was transferred into an EPR tube, frozen in liquid N2, and then subjected 
to EPR analysis at 10 K. 
 
Reacting Co(acac)2 and 4.4a under O2: Following General Procedure A, in an oven-
dried one dram vial compound 4.4a (0.043 g, 0.25 mmol) was reacted with Co(acac)2 
(0.064 g, 0.25 mmol) in DCB (1.0 mL). An O2 balloon was added, and a 100 µL aliquot of 
the reaction mixture was transferred to an EPR tube, frozen in liquid N2, and then 
subjected to EPR analysis at 10 K. The reaction was then put under an O2 balloon, and 
stirred at 90 °C for 30 min. A 100 µL aliquot of the reaction mixture was transferred into 
an EPR tube, frozen in liquid N2, and then subjected to EPR analysis at 10 K. 
 
Reacting Co(acac)2 and 4-bromophenol under O2: Following General Procedure 
A, in an oven-dried one dram vial of 4-bromophenol (0.13 g, 0.75 mmol) was reacted with 
Co(acac)2 (0.064 g, 0.25 mmol) in DCB (1.0 mL). An O2 balloon was added, and a 100 
µL aliquot of the reaction mixture was transferred to an EPR tube, frozen in liquid N2, and 
then subjected to EPR analysis at 10 K. The reaction was then put under an O2 balloon, 
and stirred at 90 °C for 30 min. A 100 µL aliquot of the reaction mixture was transferred 





Following Full Reaction Course: Following General Procedure A, in an oven-dried 
one dram vial of compound 4.4a (0.043 g, 0.25 mmol) was reacted with 4-bromophenol 
(0.13 g, 0.75 mmol) in the presence of Co(acac)2 (0.006 g, 0.03 mmol) in DCB (1.0 mL). 
An O2 balloon was added, and a 100 µL aliquot of the reaction mixture was transferred to 
an EPR tube, frozen in liquid N2, and then subjected to EPR analysis at 10 K. The reaction 
was then put under an O2 balloon, and stirred at 90 °C for 30 min. A 100 µL aliquot of the 
reaction mixture was transferred into an EPR tube, frozen in liquid N2, and then subjected 
to EPR analysis at 10 K. 
 
EPR Parameters: Full reaction course and Co(acac)2 with phenol under Ar: 
Table S1-4-6: EPR Parameters of Spectral Types Observed, 10 K 
Spectrum ID g-values Line Width Experiments 
A 7, 2.5, 2.5 75 
Co(II) and Ar 
C(II) and 4.4a and Ar 
B 5, 3, 2 150 
Co(II) and O2 




C 5.8, 3.8, 2.5 50 
Co(II), 4.2, and Ar 
Co(II), 4.2, 4.4a, and Ar 
D 4.5, 2 75 
Co(II), 4.2, and O2 
Co(II), 4.2, 4.4a, and O2 
 
Table SI-4-7: Summary of EPR Parameters for Full Dipolar Zero-Field-Splitting Hamiltonian 
 Spectrum A/B Spectrum C/D 
S 3/2 3/2 
G 2.2 2.2 
Nucleus Co Co 
A (MHz) 0 0 
Line Width 100 100 
D (MHz) 500,000 500,000 
E (MHz) 166,667 0 
 




Pathway A: Following General Procedure A, in an oven-dried one dram vial of 
compound 4.4a (0.017 g, 0.10 mmol) was reacted with 4-bromophenol (0.052 g, 0.30 
mmol) in the presence of Co(acac)2 (0.003 g, 0.01 mmol) in DCB (0.40 mL). An O2 balloon 
was added, and the reaction was stirred at 90 °C for 15 min. A 100 µL aliquot of the 
reaction mixture was transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 
µL DCB sample of BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube 
sample removed for EPR analysis at R.T.. Represents spectrum 1 in Figure SI-4-1. 
 
Pathway B: Co(acac)2 (0.026 g, 0.10 mmol) was added to an oven dried one dram 
vial. The vial was sealed with a screw-top cap containing a PTFE-lined silicon septum, 
and the reaction was evacuated and backfilled three times with N2. DCB (0.40 mL) was 
added, then put under an O2 balloon and stirred at 90 °C for 15 min. A 100 µL aliquot of 
the reaction mixture was transferred into an Eppendorf tube containing 10 µL of a 20 
mg/200 µL DCB sample of BMPO or DMPO, mixed on a Vortex mixer, and then a capillary 
tube sample removed for EPR analysis at R.T. (Figure SI-4-1, Spectrum 3). Then 4-
bromophenol (0.052 g, 0.30 mmol) in 0.40 mL DCB was added, and the reaction stirred 
at 90 ˚C for 15 min. A 100 µL aliquot of the reaction mixture was transferred into an 
Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, 
mixed on a Vortex mixer, and then a capillary tube sample removed for EPR analysis at 
R.T. (Figure SI-4-1, Spectrum 4).  Then 4.4a (0.017 g, 0.10 mmol) in 0.40 mL DCB was 
added, and the reaction stirred at 90 ̊ C for 15 min. A 100 µL aliquot of the reaction mixture 




of BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed 
for EPR analysis at R.T. (Figure SI-4-1, Spectrum 6). 
 
Pathway C: Co(acac)2 (0.026 g, 0.10 mmol) was added to an oven dried one dram 
vial. The vial was sealed with a screw-top cap containing a PTFE-lined silicon septum, 
and the reaction was evacuated and backfilled three times with N2. DCB (0.40 mL) was 
added, then put under an O2 balloon and stirred at 90 °C for 15 min. Then 4.4a (0.017 g, 
0.10 mmol) in 0.40 mL DCB was added, and the reaction stirred at 90 ˚C for 15 min. A 
100 µL aliquot of the reaction mixture was transferred into an Eppendorf tube containing 
10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, mixed on a Vortex mixer, and 
then a capillary tube sample removed for EPR analysis at R.T. (Figure SI-4-1, Spectrum 
5). Then 4-bromophenol (0.052 g, 0.30 mmol) in 0.40 mL DCB was added, and the 
reaction stirred at 90 ˚C for 15 min. A 100 µL aliquot of the reaction mixture was 
transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of 
BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed for 
EPR analysis at R.T. (Figure SI-4-1, Spectrum 7).  
Pathway D: Co(acac)2 (0.026 g, 0.10 mmol) and 4-bromophenol (0.052 g, 0.30 mmol) 
was added to an oven dried one dram vial. The vial was sealed with a screw-top cap 
containing a PTFE-lined silicon septum, and the reaction was evacuated and backfilled 
three times with N2. DCB (0.40 mL) was added, then put under an Ar balloon and stirred 




Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, 
mixed on a Vortex mixer, and then a capillary tube sample removed for EPR analysis at 
R.T. (Figure SI-4-1, Spectrum 8). Then Ar was exchanged for O2, and the reaction stirred 
at 90 ˚C for 15 min. A 100 µL aliquot of the reaction mixture was transferred into an 
Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, 
mixed on a Vortex mixer, and then a capillary tube sample removed for EPR analysis at 
R.T. (Figure SI-4-1, Spectrum 9). Then 4.4a (0.017 g, 0.10 mmol) in 0.40 mL DCB was 
added, and the reaction stirred at 90 ̊ C for 15 min. A 100 µL aliquot of the reaction mixture 
was transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample 
of BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed 
for EPR analysis at R.T. (Figure SI-4-1, Spectrum 11).  
 
Pathway E: Co(acac)2 (0.026 g, 0.10 mmol) and 4-bromophenol (0.052 g, 0.30 
mmol) was added to an oven dried one dram vial. The vial was sealed with a screw-top 
cap containing a PTFE-lined silicon septum, and the reaction was evacuated and 
backfilled three times with N2. DCB (0.40 mL) was added, then put under an Ar balloon 
and stirred at 90 °C for 15 min. Then 4.4a (0.017 g, 0.10 mmol) in 0.40 mL DCB was 
added, and the reaction stirred at 90 ̊ C for 15 min. A 100 µL aliquot of the reaction mixture 
was transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample 
of BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed 
for EPR analysis at R.T. (Figure SI-4-1, Spectrum 10). Then Ar was exchanged for O2, 




transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of 
BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed for 
EPR analysis at R.T. (Figure SI-4-1, Spectrum 12).  
 
Pathway F: Co(acac)2 (0.026 g, 0.10 mmol) and 4.4a (0.017 g, 0.10 mmol) was added 
to an oven dried one dram vial. The vial was sealed with a screw-top cap containing a 
PTFE-lined silicon septum, and the reaction was evacuated and backfilled three times 
with N2. DCB (0.40 mL) was added, then put under an Ar balloon and stirred at 90 °C for 
15 min. A 100 µL aliquot of the reaction mixture was transferred into an Eppendorf tube 
containing 10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, mixed on a Vortex 
mixer, and then a capillary tube sample removed for EPR analysis at R.T. (Figure SI-4-1, 
Spectrum 13). Then Ar was exchanged for O2, and the reaction stirred at 90 ˚C for 15 
min. A 100 µL aliquot of the reaction mixture was transferred into an Eppendorf tube 
containing 10 µL of a 20 mg/200 µL DCB sample of BMPO or DMPO, mixed on a Vortex 
mixer, and then a capillary tube sample removed for EPR analysis at R.T. (Figure SI-4-1, 
Spectrum 14). Then 4-bromophenol (0.052 g, 0.30 mmol) in 0.40 mL DCB was added, 
and the reaction stirred at 90 ˚C for 15 min. A 100 µL aliquot of the reaction mixture was 
transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of 
BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed for 





Pathway G: Co(acac)2 (0.026 g, 0.10 mmol) and 4.4a (0.017 g, 0.10 mmol) was added 
to an oven dried one dram vial. The vial was sealed with a screw-top cap containing a 
PTFE-lined silicon septum, and the reaction was evacuated and backfilled three times 
with N2. DCB (0.40 mL) was added, then put under an Ar balloon and stirred at 90 °C for 
15 min. Then 4-bromophenol (0.052 g, 0.30 mmol) in 0.40 mL DCB was added, and the 
reaction stirred at 90 ˚C for 15 min. A 100 µL aliquot of the reaction mixture was 
transferred into an Eppendorf tube containing 10 µL of a 20 mg/200 µL DCB sample of 
BMPO or DMPO, mixed on a Vortex mixer, and then a capillary tube sample removed for 
EPR analysis at R.T. (Figure SI-4-1, Spectrum 15).  
 





Table SI-4-8: Spectral Simulation Parameters for Spectrum 5 
Center Field (mT) 344   
Sweep Width (mT) 15   
Microwave Frequenct (GHz) 9.6426   
G 2.0055   













































N = 1 
 2 – 1H 
20.0400 (0.6161 
mT) 
N = 1 
Iwpp (mT) 0.45   
 
Table SI-4-9: Spectral Simulation Parameters for Spectrum 8 
Center Field (mT) 344   
Sweep Width (mT) 15   
Microwave 
Frequency (GHz) 
9.6433   
G 2.0055   
A (MHz) 1 – 
14N 
39.2349 (1.40 mT) N = 1 
 2 – 1H 64.4574 (2.30 mT) N = 1 





Experimental Procedures and Characterization of Compounds in Scheme 4-
4: 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(4-methoxyphenyl)ethan-1-ol (4.5a): Following 
General Procedure A, 0.085 g (0.50 mmol) of compound 4.4a was reacted with 0.260 g 
(1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 at 
90 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.109 g (77% 
yield) of desired product 4.5a as a pale yellow solid (MP = 51–53 °C). 
1H NMR (400 MHz, CDCl3): d 7.47 (d, J = 8.64 Hz, 2 H), 7.44–7.41 (m, 2 H), 7.01 (d, J = 
8.91 Hz, 2 H), 6.96–6.92 (m, 2H), 5.04 (td, J = 7.18, 4.29 Hz, 1 H), 3.83 (s, 3 H), 2.57 (d, 
J = 4.27 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 160.3, 149.2 (t, J = 2.40 Hz), 132.6, 129.1, 127.4, 123.6, 
122.6 (t, J = 272.76 Hz), 119.0, 113.9, 74.1 (t, J = 31.82 Hz), 55.4 










IR (film): 3424, 2957, 2911, 2838, 1891, 1613, 1586, 1515, 1485, 1465, 1442, 1399, 
1346, 1305, 1246, 1197, 1177, 1144, 1117, 1065, 1032, 1012, 939, 827, 800, 756, 745, 
716, 691, 636, 593, 535, 493 cm-1 




Following General Procedure A, 0.093 g (0.50 mmol) of compound 4.4b was reacted with 
0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.026 g (0.100 mmol) of 
Co(acac)2 at 90 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.099 
g (53% yield) of desired product 4.5b as a yellow solid (MP = 70–72 °C) 
1H NMR (400 MHz, CDCl3): d 7.45 (t, J = 8.70 Hz, 4 H), 7.28 (d, J = 8.49 Hz, 2 H), 7.01 
(d, J = 8.40 Hz, 2 H), 5.04 (t, J = 7.06 Hz, 1 H), 2.83 (bs, 1 H), 2.50 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 149.0, 139.9, 132.6, 131.9, 128.3, 126.2, 123.6, 122.4 (t, 










19F NMR (376 MHz, CDCl3): d –82.27 (dd, J = 19.13, 7.12 Hz, 2 F) 
IR (film): 3397, 2921, 2051, 1892, 1728, 1601, 1484, 1436, 1405, 1346, 1251, 1210, 
1195, 1146, 1092, 1066, 1012, 968, 941, 846, 818, 796, 758, 744, 685, 644, 539, 493 
cm-1 




(4.5c): Following General Procedure A, 0.131 g (0.500 mmol) of compound 4.4c was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 
mmol) of Co(acac)2 at 100 °C for 24 h. After workup with 1 N NaOH (aq.), the product 
was purified by flash chromatography using a gradient of 10–35% EtOAc in hexanes, 












1H NMR (400 MHz, CDCl3): d 7.44 (td, J = 7.21, 6.81, 1.94 Hz, 4 H), 7.41–7.34 (m, 2 H), 
7.34–7.28 (m, 1 H), 7.11 (d, J = 1.93 Hz, 1 H), 7.06–6.96 (m, 3 H), 6.89 (d, J = 8.29 Hz, 
1 H), 5.17 (s, 2 H), 5.00 (t, J = 7.12 Hz, 1 H), 3.90 (s, 3H), 2.83 (bs, 1 H) 
13C NMR (126 MHz, CDCl3): d 149.6, 149.1 (d, J = 2.75 Hz), 148.8, 137.0, 132.5, 128.7, 
128.3, 128.0, 127.4, 123.6, 122.5 (t, J = 272.85 Hz), 120.6, 119.0, 113.4 (d, J = 1.62 Hz), 
111.3, 74.1 (t, J = 31.44 Hz), 71.0, 56.2 
19F NMR (376 MHz, CDCl3): d –81.89 (dd, J = 141.33, 7.27 Hz, 1 F), –82.28 (dd, J = 
141.33, 7.27 Hz, 1 F) 
IR (film): 3458, 3033, 2917, 2849, 1735, 1607, 1594, 1514, 1484, 1464, 1454, 1421, 
1382, 1337, 1252, 1202, 1138, 1065, 1033, 1012, 914, 844, 827, 800, 738, 696, 648, 551, 
494 cm-1 














Following General Procedure A, 0.113 g (0.500 mmol) of compound 4.4d was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 90 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 15–50% EtOAc in hexanes, furnishing 0.044 
g (21% yield) of desired product 4.5d as an orange oil 
1H NMR (400 MHz, CDCl3): d 7.43 (d, J = 8.86 Hz, 2 H), 7.31 (t, J = 7.92 Hz, 1 H), 7.10 
(t, J = 2.00 Hz, 1 H), 7.04 (d, J = 7.93 Hz, 1 H), 7.01 (d, J = 8.62 Hz, 2 H), 6.94 (ddd, J = 
8.26, 2.55, 0.96, 1 H), 5.04 (t, J = 7.24 Hz, 1 H), 3.88–3.85 (m, 4 H), 3.20–3.17 (m, 4 H), 
2.72 (d, J = 3.57 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 151.5, 149.1 (d, J = 2.26 Hz), 136.3, 132.6, 129.3, 123.6, 
122.5 (t, J = 272.72 Hz), 119.5, 119.0, 116.4, 115.1, 74.7 (t, J = 31.27 Hz), 67.0, 49.4 
19F NMR (376 MHz, CDCl3): d –81.94 (t, J = 8.00 Hz, 2 F) 
IR (film): 3377, 2965, 2857, 1727, 1604, 1584, 1485, 1448, 1380, 1343, 1304, 1243, 
1202, 1145, 1115, 1067, 1012, 997, 978, 962, 933, 888, 827, 785, 756, 737, 698, 644, 
529, 494 cm-1 






2-(4-bromophenoxy)-1-(2,4-dimethylphenyl)-2,2-difluoroethan-1-ol (4.5e): Following 
General Procedure A, 0.084 g (0.50 mmol) of compound 4.4e was reacted with 0.260 g 
(1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 at 
90 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 0–20% EtOAc in hexanes, furnishing 0.089 g (50% 
yield) of desired product 4.5e as a pale oil 
1H NMR (400 MHz, CDCl3): d 7.58 (d, J = 7.96 Hz, 1 H), 7.43 (d, J = 8.90 Hz, 2 H), 7.11 
(d, J = 8.24 Hz, 1 H), 7.04 (d, J = 2.23 Hz, 2 H), 7.02 (s, 1 H), 5.35 (td, J = 7.18, 3.79 Hz, 
1 H), 2.85 (d, J = 4.35 Hz, 1 H), 2.40 (s, 3 H), 2.35 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 149.1 (t, J = 2.25 Hz), 138.7, 136.7, 132.5, 131.3, 130.9, 
127.3 (t, J = 1.73 Hz), 127.1, 123.5, 123.0 (t, J = 273.10 Hz), 118.8, 70.3 (t, J = 31.67 
Hz), 21.2, 19.6 
19F NMR (376 MHz, CDCl3): d  –81.41 (dd, J = 140.67, 7.53 Hz, 1 F), –81.85 (dd, J = 










IR (film): 3381, 2923, 1616, 1583, 1484, 1249, 1196, 1142, 1065, 1012, 826, 809, 760, 
748, 720, 691, 494 cm–1 
HRMS (ESI+): calc. for C16H15BrF2O2Cl (M+Cl) 390.9912, found 390.9920, 2.0 ppm. 
 
 
2-(4-bromophenoxy)-1-(3,5-dimethylphenyl)-2,2-difluoroethan-1-ol (4.5f): Following 
General Procedure A, 0.084 g (0.50 mmol) of compound 4.4f was reacted with 0.260 g 
(1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 at 
100 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 0–15% EtOAc in hexanes, furnishing 0.099 g (44% 
yield) of desired product 4.5f as a tan solid (MP = 79–81 °C) 
1H NMR (400 MHz, CDCl3): d 7.44 (d, J = 8.88 Hz, 2 H), 7.16 (bs, 2 H), 7.04 (bs, 2 H), 
7.02 (bs, 1 H), 5.00 (t, J = 7.25 Hz, 1 H), 2.74 (bs, 1 H), 2.36 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 149.2, 138.1, 135.2, 132.5, 130.9, 125.6 (d, J = 1.49 Hz), 











19F NMR (376 MHz, CDCl3): d –81.59 (dd, J = 140.92, 7.09 Hz, 1 F), –82.16 (dd, J = 
140.89, 7.38 Hz, 1 F) 
IR (film): 3395, 3011, 2919, 2051, 1891, 1760, 1609, 1583, 1484, 1399, 1379, 1345, 
1251, 1199, 1143, 1114, 1066, 1012, 953, 938, 905, 886, 828, 803, 786, 762, 744, 716, 
699, 686, 645, 561, 536, 493 cm-1 




(4.5g): Following General Procedure A, 0.119 g (0.500 mmol) of compound 4.4g was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 
mmol) of Co(acac)2 at 120 °C for 48 h. After workup with sat. Na2CO3 (aq.), the product 
was purified by flash chromatography using a gradient of 5–35% EtOAc in hexanes, 











1H NMR (400 MHz, CDCl3): d 7.68 (d, J = 16.16 Hz, 2 H), 7.56 (d, J = 7.42 Hz, 1 H), 7.52 
(dt, J = 7.88, 1.47 Hz, 1 H), 7.42–7.38 (m, 3 H), 6.98 (m, 2 H), 6.45 (d, J = 16.02 Hz, 1 
H), 5.10 (t J = 7.05 Hz, 1 H), 4.25 (q, J = 7.11 Hz, 2 H), 3.53 (bs, 1 H), 1.32 (t, J = 7.13 
Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 167.2, 148.9 (t, J = 2.32 Hz), 144.4, 136.3, 134.5, 132.5, 
129.7, 128.9, 128.6, 127.5, 122.3 (t, J = 273.04 Hz), 119.0, 118.7, 73.8 (t, J = 31.46 Hz), 
60.8, 14.4 
19F NMR (376 MHz, CDCl3): d –81.74 (dd, J = 140.69, 6.93 Hz, 1 F), –82.25 (dd, J = 
140.78, 7.25 Hz,1 F) 
IR (film): 3418, 2982, 2051, 1891, 1693, 1584, 1484, 1438, 1397, 1368, 1308, 1252, 
1225, 1188, 1148, 1113, 1098, 1066, 1012, 983, 863, 843, 825, 794, 757, 734, 696, 651, 
581, 558, 493, 465 cm-1 














(4.5h): Following General Procedure A, 0.134 g (0.500 mmol) of compound 4.4h was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 
mmol) of Co(acac)2 at 130 °C for 24 h. After workup with 1 N NaOH (aq.), the product 
was purified by flash chromatography using a gradient of 15–50% EtOAc in hexanes, 
furnishing 0.094 g (41% yield) of desired product 4.5h as a white solid (MP = 182–183 
°C) 
1H NMR (500 MHz, DMSO-D6, 60 °C): d 7.57 (dd, J = 8.45, 3.06 Hz, 4 H), 7.29 (d, J = 
7.74 Hz, 2 H), 7.08 (d, J = 8.34 Hz, 2 H), 6.51 (d, J = 5.64 Hz, 1 H), 5.10 (q, J = 7.08 Hz, 
1 H), 3.66–3.63 (m, 2 H), 1.28 (bs, 12 H) 
13C NMR (126 MHz, DMSO-D6, 60 °C): d 169.3, 148.8 (d, J = 2.31 Hz), 138.7, 137.2, 
132.3, 127.7, 124.7, 123.2, 122.6 (t, J = 272.21 Hz), 117.7, 72.0 (t, J = 31.34 Hz), 54.5, 
20.2 
19F NMR (376 MHz, CDCl3): d –81.80 (dd, J = 140.26, 7.03 Hz, 1 F), –82.22 (dd, J = 
140.26, 6.48 Hz, 1 F) 
IR (film): 3250, 2974, 2935, 1602, 1515, 1483, 1457, 1407, 1381, 1372, 1349, 1275, 
1252, 1209, 1195, 1161, 1141, 1082, 1064, 1038, 1012, 919, 883, 854, 808, 765, 750, 
681, 631, 610, 577, 548, 527, 497 cm–1 







Following General Procedure A, 0.104 g (0.500 mmol) of compound 4.4i was reacted with 
0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 140 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 0–50% EtOAc in hexanes, furnishing 0.057 
g (28% yield) of desired product 4.5i as a colorless oil 
1H NMR (400 MHz, CDCl3): d 7.82 (s, 1 H), 7.73 (d, J = 7.8 Hz, 1 H), 7.65 (d, J = 7.8 Hz, 
1 H), 7.52 (t, J = 7.8 Hz, 1 H), 7.45 – 7.37 (m, 2 H), 7.06 – 6.91 (m, 2 H), 5.15 (td, J = 7.0, 
3.6 Hz, 1 H), 2.81 (d, J = 4.0 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 148.72, 135.96, 132.55, 131.08, 131.36 – 130.33 (q, J = 
32.49 Hz), 128.82, 125.89 (q, J = 4.0 Hz), 124.63 (q, J = 4.2 Hz), 123.97 (d, J = 272.9 
Hz), 123.36, 124.32 – 119.63 (t, J = 273.01 Hz), 119.13, 74.39 – 72.98 (t, J = 31.2 Hz) 
19F NMR (376 MHz, CDCl3): d –82.05 (dd, J = 140.9, 6.7 Hz, 1 F), –82.53 (dd, J = 141.3, 










IR (film): 3414, 1584, 1485, 1327, 1250, 1161, 1122, 1064, 1012, 828, 794, 751, 737, 
701, 669, 491 cm–1 
HRMS (ESI–): calc. for C15H10BrF5O2Cl (M+Cl) 430.9478, found 430.9504, 2.6 ppm. 
 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(3-nitrophenyl)ethan-1-ol (4.5j): Following 
General Procedure A, 0.093 g (0.50 mmol) of compound 4.4j was reacted with 0.260 g 
(1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 at 
140 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.084 g (45% 
yield) of desired product 4.5j as an orange oil. 
1H NMR (400 MHz, CDCl3): d 8.46 (t, J = 1.89 Hz, 1 H), 8.27 (ddd, J = 6.22, 2.30, 1.09 
Hz, 1 H), 7.91 (d, J = 7.82 Hz, 1 H), 7.61 (t, J = 7.99 Hz, 1 H), 7.45 (d, J = 8.88 Hz, 2 H), 
7.00 (d, J = 9.03 Hz, 2 H), 5.23 (td, J = 6.90, 3.91 Hz, 1 H), 2.91 (d, J = 3.95 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 148.7 (t, J = 2.07 Hz), 148.4, 137.1, 133.9, 132.7, 129.5, 










19F NMR (376 MHz, CDCl3): d –82.02 (dd, J = 140.93, 6.87 Hz, 1 F), –82.56 (dd, J = 
140.85, 6.99 Hz, 1 F) 
IR (film): 3469, 3094, 2919, 2052, 1890, 1619, 1584, 1529, 1484, 1444, 1400, 1351, 
1276, 1251, 1195, 1151, 1115, 1066, 1012, 935, 909, 883, 843, 827, 808, 764, 750, 728, 
699, 688, 647, 546, 492 cm–1 
HRMS (ESI–): calc. for C14H10BrF2NO4Cl (M+Cl) 407.9450, found 407.9453, 0.7 ppm. 
 
 
4-(2-(4-bromophenoxy)-2,2-difluoro-1-hydroxyethyl)benzonitrile (4.5k): Following 
General Procedure A, 0.083 g (0.50 mmol) of compound 4.4k was reacted with 0.260 g 
(1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 at 
140 °C for 24 h. After workup with sat. Na2CO3 (aq.), the product was purified by flash 
chromatography using a gradient of 0–50% EtOAc in hexanes, furnishing 0.073 g (41% 










1H NMR (400 MHz, CDCl3): d 7.69 – 7.57 (m, 4 H), 7.41 – 7.32 (m, 2 H), 6.91 (d, J = 9.0 
Hz, 1 H), 5.10 (td, J = 6.9, 3.5 Hz, 2 H), 2.91 (d, J = 4.0 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 148.6, 140.1, 132.6, 132.1, 128.5, 123.4, 121.9 (t, J = 
237.2 Hz) 119.3, 118.5, 112.9, 73.6 (t, J = 31.9 Hz) 
19F NMR (376 MHz, CDCl3): d –81.75 (dd, J = 140.7, 6.9 Hz, 1 F), –82.32 (dd, J = 140.7, 
7.0 Hz, 1 F) 
IR (film): 3399, 2908, 2239, 1611, 1580, 1485, 1251, 1152, 1065, 1011, 848, 825, 804, 
763, 578, 551, 494 cm–1 
HRMS (ESI–): calc. for C15H10BrF2NO2Cl (M+Cl) 387.9557, found 387.9583, 2.6 ppm.  
 
 
2-(4-bromophenoxy)-1-(3,5-dichlorophenyl)-2,2-difluoroethan-1-ol (4.5l): Following 
General Procedure A, 0.104 g (0.500 mmol) of compound 4.4l was reacted with 0.260 g 











140 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 0–50% EtOAc in hexanes, furnishing 0.087 g (44% 
yield) of desired product 4.5l as a colorless oil. 
1H NMR (400 MHz, CDCl3): d 7.48 (dd, J = 5.4, 3.5 Hz, 4 H), 7.42 (t, J = 1.9 Hz, 1 H), 
7.12 – 6.96 (m, 2 H), 5.07 (td, J = 6.8, 3.7 Hz, 1 H), 2.85 (d, J = 4.0 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 148.6, 138.2, 135.0, 132.6, 129.2, 126.3, 123.4, 121.8 (t, 
J = 272.7), 119.3, 74.2 (t, J = 32.4 Hz) 
19F NMR (376 MHz, CDCl3): d –81.76 (dd, J = 140.8, 6.8 Hz, 1 F), –82.32 (dd, J = 140.9, 
6.9 Hz, 1 F) 
IR (film): 3400, 3083, 1592, 1572, 1484, 1435, 1206, 1150, 1065, 1011, 795, 739, 674, 
491 cm–1 













(4.5m): Following General Procedure A, 0.136 g (0.500 mmol) of compound 4.4m was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.026 g (0.100 
mmol) of Co(acac)2 at 100 °C for 48 h. After workup with 1 N NaOH (aq.), the product 
was purified by flash chromatography using a gradient of 5–25% EtOAc in hexanes, 
furnishing 0.139 g (60% yield) of desired product 4.5m as an orange oil. 
1H NMR (400 MHz, CDCl3): d 7.81 (t, J = 1.66 Hz, 1 H), 7.66 (dt, J = 7.39, 1.71 Hz, 1 H), 
7.60 (d, J = 8.45 Hz, 2 H), 7.52 (d, J = 2.18 Hz, 2 H), 7.52–7.49 (m, 2 H), 7.45 (d, J = 8.86 
Hz, 2 H), 7.04 (d, J = 8.77 Hz, 2 H), 5.16 (t, J = 7.11 Hz, 1 H), 3.00 (bs, 1 H), 1.40 (s, 9 
H) 
13C NMR (126 MHz, CDCl3): d 150.7, 149.1, 141.3, 137.9, 135.8, 132.5, 128.8, 127.8, 
126.9, 126.5, 126.4, 125.9, 123.6, 122.5 (t, J = 272.36 Hz), 119.0, 74.5 (t, J = 31.35 Hz), 
34.7, 31.5 
19F NMR (376 MHz, CDCl3): d –81.63 (dd, J = 140.63, 7.08 Hz, 1 F), –82.03 (dd, J = 
140.63, 7.16 Hz, 1 H) 
IR (film): 3401, 3065, 2962, 2904, 2867, 1580, 1483, 1399, 1363, 1252, 1209, 1140, 
1115, 1067, 1012, 954, 906, 881, 839, 825, 766, 739, 705, 675, 645, 632, 585, 545, 522, 
492 cm-1 









Following General Procedure A, 0.167 g (0.500 mmol) of compound 4.6a was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 100 °C for 36 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 15–40% EtOAc in hexanes, furnishing 0.162 
g (62% yield) of desired product 4.7a as an orange solid (MP = 53–55 °C). 
1H NMR (400 MHz, CDCl3): d 7.99 (dt, J = 8.49, 0.88 Hz), 1 H), 7.77 (d, J = 8.53 Hz, 3 
H), 7.73 (d, J = 7.75 Hz, 1 H), 7.45–7.41 (m, 2 H), 7.34 (ddd, J = 8.38, 7.16, 1.28 Hz, 1 
H), 7.28–7.24 (m, 1 H), 7.21 (d, J = 7.65 Hz, 2 H), 6.98 (dd, J = 8.76, 1.07 Hz, 2 H), 5.35 











13C NMR (126 MHz, CDCl3): d 149.0 (d, J = 1.96 Hz), 145.4, 135.2, 132.6, 130.1, 129.1, 
127.0, 125.8 (d, J = 2.00 Hz), 125.2, 123.6, 123.5, 122.5 (t, J = 272.36 Hz), 120.9 (d, J = 
1.82 Hz), 119.2, 117.0 (d, J = 1.66 Hz), 113.8, 69.1 (t, J = 33.67 Hz), 21.7 
19F NMR (376 MHz, CDCl3): d –81.47 (dd, J = 140.26, 6.78 Hz, 1 F), –82.05 (dd, J = 
140.24, 7.22 Hz, 1 F) 
IR (film): 3509, 3113, 2924, 2052, 1913, 1596, 1566, 1485, 1447, 1340, 1368, 1278, 
1255, 1189, 1172, 1122, 1084, 1066, 1012, 972, 907, 834, 811, 764, 744, 733, 703, 678, 
657, 599, 571, 537, 492 cm-1 




Following General Procedure A, 0.103 g (0.500 mmol) of compound 4.6b was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.013 g (0.050 mmol) of 












by flash chromatography using a gradient of 15–40% EtOAc in hexanes, furnishing 0.140 
g (71% yield) of desired product 4.7b as a yellow solid (MP = 70–72 ˚C) 
1H NMR (400 MHz, CDCl3): d 8.04 (s, 1 H), 7.82 (s, 1 H), 7.65 (d, J = 7.51 Hz, 2 H), 7.43 
(dd, J = 8.90, 7.22 Hz, 4 H), 7.29 (t, J = 7.45 Hz, 1 H), 7.04 (d, J = 8.57 Hz, 2 H), 5.16 (td, 
J = 6.91, 3.91 Hz, 1 H), 3.59 (d, J = 5.46 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 149.0, 140.1 (d, J = 1.95 Hz), 139.8, 132.6, 129.6, 127.0, 
126.6 (d, J = 1.86 Hz), 123.6, 122.5 (t, J = 271.91 Hz), 119.4, 119.1, 118.9 (d, J = 1.87 
Hz), 67.7 (t, J = 33.26 Hz) 
19F NMR (376 MHz, CDCl3): d –82.60 (dd, J = 140.85, 6.21 Hz, 1 F), –83.07 (dd, J = 
141.08, 6.84 Hz, 1 F) 
IR (film): 3279, 2923, 1680, 1600, 1572, 1504, 1485, 1405, 1257, 1209, 1148, 1114, 
1067, 1043, 1012, 955, 904, 826, 804, 756, 690, 492 cm-1 















yl)piperazine-1-carboxylate (4.7c): Following General Procedure A, 0.166 g (0.500 
mmol) of compound 4.6c was reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the 
presence of 0.013 g (0.050 mmol) of Co(acac)2 at 90 °C for 24 h. After workup with sat. 
Na2CO3 (aq.), the product was purified by flash chromatography using a gradient of 15–
60% EtOAc in hexanes, furnishing 0.095 g (36% yield) of desired product 4.7c as a brown 
solid (MP = 60–61 °C). 
1H NMR (400 MHz, CDCl3): d 7.46 (d, J = 8.69 Hz, 2 H), 7.23 (d, J = 0.68 Hz, 1 H), 7.06 
(d, J = 8.62 Hz, 2 H), 5.19 (t, J = 6.29 Hz, 1 H), 3.54 (dd, J = 6.43, 3.50 Hz, 4 H), 3.47 (td, 
J = 5.10, 1.76 Hz, 4 H), 1.47 (s, 9 H) 
13C NMR (126 MHz, CDCl3): d 173.0, 154.7, 148.9, 140.2, 132.7, 123.6, 122.0 (t, J = 
271.72 Hz), 120.5, 119.2, 80.5, 69.8 (t, J = 34.07 Hz), 48.2, 28.5 
19F NMR (376 MHz, CDCl3): d –81.66 (dd, J = 140.43, 5.78 Hz, 1 F), –82.45 (dd, J = 
140.58, 6.84 Hz, 1 F) 
IR (film): 3333, 2977, 2928, 2862, 2249, 2103, 1690, 1584, 1514, 1484, 1454, 1420, 
1366, 1285, 1250, 1234, 1202, 1162, 1134, 1065, 1012, 997, 970, 905, 860, 843, 829, 
805, 771, 757, 731, 692, 646, 632, 552, 493, 463 cm-1 







difluoroethan-1-ol (4.7d): Following General Procedure A, 0.145 g (0.500 mmol) of 
compound 4.6d was reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence 
of 0.013 g (0.050 mmol) of Co(acac)2 at 90 °C for 24 h. The reaction was cooled to R.T. 
and a solution of 4 N HCl in 1,4–dioxane (2.0 mL) and ethylene glycol (1.0 mL) were 
added. The solution was stirred for 2 h at 130 ˚C. After workup with 1 N NaOH (aq.), the 
product was purified by flash chromatography using a gradient of 15–40% EtOAc in 
hexanes, furnishing 0.095 g (40% yield) of desired product 4.7d as a brown solid (MP = 
85–87 °C). 
1H NMR (400 MHz, CDCl3): d 8.76 (d, J = 2.14 Hz,1 H), 8.09 (t, J = 1.72 Hz, 1 H), 7.92 
(dt, J = 7.85, 1.47 Hz, 1 H), 7.86 (dd, J = 8.19, 2.21 Hz, 1 H), 7.72 (dd, J = 8.05, 0.85 Hz, 
1 H), 7.59 (d, J = 7.70 Hz, 1 H), 7.46 (t, J = 7.74 Hz, 1 H), 7.39 (d, J = 8.69 Hz, 2 H), 6.98 
(d, J = 8.71 Hz, 2 H), 5.89 (s, 1 H), 5.09 (t, J = 7.10 Hz, 1 H), 4.36 (bs, 1 H), 4.15–4.04 












13C NMR (126 MHz, CDCl3): d 158.0, 149.2, 148.2, 139.0, 136.5, 135.5, 132.5, 132.4, 
128.9, 128.6, 127.8, 126.8, 123.6, 122.6 (t, J = 273.01 Hz), 120.8, 118.9, 102.0, 74.1 (t, 
J = 31.69 Hz), 65.6 
19F NMR (376 MHz, CDCl3): d –81.75 (t, J = 5.71 Hz, 2 F) 
IR (film): 3054, 2890, 1726, 1602, 1570, 1485, 1413, 1357, 1264, 1252, 1202, 1145, 
1067, 1027, 1012, 983, 942, 908, 841, 796, 735, 703, 650, 579, 494 cm–1 




Following General Procedure A, 0.123 g (0.500 mmol) of compound 4.6e was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.026 g (0.100 mmol) of 
Co(acac)2 at 110 °C for 48 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 5–20% EtOAc in hexanes, furnishing 0.125 










1H NMR (400 MHz, CDCl3): d 8.16 (ddd, J = 7.05, 3.87, 1.88 Hz, 2 H), 7.86–7.84 (m, 1 
H), 7.72 (d, J = 7.45 Hz, 1 H), 7.53–7.46 (m, 3 H), 7.40–7.38 (m, 2 H), 7.00 (d, J = 8.59 
Hz, 2 H), 5.45 (td, J = 7.07, 2.82 Hz, 1 H), 3.20 (d, J = 3.92 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 149.0 (d, J = 3.01 Hz), 139.5, 139.2, 136.4, 135.3, 132.5, 
129.9, 127.1, 126.2, 124.7, 124.6, 123.4, 122.7, 122.3, 121.7, 118.9, 73.7 (t, J = 32.23 
Hz) 
19F NMR (376 MHz, CDCl3): d –81.01 (dd, J = 139.12, 6.75 Hz, 1 F), –81.76 (dd, J = 
139.29, 7.33 Hz, 1 F) 
IR (film): 3412, 3064, 2922, 1888, 1762, 1583, 1550, 1525, 1484, 1444, 1401, 1342, 
1276, 1250, 1196, 1147, 1111, 1099, 1066, 1038, 1021, 1012, 938, 904, 827, 793, 750, 
706, 688, 646, 627, 577, 556, 492 cm-1 









Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.209 g (1.50 mmol) of 4-nitrophenol in the presence of 0.013 g (0.050 mmol) of Co(acac)2 
at 100 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 15–40% EtOAc in hexanes, furnishing 0.107 g (56% 
yield) of desired product 4.9a as a yellow oil (MP = 133–135 ˚C). 
1H NMR (400 MHz, CDCl3): d 8.23 (d, J = 9.19 Hz, 2 H), 7.30 (d, J = 9.27 Hz, 2 H), 6.77 
(s, 2 H), 5.07 (td, J = 7.19, 4.02 Hz, 1 H), 3.89 (s, 6 H), 3.87 (s, 3 H), 2.73 (d, J = 4.03 Hz) 
13C NMR (126 MHz, CDCl3): d 155.0 (d, J = 1.57 Hz), 153.4, 145.2, 138.9 (d, J = 1.59 
Hz), 130.3, 125.5, 122.6 (t, J = 275.02 Hz), 121.5 (d, J = 1.64 Hz), 105.0, 74.4 (t, J = 












19F NMR (376 MHz, CDCl3): d –82.02 (dd, J = 139.86, 7.08 Hz, 1 F), –82.44 (dd, J = 
139.86, 7.43 Hz, 1 F) 
IR (film): 3460, 2925, 1594, 1524, 1492, 1463, 1423, 1348, 1326, 1254, 1129, 1004, 856, 
749, 707 cm-1 




Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.179 g (1.50 mmol) of 4-hydroxybenzonitrile in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 100 °C for 24 h. After workup with sat. Na2CO3 (aq.), the product was purified 
by flash chromatography using a gradient of 10–40% EtOAc in hexanes, furnishing 0.138 
g (82% yield) of desired product 4.9b as a pale yellow solid (MP = 39–42 °C). 
1H NMR (400 MHz, CDCl3): d 7.65 (d, J = 8.77 Hz, 2 H), 7.26 (d, J = 8.80 Hz, 2 H), 6.77 












13C NMR (126 MHz, CDCl3): d 153.5, 153.3, 138.8, 133.9, 130.4, 122.6 (t, J = 274.84 Hz), 
122.0, 118.2, 109.6, 105.0, 74.5 (t, J = 31.07 Hz), 61.0, 56.4 
19F NMR (376 MHz, CDCl3): d –82.13 (d, J = 3.66 Hz, 1 F), –82.15 (d, J = 3.53 Hz, 1 F) 
IR (film): 3456, 2938, 2841, 2231, 1594, 1503, 1462, 1422, 1326, 1298, 1252, 1236, 
1126, 1074, 1004, 922, 843, 809, 790, 768, 733, 702, 661, 640, 548, 465 cm-1 




Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.245 g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 110 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 10–40% EtOAc in hexanes, furnishing 0.095 













1H NMR (400 MHz, CDCl3): d 7.42 (d, J = 2.43 Hz, 1 H), 7.28–7.25 (m ,1 H), 7.21 (dd, J 
= 8.81, 2.42 Hz, 1 H), 6.79 (s, 2 H), 5.09 (t, J = 7.27 Hz, 1 H), 3.88 (s, 6 H), 3.86 (s, 3 H), 
2.89 (bs, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 144.7 (d, J = 1.88 Hz), 138.6, 131.6, 130.3, 130.2, 
128.1, 127.8, 123.8 (t, J = 1.84 Hz), 122.6 (t, J = 275.45 Hz), 105.0, 74.4 (t, J = 30.98 
Hz), 60.9, 56.2 
19F NMR (376 MHz, CDCl3): d –81.59 (dd, J = 138.37, 6.85 Hz, 1 F), –82.67 (dd, J = 
138.48, 7.65 Hz, 1 F) 
IR (film): 3444, 3081, 2940, 2839, 2251, 1594, 1508, 1475, 1463, 1422, 1384, 1325, 
1261, 1235, 1185, 1125, 1096, 1075, 1002, 910, 868, 841, 812, 791, 770, 734, 687, 663, 
632, 568, 530 cm-1 
















(4.9d): Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was 
reacted with 0.156 mL (0.220 g, 1.50 mmol) of 3-chloro-4-fluorophenol in the presence of 
0.013 g (0.050 mmol) of Co(acac)2 at 100 °C for 24 h. After workup with 1 N NaOH (aq.), 
the product was purified by flash chromatography using a gradient of 10–40% EtOAc in 
hexanes, furnishing 0.132 g (67% yield) of desired product 4.9d as a pale solid (MP = 
115–117 °C). 
1H NMR (400 MHz, CDCl3): d 7.23 (ddd, J = 8.08, 6.36, 1.61 Hz, 1 H), 7.18 (ddd, J = 
8.52, 6.62, 1.30 Hz, 1 H), 7.01 (td, J = 8.26, 1.86 Hz, 1 H), 6.77 (s, 2 H), 5.07 (t, J = 7.23 
Hz, 1 H), 3.85 (s, 6 H), 3.84 (s, 3 H), 3.42 (bs, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 138.3, 130.8, 127.7, 124.0 (d, J = 5.69 Hz), 122.6 
(t, J = 276.48 Hz), 122.5, 122.4 (d, J = 15.56 Hz), 105.0, 74.2 (t, J = 31.07 Hz), 60.9, 56.2 
19F NMR (376 MHz, CDCl3): d –81.90 (dt, J = 138.37, 6.47 Hz, 1 F), –82.46 (dt, J = 
138.62, 6.16 Hz, 1 F), –130.23 (q, J = 5.94 Hz, 1 F) 
IR (film): 3461, 2942, 2841, 2105, 1596, 1510, 1481, 1460, 1421, 1326, 1273, 1230, 
1186, 1124, 1098, 1074, 1002, 941, 912, 850, 819, 793, 762, 748, 737, 719, 698, 663, 
623, 591, 573, 528, 467 cm-1 







Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted in 
the dark with 0.330 g (1.50 mmol) of 3-iodophenol in the presence of 0.013 g (0.050 
mmol) of Co(acac)2 at 110 °C for 24 h. After workup with 1 N NaOH (aq.), the product 
was purified by flash chromatography using a gradient of 10–35% EtOAc in hexanes, 
furnishing 0.156 g (67% yield) of desired product 4.9e as a pale solid (MP = 123–126 °C). 
1H NMR (400 MHz, CDCl3): d 7.56 (dt, J = 7.82, 1.28 Hz, 1 H), 7.51 (t, J = 1.90 Hz, 1 H), 
7.13 (ddd, J = 8.34, 2.23, 1.03 Hz, 1 H), 7.06 (t, J = 8.00 Hz, 1 H), 6.77 (s, 2 H), 5.02 (td, 
J = 7.14, 3.90 Hz, 1 H), 3.89 (s, 6 H), 3.87 (s, 3 H), 2.67 (d, J = 3.26 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 150.3 (t, J = 2.14 Hz), 135.1, 131.0, 130.9, 130.6, 
122.5 (t J = 272.99 Hz), 121.2, 105.0, 93.7, 74.4 (t, J = 31.16 Hz), 61.0, 56.4 
19F NMR (376 MHz, CDCl3): d –81.89 (ddd, J = 141.02, 7.26, 7.02 Hz, 2 F) 
IR (film): 3448, 2936, 1580, 1508, 1500, 1466, 1422, 1336, 1326, 1238, 1129, 997, 845, 
















(4.9f): Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was 
reacted with 0.302 g (1.50 mmol) of 4(2-bromoethyl)phenol in the presence of 0.026 g 
(0.10 mmol) of Co(acac)2 at 100 °C for 48 h. After workup with 1 N NaOH (aq.), the 
product was purified by flash chromatography using a gradient of 10–45% EtOAc in 
hexanes, furnishing 0.162 g (69% yield) of desired product 4.9f as a red oil. 
1H NMR (400 MHz, CDCl3): d 7.16 (d, J = 8.56 Hz, 2 H), 7.08 (d, J = 8.21 Hz, 2 H), 6.77 
(s, 2 H), 5.02 (td, J = 7.24, 3.11 Hz, 1 H), 3.86 (s, 6 H), 3.85 (s, 3 H), 3.54 (t, J = 7.49 Hz, 
2 H), 3.12 (t, J = 7.47 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 148.9 (t, J = 2.37 Hz), 138.5 (d, J = 1.63 Hz), 136.6, 













19F NMR (376 MHz, CDCl3): d –81.56 (dd, J = 141.41, 7.45 Hz, 1 F), –81.99 (dd, J = 
141.40, 7.81 Hz, 1 F) 
IR (film): 3446, 2939, 2839, 2250, 1758, 1593, 1507, 1462, 1421, 1325, 1235, 1200, 
1125, 1064, 1019, 1002, 910, 831, 809, 764, 751, 731, 697, 646, 551, 531 cm-1 
HRMS (ESI–): calc. for C19H21BrF2O5Cl (M+Cl) 481.0229, found 481.0247, 3.7 ppm. 
 
 
N-(4-hydroxyphenyl)-4-methylbenzenesulfonamide (4.8g):2 Prepared according to 
reference 2. 4-Aminophenol (1.50 g, 14.0 mmol) was dissolved in 50 mL DCM, and the 
resulting solution cooled to 0 °C under vigorous stirring. Pyridine (5.1 mL, 63 mmol) was 
added dropwise, and the resulting solution was stirred for 15 min. A solution of tosyl 
chloride (2.94 g, 15.4 mmol) in DCM (0.010 L) was added dropwise at 0 °C. The solution 
was warmed to R.T. and stirred overnight. 3 N HCl (50 mL) was added to quench the 
reaction, and the mixture was extracted DCM (three times, 15 mL each time). The organic 
layers were combined and washed with 3 N HCl (20 mL). The combined organic layers 
were dried over Na2SO4, dried in vacuo, and purified by flash chromatography (30–50% 
EtOAc in Hexanes) to provide 3.05 g (83% yield) of desired product 4.8g as a pale yellow 










methylbenzenesulfonamide (4.9g): Following General Procedure A, 0.115 g (0.500 
mmol) of compound 4.1 was reacted with 0.395 g (1.50 mmol) of N-(4-hydroxyphenyl)-4-
methylbenzenesulfonamide in the presence of 0.026 g (0.10 mmol) of Co(acac)2 at 120 
°C for 24 h. The product was purified without workup by flash chromatography using a 
gradient of 20–60% EtOAc in hexanes, furnishing 0.134 g (53% yield) of desired product 
4.9g as an orange solid (MP = 72–75 ˚C). 
1H NMR (400 MHz, CDCl3): d 7.61 (d, J = 8.27 Hz, 2 H), 7.19 (d, J = 7.78 Hz, 2 H), 7.16 
(bs, 1 H), 7.02–6.96 (m, 4 H), 6.74 (s, 2 H), 4.98 (t, J = 6.94 Hz, 1 H), 3.84 (s, 9 H), 3.10 
(bs, 1 H), 2.35 (s, 3 H) 
13C (126 MHz, CDCl3): d 153.1, 147.4 (d, J = 1.85 Hz), 144.2, 138.4, 135.9, 134.2, 131.0, 













19F NMR (376 MHz, CDCl3): d –84.19 (dd, J = 141.15, 5.92 Hz, 1 F), –84.73 (dd, J = 
141.11, 7.18 Hz, 1 F) 
IR (film): 3468, 3247, 2941, 2840, 2253, 1595, 1505, 1462, 1423, 1398, 1326, 1299, 
1275, 1253, 1234, 1201, 1186, 1153, 1126, 1090, 1068, 1018, 1001, 909, 845, 814, 798, 
765, 729, 706, 694, 663, 582, 565, 547, 511 cm–1 




Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.255 g (1.50 mmol) of 4-phenylphenol in the presence of 0.013 g (0.050 mmol) of 
Co(acac)2 at 110 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 5–40% EtOAc in hexanes, furnishing 0.157 












1H NMR (400 MHz, CDCl3): d 7.55 (d, J = 8.54 Hz, 4 H), 7.43 (t, J = 7.50 Hz, 2 H), 7.37–
7.33 (m, 1 H), 7.22 (dd, J = 8.65, 0.91 Hz, 2 H), 6.81 (s, 2 H), 5.06 (td, J = 7.09, 3.94 Hz, 
1 H), 3.90 (s, 6 H), 3.88 (s, 3 H), 2.90 (d, J = 4.01 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 149.4, 140.3, 139.1, 138.5, 131.0, 129.0, 128.2, 
127.5, 127.2, 122.6 (t, J = 272.36 Hz), 122.0, 105.1, 74.6 (t, J = 31.88 Hz), 61.0, 56.3 
19F NMR (376 MHz, CDCl3): d –81.48 (dd, J = 141.06, 6.88 Hz, 1 F), –81.99 (dd, J = 
141.05, 7.20 Hz, 1 F) 
IR (film): 3443, 2939, 2838, 2251, 1903, 1594, 1509, 1486, 1462, 1421, 1325, 1289, 
1235, 1184, 1125, 1064, 1008, 909, 842, 807, 758, 730, 698, 651, 551, 531, 500 cm-1 
HRMS (ESI+): calc. for C23H22F2O5Na (M+Na) 439.1333, found 439.1344, 2.5 ppm. 
 
 
2,2-difluoro-2-phenoxy-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (4.9i): Following 
General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 0.141 g 











36 h. After workup with 1 N NaOH (aq.), the product was purified by flash chromatography 
using a gradient of 15–40% EtOAc in hexanes, furnishing 0.106 g (62% yield) of desired 
product 4.9i as an off-white solid (MP = 100–101 °C). 
1H NMR (400 MHz, CDCl3): d 7.32 (dd, J = 8.53, 7.23 Hz, 2 H), 7.20 (t, J = 7.42 Hz, 1 H), 
7.14 (d, J = 7.18 Hz, 2 H), 6.78 (s, 2 H), 5.03 (ddd, J = 9.10, 6.73, 2.85 Hz, 1 H), 3.87 (s, 
6 H), 3.86 (s, 3 H), 3.07 (d, J = 3.91 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 150.0, 138.4, 131.1, 129.5, 125.8, 122.5 (t, J = 
271.92 Hz), 121.7, 105.0, 74.5 (t, J = 31.90 Hz), 61.0, 58.2 
19F NMR (376 MHz, CDCl3): d –81.49 (dd, J = 141.10, 6.77 Hz, 1 F), –81.97 (dd, J = 
141.10, 7.31 Hz, 1 F) 
IR (film): 3442, 2940, 2839, 1771, 1592, 1508, 1491, 1462, 1422, 1325, 1291, 1235, 
1194, 1125, 1078, 1062, 1026, 1003, 921, 898, 839, 787, 754, 732, 702, 690, 660, 558, 
530, 485 cm-1 






2,2-difluoro-2-(o-tolyloxy)-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (4.9j): Following 
General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 0.16 mL 
(1.50 mmol) of o-cresol in the presence of 0.026 g (0.100 mmol) of Co(acac)2 at 110 °C 
for 48 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 5–25% EtOAc in hexanes, furnishing 0.089 g (50% 
yield) of desired product 4.9j as an orange oil. 
1H NMR (400 MHz, CDCl3): d 7.21–7.07 (m, 4 H), 6.80 (s, 2 H), 5.07 (dd, J = 7.79, 5.83 
Hz, 1 H), 3.88 (s, 6 H), 3.86 (s, 3 H), 2.93 (bs, 1 H), 2.05 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 148.4 (d, J = 2.00 Hz), 138.6, 131.30, 131.25, 
131.18, 126.8, 125.9, 122.7 (t, J = 271.11 Hz), 122.0 (d, J = 1.66 Hz), 105.1, 74.7 (t, J = 
31.83 Hz), 61.0, 56.3, 16.3 
19F NMR (376 MHz, CDCl3): d –80.33 (dd, J = 141.28, 5.87 Hz, 1 F), –82.40 (dd, J = 
141.25, 7.82 Hz, 1 F) 
IR (film): 3445, 2939, 2839, 1594, 1507, 1492, 1461, 1421, 1325, 1251, 1234, 1178, 
















Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.21 mL (0.204 g, 1.50 mmol) of 2-isopropylphenol in the presence of 0.026 g (0.10 mmol) 
of Co(acac)2 at 110 °C for 48 h. After workup 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 5–35% EtOAc in hexanes, furnishing 0.080 
g (42% yield) of desired product 4.9k as a black oil. 
1H NMR (400 MHz, CDCl3): d 7.24 (dt, J = 7.74, 2.51 Hz, 2 H), 7.15 (ddd, J = 8.03, 5.34, 
2.08 Hz, 2 H), 6.81 (s, 2 H), 5.09 (dt, J = 8.66, 4.45 Hz, 1 H), 3.87 (s, 6 H), 3.86 (s, 3 H), 
2.82 (p, J = 6.92 Hz, 1 H), 2.74 (d, J = 3.95 Hz, 1 H), 1.03 (dd, J = 6.92, 1.01 Hz, 6 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 147.1 (d, J = 2.01 Hz), 141.5, 138.6, 131.2 (d, J = 
1.87 Hz), 126.7, 126.6, 126.2, 122.7 (dd, J = 271.38, 2.53 Hz), 121.8, 105.1, 74.9 (dd, J 












19F NMR (376 MHz, CDCl3): d –79.34 (dd, J = 140.88, 4.75 Hz, 1 F), –83.16 (dd, J = 
140.73, 8.56 Hz, 1 F) 
IR (film): 3452, 2964, 2840, 1595, 1508, 1488, 1461, 1422, 1385, 1363, 1325, 1275, 
1250, 1234, 1179, 1126, 1084, 1060, 1033, 1004, 910, 836, 812, 785, 754, 732, 698, 661, 
573, 530, 473 cm-1 




Following General Procedure A, 0.115 g (0.500 mmol) of compound 4.1 was reacted with 
0.255 g (1.50 mmol) of 2-phenylphenol in the presence of 0.026 g (0.10 mmol) of 
Co(acac)2 at 110 °C for 48 h. After workup with 1 N NaOH (aq.), the product was purified 
by flash chromatography using a gradient of 5–40% EtOAc in hexanes, furnishing 0.141 












1H NMR (400 MHz, CDCl3): d 7.42–7.31 (m, 8 H), 7.29 (dd, J = 7.31, 1.53 Hz, 1 H), 6.56 
(s, 2 H), 4.82 (td, J = 7.11, 4.18 Hz, 1 H), 3.85 (s, 3 H), 3.78 (s, 6 H), 2.32 (d, J = 4.17 Hz, 
1 H) 
13C NMR (126 MHz, CDCl3): d 153.0, 147.0, 138.3, 137.8, 135.2, 131.3, 130.8, 129.3, 
129.1, 128.5, 128.3, 128.1, 127.4, 125.9, 125.4, 122.6 (t, J = 273.57 Hz), 121.9, 104.9, 
74.5 (t, J = 31.33 Hz), 60.9, 56.1 
19F NMR (376 MHz, CDCl3): d –80.71 (dd, J = 139.63, 7.17 Hz, 1 F), –81.67 (dd, J = 
139.53, 7.09 Hz, 1 F) 
IR (film): 3454, 3059, 2940, 2838, 1595, 1506, 1479, 1463, 1422, 1325, 1264, 1236, 
1189, 1127, 1070, 1009, 910, 838, 774, 736, 700, 661, 613, 566, 530, 474 cm-1 
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Chapter 5 – Ongoing Metal-Catalyzed Dioxygenation Reactions of gem-
Difluoroalkenes 
5.1. Tunable Catalysis for Rapid Diversification  
Medicinal chemists commonly diversify a single, common intermediate to access 
many products. This strategy streamlines synthetic effort, by enabling more efficient 
synthesis of many valuable compounds. However, late stage diversification requires 
many different reactions and the catalyst systems to reach the desired products. 
Exploiting catalyst systems, wherein a small change to the catalyst system produces 
divergent products, simplifies the workflow of late stage diversification. 
Tunable, divergent catalyst systems are becoming more common, especially as C–H 
functionalization and directed reactions are developed. Often these divergent systems 
utilize distinct ligands to control the regioselectivity of transition metal catalyzed 
reactions.1 For example, in the Pd-catalyzed decarboxylative allylation of a,a-
difluoroketones, distinct Buchwald monophosphine ligand control the site of nucleophilic 
addition to provide either linear or branched products (Scheme 5-1a).1s In a second 
example, using a Cu-based catalyst system, an allyl iodide and a diazo ester form an 
iodonium ylide, which undergoes a [2,3]-rearrangement in the presence of a pyridyl 
ligand, but undergoes a [1,2]-rearrangement in the presence of a phosphine ligand 
(Scheme 5-1b).1r Finally, a Pd catalyst couples naphthols with a vinylethylene carbonate, 
where a Buchwald ligand enables [3+2] cyclization, while bidentate phosphine ligands, 
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c) Ligand Controlled [3+2] or [3+3] Cycloadditions of



















































A second strategy exploits judicious solvent selection, for instance replacing polar 
protic solvents with polar aprotic solvents, to alter reactivity without any other changes to 
the reaction conditions.2 In the addition of a-cyano nucleophiles to benzyl electrophiles 
using Pd-based catalyst systems, the use of aromatic solvents vs. polar aprotic solvents 
switches between benzylation and arylation products (Scheme 5-2a).2b The aromatic 
solvent encourages the nitrile to re-arrange from an N-bound ligand to C-bound ligand, 
followed by reductive elimination with the Pd-benzyl complex. In contrast, polar protic 
solvents stabilize the N-bound species, encouraging nucleophilic addition of the 
ketenimine to the para-position of the Pd-benzyl species.  In another example, solvent 
controlled the Co-catalyzed 1,2-oxazetidine cleavage by either stabilizing an N-Tosyl 
imine leaving group in protic solvents, or maintaining a Co-bound N-Tosyl imine and 
releasing formaldehyde in non-protic solvents, followed by C–H activation of 




Scheme 5-2: Solvent Controlled Divergent Reactions 
 
A third strategy uses additives, such as an exogenous base or acid, to control the 
reaction outcome.3 For instance, the addition of amine bases to the decarboxylative 
benzylation reaction of a,a-difluoroketones controls the whether the nucleophile attacks 
the benzyl position or adds to the aryl ring of the benzyl electrophile (Scheme 5-3a).4 In 
a Ru-catalyzed [2+2+2]  cycloaddition, a silver additive controls whether the reaction 
forms benzonitrile or pyridyl products (Scheme 5-3b).3f In this reaction, the silver additive 
alters the coordination sphere by removing a halide from the tetracoordinate, tetrahedral 
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Ru center, freeing a coordination site. Thus, the alkynyl nitrile coordinates through the N-
center, allowing the [2+2+2] cyclization to occur on the nitrile. In the absence of silver, the 
halide stays bound to the Ru center. Thus, instead of an h1 binding event through the 
nitrile nitrogen, an h3 coordination of the alkyne occurs, changing the coordination sphere 
from tetrahedral to octahedral and enabling a [2+2+2] cyclization with the alkyne 
(Scheme 5-3b).3f 
Scheme 5-3: Additive Controlled Divergent Reactions 
 
In contrast, exploiting minor changes in a catalyst system to control the final oxidation 
state of the products of oxidation reactions is relatively underexplored. Asymmetric 
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oxidation catalysts, such as the Sharpless dihydroxylation reagent, control the ultimate 
enantioselectivity through ligand control.5 However, a catalyst system in which minor 
changes selectively provide either an alcohol or a ketone product is relatively unknown. 
Such a controllable oxidation would eliminate additional oxidation or reduction steps, 
directly providing the desired final oxidation state. 
One way to access a precursor which might enable selective control of an alcohol- or 
a ketone-based product is oxidative difunctionalization reactions of alkenes. Alkenes act 
as a synthetic handle for difunctionalization, providing a rapid method of diversification, 
directly forming densely functionalized products from simple starting materials.6 Many 
oxidative difunctionalization reactions of alkenes provide access to alcohol or ether 
derived products,5-7 through strategies such as  epoxidation-nucleophilic addition7e, 8 or 
dihydroxylation5, 9 reactions. However, few alkene difunctionalization reactions selectively 
functionalize each terminus of an alkene with two different oxygen functional groups in a 
single step.10 Such an unsymmetric difunctionalization typically requires two or more 
steps8b, 8c, 9c-g or provides a regioisomeric mixture of difunctionalized products.7a-c 
The selective unsymmetric dioxygenation of a difluoroalkene under Co catalysis 
explored in Chapter 4 is one of the few reactions that selectively adds two different 
oxygen-based groups to an alkene. In this reaction, the distinct electronic character of the 
difluoroalkene substrate enables selective functionalization. This reaction only provides 
the benzylic alcohol product; however, in the absence of Co the same reaction provides 
a mixture of the benzyl alcohol and phenone products. Thus, reoptimization of the catalyst 




of reactions using Pt-based catalyst systems, where a change from a basic to an acidic 
additive controls access to b-phenoxy-b,b-difluorobenzyl alcohol or ketone products, and 
a Cu-based catalyst system to selectively provide b-phenoxy-b,b-difluorobenzyl ketones. 
5.2. Platinum Catalysis to Access b-Phenoxy-b,b-Difluorobenzyl Alcohols 
The catalytic addition of phenol to gem-difluoroalkenes using a platinum-based 
catalyst system provides similar reactivity to Co-based catalyst systems. In the presence 
of a basic additive, Pt(0)- and Pt(IV)-based precatalysts both selectively accessed the b-
phenoxy-b,b-difluorobenzyl alcohol product (Table 5-1, entries 1– 2). Interested in 
exploring the benefits of a Pt-based catalyst system relative to a Co-based catalyst 
system, we optimized the reaction of a gem-difluoroalkene and a phenol to provide a b-
phenoxy-b,b-difluorobenzyl alcohol using a Pt-based catalyst system. 
Initially, we attempted to simplify the Pt-based catalyst system, similar to the Co-based 
catalyst system in Chapter 4. To that end, we removed the base additive, unfortunately, 
both the yield and selectivity of the desired product decreased (Table 5-1, entries 3–4). 
Removing oxygen completely shut down the reaction (Table 5-1, entry 5). Notably, Pt(0)-
, Pt(II)-, and Pt(IV)-based precatalysts all provided the desired product in moderate to 
good yield and selectivity, although PtO2 was the only successful Pt(IV)-based precatalyst 
(Table 5-1, entries 1–2, 19–20). 
Exploring the basic co-catalyst, cyclic amine bases enabled the desired reactivity, with 
Dimethylaminopyridine (DMAP) providing the best yield and selectivity (Table 5-1, entries 




alcohol product 5.3 in moderate to high yields and high selectivity. Other solvents reduced 
both the yield and selectivity of the desired product (Table 5-1, entries 12–18). Based on 
the similar reactivity of Pt(PPh3)4 and Pt(acac)2 in the presence of DMAP, we settled on 
Pt(acac)2 as the ideal catalyst, as Pt(acac)2 is significantly less expensive per mole. 
However, Pt(acac)2, unlike Pt(PPh3)4, required a phosphine-based ligand to provide 
consistent results. Gratifyingly, use of PPh3 successfully improved the yield and selectivity 




Table 5-1: Initial Optimization of Pt-Catalyzed Addition / Oxidation of Phenol to gem-
Difluoroalkenes 
 
[a] Standard conditions: 5.1 (1.0 equiv., 0.10 mmol), 5.2 (3.0 equiv., 0.30 mmol), 
DMAP (10 mol%, 0.010 mmol), DCB (0.25 M, 0.40 mL), Pt(PPh3)4 (10 mol%, 0.010 
mmol), 100 ˚C, for 18 h under an O2 atmosphere. [b] Determined by 19F NMR analysis of 






































































































































































































(TFT). [c] N2 atmosphere. [d] 10% PPh3. [e] 20% PPh3. [f] 40% PPh3. DCB = 1,2-
Dichlorobenzene. DBU = 1,8-Diazabicyclo[5.4.0]undec-7-ene. DABCO = 1,4-
Diazabicyclo[2.2.2]octane. TBD = 1,5,7-Triazabicyclo[4.4.0]dec-5-ene. 
Unfortunately, with more demanding substrates, such as electron-deficient or 
sterically congested gem-difluoroalkenes, the PPh3-ligated system failed to provide high 
yields. Thus, a variety of ligands were screened, and the use of three distinct ligands 
improved the reaction (Table 5-2). The use of PPh3 [1:1 with Pt(acac)2] provided the best 
selectivity, but lower reactivity than bidentate phosphines (Table 5-2, entry 1). The use of 
DPPE or BINAP [0.5:1 with Pt(acac)2] improved the yield but reduced the selectivity 
(Table 5-2, entry 9 and 13). The use of DPPE balanced reactivity and selectivity better 
than BINAP, which provided the highest yield but the lowest selectivity of the three 
ligands. Thus, we settled on a catalyst system employing 10% Pt(acac)2, ligated with 
either 10% PPh3 or 5% bidentate phosphine, with a 10% DMAP co-catalyst, in DCB at 




































































































































[a] Standard conditions: 5.8a (1.0 equiv., 0.10 mmol), 5.2 (3.0 equiv., 0.30 mmol), 
DMAP (10 mol%, 0.010 mmol), DCB (0.25 M, 0.40 mL), Pt(PPh3)4 (10 mol%, 0.010 
mmol), 130 ˚C, for 18 h under an O2 atmosphere. [b] Determined by 19F NMR analysis of 
the crude reaction mixture, standardized with 10 µL (0.080 mmol) of TFT. 5.9c and 5.10c 
refer to Scheme 5-5. 
Under these conditions, the Pt-based catalyst system performs similarly to the Co-
based catalyst system for electron-rich and electron-neutral difluoroalkenes (Scheme 
5-4, 5.6a–d). However, using the Pt-based systems the desired compounds are easier to 
purify than under the Co catalyzed conditions. Notably, the Pt-based catalyst system 
outperforms the Co-catalyst system for electron-deficient and ortho-substituted 
difluoroalkenes (5.6e, g–i). In these cases, the Pt-catalyst system routinely increased the 
yield of the desired product by 10–20%, without compromising selectivity. However, 




Scheme 5-4: Scope of gem-Difluoroalkenes in Pt-Catalyzed Addition / Oxidation of 
Phenols[a] 
 
[a] Standard conditions: 5.5a–n (1.0 equiv., 0.50 mmol), 5.2 (3.0 equiv., 1.5 mmol), 
DMAP (10 mol%, 0.050 mmol), Ligand (5–10 mol%, 0.025–0.050 mmol), DCB (0.25 M, 
2.0 mL), Pt(acac)2 (10 mol%, 0.050 mmol), temperature as indicated, for 24 h under an 




































































































the crude reaction mixture, standardized with 50 µL (0.40 mmol) of TFT, and is reported 
in parentheses. Yields represent the average of 2 runs. [b] PPh3 (10 mol%, 0.050 mmol). 
[c] DPPE (5 mol%, 0.025 mmol). [d] rac-BINAP (5 mol%, 0.025 mmol).  
Using this system, heteroaryl difluoroalkenes reacted in much the same manner as 
aryl difluoroalkenes (Scheme 5-5). While the bulk of difluoroalkenes provided similar 
yields and selectivity under both the Pt- and Co-catalyst system, two cases demonstrate 
the complementary nature of these two systems. First, the electron rich, piperazine 
substituted thiazole, which required low temperature to avoid degradation using the Co-
based catalyst system, degrades completely under Pt catalysis (5.9d). In the case of the 
bulky, 2-substituted benzothiophene, the Pt-based catalyst system outperforms the Co-
based catalyst system (5.9c). 
Scheme 5-5: Scope of Heteroaryl gem-Difluoroalkenes in Pt-Catalyzed Addition / 




























































[a] Standard conditions: 5.8a–d (1.0 equiv., 0.50 mmol), 5.2 (3.0 equiv., 1.5 mmol), 
DMAP (10 mol%, 0.050 mmol), Ligand (5–10 mol%, 0.050 mmol), DCB (0.25 M, 2.0 mL), 
Pt(acac)2 (10 mol%, 0.050 mmol), temperature as indicated, for 24 h under an O2 
atmosphere. The selectivity of alcohol:ketone was determined by 19F NMR analysis of the 
crude reaction mixture, standardized with 50 µL (0.40 mmol) of TFT, and is reported in 
parentheses. Yields represent the average of 2 runs. [b] PPh3 (10 mol%, 0.050 mmol). [c] 
DPPE (5 mol%, 0.025 mmol).  
Subjecting diverse phenols to the Pt-catalyst system revealed no major difference 
between the Pt- and the Co-based catalyst systems (Scheme 5-6). Electron-rich, -neutral, 
and -deficient phenols all reacted well using the Pt-based catalyst system, providing the 
desired product in moderate to high yields and selectivities. Notably, ortho substituted 
phenols did not react favorably using the Pt-based catalyst systems compared to the Co-
based catalyst systems. However, a hydroxypyridine substrate (5.12g), which did not 



















































































































[a] Standard conditions: 5.1 (1.0 equiv., 0.50 mmol), 5.11a-f (3.0 equiv., 1.5 mmol), 
DMAP (10 mol%, 0.050 mmol), Ligand (5–10 mol%, 0.050 mmol), DCB (0.25 M, 2.0 mL), 
Pt(acac)2 (10 mol%, 0.050 mmol), temperature as indicated, for 24 h under an O2 
atmosphere. The selectivity of alcohol:ketone was determined by 19F NMR analysis of the 
crude reaction mixture, standardized with 50 µL (0.40 mmol) of TFT, and is reported in 
parentheses. Yields represent the average of 2 runs. [b] PPh3 (10 mol%, 0.050 mmol). [c] 
DPPE (5 mol%, 0.025 mmol). [d] 5.1 (1.0 equiv., 0.10 mmol), 5.11g (3.0 equiv., 0.30 
mmol), DMAP (20 mol%, 0.020 mmol), Pt(acac)2 (20 mol%, 0.020 mmol), PPh3 (20 mol%, 
0.020 mmol) 
Further, the Pt-based catalyst system, unlike the Co-based catalyst system, activates 
aliphatic alcohols and difluoroalkenes. Currently, these reactions do not selectively 
generate the desired product over the non-oxidized addition product and the trifluoroethyl 





Scheme 5-7: Representative Reactions of Aliphatic Difluoroalkenes or Alcohols Using a 
Pt-Catalyst System[a] 
 
[a] Standard conditions: 5.1  or 5.14a–c (1.0 equiv., 0.10 mmol), 5.2 or 5.18a–d (3.0 
equiv., 0.30 mmol), DMAP (20 mol%, 0.020 mmol), PPh3 (20 mol%, 0.020 mmol), DCB 
(0.25 M, 0.40 mL), Pt(acac)2 (20 mol%, 0.020 mmol), 120 ˚C, for 24 h under an O2 
atmosphere. The yield and selectivity of 5.15:5.16:5.17 or 5.19:5.20:5.21 was determined 
by 19F NMR analysis of the crude reaction mixture, standardized with 10 µL (0.080 mmol) 










































































































5.3. Mechanistic Considerations 
The Co-based catalyst system provides the desired b-phenoxy-b,b-difluorobenzyl 
alcohol product via a one-electron process. While comprehensive mechanistic studies 
have not been undertaken, the Pt-based catalyst system might employ a two-electron 
process to affect the oxidative addition of phenol to difluoroalkenes. Pt(0)-, Pt(II)-, and 
Pt(IV)-precatalysts all provided highly selective access to the desired product, which 
implies that two-electron oxidative addition at Pt occurs. Further, the reaction requires a 
base co-catalysis to promote addition of phenol, indicating the involvement of a phenoxide 
intermediate. Finally, there are few examples of Pt(III) in catalytic reactions.  
5.4. Copper Catalysis to Access b-Phenoxy-b,b-Difluorobenzyl Ketones 
While a co-catalytic system of Pt and base enabled the production of b-phenoxy-b,b-
difluorobenzyl alcohols, a co-catalytic system of Pt and acid provided the b-phenoxy-b,b-
difluorobenzyl ketone products in high selectivity and low yield. Screening of various acids 
revealed para-toluene sulfonic acid (PTSA) as optimal, with other sulfonic acids not 
improving the reaction, reducing the selectivity for the ketone-derived product (Table 5-3). 
From a screen of ligands, pyridyl ligands demonstrated improved selectivity, with multi-
dentate pyridyl ligands such as terpyridine and phenanthroline proving superior (Table 




Table 5-3: Optimization of Pt-Catalyzed Addition / Oxidation of Phenols to gem-
Difluoroalkenes to Provide b-Phenoxy-b,b-Difluorobenzyl Ketones[a] 
 
[a] Standard conditions: 5.1 (1.0 equiv., 0.10 mmol), 5.2 (3.0 equiv., 0.30 mmol), Acid 
(1 equiv., 0.10 mmol), DCB (0.25 M, 0.40 mL), Pt(PPh3)4 (10 mol%, 0.010 mmol), 100 ˚C, 
for 18 h under an O2 atmosphere. [b] Determined by 19F NMR analysis of the crude 
reaction mixture, standardized with 10 µL (0.080 mmol) of TFT. [c] 50% Acid. [d] 25% 
Acid. [e] 10% Acid. [f] 120 ̊ C. TFA = Trifluoroacetic Acid. MsOH = Methane Sulfonic Acid. 

















































































































Further optimization failed to increase the yield of the desired ketone in a more 
challenging substrate (5.10c) beyond 50%. Thinking that more oxidizing conditions might 
increase reactivity, we attempted Wacker-type conditions (Table 5-4, entries 4–7),11 
which increased yield. Further studies revealed that these conditions did not require Pt, 
instead operating exclusively through the Cu-based catalyst (Table 5-4, entry 11). Thus, 
further optimization was conducted using Cu.  
Table 5-4: Initial Discovery of Cu-Catalyzed Addition / Oxidation of Phenols to gem-












































































































[a] Standard conditions: 5.8c (1.0 equiv., 0.10 mmol), 5.2 (3.0 equiv., 0.30 mmol), Acid 
(50 mol%, 0.050 mmol), Ligand (5.0 mol%, 0.0050 mmol), DCB (0.25 M, 0.40 mL), 
Pt(PPh3)4 (10 mol%, 0.010 mmol), 140 ˚C, for 18 h under an O2 atmosphere. [b] 
Determined by 19F NMR analysis of the crude reaction mixture, standardized with 10 µL 
(0.080 mmol) of TFT. [c] 0% Acid. [d] 0% Pt, 20% Terpyridine. 5.9c and 5.10c refer to 
Scheme 5-5. 
Under these conditions, terpyridine remained the optimal ligand; however, acidic co-
catalysts were no longer useful (Table 5-4, entries 8–11). Instead, the solvent controlled 
the reactivity of the system (Table 5-5). The use of aromatic solvents provided high yields 
with moderate selectivity, generally 1:3 for 5.9c:5.10c (Table 5-5, entry 10). The use of 
dimethylsulfoxide (DMSO) improved the selectivity, providing undetectable amounts of 
the undesired alcohol side product 5.9c, but unfortunately the yield of 5.10c was low 
(Table 5-5, entry 12). The combination of DMSO and DCB prevented formation of the 
undesired side product 5.9c without reducing the yield of 5.10c (Table 5-5, entries 15–
17). We settled on an optimal catalyst system of 20% CuCl2 ligated with 20% terpyridine 




Table 5-5: Optimization of Cu-Catalyzed Addition / Oxidation of Phenols to gem-
Difluoroalkenes to Provide b-Phenoxy-b,b-Difluorobenzyl Ketones[a] 
 
[a] Standard conditions: 5.8c (1.0 equiv., 0.10 mmol), 5.2 (3.0 equiv., 0.30 mmol), 
Ligand (20 mol%, 0.020 mmol), DCB (0.25 M, 0.40 mL), Cu (20 mol%, 0.020 mmol), 120 
˚C, for 18 h under an O2 atmosphere. [b] Determined by 19F NMR analysis of the crude 




























































































































































A variety of substrates were screened using the optimized conditions. Electron-rich 
difluoroalkenes provided high selectivity but low conversion. Alternately, electron-
deficient difluoroalkenes gave moderate to low selectivity and conversion. A 2,6-
dimethylsubstituted difluoroalkene showed low reactivity; however, some formation of 
product was observed (5.7f). Heteroaryl difluoroalkenes provided moderate to good 
selectivity, but moderate conversion (5.10a, c). Phenols provided low conversion, but 
what converted generally provided yield in good selectivity. However, a 4-OMe 




Scheme 5-8: Initial Scope of Cu-Catalyzed Addition / Oxidation of Phenols to gem-
Difluoroalkenes[a] 
 
[a] Standard conditions: 5.1, 5.5, or 5.8 (1.0 equiv., 0.10 mmol), 5.2  or 5.11 (3.0 equiv., 
0.30 mmol), Terpyridine (20 mol%, 0.020 mmol), CuCl2 (20 mol%, 0.020 mmol), DCB 
(0.38 mL), DMSO (0.020 mL), 100 ˚C, for 24 h under an O2 atmosphere. Yield of 5.7, 






























































































the crude reaction mixture, standardized with 10 µL (0.080 mmol) of TFT. [c] 100 ˚C. [d] 
5.1 in place of 5.8c. 
Overall, the current reaction provides a basis from which to finalize the Cu-based 
catalyst system for the selective synthesis of b-phenoxy-b,b-difluorobenzyl ketones from 
gem-difluoroalkenes and phenols. Currently, the catalyst system does not fully convert 
gem-difluoroalkenes to b-phenoxy-b,b-difluorobenzyl ketones, presenting several 
potential pathways forwards. First, the temperature can increase from 100 ˚C, as the 
current solvent system of DCB:DMSO (95:5) contains two high boiling solvents. However, 
some substrates (5.7f, 5.13a, 5.7h) give low yield with moderately high conversions, 
indicating that simply increasing temperature will not solve the issue. Thus, a second 
strategy is the addition of an external oxidant, such as tert-butyl hydroperoxide, commonly 
employed in Cu-based oxidation reactions. Finally, alternate solvent systems, or alternate 
metal catalysts, might enable improved oxidation conditions. However, initial attempts at 
Fe-based catalyst systems did not improve the yield or selectivity of b-phenoxy-b,b-
difluorobenzyl ketones. 
5.5. Conclusions 
In conclusion, a Pt-based catalyst system provides similar reactivity to the Co-based 
catalyst system detailed in Chapter 4, where in the presence of a basic co-catalyst a 
phenolic nucleophile and O2 are added to gem-difluoroalkenes to provide b-phenoxy-b,b-
difluorobenzyl alcohols. This catalyst system outperforms the Co-based catalyst system 




otherwise performs similarly. Furthermore, the Pt-based catalyst system activates both 
aliphatic gem-difluoroalkenes and alcohols, although further optimization is required. 
Additionally, a Pt-based catalyst system provided tunable reactivity to generate b-
phenoxy-b,b-difluorobenzyl ketone products. This reactivity required the exchange of the 
base co-catalyst for an acid co-catalyst, although the yield could not increase beyond 
50%. However, changing to a Cu-based catalyst system improved reactivity, and the 
current optimized conditions provide b-phenoxy-b,b-difluorobenzyl ketone products from 
a variety of gem-difluoroalkenes and phenols. This reaction requires the final 
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Unless otherwise noted, reactions were performed under an atmosphere of air using 
oven-dried glassware. Selective dioxygenation reactions of phenols and difluorostyrenes 
were performed in 20 mL borosilicate glass scintillation vials sealed with a PTFE-lined 
screw-top cap. All other reactions were performed in round-bottom flasks sealed with 
rubber septa. Stainless-steel syringes were used to transfer air- and moisture-sensitive 
liquid reagents. Reactions were monitored by either 19F NMR with an internal standard of 
a,a,a-trifluorotoluene or by thin-layer chromatography (TLC) on UNIPLATE Silica Gel 
HLF plates, visualized by quenching of fluorescence. Column chromatography was 
conducted using a Teledyne Isco CombiFlash Rf 200 system utilizing gradient elution. 
Isolated yields reported in the manuscript represent an average of at least 2 independent 
runs of final compound deemed to be at least 95% pure by NMR. Yields reported in the 
supporting information refer to a single experiment. 
 
Unless otherwise noted, reagents were purchased from commercial sources and used 
as received. Cobalt(II) 2,4-pentanedionate [Co(acac)2] was purchased from Alfa Aesar. 
1,2–Dichlorobenzene (DCB, anhydrous, 99+%) and N-methylpyrrolidine (NMP, 
anhydrous) were purchased from Sigma Aldrich. Solvents, including dimethylformamide 
(DMF), toluene (PhMe), dichloromethane (DCM), methanol (MeOH), acetonitrile (MeCN), 





solvent was dried by passage through two columns of activated alumina under argon. 
Other chemical abbreviations utilized in this document include: a,a,a-trifluorotoluene 
(TFT), sodium sulfate (Na2SO4), magnesium sulfate (MgSO4), ethyl acetate (EtOAc), 
diethyl ether (Et2O), ammonium chloride (NH4Cl), nbutyl lithium (nBuLi), sodium hydroxide 
(NaOH), room temperature (R.T.), tbutyl carbonate anhydride (Boc2O), potassium 
carbonate (K2CO3), 1,5,7–triazabicyclo[4.4.0]dec-5-ene (TBD), and hydrochloric acid 
(HCl). 
 
Proton nuclear magnetic resonance (1H NMR) and fluorine nuclear magnetic 
resonance (19F NMR) were taken on a Bruker AVIIIHD 400 AVANCE spectrometer (400 
and 376 MHz respectively). Proton and carbon nuclear magnetic resonance (13C NMR) 
were taken on a Bruker AVIII 500 Avance spectrometer with a CPDUL cryoprobe (500 
and 126 MHz respectively). Chemical shifts (d) for protons are reported in parts per million 
(ppm) downfield from tetramethylsilane, and are referenced to the proton resonance of 
residual solvent in the NMR solvent (CHCl3: d = 7.26 ppm; DMSO: d = 2.50 ppm). 
Chemical shifts (d) for carbon are reported in ppm downfield from tetramethylsilane, and 
are referenced to the carbon resonance of the solvent residual peak (CDCl3: d = 77.2 
ppm; DMSO: d = 39.52 ppm). Chemical shifts for fluorine are reported uncorrected in ppm 
upfield from trichlorofluoromethane (0 ppm). NMR data are represented as follows: 





m = multiplet), coupling constant in Hertz (Hz), integration. Electron paramagnetic 
resonance (EPR) were taken on a Bruker EMXplus EPR spectrometer with an Oxford 
cryostat. High-resolution mass determinations were obtained either by electrospray 
ionization (ESI) on a Waters LCT PremierTM mass spectrometer or by atmospheric-
pressure chemical ionization (APCI-hexane/PhMe) on a Waters Q-Tof PremierTM, for 
which sample plus near mass internal exact mass standard were dissolved in hexane, 
and hexane or PhMe/hexane were used as ionization solvent. Infrared spectra were 
measured on a Perkin Elmer Spectrum Two Fourier Transform Infrared Spectrometer by 
drying samples on a diamond ATR Sample base plate. Uncorrected melting points were 
measured on a Thomas Hoover Capillary Melting Point apparatus. 
Preparation and Characterization of Gem-Difluoroalkenes 
 
5-(2,2-difluorovinyl)-1,2,3-trimethoxybenzene (5.1): Compound 5.1 corresponds to 
compound 2.1 in Chapter 2, and was synthesized according to the procedure in the 












1-(2,2-difluorovinyl)-4-methoxybenzene (5.5a): Compound 5.5a corresponds to 
compound 2.5a in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
1-(benzyloxy)-4-(2,2-difluorovinyl)-2-methoxybenzene (5.5b): Compound 5.5b 
corresponds to compound 2.5h in Chapter 2, and was synthesized according to the 

















1-(tert-butyl)-4-(2,2-difluorovinyl)benzene (5.5c): Compound 5.5c corresponds to 
compound 3.8f in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
1-(2,2-difluorovinyl)-3,5-dimethylbenzene (5.5d): Compound 5.5d corresponds to 
compound 3.8g in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
1-(2,2-difluorovinyl)-2,4-dimethylbenzene (5.5e): Compound 5.5e corresponds to 
compound 3.8h in Chapter 3, and was synthesized according to the procedure in the 














2-(2,2-difluorovinyl)-1,3-dimethylbenzene (5.5f): Compound 5.5f corresponds to 
compound 3.8i in Chapter 3, and was synthesized according to the procedure in the 
Chapter 3 Appendix. 
 
 
4'-(tert-butyl)-2-(2,2-difluorovinyl)-1,1'-biphenyl (5.5g): Compound 5.5g corresponds 
to compound 2.5g in Chapter 2, and was synthesized according to the procedure in the 














ethyl (E)-3-(3-(2,2-difluorovinyl)phenyl)acrylate (5.5h): Compound 5.5h corresponds 
to compound 2.5j in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(2,2-difluorovinyl)-N,N-diisopropylbenzamide (5.5i): Compound 5.5i corresponds to 
compound 3.8q in Chapter 3, and was synthesized according to the procedure in the 




















4-(2,2-difluorovinyl)-1-phenyl-1H-pyrazole (5.8a): Compound 5.8a corresponds to 
compound 2.7c in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
3-(2,2-difluorovinyl)-1-tosyl-1H-indole (5.8b): Compound 5.8b corresponds to 
compound 2.7a in Chapter 2, and was synthesized according to the procedure in the 
Chapter 2 Appendix. 
 
 
4-(2,2-difluorovinyl)dibenzo[b,d]thiophene (5.8c): Compound 5.8c corresponds to 
compound 2.7d in Chapter 2, and was synthesized according to the procedure in the 














tert-butyl 4-(5-(2,2-difluorovinyl)thiazol-2-yl)piperazine-1-carboxylate (5.8d): 
Compound 5.8d corresponds to compound 2.7f in Chapter 2, and was synthesized 
according to the procedure in the Chapter 2 Appendix. 
 
General Procedure for the Selective Unsymmetric Dioxygenation of 
Difluoroalkenes with Phenols (A-1): 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stirbar, was charged 
with difluoroalkene (0.50 mmol), phenol (1.50 mmol), DMAP (0.05 mmol), PPh3 (0.05 
mmol), and Pt(acac)2 (0.05 mmol). The system was purged with O2 gas for 1 min before 
anhydrous DCB (2.0 mL) was added to the system under a stream of O2 gas. The system 
was sealed with a PTFE-lined screw-top cap and stirred for 1 min at R.T. Subsequently, 
the vial was placed into a pre-heated reaction block and stirred vigorously at 90–140 °C 
for 24 h. The vial was cooled to R.T., and 50 µL (0.40 mmol) of TFT was added via 










at R.T. for 10 min to allow adequate mixing. After mixing, an aliquot was removed from 
the vial and passed through a pad of silica gel into an NMR tube using acetone as eluent 
to remove Pt(acac)2, after which the reaction was analyzed by 19F NMR for completion 
and selectivity. After 19F NMR analysis, the aliquot was sampled for TLC analysis 
(visualized with 10% phosphomolybdic acid in EtOH) then returned to the vial. Aqueous 
base (sat. NaOH or Na2CO3) was added to the solution and stirred for 30 min, and then 
extracted with DCM (four times). The combined organic layers were washed with brine, 
dried over Na2SO4, concentrated in vacuo, and then purified by flash chromatography 
using EtOAc and hexanes. 
 
General Procedure for the Selective Unsymmetric Dioxygenation of 
Difluoroalkenes with Phenols (A-2): 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stirbar, was charged 
with difluoroalkene (0.50 mmol), phenol (1.50 mmol), DMAP (0.05 mmol), DPPE (0.025 
mmol), and Pt(acac)2 (0.05 mmol). The system was purged with O2 gas for 1 min before 
anhydrous DCB (2.0 mL) was added to the system under a stream of O2 gas. The system 
was sealed with a PTFE-lined screw-top cap and stirred for 1 min at R.T. Subsequently, 
the vial was placed into a pre-heated reaction block and stirred vigorously at 90–140 °C 
for 24 h. The vial was cooled to R.T., and 50 µL (0.40 mmol) of TFT was added via 





at R.T. for 10 min to allow adequate mixing. After mixing, an aliquot was removed from 
the vial and passed through a pad of silica gel into an NMR tube using acetone as eluent 
to remove Pt(acac)2, after which the reaction was analyzed by 19F NMR for completion 
and selectivity. After 19F NMR analysis, the aliquot was sampled for TLC analysis 
(visualized with 10% phosphomolybdic acid in EtOH) then returned to the vial. Aqueous 
base (sat. NaOH or Na2CO3) was added to the solution and stirred for 30 min, and then 
extracted with DCM (four times). The combined organic layers were washed with brine, 
dried over Na2SO4, concentrated in vacuo, and then purified by flash chromatography 
using EtOAc and hexanes. 
 
General Procedure for the Selective Unsymmetric Dioxygenation of 
Difluoroalkenes with Phenols (A-3): 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stirbar, was charged 
with difluoroalkene (0.50 mmol), phenol (1.50 mmol), DMAP (0.05 mmol), rac-BINAP 
(0.025 mmol), and Pt(acac)2 (0.05 mmol). The system was purged with O2 gas for 1 min 
before anhydrous DCB (2.0 mL) was added to the system under a stream of O2 gas. The 
system was sealed with a PTFE-lined screw-top cap and stirred for 1 min at R.T. 
Subsequently, the vial was placed into a pre-heated reaction block and stirred vigorously 
at 90–140 °C for 24 h. The vial was cooled to R.T., and 50 µL (0.40 mmol) of TFT was 





then stirred at R.T. for 10 min to allow adequate mixing. After mixing, an aliquot was 
removed from the vial and passed through a pad of silica gel into an NMR tube using 
acetone as eluent to remove Pt(acac)2, after which the reaction was analyzed by 19F NMR 
for completion and selectivity. After 19F NMR analysis, the aliquot was sampled for TLC 
analysis (visualized with 10% phosphomolybdic acid in EtOH) then returned to the vial. 
Aqueous base (sat. NaOH or Na2CO3) was added to the solution and stirred for 30 min, 
and then extracted with DCM (four times). The combined organic layers were washed 
with brine, dried over Na2SO4, concentrated in vacuo, and then purified by flash 
chromatography using EtOAc and hexanes. 
 
Preparation and Characterization of Compounds in Table 5-1: 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (5.3): 
Following General Procedure A-1, 0.115 g (0.500 mmol) of compound 5.1 was reacted 













DMAP, 0.014 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 100 °C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.148 g (71% 
yield) of desired product 5.3 as a yellow solid (MP = 93–95 °C). 
1H NMR (400 MHz, CDCl3): d 7.45–7.41 (m, 2 H), 7.03–6.99 (m, 2 H), 6.74 (s, 2 H), 5.00 
(td, J = 7.24, 3.49 Hz, 1 H), 3.86 (s, 6H), 3.85 (s, 3 H), 3.14 (d, J = 3.74 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 149.1 (t, J = 2.05 Hz), 138.4 (d, J = 2.06 Hz), 132.6, 
131.0, 123.6, 122.4 (t, J = 273.70 Hz), 119.0, 105.0, 74.2 (t, J = 31.70 Hz), 61.0, 56.3 
19F NMR (376 MHz, CDCl3): d  –81.65 (dd, J = 141.05, 6.98 Hz, 1 F), –82.16 (dd, J = 
140.99, 7.23 Hz, 1 F) 
IR (film): 3450, 2939, 1595, 1508, 1485, 1464, 1422, 1326, 1253, 1129, 1068, 1011, 829, 
750, 710 cm-1 






Experimental Procedures for Table 5-1: 
 
Following General Procedure A-1, 0.023 g (0.10 mmol) of 5.1 was reacted with 0.052 
g (0.30 mmol) of 4-bromophenol in the presence of 0.010 mmol of base and 0.010 mmol 
of a Pt salt in 0.40 mL of DCB at 100 ˚C for 18 h. The reactions were cooled to R.T., and 







































































































































































































and allowed to stir for 5 min. An aliquot was removed and passed through a silica gel plug 





































































































































Following General Procedure A-1, 0.025 g (0.10 mmol) of 5.8c was reacted with 0.052 
g (0.30 mmol) of 4-bromophenol in the presence of 0.001 g (0.010 mmol) of DMAP, 
0.0050 or 0.010 mmol of ligand, and 0.004 g (0.010 mmol) of Pt(acac)2 in 0.40 mL of DCB 
at 130 ˚C for 18 h. The reactions were cooled to R.T., and 10 µL (0.080 mmol) of TFT 
were added. The reactions were diluted with 2.0 mL of DCM, and allowed to stir for 5 min. 
An aliquot was removed and passed through a silica gel plug to remove the Pt, and then 
analyzed by 19F NMR for completion, yield, and selectivity. 
 
Experimental Procedures and Characterization of Compounds in Scheme 5-
4: 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(4-methoxyphenyl)ethan-1-ol (5.6a): Following 
General Procedure A-1, 0.085 g (0.50 mmol) of compound 5.5a was reacted with 0.260 
g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 mmol) of DMAP, 0.013 











workup with 1 N NaOH (aq.), the product was purified by flash chromatography using a 
gradient of 10–35% EtOAc in hexanes, furnishing 0.110 g (61% yield) of desired product 
5.6a as a pale yellow solid (MP = 51–53 °C). 
1H NMR (400 MHz, CDCl3): d 7.47 (d, J = 8.64 Hz, 2 H), 7.44–7.41 (m, 2 H), 7.01 (d, J = 
8.91 Hz, 2 H), 6.96–6.92 (m, 2H), 5.04 (td, J = 7.18, 4.29 Hz, 1 H), 3.83 (s, 3 H), 2.57 (d, 
J = 4.27 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 160.3, 149.2 (t, J = 2.40 Hz), 132.6, 129.1, 127.4, 123.6, 
122.6 (t, J = 272.76 Hz), 119.0, 113.9, 74.1 (t, J = 31.82 Hz), 55.4 
19F NMR (376 MHz, CDCl3): d –82.39 (d, J = 7.21 Hz, 2 F) 
IR (film): 3424, 2957, 2911, 2838, 1891, 1613, 1586, 1515, 1485, 1465, 1442, 1399, 
1346, 1305, 1246, 1197, 1177, 1144, 1117, 1065, 1032, 1012, 939, 827, 800, 756, 745, 
716, 691, 636, 593, 535, 493 cm-1 








(5.6b): Following General Procedure A-1, 0.131 g (0.500 mmol) of compound 5.5b was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 
mmol) of DMAP, 0.014 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 
100 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.156 g (70% 
yield) of desired product 5.6b as a light orange solid (MP = 87–88 °C) 
1H NMR (400 MHz, CDCl3): d 7.44 (td, J = 7.21, 6.81, 1.94 Hz, 4 H), 7.41–7.34 (m, 2 H), 
7.34–7.28 (m, 1 H), 7.11 (d, J = 1.93 Hz, 1 H), 7.06–6.96 (m, 3 H), 6.89 (d, J = 8.29 Hz, 
1 H), 5.17 (s, 2 H), 5.00 (t, J = 7.12 Hz, 1 H), 3.90 (s, 3H), 2.83 (bs, 1 H) 
13C NMR (126 MHz, CDCl3): d 149.6, 149.1 (d, J = 2.75 Hz), 148.8, 137.0, 132.5, 128.7, 
128.3, 128.0, 127.4, 123.6, 122.5 (t, J = 272.85 Hz), 120.6, 119.0, 113.4 (d, J = 1.62 Hz), 












19F NMR (376 MHz, CDCl3): d –81.89 (dd, J = 141.33, 7.27 Hz, 1 F), –82.28 (dd, J = 
141.33, 7.27 Hz, 1 F) 
IR (film): 3458, 3033, 2917, 2849, 1735, 1607, 1594, 1514, 1484, 1464, 1454, 1421, 
1382, 1337, 1252, 1202, 1138, 1065, 1033, 1012, 914, 844, 827, 800, 738, 696, 648, 551, 
494 cm-1 
HRMS (ESI+): calc. for C22H19BrF2O4K (M+K) 503.0072, found 503.0078, 1.2 ppm. 
 
 
2-(4-bromophenoxy)-1-(4-(tert-butyl)phenyl)-2,2-difluoroethan-1-ol (5.6c): Following 
General Procedure A-1, 0.098 g (0.50 mmol) of compound 5.5c was reacted with 0.0259 
g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 mmol) of DMAP, 0.013 
g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) or Pt(acac)2 at 100 ˚C for 24 h. After 
workup with 1 N NaOH (aq.), the product was purified by flash chromatography using a 











1H NMR (500 MHz, CDCl3) d 7.47 (d, J = 8.62 Hz, 2 H), 7.44–7.43 (m, 4 H), 7.02 (d, J = 
8.83 Hz, 2 H), 5.06 (td, J = 7.18, 4.50 Hz, 1 H), 2.56 (d, J = 4.50 Hz, 1 H), 1.34 (s, 9 H) 
13C NMR (126 MHz, CDCl3): d 152.3, 149.2, 132.6, 132.3, 127.5, 125.5, 123.6, 122.6 (t, 
J = 272.79 Hz), 119.0, 74.4 (t, J = 31.60 Hz), 34.8, 31.4 
19F NMR (376 MHz, CDCl3): d –82.82 (dd, J = 140.87, 7.24 Hz, 1 F), –83.22 (dd, J = 
140.93, 7.21 Hz, 1 F) 
HRMS (ESI–): calc. for C18H19BrF2O2Cl (M+Cl) 419.0225, found 419.0240, 3.6 ppm. 
 
 
2-(4-bromophenoxy)-1-(3,5-dimethylphenyl)-2,2-difluoroethan-1-ol (5.6d): Following 
General Procedure A-1, 0.084 g (0.50 mmol) of compound 5.5d was reacted with 0.260 
g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 mmol) of DMAP, 0.013 












workup with 1 N NaOH (aq.), the product was purified by flash chromatography using a 
gradient of 0–15% EtOAc in hexanes, furnishing 0.103 g (58% yield) of desired product 
5.6d as a tan solid (MP = 79–81 °C) 
1H NMR (400 MHz, CDCl3): d 7.44 (d, J = 8.88 Hz, 2 H), 7.16 (bs, 2 H), 7.04 (bs, 2 H), 
7.02 (bs, 1 H), 5.00 (t, J = 7.25 Hz, 1 H), 2.74 (bs, 1 H), 2.36 (s, 6 H) 
13C NMR (126 MHz, CDCl3): d 149.2, 138.1, 135.2, 132.5, 130.9, 125.6 (d, J = 1.49 Hz), 
123.6, 122.5 (t, J = 272.07 Hz), 118.9, 74.6 (t, J = 31.54 Hz), 21.5 
19F NMR (376 MHz, CDCl3): d –81.59 (dd, J = 140.92, 7.09 Hz, 1 F), –82.16 (dd, J = 
140.89, 7.38 Hz, 1 F) 
IR (film): 3395, 3011, 2919, 2051, 1891, 1760, 1609, 1583, 1484, 1399, 1379, 1345, 
1251, 1199, 1143, 1114, 1066, 1012, 953, 938, 905, 886, 828, 803, 786, 762, 744, 716, 
699, 686, 645, 561, 536, 493 cm-1 







2-(4-bromophenoxy)-1-(2,4-dimethylphenyl)-2,2-difluoroethan-1-ol (5.6e): Following 
General Procedure A-1, 0.084 g (0.50 mmol) of compound 5.5e was reacted with 0.260 
g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 mmol) of DMAP, 0.013 
g (0.050 mmol) PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 120 ˚C for 24 h. After 
workup with 1 N NaOH (aq.), the product was purified by flash chromatography using a 
gradient of 0–20% EtOAc in hexanes, furnishing 0.114 g (64% yield) of desired product 
5.6e as a pale oil 
1H NMR (400 MHz, CDCl3): d 7.58 (d, J = 7.96 Hz, 1 H), 7.43 (d, J = 8.90 Hz, 2 H), 7.11 
(d, J = 8.24 Hz, 1 H), 7.04 (d, J = 2.23 Hz, 2 H), 7.02 (s, 1 H), 5.35 (td, J = 7.18, 3.79 Hz, 
1 H), 2.85 (d, J = 4.35 Hz, 1 H), 2.40 (s, 3 H), 2.35 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 149.1 (t, J = 2.25 Hz), 138.7, 136.7, 132.5, 131.3, 130.9, 
127.3 (t, J = 1.73 Hz), 127.1, 123.5, 123.0 (t, J = 273.10 Hz), 118.8, 70.3 (t, J = 31.67 











19F NMR (376 MHz, CDCl3): d  –81.41 (dd, J = 140.67, 7.53 Hz, 1 F), –81.85 (dd, J = 
140.45, 7.12 Hz, 1 F) 
IR (film): 3381, 2923, 1616, 1583, 1484, 1249, 1196, 1142, 1065, 1012, 826, 809, 760, 
748, 720, 691, 494 cm–1 




(5.6g): Following General Procedure A-2, 0.136 g (0.500 mmol) of compound 5.5g was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.026 g (0.100 
mmol) of 0.006 g (0.050 mmol) of DMAP, 0.010 g (0.025 mmol) DPPE, and 0.020 g (0.050 
mmol) of Pt(acac)2 at 130 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was 
purified by flash chromatography using a gradient of 5–25% EtOAc in hexanes, furnishing 











1H NMR (400 MHz, CDCl3): d 7.81 (t, J = 1.66 Hz, 1 H), 7.66 (dt, J = 7.39, 1.71 Hz, 1 H), 
7.60 (d, J = 8.45 Hz, 2 H), 7.52 (d, J = 2.18 Hz, 2 H), 7.52–7.49 (m, 2 H), 7.45 (d, J = 8.86 
Hz, 2 H), 7.04 (d, J = 8.77 Hz, 2 H), 5.16 (t, J = 7.11 Hz, 1 H), 3.00 (bs, 1 H), 1.40 (s, 9 
H) 
13C NMR (126 MHz, CDCl3): d 150.7, 149.1, 141.3, 137.9, 135.8, 132.5, 128.8, 127.8, 
126.9, 126.5, 126.4, 125.9, 123.6, 122.5 (t, J = 272.36 Hz), 119.0, 74.5 (t, J = 31.35 Hz), 
34.7, 31.5 
19F NMR (376 MHz, CDCl3): d –81.63 (dd, J = 140.63, 7.08 Hz, 1 F), –82.03 (dd, J = 
140.63, 7.16 Hz, 1 H) 
IR (film): 3401, 3065, 2962, 2904, 2867, 1580, 1483, 1399, 1363, 1252, 1209, 1140, 
1115, 1067, 1012, 954, 906, 881, 839, 825, 766, 739, 705, 675, 645, 632, 585, 545, 522, 
492 cm-1 








(5.6h): Following General Procedure A-3, 0.119 g (0.500 mmol) of compound 5.5h was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 
mmol) of DMAP, 0.016 g (0.025 mmol) of rac-BINAP, and 0.020 g (0.050 mmol) of 
Pt(acac)2 at 140 °C for 24 h. After workup with sat. Na2CO3 (aq.), the product was purified 
by flash chromatography using a gradient of 5–35% EtOAc in hexanes, furnishing 0.110 
g (51% yield) of desired product 5.6h as an orange oil 
1H NMR (400 MHz, CDCl3): d 7.68 (d, J = 16.16 Hz, 2 H), 7.56 (d, J = 7.42 Hz, 1 H), 7.52 
(dt, J = 7.88, 1.47 Hz, 1 H), 7.42–7.38 (m, 3 H), 6.98 (m, 2 H), 6.45 (d, J = 16.02 Hz, 1 
H), 5.10 (t J = 7.05 Hz, 1 H), 4.25 (q, J = 7.11 Hz, 2 H), 3.53 (bs, 1 H), 1.32 (t, J = 7.13 
Hz, 3 H) 
13C NMR (126 MHz, CDCl3): d 167.2, 148.9 (t, J = 2.32 Hz), 144.4, 136.3, 134.5, 132.5, 













19F NMR (376 MHz, CDCl3): d –81.74 (dd, J = 140.69, 6.93 Hz, 1 F), –82.25 (dd, J = 
140.78, 7.25 Hz,1 F) 
IR (film): 3418, 2982, 2051, 1891, 1693, 1584, 1484, 1438, 1397, 1368, 1308, 1252, 
1225, 1188, 1148, 1113, 1098, 1066, 1012, 983, 863, 843, 825, 794, 757, 734, 696, 651, 
581, 558, 493, 465 cm-1 




(5.6i): Following General Procedure A-3, 0.134 g (0.500 mmol) of compound 5.5i was 
reacted with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 
mmol) of DMAP, 0.016 g (0.025 mmol) of rac-BINAP, and 0.020 g (0.050 mmol) of 












by flash chromatography using a gradient of 15–50% EtOAc in hexanes, furnishing 0.096 
g (49% yield) of desired product 5.6i as a white solid (MP = 182–183 °C) 
1H NMR (500 MHz, DMSO-D6, 60 °C): d 7.57 (dd, J = 8.45, 3.06 Hz, 4 H), 7.29 (d, J = 
7.74 Hz, 2 H), 7.08 (d, J = 8.34 Hz, 2 H), 6.51 (d, J = 5.64 Hz, 1 H), 5.10 (q, J = 7.08 Hz, 
1 H), 3.66–3.63 (m, 2 H), 1.28 (bs, 12 H) 
13C NMR (126 MHz, DMSO-D6, 60 °C): d 169.3, 148.8 (d, J = 2.31 Hz), 138.7, 137.2, 
132.3, 127.7, 124.7, 123.2, 122.6 (t, J = 272.21 Hz), 117.7, 72.0 (t, J = 31.34 Hz), 54.5, 
20.2 
19F NMR (376 MHz, CDCl3): d –81.80 (dd, J = 140.26, 7.03 Hz, 1 F), –82.22 (dd, J = 
140.26, 6.48 Hz, 1 F) 
IR (film): 3250, 2974, 2935, 1602, 1515, 1483, 1457, 1407, 1381, 1372, 1349, 1275, 
1252, 1209, 1195, 1161, 1141, 1082, 1064, 1038, 1012, 919, 883, 854, 808, 765, 750, 
681, 631, 610, 577, 548, 527, 497 cm–1 










Following General Procedure A-1, 0.103 g (0.500 mmol) of compound 5.9a was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.007 g (0.050 mmol) of 
DMAP, 0.014 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 100 °C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 15–40% EtOAc in hexanes, furnishing 0.083 g (42% 
yield) of desired product 5.9a as a yellow solid (MP = 70–72 ˚C) 
1H NMR (400 MHz, CDCl3): d 8.04 (s, 1 H), 7.82 (s, 1 H), 7.65 (d, J = 7.51 Hz, 2 H), 7.43 
(dd, J = 8.90, 7.22 Hz, 4 H), 7.29 (t, J = 7.45 Hz, 1 H), 7.04 (d, J = 8.57 Hz, 2 H), 5.16 (td, 













13C NMR (126 MHz, CDCl3): d 149.0, 140.1 (d, J = 1.95 Hz), 139.8, 132.6, 129.6, 127.0, 
126.6 (d, J = 1.86 Hz), 123.6, 122.5 (t, J = 271.91 Hz), 119.4, 119.1, 118.9 (d, J = 1.87 
Hz), 67.7 (t, J = 33.26 Hz) 
19F NMR (376 MHz, CDCl3): d –82.60 (dd, J = 140.85, 6.21 Hz, 1 F), –83.07 (dd, J = 
141.08, 6.84 Hz, 1 F) 
IR (film): 3279, 2923, 1680, 1600, 1572, 1504, 1485, 1405, 1257, 1209, 1148, 1114, 
1067, 1043, 1012, 955, 904, 826, 804, 756, 690, 492 cm-1 




Following General Procedure A-1, 0.167 g (0.500 mmol) of compound 5.8b was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.007 g (0.050 mmol) of 












for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 15–40% EtOAc in hexanes, furnishing 0.151 g (58% 
yield) of desired product 5.9b as an orange solid (MP = 53–55 °C). 
1H NMR (400 MHz, CDCl3): d 7.99 (dt, J = 8.49, 0.88 Hz), 1 H), 7.77 (d, J = 8.53 Hz, 3 
H), 7.73 (d, J = 7.75 Hz, 1 H), 7.45–7.41 (m, 2 H), 7.34 (ddd, J = 8.38, 7.16, 1.28 Hz, 1 
H), 7.28–7.24 (m, 1 H), 7.21 (d, J = 7.65 Hz, 2 H), 6.98 (dd, J = 8.76, 1.07 Hz, 2 H), 5.35 
(td, J = 6.73, 4.53 Hz, 1 H), 2.68 (d, J = 4.95 Hz, 1 H), 2.34 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 149.0 (d, J = 1.96 Hz), 145.4, 135.2, 132.6, 130.1, 129.1, 
127.0, 125.8 (d, J = 2.00 Hz), 125.2, 123.6, 123.5, 122.5 (t, J = 272.36 Hz), 120.9 (d, J = 
1.82 Hz), 119.2, 117.0 (d, J = 1.66 Hz), 113.8, 69.1 (t, J = 33.67 Hz), 21.7 
19F NMR (376 MHz, CDCl3): d –81.47 (dd, J = 140.26, 6.78 Hz, 1 F), –82.05 (dd, J = 
140.24, 7.22 Hz, 1 F) 
IR (film): 3509, 3113, 2924, 2052, 1913, 1596, 1566, 1485, 1447, 1340, 1368, 1278, 
1255, 1189, 1172, 1122, 1084, 1066, 1012, 972, 907, 834, 811, 764, 744, 733, 703, 678, 
657, 599, 571, 537, 492 cm-1 








Following General Procedure A-2, 0.123 g (0.500 mmol) of compound 5.8c was reacted 
with 0.260 g (1.50 mmol) of 4-bromophenol in the presence of 0.006 g (0.050 mmol) of 
DMAP, 0.016 g (0.025 mmol) of rac-BINAP, and 0.020 g (0.050 mmol) of Pt(acac)2 at 130 
°C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 5–20% EtOAc in hexanes, furnishing 0.103 g (49% 
yield) of desired product 5.9c as a pale yellow oil. 
1H NMR (400 MHz, CDCl3): d 8.16 (ddd, J = 7.05, 3.87, 1.88 Hz, 2 H), 7.86–7.84 (m, 1 
H), 7.72 (d, J = 7.45 Hz, 1 H), 7.53–7.46 (m, 3 H), 7.40–7.38 (m, 2 H), 7.00 (d, J = 8.59 
Hz, 2 H), 5.45 (td, J = 7.07, 2.82 Hz, 1 H), 3.20 (d, J = 3.92 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 149.0 (d, J = 3.01 Hz), 139.5, 139.2, 136.4, 135.3, 132.5, 













19F NMR (376 MHz, CDCl3): d –81.01 (dd, J = 139.12, 6.75 Hz, 1 F), –81.76 (dd, J = 
139.29, 7.33 Hz, 1 F) 
IR (film): 3412, 3064, 2922, 1888, 1762, 1583, 1550, 1525, 1484, 1444, 1401, 1342, 
1276, 1250, 1196, 1147, 1111, 1099, 1066, 1038, 1021, 1012, 938, 904, 827, 793, 750, 
706, 688, 646, 627, 577, 556, 492 cm-1 
HRMS (ESI–): calc. for C20H13BrF2O2SCl (M+Cl) 468.9476, found 468.9471, 1.1 ppm. 
 




Following General Procedure A-1, 0.115 g (0.50 mmol) of compound 5.1 was reacted 













DMAP, 0.013 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 120 ˚C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 0–35% EtOAc in hexanes, furnishing 0.126 g (68% 
yield) of desired product 5.12a as an orange oil. 
1H NMR (500 MHz, CDCl3): d 7.05 (d, J = 8.88 Hz, 2 H), 6.82 (d, J = 9.13 Hz, 2 H), 6.77 
(s, 2 H), 5.00 (t, J = 7.10 Hz, 1 H), 3.86 (s, 6 H), 3.85 (s, 3 H), 3.76 (s, 3 H), 3.13 (s, 1 H) 
13C NMR (126 MHz, CDCl3): d 157.5, 153.1, 131.2, 123.1, 122.4 (t, J = 270.28 Hz), 120.1, 
115.0, 114.4, 105.0, 74.4 (t, J = 31.76 Hz), 60.9, 56.2, 55.6 
19F NMR (376 MHz, CDCl3): d –81.60 (dd, J = 141.70, 6.94 Hz, 1 F), –82.23 (dd, J = 
141.70, 7.41 Hz, 1 F) 














2,2-difluoro-2-phenoxy-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (5.12b): Following 
General Procedure A-2, 0.115 g (0.500 mmol) of compound 5.1 was reacted with 0.141 
g (1.50 mmol) of phenol in the presence of 0.006 g (0.05 mmol) of DMAP, 0.010 g (0.025 
mmol) of DPPE, and 0.019 g (0.050 mmol) of Pt(acac)2 at 130 °C for 24 h. After workup 
with 1 N NaOH (aq.), the product was purified by flash chromatography using a gradient 
of 15–40% EtOAc in hexanes, furnishing 0.098 g (58% yield) of desired product 5.12b as 
an off-white solid (MP = 100–101 °C). 
1H NMR (400 MHz, CDCl3): d 7.32 (dd, J = 8.53, 7.23 Hz, 2 H), 7.20 (t, J = 7.42 Hz, 1 H), 
7.14 (d, J = 7.18 Hz, 2 H), 6.78 (s, 2 H), 5.03 (ddd, J = 9.10, 6.73, 2.85 Hz, 1 H), 3.87 (s, 
6 H), 3.86 (s, 3 H), 3.07 (d, J = 3.91 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 150.0, 138.4, 131.1, 129.5, 125.8, 122.5 (t, J = 
271.92 Hz), 121.7, 105.0, 74.5 (t, J = 31.90 Hz), 61.0, 58.2 
19F NMR (376 MHz, CDCl3): d –81.49 (dd, J = 141.10, 6.77 Hz, 1 F), –81.97 (dd, J = 
141.10, 7.31 Hz, 1 F) 
IR (film): 3442, 2940, 2839, 1771, 1592, 1508, 1491, 1462, 1422, 1325, 1291, 1235, 
1194, 1125, 1078, 1062, 1026, 1003, 921, 898, 839, 787, 754, 732, 702, 690, 660, 558, 
530, 485 cm-1 







2,2-difluoro-2-(o-tolyloxy)-1-(3,4,5-trimethoxyphenyl)ethan-1-ol (5.12c): Following 
General Procedure A-2, 0.115 g (0.500 mmol) of compound 5.1 was reacted with 0.16 
mL (1.50 mmol) of o-cresol in the presence of 0.007 g (0.050 mmol) of DMAP, 0.010 g 
(0.025 mmol) of DPPE, and 0.020 g (0.050 mmol) of Pt(acac)2 at 130 °C for 24 h. After 
workup with 1 N NaOH (aq.), the product was purified by flash chromatography using a 
gradient of 5–25% EtOAc in hexanes, furnishing 0.082 g (46% yield) of desired product 
5.12c as an orange oil. 
1H NMR (400 MHz, CDCl3): d 7.21–7.07 (m, 4 H), 6.80 (s, 2 H), 5.07 (dd, J = 7.79, 5.83 
Hz, 1 H), 3.88 (s, 6 H), 3.86 (s, 3 H), 2.93 (bs, 1 H), 2.05 (s, 3 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 148.4 (d, J = 2.00 Hz), 138.6, 131.30, 131.25, 
131.18, 126.8, 125.9, 122.7 (t, J = 271.11 Hz), 122.0 (d, J = 1.66 Hz), 105.1, 74.7 (t, J = 
31.83 Hz), 61.0, 56.3, 16.3 
19F NMR (376 MHz, CDCl3): d –80.33 (dd, J = 141.28, 5.87 Hz, 1 F), –82.40 (dd, J = 













IR (film): 3445, 2939, 2839, 1594, 1507, 1492, 1461, 1421, 1325, 1251, 1234, 1178, 
1125, 1062, 1003, 922, 844, 819, 787, 745, 712, 694, 660, 559, 527 cm-1 




(5.12d): Following General Procedure A-1, 0.115 g (0.500 mmol) of compound 5.1 was 
reacted with 0.255 g (1.50 mmol) of 4-phenylphenol in the presence of 0.007 g (0.050 
mmol) of DMAP, 0.013 (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 
120 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 5–40% EtOAc in hexanes, furnishing 0.147 g (71% 













1H NMR (400 MHz, CDCl3): d 7.55 (d, J = 8.54 Hz, 4 H), 7.43 (t, J = 7.50 Hz, 2 H), 7.37–
7.33 (m, 1 H), 7.22 (dd, J = 8.65, 0.91 Hz, 2 H), 6.81 (s, 2 H), 5.06 (td, J = 7.09, 3.94 Hz, 
1 H), 3.90 (s, 6 H), 3.88 (s, 3 H), 2.90 (d, J = 4.01 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 149.4, 140.3, 139.1, 138.5, 131.0, 129.0, 128.2, 
127.5, 127.2, 122.6 (t, J = 272.36 Hz), 122.0, 105.1, 74.6 (t, J = 31.88 Hz), 61.0, 56.3 
19F NMR (376 MHz, CDCl3): d –81.48 (dd, J = 141.06, 6.88 Hz, 1 F), –81.99 (dd, J = 
141.05, 7.20 Hz, 1 F) 
IR (film): 3443, 2939, 2838, 2251, 1903, 1594, 1509, 1486, 1462, 1421, 1325, 1289, 
1235, 1184, 1125, 1064, 1008, 909, 842, 807, 758, 730, 698, 651, 551, 531, 500 cm-1 

















Following General Procedure A-1, 0.115 g (0.500 mmol) of compound 5.1 was reacted 
with 0.245 g (1.50 mmol) of 2,4-dichlorophenol in the presence of 0.006 g (0.050 mmol) 
of DMAP, 0.013 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 100 
°C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–40% EtOAc in hexanes, furnishing 0.127 g (62% 
yield) of desired product 5.12e as a yellow oil. 
1H NMR (400 MHz, CDCl3): d 7.42 (d, J = 2.43 Hz, 1 H), 7.28–7.25 (m ,1 H), 7.21 (dd, J 
= 8.81, 2.42 Hz, 1 H), 6.79 (s, 2 H), 5.09 (t, J = 7.27 Hz, 1 H), 3.88 (s, 6 H), 3.86 (s, 3 H), 
2.89 (bs, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.1, 144.7 (d, J = 1.88 Hz), 138.6, 131.6, 130.3, 130.2, 
128.1, 127.8, 123.8 (t, J = 1.84 Hz), 122.6 (t, J = 275.45 Hz), 105.0, 74.4 (t, J = 30.98 
Hz), 60.9, 56.2 
19F NMR (376 MHz, CDCl3): d –81.59 (dd, J = 138.37, 6.85 Hz, 1 F), –82.67 (dd, J = 
138.48, 7.65 Hz, 1 F) 
IR (film): 3444, 3081, 2940, 2839, 2251, 1594, 1508, 1475, 1463, 1422, 1384, 1325, 
1261, 1235, 1185, 1125, 1096, 1075, 1002, 910, 868, 841, 812, 791, 770, 734, 687, 663, 
632, 568, 530 cm-1 








Following General Procedure A-1, 0.115 g (0.500 mmol) of compound 5.1 was reacted in 
the dark with 0.330 g (1.50 mmol) of 3-iodophenol in the presence of 0.007 g (0.050 
mmol) of DMAP, 0.014 g (0.050 mmol) of PPh3, and 0.020 g (0.050 mmol) of Pt(acac)2 at 
100 °C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 10–35% EtOAc in hexanes, furnishing 0.147 g (63% 
yield) of desired product 5.12f as a pale solid (MP = 123–126 °C). 
1H NMR (400 MHz, CDCl3): d 7.56 (dt, J = 7.82, 1.28 Hz, 1 H), 7.51 (t, J = 1.90 Hz, 1 H), 
7.13 (ddd, J = 8.34, 2.23, 1.03 Hz, 1 H), 7.06 (t, J = 8.00 Hz, 1 H), 6.77 (s, 2 H), 5.02 (td, 
J = 7.14, 3.90 Hz, 1 H), 3.89 (s, 6 H), 3.87 (s, 3 H), 2.67 (d, J = 3.26 Hz, 1 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 150.3 (t, J = 2.14 Hz), 135.1, 131.0, 130.9, 130.6, 













19F NMR (376 MHz, CDCl3): d –81.89 (ddd, J = 141.02, 7.26, 7.02 Hz, 2 F) 
IR (film): 3448, 2936, 1580, 1508, 1500, 1466, 1422, 1336, 1326, 1238, 1129, 997, 845, 
758, 706 cm-1 




Following General Procedure A-1, 0.023 g (0.10 mmol) of compound 5.1 was reacted 
with 0.052 g (0.30 mmol) of 4-bromophenol in the presence of 0.003 g (0.020 mmol) of 
DMAP, 0.006 g (0.020 mmol) of PPh3, and 0.007 g (0.020 mmol) of Pt(acac)2 in 0.40 mL 
of DCB at 120 ˚C for 24 h. After workup with 1 N NaOH (aq.), the product was purified by 
flash chromatography using a gradient of 0–45% EtOAc in hexanes, furnishing 0.027 g 













1H NMR (500 MHz, CDCl3): d 7.45 (d, J = 8.92 Hz, 2 H), 7.02 (d, J = 8.90 Hz, 2 H), 6.77 
(s, 2 H), 5.02 (td, J = 7.10, 4.13 Hz, 1 H), 3.88 (s, 6 H), 3.87 (s, 3 H), 2.74 (d, J = 3.97 Hz, 
1 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 149.2, 138.9, 132.7, 130.8, 123.6, 122.5 (J = 273.33 
Hz), 119.1, 105.2, 74.6 (t, J = 31.42 Hz), 61.0, 56.4 
19F NMR (376 MHz, CDCl3): d –82.74 (dd, J = 141.16, 7.10 Hz, 1 F), –83.17 (dd, J = 




(5.12h): Following General Procedure A-2, 0.115 g (0.50 mmol) of compound 5.1 was 
reacted with 0.256 g (1.50 mmol) 2-phenylphenol in the presence of 0.006 g (0.050 mmol) 
of DMAP, 0.010 (0.025 mmol) of DPPE, and 0.019 g (0.050 mmol) of Pt(acac)2 at 130 ˚C 














chromatography using a gradient of 0–15% EtOAc in hexanes, furnishing 0.116 g (56% 
yield) of desired compound 5.12h as a pale yellow solid (MP = 42 °C). 
1H NMR (400 MHz, CDCl3): d 7.42–7.31 (m, 8 H), 7.29 (dd, J = 7.31, 1.53 Hz, 1 H), 6.56 
(s, 2 H), 4.82 (td, J = 7.11, 4.18 Hz, 1 H), 3.85 (s, 3 H), 3.78 (s, 6 H), 2.32 (d, J = 4.17 Hz, 
1 H) 
13C NMR (126 MHz, CDCl3): d 153.0, 147.0, 138.3, 137.8, 135.2, 131.3, 130.8, 129.3, 
129.1, 128.5, 128.3, 128.1, 127.4, 125.9, 125.4, 122.6 (t, J = 273.57 Hz), 121.9, 104.9, 
74.5 (t, J = 31.33 Hz), 60.9, 56.1 
19F NMR (376 MHz, CDCl3): d –80.71 (dd, J = 139.63, 7.17 Hz, 1 F), –81.67 (dd, J = 
139.53, 7.09 Hz, 1 F) 
IR (film): 3454, 3059, 2940, 2838, 1595, 1506, 1479, 1463, 1422, 1325, 1264, 1236, 
1189, 1127, 1070, 1009, 910, 838, 774, 736, 700, 661, 613, 566, 530, 474 cm-1 








Following General Procedure A-2, 0.115 g (0.50 mmol) of compound 5.1 was reacted 
with 0.21 mL (1.50 mmol) 2-iso-propylphenol in the presence of 0.006 g (0.050 mmol) of 
DMAP, 0.010 (0.025 mmol) of DPPE, and 0.019 g (0.050 mmol) of Pt(acac)2 at 130 ˚C 
for 24 h. After workup with 1 N NaOH (aq.), the product was purified by flash 
chromatography using a gradient of 0–15% EtOAc in hexanes, furnishing 0.085 g (44% 
yield) of desired compound 5.12i as a black semisolid. 
1H NMR (400 MHz, CDCl3): d 7.24 (dt, J = 7.74, 2.51 Hz, 2 H), 7.15 (ddd, J = 8.03, 5.34, 
2.08 Hz, 2 H), 6.81 (s, 2 H), 5.09 (dt, J = 8.66, 4.45 Hz, 1 H), 3.87 (s, 6 H), 3.86 (s, 3 H), 
2.82 (p, J = 6.92 Hz, 1 H), 2.74 (d, J = 3.95 Hz, 1 H), 1.03 (dd, J = 6.92, 1.01 Hz, 6 H) 
13C NMR (126 MHz, CDCl3): d 153.3, 147.1 (d, J = 2.01 Hz), 141.5, 138.6, 131.2 (d, J = 
1.87 Hz), 126.7, 126.6, 126.2, 122.7 (dd, J = 271.38, 2.53 Hz), 121.8, 105.1, 74.9 (dd, J 














19F NMR (376 MHz, CDCl3): d –79.34 (dd, J = 140.88, 4.75 Hz, 1 F), –83.16 (dd, J = 
140.73, 8.56 Hz, 1 F) 
IR (film): 3452, 2964, 2840, 1595, 1508, 1488, 1461, 1422, 1385, 1363, 1325, 1275, 
1250, 1234, 1179, 1126, 1084, 1060, 1033, 1004, 910, 836, 812, 785, 754, 732, 698, 661, 
573, 530, 473 cm-1 




(5.12j): Following General Procedure A-1, 0.115 g (0.50 mmol) of compound 5.1 was 
reacted with 0.302 g (1.50 mmol) 4-(2-bromoethyl)phenol in the presence of 0.006 g 
(0.050 mmol) of DMAP, 0.013 (0.050 mmol) of PPh3, and 0.019 g (0.050 mmol) of 













by flash chromatography using a gradient of 0–15% EtOAc in hexanes, furnishing 0.103 
g (46% yield) of desired compound 5.12j as a red oil. 
1H NMR (400 MHz, CDCl3): d 7.16 (d, J = 8.56 Hz, 2 H), 7.08 (d, J = 8.21 Hz, 2 H), 6.77 
(s, 2 H), 5.02 (td, J = 7.24, 3.11 Hz, 1 H), 3.86 (s, 6 H), 3.85 (s, 3 H), 3.54 (t, J = 7.49 Hz, 
2 H), 3.12 (t, J = 7.47 Hz, 2 H) 
13C NMR (126 MHz, CDCl3): d 153.2, 148.9 (t, J = 2.37 Hz), 138.5 (d, J = 1.63 Hz), 136.6, 
130.9, 129.8, 122.5 (t, J = 271.38 Hz), 121.9, 105.0, 74.4 (t, J = 31.77 Hz), 61.0, 56.3, 
38.7, 32.9 
19F NMR (376 MHz, CDCl3): d –81.56 (dd, J = 141.41, 7.45 Hz, 1 F), –81.99 (dd, J = 
141.40, 7.81 Hz, 1 F) 
IR (film): 3446, 2939, 2839, 2250, 1758, 1593, 1507, 1462, 1421, 1325, 1235, 1200, 
1125, 1064, 1019, 1002, 910, 831, 809, 764, 751, 731, 697, 646, 551, 531 cm-1 
HRMS (ESI–): calc. for C19H21BrF2O5Cl (M+Cl) 481.0229, found 481.0247, 3.7 ppm. 
 
General Procedure for the Cu-Catalyzed Selective Unsymmetric 
Dioxygenation of Difluoroalkenes with Phenols (B): 
An oven-dried one-dram vial, equipped with a magnetic stirbar, was charged with 





mmol). The system was purged with O2 gas for 1 min before anhydrous DCB (2.0 mL) 
was added to the system under a balloon of O2 gas. The system was sealed with a PTFE-
lined screw-top cap and stirred for 1 min at R.T. Subsequently, the vial was placed into a 
pre-heated reaction block and stirred vigorously at 100 °C for 24 h. The vial was cooled 
to R.T., and 10 µL (0.080 mmol) of TFT was added via microsyringe. The solution was 
diluted with approximately 1 mL of DCM and then stirred at R.T. for 10 min to allow 
adequate mixing. After mixing, an aliquot was removed from the vial and analyzed by 19F 






Experimental Procedures for Table 5-3: 
 
Following General Procedure B, 0.023 g (0.10 mmol) of 5.1 was reacted with 0.052 g 
(0.30 mmol) of 4-bromophenol in the presence of 0.050 mmol of acid and 0.012 g (0.010 
mmol) of Pt(PPh3)4 in 0.40 mL of DCB at 100 ˚C for 18 h. The reactions were cooled to 
R.T., and 10 µL (0.080 mmol) of TFT were added. The reactions were diluted with 2.0 mL 
of DCM, and allowed to stir for 5 min. An aliquot was removed and passed through a silica 




















































































































Experimental Procedures for Table 5-4: 
 
Following General Procedure B, 0.025 g (0.10 mmol) of 5.8c was reacted with 0.052 
g (0.30 mmol) of 4-bromophenol in the presence of 0.020 mmol of ligand and 0.004 g 
(0.010 mmol) of Pt(acac)2 in 0.40 mL of DCB at 140 ˚C for 18 h, with or without 0.003 g 












































































































TFT were added. The reactions were diluted with 2.0 mL of DCM, and allowed to stir for 
5 min. An aliquot was removed and passed through a silica gel plug to remove the Pt, 
and then analyzed by 19F NMR for completion, yield, and selectivity. 
 





























































































































































Following General Procedure B, 0.025 g (0.10 mmol) of 5.8c was reacted with 0.052 
g (0.30 mmol) of 4-bromophenol in the presence of 0.020 mmol of ligand and 0.020 mmol 
of copper salts in 0.40 mL of solvent at 120 ˚C for 18 h. The reactions were cooled to 
R.T., and 10 µL (0.080 mmol) of TFT were added. The reactions were diluted with 2.0 mL 
of DCM, and allowed to stir for 5 min. An aliquot was removed and passed through a silica 
gel plug to remove the Pt, and then analyzed by 19F NMR for completion, yield, and 
selectivity. 
 
Characterization of Compounds in Table 5-3, 5-4, and 5-5: 
 
2-(4-bromophenoxy)-2,2-difluoro-1-(3,4,5-trimethoxyphenyl)ethan-1-one (5.4):  
1H NMR (500 MHz, CDCl3): d 7.47 (s, 2 H), 7.24–7.20 (m, 4 H), 3.98 (s, 3 H), 3.93 (s, 6 
H) 














2-(4-bromophenoxy)-1-(dibenzo[b,d]thiophen-4-yl)-2,2-difluoroethan-1-one (5.10c):  
1H NMR (500 MHz, CDCl3): d 8.51 (dd, J = 7.74, 1.05 Hz, 1 H), 8.50–8.48 (m, 1 H), 8.25–
8.23 (m, 1 H), 7.99–7.97 (m, 1 H), 7.67 (t, J = 7.76 Hz, 1 H), 7.58–7.50 (m, 4 H), 7.21 (d, 
J = 8.97 Hz, 2 H) 
19F NMR (376 MHz, CDCl3): d –73.26 (s, 2 F) 
 
O
5.10c
S
F
F
Br
O
